
<html lang="en"     class="pb-page"  data-request-id="e8fc4d1a-9c74-4cb4-b82c-e40e6f9a3d92"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.9b00681;issue:issue:10.1021/jmcmar.2019.62.issue-15;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Development of Dual Chitinase Inhibitors as Potential New Treatment for Respiratory System Diseases" /></meta><meta name="dc.Creator" content="Marzena  Mazur" /></meta><meta name="dc.Creator" content="Barbara  Dymek" /></meta><meta name="dc.Creator" content="Robert  Koralewski" /></meta><meta name="dc.Creator" content="Piotr  Sklepkiewicz" /></meta><meta name="dc.Creator" content="Sylwia  Olejniczak" /></meta><meta name="dc.Creator" content="Marcin  Mazurkiewicz" /></meta><meta name="dc.Creator" content="Michał  Piotrowicz" /></meta><meta name="dc.Creator" content="Magdalena  Salamon" /></meta><meta name="dc.Creator" content="Karol  Jędrzejczak" /></meta><meta name="dc.Creator" content="Agnieszka  Zagozdzon" /></meta><meta name="dc.Creator" content="Wojciech  Czestkowski" /></meta><meta name="dc.Creator" content="Krzysztof  Matyszewski" /></meta><meta name="dc.Creator" content="Bartłomiej  Borek" /></meta><meta name="dc.Creator" content="Agnieszka  Bartoszewicz" /></meta><meta name="dc.Creator" content="Elżbieta  Pluta" /></meta><meta name="dc.Creator" content="Aleksandra  Rymaszewska" /></meta><meta name="dc.Creator" content="Witold  Mozga" /></meta><meta name="dc.Creator" content="Filip  Stefaniak" /></meta><meta name="dc.Creator" content="Paweł  Dobrzański" /></meta><meta name="dc.Creator" content="Karolina  Dzwonek" /></meta><meta name="dc.Creator" content="Jakub  Golab" /></meta><meta name="dc.Creator" content="Adam  Golebiowski" /></meta><meta name="dc.Creator" content="Jacek  Olczak" /></meta><meta name="dc.Description" content="Acidic mammalian chitinase (AMCase) and chitotriosidase-1 (CHIT1) are two enzymatically active proteins produced by mammals capable of cleaving the glycosidic bond in chitin. Based on the clinical ..." /></meta><meta name="Description" content="Acidic mammalian chitinase (AMCase) and chitotriosidase-1 (CHIT1) are two enzymatically active proteins produced by mammals capable of cleaving the glycosidic bond in chitin. Based on the clinical ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 10, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00681" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00681" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00681" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00681" /></link>
        
    
    

<title>Development of Dual Chitinase Inhibitors as Potential New Treatment for Respiratory System Diseases | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00681" /></meta><meta property="og:title" content="Development of Dual Chitinase Inhibitors as Potential New Treatment for Respiratory System Diseases" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0021.jpeg" /></meta><meta property="og:description" content="Acidic mammalian chitinase (AMCase) and chitotriosidase-1 (CHIT1) are two enzymatically active proteins produced by mammals capable of cleaving the glycosidic bond in chitin. Based on the clinical findings and animal model studies, involvement of chitinases has been suggested in several respiratory system diseases including asthma, COPD, and idiopathic pulmonary fibrosis. Exploration of structure–activity relationships within the series of 1-(3-amino-1H-1,2,4-triazol-5-yl)-piperidin-4-amines, which was earlier identified as a scaffold of potent AMCase inhibitors, led us to discover highly active dual (i.e., AMCase and CHIT1) inhibitors with very good pharmacokinetic properties. Among them, compound 30 was shown to reduce the total number of cells in bronchoalveolar lavage fluid of mice challenged with house dust mite extract after oral administration (50 mg/kg, qd). In addition, affinity toward the hERG potassium channel of compound 30 was significantly reduced when compared to the earlier reported chitinase inhibitors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00681"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00681">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00681&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00681&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00681&amp;href=/doi/10.1021/acs.jmedchem.9b00681" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 7126-7145</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00652" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00665" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Development of Dual Chitinase Inhibitors as Potential New Treatment for Respiratory System Diseases</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Marzena Mazur</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marzena Mazur</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">OncoArendi Therapeutics SA, Żwirki i Wigury 101, 02-089 Warsaw, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marzena++Mazur">Marzena Mazur</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Barbara Dymek</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Barbara Dymek</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">OncoArendi Therapeutics SA, Żwirki i Wigury 101, 02-089 Warsaw, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Barbara++Dymek">Barbara Dymek</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Robert Koralewski</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Robert Koralewski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">OncoArendi Therapeutics SA, Żwirki i Wigury 101, 02-089 Warsaw, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Koralewski">Robert Koralewski</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Piotr Sklepkiewicz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Piotr Sklepkiewicz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">OncoArendi Therapeutics SA, Żwirki i Wigury 101, 02-089 Warsaw, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Piotr++Sklepkiewicz">Piotr Sklepkiewicz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sylwia Olejniczak</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sylwia Olejniczak</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">OncoArendi Therapeutics SA, Żwirki i Wigury 101, 02-089 Warsaw, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sylwia++Olejniczak">Sylwia Olejniczak</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marcin Mazurkiewicz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marcin Mazurkiewicz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">OncoArendi Therapeutics SA, Żwirki i Wigury 101, 02-089 Warsaw, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marcin++Mazurkiewicz">Marcin Mazurkiewicz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michał Piotrowicz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michał Piotrowicz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">OncoArendi Therapeutics SA, Żwirki i Wigury 101, 02-089 Warsaw, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Micha%C5%82++Piotrowicz">Michał Piotrowicz</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7214-858X" title="Orcid link">http://orcid.org/0000-0001-7214-858X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Magdalena Salamon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Magdalena Salamon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">OncoArendi Therapeutics SA, Żwirki i Wigury 101, 02-089 Warsaw, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Magdalena++Salamon">Magdalena Salamon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Karol Jędrzejczak</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Karol Jędrzejczak</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">OncoArendi Therapeutics SA, Żwirki i Wigury 101, 02-089 Warsaw, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Karol++J%C4%99drzejczak">Karol Jędrzejczak</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Agnieszka Zagozdzon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Agnieszka Zagozdzon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">OncoArendi Therapeutics SA, Żwirki i Wigury 101, 02-089 Warsaw, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Agnieszka++Zagozdzon">Agnieszka Zagozdzon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wojciech Czestkowski</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wojciech Czestkowski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">OncoArendi Therapeutics SA, Żwirki i Wigury 101, 02-089 Warsaw, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wojciech++Czestkowski">Wojciech Czestkowski</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Krzysztof Matyszewski</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Krzysztof Matyszewski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">OncoArendi Therapeutics SA, Żwirki i Wigury 101, 02-089 Warsaw, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Krzysztof++Matyszewski">Krzysztof Matyszewski</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bartłomiej Borek</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bartłomiej Borek</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">OncoArendi Therapeutics SA, Żwirki i Wigury 101, 02-089 Warsaw, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bart%C5%82omiej++Borek">Bartłomiej Borek</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Agnieszka Bartoszewicz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Agnieszka Bartoszewicz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">OncoArendi Therapeutics SA, Żwirki i Wigury 101, 02-089 Warsaw, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Agnieszka++Bartoszewicz">Agnieszka Bartoszewicz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Elżbieta Pluta</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Elżbieta Pluta</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">OncoArendi Therapeutics SA, Żwirki i Wigury 101, 02-089 Warsaw, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=El%C5%BCbieta++Pluta">Elżbieta Pluta</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Aleksandra Rymaszewska</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Aleksandra Rymaszewska</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">OncoArendi Therapeutics SA, Żwirki i Wigury 101, 02-089 Warsaw, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Aleksandra++Rymaszewska">Aleksandra Rymaszewska</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Witold Mozga</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Witold Mozga</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">OncoArendi Therapeutics SA, Żwirki i Wigury 101, 02-089 Warsaw, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Witold++Mozga">Witold Mozga</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Filip Stefaniak</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Filip Stefaniak</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">OncoArendi Therapeutics SA, Żwirki i Wigury 101, 02-089 Warsaw, Poland</div><div class="loa-info-affiliations-info">Laboratory of Bioinformatics and Protein Engineering, International Institute of Molecular and Cell Biology in Warsaw, Ks. Trojdena 4, 02-109 Warsaw, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Filip++Stefaniak">Filip Stefaniak</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Paweł Dobrzański</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paweł Dobrzański</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">OncoArendi Therapeutics SA, Żwirki i Wigury 101, 02-089 Warsaw, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pawe%C5%82++Dobrza%C5%84ski">Paweł Dobrzański</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Karolina Dzwonek</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Karolina Dzwonek</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">OncoArendi Therapeutics SA, Żwirki i Wigury 101, 02-089 Warsaw, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Karolina++Dzwonek">Karolina Dzwonek</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jakub Golab</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jakub Golab</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">OncoArendi Therapeutics SA, Żwirki i Wigury 101, 02-089 Warsaw, Poland</div><div class="loa-info-affiliations-info">Department of Immunology, Medical University of Warsaw, Nielubowicza 5, 02-097 Warsaw, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jakub++Golab">Jakub Golab</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Adam Golebiowski</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Adam Golebiowski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">OncoArendi Therapeutics SA, Żwirki i Wigury 101, 02-089 Warsaw, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Adam++Golebiowski">Adam Golebiowski</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5960-2995" title="Orcid link">http://orcid.org/0000-0001-5960-2995</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Jacek Olczak</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jacek Olczak</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">OncoArendi Therapeutics SA, Żwirki i Wigury 101, 02-089 Warsaw, Poland</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#0e642061626d746f654e61606d616f7c6b606a67206d6163"><span class="__cf_email__" data-cfemail="056f2b6a69667f646e456a6b666a6477606b616c2b666a68">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jacek++Olczak">Jacek Olczak</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9932-2373" title="Orcid link">http://orcid.org/0000-0001-9932-2373</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00681&amp;href=/doi/10.1021%2Facs.jmedchem.9b00681" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 7126–7145</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 10, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>25 April 2019</li><li><span class="item_label"><b>Published</b> online</span>10 July 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 August 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00681" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00681</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7126%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMarzena%2BMazur%252C%2BBarbara%2BDymek%252C%2BRobert%2BKoralewski%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D15%26contentID%3Dacs.jmedchem.9b00681%26title%3DDevelopment%2Bof%2BDual%2BChitinase%2BInhibitors%2Bas%2BPotential%2BNew%2BTreatment%2Bfor%2BRespiratory%2BSystem%2BDiseases%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7145%26publicationDate%3DAugust%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00681"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1420</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">9</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00681" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Development of Dual Chitinase Inhibitors as Potential New Treatment for Respiratory System Diseases&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Marzena&quot;,&quot;last_name&quot;:&quot;Mazur&quot;},{&quot;first_name&quot;:&quot;Barbara&quot;,&quot;last_name&quot;:&quot;Dymek&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Koralewski&quot;},{&quot;first_name&quot;:&quot;Piotr&quot;,&quot;last_name&quot;:&quot;Sklepkiewicz&quot;},{&quot;first_name&quot;:&quot;Sylwia&quot;,&quot;last_name&quot;:&quot;Olejniczak&quot;},{&quot;first_name&quot;:&quot;Marcin&quot;,&quot;last_name&quot;:&quot;Mazurkiewicz&quot;},{&quot;first_name&quot;:&quot;Michał&quot;,&quot;last_name&quot;:&quot;Piotrowicz&quot;},{&quot;first_name&quot;:&quot;Magdalena&quot;,&quot;last_name&quot;:&quot;Salamon&quot;},{&quot;first_name&quot;:&quot;Karol&quot;,&quot;last_name&quot;:&quot;Jędrzejczak&quot;},{&quot;first_name&quot;:&quot;Agnieszka&quot;,&quot;last_name&quot;:&quot;Zagozdzon&quot;},{&quot;first_name&quot;:&quot;Wojciech&quot;,&quot;last_name&quot;:&quot;Czestkowski&quot;},{&quot;first_name&quot;:&quot;Krzysztof&quot;,&quot;last_name&quot;:&quot;Matyszewski&quot;},{&quot;first_name&quot;:&quot;Bartłomiej&quot;,&quot;last_name&quot;:&quot;Borek&quot;},{&quot;first_name&quot;:&quot;Agnieszka&quot;,&quot;last_name&quot;:&quot;Bartoszewicz&quot;},{&quot;first_name&quot;:&quot;Elżbieta&quot;,&quot;last_name&quot;:&quot;Pluta&quot;},{&quot;first_name&quot;:&quot;Aleksandra&quot;,&quot;last_name&quot;:&quot;Rymaszewska&quot;},{&quot;first_name&quot;:&quot;Witold&quot;,&quot;last_name&quot;:&quot;Mozga&quot;},{&quot;first_name&quot;:&quot;Filip&quot;,&quot;last_name&quot;:&quot;Stefaniak&quot;},{&quot;first_name&quot;:&quot;Paweł&quot;,&quot;last_name&quot;:&quot;Dobrzański&quot;},{&quot;first_name&quot;:&quot;Karolina&quot;,&quot;last_name&quot;:&quot;Dzwonek&quot;},{&quot;first_name&quot;:&quot;Jakub&quot;,&quot;last_name&quot;:&quot;Golab&quot;},{&quot;first_name&quot;:&quot;Adam&quot;,&quot;last_name&quot;:&quot;Golebiowski&quot;},{&quot;first_name&quot;:&quot;Jacek&quot;,&quot;last_name&quot;:&quot;Olczak&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;7126-7145&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00681&quot;},&quot;abstract&quot;:&quot;Acidic mammalian chitinase (AMCase) and chitotriosidase-1 (CHIT1) are two enzymatically active proteins produced by mammals capable of cleaving the glycosidic bond in chitin. Based on the clinical findings and animal model studies, involvement of chitinases has been suggested in several respiratory system diseases including asthma, COPD, and idiopathic pulmonary fibrosis. Exploration of structure–activity relationships within the series of 1-(3-amino-1H-1,2,4-triazol-5-yl)-piperidin-4-amines, which was earlier identified as a scaffold of potent AMCase inhibitors, led us to discover highly active dual (i.e., AMCase and CHIT1) inhibitors with very good pharmacokinetic properties. Among them, compound 30 was shown to reduce the total number of cells in bronchoalveolar lavage fluid of mice challenged with house dust mite extract after oral administration (50 mg/kg, qd). In addition, affinity toward the hERG potassium channel of compound 30 was significantly reduced when compared to the earlier reported chitinase &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00681&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00681" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00681&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00681" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00681&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00681" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00681&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00681&amp;href=/doi/10.1021/acs.jmedchem.9b00681" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00681" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00681" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00681%26sid%3Dliteratum%253Aachs%26pmid%3D31291098%26genre%3Darticle%26aulast%3DMazur%26date%3D2019%26atitle%3DDevelopment%2Bof%2BDual%2BChitinase%2BInhibitors%2Bas%2BPotential%2BNew%2BTreatment%2Bfor%2BRespiratory%2BSystem%2BDiseases%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D15%26spage%3D7126%26epage%3D7145%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (5)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/jmcmar.2019.62.issue-15/20190808/jmcmar.2019.62.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Acidic mammalian chitinase (AMCase) and chitotriosidase-1 (CHIT1) are two enzymatically active proteins produced by mammals capable of cleaving the glycosidic bond in chitin. Based on the clinical findings and animal model studies, involvement of chitinases has been suggested in several respiratory system diseases including asthma, COPD, and idiopathic pulmonary fibrosis. Exploration of structure–activity relationships within the series of 1-(3-amino-1<i>H</i>-1,2,4-triazol-5-yl)-piperidin-4-amines, which was earlier identified as a scaffold of potent AMCase inhibitors, led us to discover highly active dual (i.e., AMCase and CHIT1) inhibitors with very good pharmacokinetic properties. Among them, compound <b>30</b> was shown to reduce the total number of cells in bronchoalveolar lavage fluid of mice challenged with house dust mite extract after oral administration (50 mg/kg, qd). In addition, affinity toward the hERG potassium channel of compound <b>30</b> was significantly reduced when compared to the earlier reported chitinase inhibitors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61215" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61215" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Asthma is a chronic inflammatory disease that affects over 330 million people worldwide.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Despite availability of rapidly acting bronchodilators and anti-inflammatory drugs such as steroids, asthma remains an unmet medical need because of variable pathogenesis, side effects of current therapeutics, resistance to treatment developing in subsets of patients, and poor patients’ compliance to inhaled drugs.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> There is compelling evidence implicating type 2 immune response in development of asthma pathogenesis.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> A chronic pulmonary inflammation leads to development of airway hyperresponsiveness, airways remodeling, and fibrosis. Remarkably, an increasing number of studies report changes in the expression and activity of chitinases in patients with asthma<a onclick="showRef(event, 'ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7">(4−7)</a> and other chronic lung diseases.<a onclick="showRef(event, 'ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15">(8−15)</a> Chitinases are chitin-degrading enzymes that belong to the 18 glycosyl hydrolase family, which consists of two enzymatically active molecules (chitotriosidase [CHIT1] and acidic mammalian chitinase [AMCase]) as well as several chitinase-like proteins that lack enzymatic activity.<a onclick="showRef(event, 'ref4 ref7 ref12 ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref4 ref7 ref12 ref16 ref17 ref18 ref19">(4,7,12,16−19)</a> Chitinases were initially hypothesized to play a significant role in immune response modulation in asthma, owing to the observation that predominant aeroallergen sources, such as house dust mites (HDM), cockroaches and fungi, are chitin-containing organisms.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> However, several reports have clearly shown their critical role in facilitating the immune response and tissue repair processes in a chitin-independent manner. For example, both enzymes were shown to actively participate in interleukin-13-driven development of type 2 immune response in asthma<a onclick="showRef(event, 'ref7 ref16 ref21'); return false;" href="javascript:void(0);" class="ref ref7 ref16 ref21">(7,16,21)</a> or tissue repair in pulmonary fibrosis<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> in animal models induced by non-chitin containing insults, such as ovalbumin (OVA) and bleomycin.</div><div class="NLM_p">AMCase is produced by lung epithelial cells and macrophages at sites of Th2 inflammation in animal models of asthma, induced by HDM, <i>Aspergillus</i> sp., OVA, and IL-13.<a onclick="showRef(event, 'ref7 ref20 ref22'); return false;" href="javascript:void(0);" class="ref ref7 ref20 ref22">(7,20,22)</a> Moreover, this enzyme is believed to be the dominant true chitinase in mouse lungs.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> AMCase expression and activity was mostly described to modulate the type 2 immune response in mouse models of asthma<a onclick="showRef(event, 'ref7 ref16 ref17 ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref7 ref16 ref17 ref20 ref21 ref22 ref23">(7,16,17,20−23)</a> and was linked to human asthma pathogenesis.<a onclick="showRef(event, 'ref5 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref7">(5,7)</a> However, the increase in overall chitinolytic activity observed in the lungs of patients with chronic and interstitial lung diseases has recently been mostly attributed to CHIT1 enzymatic activity.<a onclick="showRef(event, 'ref6 ref8 ref11 ref12 ref13 ref14 ref15 ref24'); return false;" href="javascript:void(0);" class="ref ref6 ref8 ref11 ref12 ref13 ref14 ref15 ref24">(6,8,11−15,24)</a></div><div class="NLM_p">Studies in animal models revealed that CHIT1 deficiency results in decreased TGFβ and IL-13-driven fibrotic responses in the lungs.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Also, other observations support the central role of CHIT1 in human lungs and in expanding spectrum of human lungs disorders ranging from asthma throughout granulomatous diseases such as sarcoidosis<a onclick="showRef(event, 'ref11 ref12 ref13 ref18'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref18">(11−13,18)</a> and tuberculosis<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> to interstitial lung fibrosis.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> All these observations suggest that dual chitinase inhibition could potentially be considered as the therapeutic strategy not only for asthma patients, where AMCase is considered to be a crucial modulator of Th2 inflammatory response, but also for chronic interstitial lung diseases dominated by chronic inflammation and ongoing pulmonary fibrosis.</div><div class="NLM_p last">Our group has recently described compound <b>3b</b><a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> that displays AMCase versus CHIT1 selectivity (150-times and 15-times in murine and human enzymes, respectively), has a good pharmacokinetic profile in mice, and shows significant anti-inflammatory efficacy in the HDM-induced asthma model after oral administration. Starting from compound <b>3b</b>, we sought to identify a dual specificity inhibitor targeting both chitinases simultaneously and which is capable of ameliorating both pulmonary inflammation and bronchial fibrosis.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12626" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12626" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We have previously reported<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> that shifting the position of the central nitrogen atom from the piperazine ring to the 4-aminopiperidine system in a moderately potent dual chitinase inhibitor (compound <b>1</b>), discovered by the Wyeth group (Wyeth 1, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>),<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> led to a significant, over 1 order of magnitude increase in the inhibitory potency against both chitinases (compound <b>2</b>, R = Me). Initial exploration of SAR revealed, however, that increasing the size of the hydrophobic substituent on the central nitrogen atom exemplified by compounds <b>3a</b> and <b>3b–d</b> leads to a further increase in potency against hAMCase, but not hCHIT1.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Early optimization of Wyeth 1—moderately potent dual chitinase inhibitor (replacement of bromine by the chlorine atom in the phenyl ring has no major impact on inhibitory potency).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Examination of the published X-ray structures of complexes of hCHIT1 and hAMCase with their small-molecule inhibitors<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> indicated that the active sites of both enzymes are very similar and differ by only two amino acids: Met300 and Arg269 in hCHIT1 are replaced by Ile300 and His269 in hAMCase. Our previously reported compounds bind to the acidic binding site of the enzymes through the network of the hydrogen bonds between 3-aminotriazole moiety and Tyr27, Asp138, and Glu140 residues.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Critical for the high activity of those inhibitors is the salt bridge (length of 2.8 Å) between the central basic nitrogen of the 4-aminopiperidine fragment and carboxylic group of Asp213. The hydrophobic interactions of the <i>para</i>-halogenated phenethyl group and hydrophobic pocket created by Tyr267, Glu297, and Met300 (hCHIT1) or Ile300 (hAMCase) residues appear to be well optimized. As shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, with enlargement of the size of the hydrophobic substituent on the central nitrogen atom from methyl to isobutyl or (ring-substituted)benzyl, the inhibitory activity against hAMCase is increased by 2 orders of magnitude, while no analogous effect is observed for hCHIT1. We hypothesized that the key factor determining this high activity against hAMCase are the hydrophobic interactions of the aliphatic substituent with Ile300 and His269 in the enzyme binding pocket. On the other hand, such a bulky N-substituent causes the steric clash with the positively charged, guanidine-containing Arg269 side chain in hCHIT1, which is reflected in no activity gain.</div><div class="NLM_p">Another difference between the analyzed structures was the orientation of Trp99 side chain. While in the hAMCase-compound <b>1</b> complex (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RM4">3RM4</a>) the indole ring of this amino acid residue is directed slightly outside of the binding pocket (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A), it is directed toward the pocket in hCHIT1 complexed with compound <b>3a</b> (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NRA">5NRA</a>; <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). As this residue plays an important role in binding of both the oligosaccharide substrate and small-molecule inhibitors, we performed analysis of the experimentally solved structures of hAMCase (see: Figure S5 in <a href="/doi/suppl/10.1021/acs.jmedchem.9b00681/suppl_file/jm9b00681_si_001.pdf" class="ext-link">Supporting Information</a>). In six structures, both apo and with ligands, the Trp99 side chain is placed in the same position as in the hAMCase-compound <b>1</b> complex. In one complex (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RM9">3RM9</a>), Trp99 can adopt a double conformation and only in one case (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RM8">3RM8</a>), the Trp99 is in the same position as in hCHIT1 complexed with compound <b>3b</b>. It may be concluded that although for hAMCase, the Trp99 side chain may adopt both conformations, the preferred state is toward outside of the binding pocket. It is also not fully clear what structural features of the ligand induce the flip of this residue.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Docking of compound <b>2</b> to the binding pocket of hAMCase (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RM4">3RM4</a><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a>) and (B) structure of the hCHIT1–compound <b>2</b> complex (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NR8">5NR8</a>). For ligands, carbon atoms are colored in green, nitrogen atoms in blue, oxygen atoms in red, sulfur atoms in yellow, and bromine atoms in dark red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In order to design the equally active inhibitor for these two enzymes, during optimization of the structure of compound <b>2</b>, we explored only these fragments of the binding pockets, which are conserved among binding sites of both proteins. Therefore, our initial design strategy to improve interactions of the inhibitor molecule with the hCHIT1 active site (while maintaining high hAMCase affinity) was based on the introduction of the small N-substituents containing polar functional groups that might be capable of creating the additional binding interactions with the guanidine moiety of Arg269 in hCHIT1. Such an approach was also driven by the fact that our first-generation inhibitors displayed considerable activity against the hERG potassium channel and dopamine and serotonin transporters.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> While we realized that the presence of the central basic nitrogen atom and the phenethylamine fragment are the possible structural features of our inhibitors that trigger those two off-targets activities, we also assumed that we could not afford losing the strong interaction between the central amine and the Asp213 residue and therefore decided that this structural motif would be kept intact. On the other hand, it is known from the previous studies<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> that implementation of a polar fragment into the peripheral part of the inhibitor resulting in the overall decrease of the lipophilicity of the final molecule oftentimes attenuates interaction with the hERG potassium channel. In a similar manner, introduction of the alkoxy/hydroxyl group at the β-position with respect to the amino group, causing reduction of its basicity, could provide yet another measure of destabilizing interactions with hERG. We also hoped that the presence of the polar moiety in the inhibitor molecule would help to reduce the monoamine transporters’ off-target activity.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> First Approach—Compounds With Small N-Substituents Containing Polar Groups</h3><div class="NLM_p">As seen in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, introduction of the carboxylic group (compound <b>4</b>) led to a significant decrease in activity against both human chitinases in comparison with the parent compound <b>2</b>. Amidation of the carboxylic group (compound <b>5</b>) partially restored the inhibitory potency against hAMCase, but the activity versus hCHIT1 remained at over 1 μM level. Reversal of the sequence of the amide fragment (compound <b>6</b>) and especially replacement of the acetyl group with the methanesulfonyl group (compound <b>7</b>) led to a further increase in activity versus hAMCase with only marginal improvement of hCHIT1 inhibitory potency. Sulfonamide <b>8</b> exhibited an analogous profile as its parent counterpart <b>7</b>, but introduction of the <i>N</i>-methylcarbamoyl moiety effected in a significantly less active inhibitor (compound <b>9</b>). In contrast to analogs <b>5–8</b> that were either hAMCase-selective inhibitors or only moderately active dual inhibitors (compounds <b>4</b> and <b>9</b>), compound <b>10</b> containing the hydroxyethyl group on the central nitrogen atom displayed only ca. 3-fold hAMCase/hCHIT1 selectivity and reasonable activity against both enzymes (IC<sub>50</sub> 111 and 384 nM, respectively). Methylation of the hydroxyl group provided compound <b>11</b> that approached the desired dual inhibitor profile even more closely. Introduction of additional methyl groups of the defined stereochemistry into the hydroxy/methoxyethyl substituent (analogs <b>12–15</b>) resulted in general in no positive impact on the inhibitory activity with the exception of compound <b>15</b> (IC<sub>50</sub> 103 and 44 nM against hAMCase and hCHIT1, respectively). It is worth noting that the low hERG inhibition of analog <b>15</b> was achieved by quite minor structural change (as compared to the parent compound <b>11</b>: IC<sub>50</sub> 17.6 μM vs 2.8 μM respectively). However, 20-fold selectivity in murine enzymes and 33% inhibition at 10 μM of dopamine transporter (DAT) appeared to be serious shortcomings of compound <b>15</b>. Adding one more methyl group afforded compounds <b>16</b> and <b>17</b> displaying distinct AMCase-selectivity both in human and murine enzymes. Similar selectivity was found for oxetane-containing inhibitor <b>18</b>, while, conversely, the other two compounds (<b>19</b> and <b>20</b>) incorporating the cyclic ether moieties (tetrahydrofuran and tetrahydropyran respectively) showed very promising potency against both human proteins. However, these two analogs suffered from the undesired mAMCase-selectivity and were quite active against both off-targets investigated.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structure–Activity Relationship of the Series of Polar Group-Containing Inhibitors<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0017.gif" alt="" id="GRAPHIC-d7e719-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0018.gif" alt="" id="gr17" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> data of each compound were determined in 2–3 independent assays, and mean IC<sub>50</sub> ± SD values are shown in the table. Cmpd, abbreviation of compound. SD, standard deviation.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Data from Predictor hERG fluorescence polarization assay.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Data from DAT human dopamine transporter binding (antagonist radioligand) assay, Cerep.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></p></div></div><div></div></div><div class="NLM_p">It is worth noting that while we were able to achieve good activity against three out of four enzymes tested, even best compounds of this series (analogs <b>11</b>, <b>19</b>, and <b>20</b>) only moderately inhibited murine CHIT1. As no crystal structures of the murine chitinases are known, we compared their sequences and three-dimensional models of binding pockets in order to explain observed differences in activities of our inhibitors between human and murine enzymes.</div><div class="NLM_p">With regard to AMCase, the only differences within binding pockets observed on the structural level between human and murine proteins are residues 297 (Glu for human and Gln for murine) and 300 (Ile and Phe, respectively). Glu and Gln are similar in size, and they may form analogous interactions with the ligand. Ile and Phe are both hydrophobic amino acids, and despite Phe being more bulky, its rotation allows for accommodation of even relatively big substituents (like tetrahydrofuran and tetrahydropyran fragments in compounds <b>19</b> and <b>20</b>).</div><div class="NLM_p last">Human and murine CHIT1 binding pockets differ in residues at the same positions as in AMCase. Residue 297 is Glu for human enzyme and Asp for murine protein, and residue 300 is Met and Val, respectively. The observed lower activity of our compounds against mCHIT1 may indicate importance of interactions of Met300 of human protein with the haloaromatic ring of inhibitors. Also, while formation of the hydrogen bonds between ligands and Glu297 of human enzymes could be predicted by molecular modeling, it appears that the carboxylic group of Asp297 in mCHIT1 is too distant to form this type of interactions with inhibitors.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Second Approach—Conformationally Constrained Compounds with Oxygen Atom Containing Functionality in the Beta-Position with Respect to the Central Amine Group</h3><div class="NLM_p">Analysis of the crystallographic structures of complexes of hCHIT1 with inhibitors <b>2</b> and <b>3a</b> supported by molecular modeling studies indicated that two linear substituents present on the central nitrogen atom in all of the analogs we synthesized so far could be joined one to another to form new four-, five-, or six-membered ring (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). We predicted that for both human chitinases, the binding mode of the resulting compounds would be similar to their noncyclic analogs. The calculated binding score values suggested that the benzylic position as the site of cyclization, resulting in considerably constrained 3-aryl-substituted nitrogen-containing heterocycle, is slightly preferred (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). However, the alternative mode of cyclization at the homo-benzylic position (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B), while providing less effective conformational constraint, allowed for better alignment of the benzyl fragment to the hydrophobic pockets of the enzymes.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Two possible modes of cyclization of two linear N-substituents leading to (A) more and (B) less rigidified (4-chlorophenyl)-<i>N</i>-heterocycles.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">3-(4-Chlorophenyl)pyrrolidine and 3-(4-chlorophenyl)piperidine required for the synthesis of the more conformationally constrained inhibitors were commercially available, which prompted us to synthesize the corresponding analogs in their racemic forms. On the other hand, the 2-(4-chlorobenzyl)pyrrolidine and 2-(4-chlorobenzyl)piperidine required for the synthesis of more flexible inhibitors had to be synthesized. Careful examination of the experimentally solved structure of hCHIT1 complexed with compound <b>2</b> (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NR8">5NR8</a>) clearly indicated that only one of the enantiomers can fulfill the constraints of the binding site (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), and thus, we decided to prepare these cyclic amines in the optically pure form.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Binding site of hCHIT1 complexed with compound <b>2</b> (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NR8">5NR8</a>); homobenzylic hydrogens marked as H<sub>A</sub> and H<sub>B</sub>. H<sub>A</sub> can be substituted by the incoming alkyl linker joining the homobenzylic position with the <i>N</i>-methyl group (the resulting 2-(4-chlorobenzyl)pyrrolidine of the <i>R</i> configuration shown). On the other hand, H<sub>B</sub> cannot be displaced in the same way without disrupting conformation of the <i>p</i>-halophenetyl substituent.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As seen in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, comparison of the biochemical potencies of inhibitors containing 3-(4-chlorophenyl)-substituted N-heterocycles (compounds <b>21</b> and <b>22</b>) with more conformationally flexible analogues <b>23</b> and <b>24</b> clearly indicated the favored mode of cyclization. Introduction of the 3-(4-chlorophenyl)pyrrolidine fragment resulted in poorly active compound <b>21</b> (IC<sub>50</sub> 6 and 19.5 μM vs hAMCase and hCHIT1, respectively), and the 3-(4-chlorophenyl)piperidine moiety provided only modest improvement of activity against both human chitinases. On the other hand, analogue <b>23</b>, and especially <b>24</b>, approached the targeted in vitro pharmacological profile very closely, being potent, non-selective chitinases inhibitors against both human and murine enzymes. However, the single-digit micromolar level of hERG inhibition displayed by those two compounds was perceived as a serious disadvantage and the introduction of the oxygen-containing functionality placed in the β-position with respect to the amino functionality was attempted as a countermeasure to this undesired side activity. The first attempt was not very successful, as the 2-(4-chlorobenzyl)-3-methoxyazetidine containing compound <b>25</b> not only was the most potent hERG inhibitor we synthesized, but also its inhibitory activities against chitinases were greatly diminished. Conversely, introduction of oxygen-containing functionality into position 4 of the pyrrolidine ring provided analogs <b>26–29</b>, whose inhibition ability of chitinases was (regardless the configuration of the additional chiral center) retained by a larger part, while their hERG activity was significantly attenuated. The in vitro pharmacological profile of the best compound of this series <b>28</b> was further improved two-fold, by replacement of the 2-(4-chlorobenzyl)-4-hydroxypyrrolidine fragment with 2-(4-chlorobenzyl)morpholine resulting in inhibitor <b>30</b> that displayed only two- and four-fold selectivity AMCase versus CHIT1 in murine and human enzymes, respectively. The so obtained analog <b>30</b> represented the optimum combination of structural features to achieve the desired dual inhibition both in human and murine enzymes, while maintaining acceptable hERG channel affinity level of 39 μM, and therefore meeting the selected criteria of the primary pharmacological parameters and justifying its further in vitro and in vivo profiling.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Structure–Activity Relationship of the Conformationally Constrained Analogs<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0019.gif" alt="" id="GRAPHIC-d7e900-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0020.gif" alt="" id="gr18" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> data of each compound were determined in 2–3 independent assays, and mean IC<sub>50</sub> ± SD values are shown in the table. Cmpd, abbreviation of compound. SD, standard deviation.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Data from Predictor hERG fluorescence polarization assay.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Data from DAT human dopamine transporter binding (antagonist radioligand) assay, Cerep.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">p<i>K</i><sub>a</sub> values were calculated online using <a href="http://chemicalize.com" class="ext-link">chemicalize.com</a> freeware by ChemAxon.</p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">Measured values.</p></div></div><div></div></div><div class="NLM_p">Because lowering of lipophilicity and basicity of the compound is considered to be the method of controlling the inhibition of the hERG channel, the p<i>K</i><sub>a</sub> values were calculated and log <i>D</i><sub>7.4</sub> values were measured for the most interesting compounds (<b>23–30</b>). Unfortunately, based on this valuation, no simple conclusions could be drawn in relation to how these parameters affect the affinity of our inhibitors for hERG. Two compounds of comparable (and low-p<i>K</i><sub>a</sub> of ca. 7.5) basicity of the central amine, <b>25</b> and <b>30</b>, were the most potent (IC<sub>50</sub> 0.34 μM) and second least potent (IC<sub>50</sub> 39 μM) hERG inhibitors, respectively, spanning over 2 orders of magnitude of activity. Also a pair of stereoisomers, compounds <b>26</b> and <b>28</b>, sharing the same calculated value of p<i>K</i><sub>a</sub>, showed significant, 4-fold, difference in hERG activity (IC<sub>50</sub> 13.2 and 55 μM, respectively). Lipophilicity of the inhibitors within this series of analogues spanned only 1.3 unit of magnitude (log <i>D</i><sub>7.4</sub> = 0.68 for <b>28</b> and log <i>D</i><sub>7.4</sub> = 1.96 for <b>30</b>; solubility of compound <b>30</b> in water was measured to be 0.31 mg/mL), so the significant variability of impact of this parameter on the hERG inhibition should not be expected. Nevertheless, it was these two compounds that proved to be the best and the second best analogs, respectively, in terms of avoiding the potassium channel binding.</div><div class="NLM_p last">In summary, it can be concluded that the structural factors rather than the physicochemical properties govern the activity against hERG in this series of the conformationally constrained chitinase inhibitors.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Pharmacokinetic and Anti-Inflammatory Effects of Compound <b>30</b></h3><div class="NLM_p">Good oral bioavailability of compound <b>30</b> and low clearance provided sufficient exposure for efficacy examination following once daily oral administration in mice (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). The considerably higher clearance value in rats (accompanied by still very good bioavailability, though) suggests that more frequent dosing of inhibitor <b>30</b> may be required for in vivo studies in higher species.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Plasma total concentration–time course for compound <b>30</b> after 3 mg/kg IV bolus and after 10 mg/kg oral administration (PO) to female BALB/c mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vivo Pharmacokinetic Profile of Compound <b>30</b> in Mice and Rats after 3 mg/kg IV and 10 mg/kg PO Administration</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">mouse IV</th><th class="colsep0 rowsep0" align="center">mouse PO</th><th class="colsep0 rowsep0" align="center">rat IV</th><th class="colsep0 rowsep0" align="center">rat PO</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–inf</sub> (mg h/L)</td><td class="colsep0 rowsep0" align="left">4.76</td><td class="colsep0 rowsep0" align="left">11.1</td><td class="colsep0 rowsep0" align="left">4.98</td><td class="colsep0 rowsep0" align="left">8.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (mg/L)</td><td class="colsep0 rowsep0" align="left">1.59</td><td class="colsep0 rowsep0" align="left">2.39</td><td class="colsep0 rowsep0" align="left">16.5</td><td class="colsep0 rowsep0" align="left">1.56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">10.5</td><td class="colsep0 rowsep0" align="left">n/a</td><td class="colsep0 rowsep0" align="left">33.7</td><td class="colsep0 rowsep0" align="left">n/a</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">2.50</td><td class="colsep0 rowsep0" align="left">2.68</td><td class="colsep0 rowsep0" align="left">7.95</td><td class="colsep0 rowsep0" align="left">2.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="left">n/a</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">n/a</td><td class="colsep0 rowsep0" align="left">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="left">n/a</td><td class="colsep0 rowsep0" align="left">70</td><td class="colsep0 rowsep0" align="left">n/a</td><td class="colsep0 rowsep0" align="left">48</td></tr></tbody></table></div></div><div class="NLM_p">Compound <b>30</b> passed the test for potential genotoxicity (AMES test<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> was negative) and was evaluated in the Cerep Diversity Panel<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> in order to identify the possible off-target activities. The hERG potassium channel was found to be inhibited with IC<sub>50</sub> of 12 μM in the automated patch-clamp assay,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and also considerable DAT inhibition was revealed showing IC<sub>50</sub> of 7.9 and 0.3 μM in DAT cell-based assay<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> and DAT radioligand binding assay,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> respectively. This result prompted us to study the plasma and brain concentration of inhibitor <b>30</b> following oral administration in mice in the context of possible occurrence of the CNS-related side-effects. By comparison of AUCs in plasma and brain, it was found that approximately 6.8% of <b>30</b> crosses the blood–brain barrier approaching the DAT IC<sub>50</sub> radioligand assay value during first 2 h after administration (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Plasma and brain total concentrations of <b>30</b> after 10 mg/kg oral administration in female BALB/c mice compared to the observed off-target activities.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A common, clinically relevant aeroallergen–HDM extract was used to induce allergic airway inflammation in C57BL/6 mice which was represented by the increased CD45-positive leukocytes influx to the lungs and chitinolytic activity in bronchoalveolar lavage fluid (BALf) of mice challenged with HDM as compared to phosphate buffered saline (PBS) challenged mice (control group) (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). Oral administration of compound <b>30</b> (50 mg/kg, qd) starting from day 7 after the beginning of the HDM challenge led to a significant reduction of the total CD45-positive leukocyte number (37%) as compared to the HDM vehicle group.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Dual AMCase/CHIT1 inhibition with compound <b>30</b> results in significant anti-inflammatory effects in the HDM-induced asthma mouse model. Flow cytometry analysis of total infiltrating leukocytes numbers in BALf recovered from naive mice challenged with PBS or HDM with or without compound <b>30</b> (50 mg/kg; PO; qd) or dexamethasone (10 mg/kg, IP, qd) treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Molecular docking of <b>30</b> to binding pockets of hAMCase and hCHIT1 (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A,C and B,D, respectively) revealed that the morpholine ring is indeed too distant to interact with residues at positions 269 and 300. The interaction network formed by the 2-aminotriazole ring of <b>30</b> in both proteins is analogous to that described earlier:<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> direct hydrogen bonds are formed with Tyr27 and Asp138 and the water-mediated hydrogen bond is possibly formed with Glu140. The heterocyclic ring is further stabilized by the Met−π interaction formed by Met210. Similar to the earlier described structures of hCHIT1 complexes with compounds <b>2</b> and <b>3a</b>, the nitrogen of the central 4-aminopiperidine ring may form the hydrogen bond with Asp213; however, in the hCHIT1–<b>30</b> and hAMCase–<b>30</b> complexes, the distances between the carboxylic group of aspartic acid residue and the amino group of the ligand appear to be longer (3.7 and 3.5 Å respectively). The 4-Chlorobenzyl fragment is located within the hydrophobic pocket formed by Leu362, Ala302, Leu301, Tyr267 (in both enzymes), Ile300 (hAMCase), and Met300 (hCHIT1) residues. This last residue may further stabilize the phenyl ring by Met−π interaction in the hCHIT1 binding pocket. The oxygen atom in the morpholine ring of <b>30</b> may also form a weak hydrogen bond with Trp99 of hCHIT1 and also in hAMCase, provided that the side chain of this residue is directed toward the binding pocket (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>C).</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Compound <b>30</b> docked to the hAMCase [PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RM4">3RM4</a>, panes (A,C)] and hCHIT1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NR8">5NR8</a>, panes (B,D)) binding pockets. Upper panes (A,B) show key residues forming the binding pockets of both proteins. Bottom panes (C,D) show a sphere representation of binding pockets of proteins; distinct residues (269 and 300) and Trp99 are shown as sticks. For ligands, carbon atoms are colored in green, nitrogen atoms in blue, oxygen atoms in red, and sulfur atoms in yellow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Synthesis</h3><div class="NLM_p">Synthesis of analogs <b>4–20</b> was accomplished in a similar fashion as described previously<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> for compounds <b>2</b>, <b>3a</b>, and <b>3b</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). <i>N</i>-Boc-4-piperidone <b>31</b> was reductively aminated with a set of commercially available primary amines, and the resulting intermediate amines were in situ subjected to the second reductive alkylation with 4-chlorophenylacetaldehyde to provide compounds <b>32a–q</b>. Acidic deprotection of the piperidine followed by a two-step 3-aminotriazole ring formation completed synthesis of the target compounds. An additional step of the hydrolysis of the methyl ester was required for the synthesis of compound <b>4</b>.</div><figure id="sch1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of Compounds <b>4–20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) R<sub>1</sub>–NH<sub>2</sub>, NaBH(OAc)<sub>3</sub>, DCE, rt; then (b) 4-chlorophenylacetaldehyde, NaBH(OAc)<sub>3</sub>, DCE, rt, 45–88% over 2 steps (c) HCl, AcOEt, rt; (d) <i>S</i>,<i>S</i>′-dimethyl <i>N</i>-cyanodithioiminocarbonate, K<sub>2</sub>CO<sub>3</sub>, MeCN, 82 °C; (e) hydrazine, MeCN, 82 °C, 15–55% over 3 steps; (f) NaOH, H<sub>2</sub>O, reflux, 10%.</p></p></figure><div class="NLM_p">Analogues <b>21</b> and <b>22</b> were prepared in a straightforward manner from commercially available racemic 3-(4-chlorophenyl)pyrrolidine and 3-(4-chlorophenyl)piperidine, respectively, by the reductive amination of <i>N</i>-Boc-4-piperidone that yielded intermediates <b>34</b> and <b>35</b>. N-deprotection and 3-aminotriazole ring installation afforded the final analogues (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Analogues <b>21</b> and <b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 3-(4-chlorophenyl)pyrrolidine (for <b>34</b>) or 3-(4-chlorophenyl)piperidine (for <b>35</b>), NaBH(OAc)<sub>3</sub>, AcOH, DCE, rt, 45 and 23% for <b>34</b> and <b>35</b>, respectively; (b) HCl, AcOEt, rt; (c) <i>S</i>,<i>S</i>′-dimethyl <i>N</i>-cyanodithioiminocarbonate, K<sub>2</sub>CO<sub>3</sub>, MeCN, 82 °C; (d) hydrazine, MeCN, 82 °C, 55 and 14% over 3 steps for <b>21</b> and <b>22</b>, respectively.</p></p></figure><div class="NLM_p">The syntheses of compounds <b>23–30</b> required the prerequisite cyclic secondary amines that would be incorporated into the molecules of the final inhibitors to be prepared. Accordingly, Boc-<span class="smallcaps smallerCapital">d</span>-proline <b>36</b> was coupled with <i>N</i>,<i>O</i>-dimethylhydroxylamine, and the resulting Weinreb amide <b>37</b> was reacted with 4-chlorophenyl magnesium bromide affording ketone <b>38</b> that was reduced with concomitant removal of the Boc-group by treatment with the AlCl<sub>3</sub>/Et<sub>3</sub>SiH system to give the desired (<i>S</i>)-2-(4-chlorobenzyl)pyrrolidine <b>39</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of (<i>R</i>)-2-(4-Chlorobenzyl)pyrrolidine <b>39</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HN(Me)OMe, CDI, DCM, rt, 52%; (b) 4-chlorophenymagnesium bromide, Et<sub>2</sub>O, −70 °C to rt, 69%; (c) AlCl<sub>3</sub>, Et<sub>3</sub>SiH, DCM, 0 °C to rt, 99%; (d) <i>N</i>-Boc-piperid-4-one, NaBH(OAc)<sub>3</sub>, AcOH, DCE, rt, 45%; (e) HCl, AcOEt, rt; (f) <i>S</i>,<i>S</i>′-dimethyl <i>N</i>-cyanodithioiminocarbonate, K<sub>2</sub>CO<sub>3</sub>, MeCN, 82 °C; (g) hydrazine, MeCN, 82 °C, 39% over 3 steps.</p></p></figure><div class="NLM_p">(<i>S</i>)-2-Methyl-2-propanesulfinamide <b>40</b> was condensed with 4-chlorophenylacetaldehyde providing sulfinimine <b>41</b>, to which allyl Grignard reagent was added yielding sulfinamide <b>42</b>. The nitrogen atom was deprotonated with sodium hydride followed by allylation with allyl bromide, and the resulting diene <b>43</b> was subjected to the ring-closing metathesis reaction using the Grubbs catalyst (first generation). Hydrogenation of the double bond in the resulting (<i>R</i>)-6-(4-chlorobenzyl)-3,4-dehydropiperidine <b>44</b> followed by the removal of the <i>tert</i>-butyl sulfonamide group in acidic conditions from intermediate <b>45</b> completed the synthesis of (<i>R</i>)-2-(4-chlorobenzyl)piperidine <b>46</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).</div><figure id="sch4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of (<i>R</i>)-2-(4-Chlorobenzyl)piperidine <b>46</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 4-chlorophenylacetaldehyde, Ti(OEt)<sub>4</sub>, DCM, reflux, then rt; (b) allylmagnesium bromide, −20 °C to rt, 23% over two steps; (c) allyl bromide, NaH, DMF, rt, 71%; (d) Grubbs catalyst first generation, DCM, reflux, 94%; (e) H<sub>2</sub>, Pd/C (cat.), MeOH, rt, 77%; (f) HCl, MeOH, rt, 72%.</p></p></figure><div class="NLM_p">Boc-<span class="smallcaps smallerCapital">l</span>-(4-chloro)phenylalanine <b>47</b> was transformed into the corresponding α-diazoketone <b>48</b> via reaction of the preformed mixed anhydride with an excess of diazomethane. Rhodium acetate-catalyzed cyclization afforded <i>S</i>-2-(4-chlorophenyl)azetidinone <b>49</b> that was stereoselectively reduced to the secondary alcohol <b>50</b> (stereoselectivity > 10:1; minor isomer was rejected by crystallization from an ethyl acetate/hexanes mixture, ca. 1:5 ratio; the configuration of the newly created chiral center was confirmed by single-crystal X-ray diffraction—see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00681/suppl_file/jm9b00681_si_001.pdf" class="ext-link">Supporting Information</a>). Williamson etherification of the hydroxyl group and removal of the <i>N</i>-Boc protection from intermediate <b>51</b> afforded the desired azetidine <b>52</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>).</div><figure id="sch5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of (2<i>S</i>,3<i>S</i>)-2-(4-Chlorobenzyl)-3-methoxyazetidine <b>52</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) methyl chloroformate, Et<sub>3</sub>N, THF, −15 °C, then CH<sub>2</sub>N<sub>2</sub> solution in Et<sub>2</sub>O, −30 °C to rt, 96%; (b) Rh<sub>2</sub>(OAc)<sub>4</sub> (0.5% mol), Et<sub>3</sub>N (1% mol), DCM, 0 °C to rt, 46%; (c) NaBH<sub>4</sub>, MeOH, 0 °C to rt, 86%; (d) NaH, MeI, DMF, rt, 100%; (e) HCl, 1,4-dioxane, rt, 77%.</p></p></figure><div class="NLM_p">Fully protected Weinreb amides <b>55</b> and <b>61</b> were prepared in few straightforward synthetic steps starting from commercially available <i>trans</i>- and <i>cis</i>-<span class="smallcaps smallerCapital">d</span>-4-hydroxyproline derivatives <b>53</b> and <b>58</b>, respectively, and reacted with 4-chlorophenyl magnesium bromide yielding ketones <b>56</b> and <b>62</b>. Reduction of carbonyl groups in strongly acidic conditions accompanied by concomitant removal of protecting groups afforded the desired (2<i>S</i>,4<i>S</i>)-2-(4-chlorobenzyl)-4-hydroxypyrrolidine <b>57</b> and (2<i>S</i>,4<i>R</i>)-2-(4-chlorobenzyl)-4-hydroxypyrrolidine <b>63</b> (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>).</div><figure id="sch6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of (2<i>S</i>,4<i>S</i>)-2-(4-Chlorobenzyl)-4-hydroxypyrrolidine <b>57</b> and (2<i>S</i>,4<i>R</i>)-2-(4-Chlorobenzyl)-4-hydroxypyrrolidine <b>63</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HN(Me)OMe, CDI, DCM, rt, 49% for <b>54</b>, 67% for <b>61</b>; (b) TBSCl, imidazole, DMF, rt, 92%; (c) 4-chlorophenymagnesium bromide, Et<sub>2</sub>O, −70 °C to rt, 86% for <b>56</b>, 40% for <b>62</b>; (d) AlCl<sub>3</sub>, Et<sub>3</sub>SiH, DCM, 0 °C to rt, 81% for <b>57</b>, 98% for <b>63</b>; (e) Boc<sub>2</sub>O, Mg(ClO<sub>4</sub>)<sub>2</sub>, DCM, reflux, 68%; (f) LiOH, THF/MeOH/H<sub>2</sub>O, rt, 94%.</p></p></figure><div class="NLM_p">(<i>S</i>)-2-Amino-(4-chlorophenyl)propan-1-ol <b>64</b> was reacted with chloroacetyl chloride, and the resulting amide <b>65</b> was cyclized in basic conditions. The so-obtained <i>S</i>-5-(4-chlorophenyl)morpholin-3-one <b>66</b> was reduced with a borane dimethyl sulfide complex affording morpholine <b>67</b> (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>).</div><figure id="sch7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of (<i>S</i>)-3-(4-Chlorobenzyl)morpholine <b>67</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) chloroacetyl chloride, Et<sub>3</sub>N, THF, 0 °C, 85%; (b) NaH, THF, 0 °C to rt, 59%; (c) BH<sub>3</sub>·DMS complex, THF, reflux, 73%.</p></p></figure><div class="NLM_p"><i>N</i>-Boc-piperid-4-one <b>31</b> was subjected to the reductive amination reaction with the heterocyclic amines <b>39</b>, <b>46</b>, <b>52</b>, <b>57</b>, <b>63</b>, and <b>67</b> in slightly modified conditions as compared to the usual procedure (see the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for details). Out of the so-obtained intermediates <b>67–72</b>, portions of compounds <b>70</b> and <b>71</b>, bearing the free hydroxylic group in position 4 of the pyrrolidine ring, were methylated, affording intermediates <b>73</b> and <b>74</b>. Acidic removal of the Boc group followed by the usual two-step 3-aminotriazole ring formation completed the syntheses of the target analogues <b>23–30</b> (<a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>).</div><figure id="sch8" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. General Synthesis of Compounds <b>23–30</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>N</i>-Boc-piperid-4-one <b>31</b>, NaBH(OAc)<sub>3</sub>, AcOH, DCE, rt, 45–85%; (b) MeI, NaH, DMF, rt, 95 and 77% for <b>74</b> and <b>75</b>, respectively; (c) HCl, AcOEt, rt; (d) <i>S</i>,<i>S</i>′-dimethyl <i>N</i>-cyanodithioiminocarbonate, K<sub>2</sub>CO<sub>3</sub>, MeCN, 82 °C; (e) hydrazine, MeCN, 82 °C, 15–84% over three steps.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53667" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53667" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Structure-based drug design directed to the optimization of previously described chitinase inhibitors led us to the discovery of compound <b>30</b>—a highly potent inhibitor, similarly active against both human and murine enzymes. Given once daily at a dose of 50 mg/kg orally in vivo, compound <b>30</b> showed significant reduction of HDM-induced pulmonary inflammation in mice. Thus, generation of a dual chitinase inhibitor seems to be a rational approach for the management of incurable chronic pulmonary diseases by targeting ongoing AMCase-dependent pulmonary inflammation and potentially modulating CHIT1-dependent excessive tissue repair processes in severe asthma or ILDs such as sarcoidosis and IPF. Moreover, significant activity of compound <b>30</b> toward CHIT1 in addition to AMCase could serve as a great tool to understand the profit of chitinase inhibition in animal models of chronic lung diseases, but also to evaluate the role of individual chitinase in the area of lung inflammation and fibrotic remodeling. The hERG activity was brought to the acceptable level from the further preclinical development standpoint, but the inhibition of DAT still remains an unresolved issue and needs further optimization. Inhibitor <b>30</b> is an advanced lead compound that paved the way to the discovery of our clinical candidate OATD-01—currently in phase Ib, as a new therapy against chronic lung diseases relying on the simultaneous inhibition of both human chitinases.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17421" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17421" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Chemical Methods</h3><div class="NLM_p">All solvents, substrates, and reagents that were commercially available were used without further purification. TLC analysis was performed using precoated glass plates (0.2 ± 0.03 mm thickness, GF-254, particle size 0.01–0.04 mm) from Fluorochem Ltd, UK. Column chromatography was performed using high-purity grade silica gel (pore size 60 Å, 220–440 mesh particle size, 35–75 μm particle size) from Fluka. Preparative HPLC was performed on LC-20AP Shimadzu with an ELSD-LTII detector equipped with Hypersil GOLD 21.2/250 mm, 5 μm C18 column. <sup>1</sup>H NMR spectra were recorded on Bruker AVANCE DRX500, AVANCE DRX600 or Bruker AVANCE II PLUS (respectively at 500, 600 or 700 MHz) NMR spectrometers. All spectra were recorded in appropriate deuterated solvents (CDCl<sub>3</sub>, DMSO-<i>d</i><sub>6</sub>, D<sub>2</sub>O and CD<sub>3</sub>OD). Resonances are given in parts per million relative to tetramethylsilane. Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, m = multiplet, br = broad), coupling constants (<i>J</i> in Hz), and integration. LC–MS spectra were recorded on a Shimadzu LC-20AD LPG separation module with a SPD-M20A UV detector and an LCMS-2020 mass detector equipped with Kinetex 2.1/50 mm, 2.6 μm C18 column eluted with 0.5 mL/min flow of 10–90% gradient (over 6 min) of acetonitrile in water. Purities of all final reported compounds were greater than 95% based on HPLC chromatograms. Purification of the final compounds by preparative HPLC was accomplished on a C-18 250 × 21 mm column in 0.05% TFA in water/acetonitrile 95:5 → 45:55 gradient over 30 min followed by freeze-drying of the pooled fractions containing pure products. In some cases, the so-obtained trifluoroacetate salts of the final compounds were judged to be of insufficient quality for biological testing because of their physical appearance (oils with a distinguished scent of trifluoroacetic acid). Therefore, they were re-dissolved in a small amount of 0.1 M HCl and subjected to the second lyophilization providing well-behaving hydrochloride salts. HRMS–ESI spectra were recorded on a Bruker Maxis Impact instrument. Purities of all reported compounds were greater than 95% based on HPLC chromatograms. HPLC analyses were performed on a Waters Acquity UPLC system fitted with a Phenomenex 5 μm, 100A, PFP(2) column (4.6 mm × 150 mm) and with UV detection (220 nm), gradient 10–90% of acetonitrile in water, flow rate 1.5 mL/min over 10 min, then 90% acetonitrile over 5 min. Analysis of optical purity of compound <b>30</b> was accomplished on the same HPLC system fitted with a Phenomenex Luna Cellulose-4 column (150 × 4.6 mm; 5 μm) in isocratic flow of isopropanol/hexanes (70:30, 1 mL/min) over 20 min.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> General Procedure A for Compounds <b>32a–q</b> (One-Pot Double Reductive Amination Procedure)</h4><div class="NLM_p last">To a stirred solution of <i>N</i>-Boc-4-piperidone (<b>31</b>, 0.4 g, 2 mmol) and appropriate primary amine or its hydrochloride salt (depending on the availability) (2 mmol) in 1,2-dichloroethane (6 mL), sodium triacetoxyborohydride (0.85 g, 4 mmol) was added. The reaction mixture was stirred at ambient temperature overnight, and 4-chlorophenylacetaldehyde (0.3 g, 2 mmol) followed by the second portion of sodium triacetoxyborohydride (0.85 g, 4 mmol) were added. Stirring was continued for 1–2 h (TLC control), after which time the reaction was stopped by addition of 5% solution of NaHCO<sub>3</sub> (10 mL) and the biphasic mixture was stirred for 30 min. The layers were separated and the aqueous layer was additionally extracted with DCM twice. The combined organic extracts were then dried over MgSO<sub>4</sub> and filtered, and solvent was removed in vacuo. The crude residue was purified by flash chromatography to afford compounds <b>32a–q</b>.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> General Procedure B for Compounds <b>34</b>, <b>35</b>, and <b>68–73</b> (Reductive Amination of <i>N</i>-Boc-4-piperidone with Cyclic Secondary Amines: 3-(4-Chlorophenyl)pyrrolidine, 3-(4-Chlorophenyl)piperidine, and Compounds: <b>39</b>, <b>46</b>, <b>52</b>, <b>57</b>, <b>63</b>, and <b>67</b>)</h4><div class="NLM_p last">To a stirred solution of <i>N</i>-Boc-4-piperidone (<b>31</b>, 0.4 g, 1 mmol) and secondary amine or its hydrochloride salt (1 mmol) in 1,2-dichloroethane (3 mL), acetic acid (0.36 mL, 3 mmol) was added, and the resulting mixture was stirred in room temperature until clear solution was obtained (overnight, if necessary). It was concentrated in vacuo to about 30–50% of its initial volume, and sodium triacetoxyborohydride (0.42 g, 2 mmol) was added. The thick reaction mixture was stirred at ambient temperature overnight, after which time it was diluted with 3 mL of DCM and quenched by addition of 5% solution of NaHCO<sub>3</sub> (6 mL). Compounds <b>34</b>, <b>35</b>, and <b>68–73</b> were isolated by usual aqueous work-up and purified by flash chromatography in an appropriate solvent system.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> General Procedure C for Compounds <b>4–30</b> (<i>N</i>-Boc- Group Removal Followed by 3-Aminotriazole Ring Formation)</h4><div class="NLM_p last">To a solution of Boc-protected compounds <b>32a–q</b>, <b>34</b>, <b>35</b>, and <b>68–75</b> in EtOAc (0.5 mL/mmol), 4 M HCl in EtOAc solution was added (3 mL/mmol), and the reaction mixture was stirred in room temperature until chromatography (either TLC or LC–MS) indicated complete consumption of a starting material (typically 30 min to 2 h). Volatiles were removed in vacuo, and the residue was triturated thrice with diethyl ether and dried under high vacuum for 1 h. The crude hydrochloride salt was suspended in acetonitrile (4 mL/mmol, assuming quantitative yield of the deprotection step), and solid K<sub>2</sub>CO<sub>3</sub> (3 equiv) followed by <i>S</i>,<i>S</i>′-dimethyl <i>N</i>-cyanodithioiminocarbonate (1.1 equiv) were added, and the reaction mixture was refluxed until complete consumption of the starting material was achieved as judged by chromatography (typically 2–3 h). Hydrazine hydrate (4 equiv) was then added and reaction was further refluxed for 3–5 h, after which time it was cooled, and poured into the vigorously stirred biphasic mixture of 5% NaHCO<sub>3</sub> and ethyl acetate. After the separation of the phases, the organic layer was additionally washed by water and brine, dried with anhydrous MgSO<sub>4</sub>, filtered, and concentrated. Depending on the amount of the compound synthesized, the final products were purified by crystallization, flash chromatography, or reversed-phase chromatography.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>N</i>-(1-(3-Amino-1<i>H</i>-1,2,4-triazol-5-yl)piperidin-4-yl)-<i>N</i>-(4-chlorophenethyl)glycine 2,2,2-Trifluoroacetate (<b>4</b>)</h4><div id="sec4_1_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> Step 1: Synthesis of <i>tert</i>-Butyl 4-((4-Chlorophenethyl)(2-methoxy-2-oxoethyl)amino)piperidine-1-carboxylate (<b>32a</b>)</h5><div class="NLM_p last">The title compound was prepared according to the general procedure A on 2 mmol scale from <i>N</i>-Boc-4-piperidone and glycine methyl ester hydrochloride. <b>32a</b> (600 mg, 1.46 mmol, yield 73%) was obtained in the form of transparent thick oil after purification by flash column chromatography (gradient elution 1–5% MeOH in DCM). LC–MS (ES+) <i>m</i>/<i>z</i>: 410.8/412.7 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> Step 2: Synthesis of Methyl <i>N</i>-(1-(3-Amino-1<i>H</i>-1,2,4-triazol-5-yl)piperidin-4-yl)-<i>N</i>-(4-chlorophenethyl)glycinate Bis-2,2,2-trifluoroacetate (<b>33</b>)</h5><div class="NLM_p last">Starting with 300 mg (0.73 mmol) of compound <b>32a</b>, 200 mg (0.32 mmol, yield 44%) of methyl <i>N</i>-(1-(3-amino-1<i>H</i>-1,2,4-triazol-5-yl)piperidin-4-yl)-<i>N</i>-(4-chlorophenethyl)glycinate in the form of bis-trifluoroacetate salt (<b>33</b>) was obtained according to the general procedure C after purification by reversed-phase chromatography. LC–MS (ES+) <i>m</i>/<i>z</i>: 392.9/394.8 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, CD<sub>3</sub>OD): δ 7.35 (d, <i>J</i> = 8.4 Hz, 2H), 7.29 (d, <i>J</i> = 8.4 Hz, 2H), 4.18 (s, 2H), 3.97–3.95 (m, 2H), 3.86 (s, 3H), 3.61–3.56 (m, 1H), 3.41–3.39 (m, 2H), 3.04–3.02 (m, 2H), 2.99–2.95 (m, 2H), 2.08 (br d, <i>J</i> = 12.6 Hz, 2H), 1.83–1.78 (m, 2H).</div></div><div id="sec4_1_4_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> Step 3: Synthesis of <i>N</i>-(1-(3-Amino-1<i>H</i>-1,2,4-triazol-5-yl)piperidin-4-yl)-<i>N</i>-(4-chlorophenethyl)glycine 2,2,2-Trifluoroacetate Salt (<b>4</b>)</h5><div class="NLM_p last">Solution of compound <b>33</b> (180 mg, 0.29 mmol) in MeOH (2 mL) was treated with aqueous solution of NaOH (56 mg, 1.4 mmol dissolved in 0.5 mL of water) and heated at 50 °C for 2 h. The reaction was then cooled to room temperature, acidified with 2 M HCl to the neutral pH, and solvents were removed in vacuo. The residue was purified by the reversed-phase chromatography affording compound <b>4</b> (15 mg, 0.03 mmol, yield 10%). LC–MS (ES+) <i>m</i>/<i>z</i>: 379.0/381.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, CD<sub>3</sub>OD): δ 7.36 (d, <i>J</i> = 8.4 Hz, 2H), 7.31 (d, <i>J</i> = 8.4 Hz, 2H), 4.06 (s, 2H), 3.98–3.95 (m, 2H), 3.66 (tt, <i>J</i> = 12.6, 3.5 Hz, 1H), 3.47–3.44 (m, 2H), 3.09–3.07 (m, 2H), 3.04–3.00 (m, 2H), 2.13–2.11 (m, 2H), 1.89–1.83 (m, 2H).</div></div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 2-((1-(3-Amino-1<i>H</i>-1,2,4-triazol-5-yl)piperidin-4-yl)(4-chlorophenethyl)amino)-<i>N</i>-methylacetamide Dihydrochloride (<b>5</b>)</h4><div class="NLM_p last">It was obtained from 2-amino-<i>N</i>-methylacetamide hydrochloride in two steps according to the general procedures A (yield 55%) and C (yield 15%). The final compound (23 mg, 0.05 mmol) was obtained as a dihydrochloride salt after reversed-phase purification and lyophilization from 0.1 M HCl solution. LC–MS (ES+) <i>m</i>/<i>z</i>: 392.1/394.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, 348 K): δ 7.34 (d, <i>J</i> = 8.4 Hz, 2H), 7.30 (d, <i>J</i> = 8.4 Hz, 2H), 3.99 (s, 2H), 3.88 (brd, <i>J</i> = 13.4 Hz, 2H), 3.65 (ddd, <i>J</i> = 15.3, 7.7, 3.4 Hz, 1H), 3.40–3.37 (m, 2H), 3.02–2.97 (m, 4H), 2.69 (s, 3H), 2.07 (brd, <i>J</i> = 11.9 Hz, 2H), 1.73 (qd, <i>J</i> = 12.2, 4.0 Hz, 2H).</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>N</i>-(2-((1-(3-Amino-1<i>H</i>-1,2,4-triazol-5-yl)piperidin-4-yl)(4-chlorophenethyl)amino)ethyl)acetamide Dihydrochloride (<b>6</b>)</h4><div class="NLM_p last">It was obtained from <i>N</i>-(2-aminoethyl)acetamide in two steps according to general procedures A (yield 51%) and C (yield 27%). The final compound (10 mg, 0.02 mmol) was obtained as a dihydrochloride salt after reversed-phase purification and lyophilization from 0.1 M HCl solution. LC–MS (ES+) <i>m</i>/<i>z</i>: 406.0/408.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, 348 K): δ 7.36–7.33 (m, 4H), 3.89 (d, <i>J</i> = 13.3 Hz, 2H), 3.66 (tt, <i>J</i> = 11.9, 3.4 Hz, 1H), 3.50–3.48 (m, 2H), 3.35–3.33 (m, 2H), 3.29–3.27 (m, 2H), 3.10–3.08 (m, 2H), 3.04–3.00 (m, 2H), 2.14–2.12 (m, 2H), 1.87 (s, 3H), 1.78 (qd, <i>J</i> = 12.2, 4.1 Hz, 2H).</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>N</i>-(2-((1-(3-Amino-4<i>H</i>-1,2,4-triazol-5-yl)piperidin-4-yl)(4-chlorophenethyl)amino)ethyl)methanesulfonamide Dihydrochloride (<b>7</b>)</h4><div class="NLM_p last">It was obtained from <i>N</i>-(2-aminoethyl)methanesulfonamide hydrochloride in two steps according to general procedures A (yield 49%) and C (yield 30%). The final compound (55 mg, 0.11 mmol) was obtained as a dihydrochloride salt after reversed-phase purification and lyophilization from 0.1 M HCl solution. LC–MS (ES+) <i>m</i>/<i>z</i>: 442.0/444.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, 348 K): δ 7.36 (brd, <i>J</i> = 8.6 Hz, 2H), 7.33 (d, <i>J</i> = 8.6 Hz, 2H), 3.87 (d, <i>J</i> = 13.3 Hz, 2H), 3.64 (tt, <i>J</i> = 11.9, 3.4 Hz, 1H), 3.42 (t, <i>J</i> = 6.2 Hz, 2H overlapping with water), 3.37–3.31 (m, 4H), 3.08–3.04 (m, 2H), 3.01–2.95 (m, 5H), 2.10 (brd, <i>J</i> = 12.0 Hz, 2H), 1.77 (qd, <i>J</i> = 12.2, 4.3 Hz, 2H).</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 2-((1-(3-Amino-1<i>H</i>-1,2,4-triazol-5-yl)piperidin-4-yl)(4-chlorophenethyl)amino)-<i>N</i>-methylethane-1-sulfonamide (<b>8</b>)</h4><div class="NLM_p last">It was obtained from 2-amino-<i>N</i>-methylethanesulfonamide hydrochloride in two steps according to general procedures A (yield 63%) and C (yield 48%). The final compound (360 mg, 0.81 mmol) was obtained after purification by silica-gel chromatography in the CHCl<sub>3</sub>/MeOH solvent system (gradient elution from 100:1 to 20:1) followed by trituration of the so-obtained white solid with diethyl ether and drying under high vacuum. LC–MS (ES+) <i>m</i>/<i>z</i>: 442.1/444.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, 348 K): δ 7.37 (d, <i>J</i> = 8.5 Hz, 2H), 7.33 (d, <i>J</i> = 8.5 Hz, 2H), 3.86 (brd, <i>J</i> = 12.8 Hz, 2H), 3.53–3.22 (m, 7H), 2.96–2.94 (m, 2H), 2.78 (t, <i>J</i> = 12.0 Hz, 2H), 2.60 (s, 3H), 1.95–1.93 (m, 2H), 1.65–1.59 (m, 2H).</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 1-(2-((1-(3-Amino-1<i>H</i>-1,2,4-triazol-5-yl)piperidin-4-yl)(4-chlorophenethyl)amino)ethyl)-3-methylurea Dihydrochloride (<b>9</b>)</h4><div class="NLM_p last">It was obtained from 1-(2-aminoethyl)-3-methylurea hydrochloride in two steps according to general procedures A (yield 67%) and C (yield 34%). The final compound (85 mg, 0.17 mmol) was obtained as a dihydrochloride salt after reversed-phase purification and lyophilization from 0.1 M HCl solution. LC–MS (ES+) <i>m</i>/<i>z</i>: 421.2/423.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, CD<sub>3</sub>OD): δ 7.36–7.33 (m, 4H), 4.00–3.97 (m, 2H), 3.74 (tt, <i>J</i> = 11.9, 3.5 Hz, 1H), 3.54–3.47 (m, 4H), 3.35–3.32 (m, 1H), 3.28–3.24 (m, 1H), 3.15–3.11 (m, 2H), 3.07–3.03 (m, 2H), 2.71 (s, 3H), 2.16–2.07 (m, 2H), 1.92–1.87 (m, 2H).</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-((1-(3-Amino-4<i>H</i>-1,2,4-triazol-5-yl)piperidin-4-yl)(4-chlorophenethyl)amino)ethan-1-ol Dihydrochloride (<b>10</b>)</h4><div class="NLM_p last">It was obtained from 2-aminoethanol in two steps according to general procedures A (yield 45%) and C (yield 25%). The final compound (45 mg, 0.10 mmol) was obtained as a dihydrochloride salt after reversed-phase purification and lyophilization from 0.1 M HCl solution. LC–MS (ES+) <i>m</i>/<i>z</i>: 365.0/367.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O): δ 7.40–7.35 (m, 2H), 7.33–7.29 (m, 2H), 3.86–3.81 (m, 2H), 3.74–3.68 (m, 2H), 3.60 (tt, <i>J</i> = 12.0, 3.6 Hz, 1H), 3.39–3.27 (m, 3H), 3.24–3.16 (m, 1H), 3.02 (q, <i>J</i> = 9.8 Hz, 2H), 2.96–2.88 (m, 2H), 2.10–1.97 (m, 2H), 1.77–1.65 (m, 2H).</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 1-(3-Amino-4<i>H</i>-1,2,4-triazol-5-yl)-<i>N</i>-(4-chlorophenethyl)-<i>N</i>-(2-methoxyethyl)piperidin-4-amine Dihydrochloride (<b>11</b>)</h4><div class="NLM_p last">It was obtained from 2-methoxyethylamine in two steps according to general procedures A (yield 67%) and C (yield 32%). The final compound (50 mg, 0.11 mmol) was obtained as a dihydrochloride salt after reversed-phase purification and lyophilization from 0.1 M HCl solution. LC–MS (ES+) <i>m</i>/<i>z</i>: 379.0/381.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O): δ 7.40–7.36 (m, 2H), 7.34–7.30 (m, 2H), 3.86–3.80 (m, 2H), 3.69–3.64 (m, 2H), 3.59 (tt, <i>J</i> = 12.1, 3.7 Hz, 1H), 3.46 (d, <i>J</i> = 15.8 Hz, 1H), 3.36–3.25 (m, 6H), 3.04–2.90 (m, 4H), 2.09–1.98 (m, 2H), 1.81–1.67 (m, 2H).</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (<i>R</i>)-1-((1-(3-Amino-1<i>H</i>-1,2,4-triazol-5-yl)piperidin-4-yl)(4-chlorophenethyl)amino)propan-2-ol Bis-2,2,2-trifluoroacetate (<b>12</b>)</h4><div class="NLM_p last">It was obtained from (<i>R</i>)-1-amino-2-propanol in two steps according to general procedures A (yield 51%) and C (yield 19%). The final compound (72 mg, 0.12 mmol) was obtained as a bis-trifluoroacetate salt after reversed-phase purification. LC–MS (ES+) <i>m</i>/<i>z</i>: 379.2/381.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, 348 K): δ 7.38 (d, <i>J</i> = 8.3 Hz, 2H), 7.33 (d, <i>J</i> = 8.0 Hz, 2H), 4.03–4.01 (m, 1H), 3.83 (brd, <i>J</i> = 14.2 Hz, 2H), 3.59 (tt, <i>J</i> = 12.0, 3.3 Hz, 1H), [3.35–3.29 (m, 2.5H), 3.08–2.99 (m, 3.5H) rotamers], 2.94 (t, <i>J</i> = 12.6 Hz, 2H), 2.09–1.99 (m, 2H), 1.80–1.65 (m, 2H), 1.15 (d, <i>J</i> = 4.1 Hz, 3H).</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (<i>R</i>)-1-((1-(3-Amino-1<i>H</i>-1,2,4-triazol-5-yl)piperidin-4-yl)(4-chlorophenethyl)amino)propan-2-ol Bis-2,2,2-trifluoroacetate (<b>13</b>)</h4><div class="NLM_p last">It was obtained from (<i>R</i>)-2-methoxypropylamine hydrochloride in two steps according to general procedures A (yield 66%) and C (yield 33%). The final compound (25 mg, 0.04 mmol) was obtained as a bis-trifluoroacetate salt after reversed-phase purification. LC–MS (ES+) <i>m</i>/<i>z</i>: 393.0/395.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, 348 K): δ 7.37 (d, <i>J</i> = 8.5 Hz, 2H), 7.31 (d, <i>J</i> = 8.4 Hz, 2H), 3.88 (brd, <i>J</i> = 13.2 Hz, 2H), 3.76–3.72 (m, 1H), 3.58–3.53 (m, 1H), 3.36–3.31 (m, 2H), 3.29 (s, 3H), 3.25–3.22 (m, 1H), 3.18–3.14 (m, 1H), 3.05–3.00 (m, 2H), 2.92–2.88 (m, 2H), 2.06–2.01 (m, 2H), 1.79–1.69 (m, 2H), 1.15 (d, <i>J</i> = 6.1 Hz, 3H).</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (<i>S</i>)-1-((1-(3-Amino-1<i>H</i>-1,2,4-triazol-5-yl)piperidin-4-yl)(4-chlorophenethyl)amino)propan-2-ol Bis-2,2,2-trifluoroacetate (<b>14</b>)</h4><div class="NLM_p last">It was obtained from (<i>S</i>)-1-amino-2-propanol in two steps according to general procedures A (yield 60%) and C (yield 21%). The final compound (80 mg, 0.13 mmol) was obtained as a bis-trifluoroacetate salt after reversed-phase purification. LC–MS (ES+) <i>m</i>/<i>z</i>: 379.2/381.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, 300 K): δ 7.37 (d, <i>J</i> = 8.0 Hz, 2H), 7.32 (d, <i>J</i> = 7.3 Hz, 2H), 4.02–4.00 (m, 1H), 3.83–3.81 (m, 2H), 3.58 (tt, <i>J</i> = 12.8, 3.3 Hz, 1H), [3.33–3.28 (m, 2.3H), 3.10–2.99 (m, 3.7H) rotamers], 2.92 (t, <i>J</i> = 12.4 Hz, 2H), 2.07–1.98 (m, 2H), 1.79–1.64 (m, 2H), 1.14 (d, <i>J</i> = 4.1 Hz, 3H).</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (<i>S</i>)-1-(3-Amino-1<i>H</i>-1,2,4-triazol-5-yl)-<i>N</i>-(4-chlorophenethyl)-<i>N</i>-(2-methoxypropyl)piperidin-4-amine Bis-2,2,2-trifluoroacetate (<b>15</b>)</h4><div class="NLM_p last">It was obtained from (<i>S</i>)-2-methoxypropylamine hydrochloride in two steps according to general procedures A (yield 72%) and C (yield 32%). The final compound (50 mg, 0.08 mmol) was obtained as a bis-trifluoroacetate salt after reversed-phase purification. LC–MS (ES+) <i>m</i>/<i>z</i>: 393.0/395.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, 348 K): δ 7.37 (d, <i>J</i> = 8.5 Hz, 2H), 7.31 (d, <i>J</i> = 8.4 Hz, 2H), 3.88 (brd, <i>J</i> = 13.2 Hz, 2H), 3.76–3.72 (m, 1H), 3.58–3.53 (m, 1H), 3.35–3.32 (m, 2H), 3.29 (s, 3H), 3.25–3.21 (m, 1H), 3.18–3.14 (m, 1H), 3.05–3.00 (m, 2H), 2.93–2.89 (m, 2H), 2.06–2.01 (m, 2H), 1.79–1.69 (m, 2H), 1.15 (d, <i>J</i> = 6.1 Hz, 3H).</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 1-((1-(3-Amino-1<i>H</i>-1,2,4-triazol-5-yl)piperidin-4-yl)(4-chlorophenethyl)amino)-2-methylpropan-2-ol (<b>16</b>)</h4><div class="NLM_p last">It was obtained from 1-amino-2-methypropan-2-ol in two steps according to general procedures A (yield 54%) and C (yield 32%). The final compound (197 mg, 0.50 mmol) was obtained after purification by silica-gel chromatography in the CHCl<sub>3</sub>/MeOH solvent system (gradient elution from 100:1 to 15:1) followed by trituration of the so-obtained white solid with diethyl ether and drying under high vacuum. LC–MS (ES+) <i>m</i>/<i>z</i>: 393.0/395.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, 348 K): δ 7.39–7.34 (m, 2H), 7.33–7.29 (m, 2H), 3.92–3.85 (m, 2H), 3.64 (tt, <i>J</i> = 12.1, 3.6 Hz, 1H), 3.44–3.40 (m, 2H), 3.18 (br s, 2H), 3.12–3.06 (m, 2H), 2.98–2.89 (m, 2H), 2.14–2.05 (m, 2H), 1.82–1.70 (m, 2H), 1.28 (s, 6H).</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 1-(3-Amino-1<i>H</i>-1,2,4-triazol-5-yl)-<i>N</i>-(4-chlorophenethyl)-<i>N</i>-(2-methoxy-2-methylpropyl)piperidin-4-amine (<b>17</b>)</h4><div class="NLM_p last">It was obtained from 2-methoxy-2-methylpropylamine in two steps according to general procedures A (yield 75%) and C (yield 41%). The final compound (158 mg, 0.39 mmol) was obtained after purification by silica-gel chromatography in the CHCl<sub>3</sub>/MeOH solvent system (gradient elution from 100:1 to 25:1) followed by trituration of the so-obtained white solid with diethyl ether and drying under high vacuum. LC–MS (ES+) <i>m</i>/<i>z</i>: 407.0/409.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, 348 K): δ 7.38–7.35 (m, 2H), 7.32–7.29 (m, 2H), 3.90–3.88 (m, 1H), 3.88–3.86 (m, 1H), 3.59 (tt, <i>J</i> = 11.9, 3.5 Hz, 1H), 3.41–3.36 (m, 2H), 3.27–3.21 (m, 2H), 3.18 (s, 3H), 3.10–3.04 (m, 2H), 2.96–2.90 (m, 2H), 2.11–2.04 (m, 2H), 1.81–1.70 (m, 2H), 1.26 (s, 6H).</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 1-(3-Amino-1<i>H</i>-1,2,4-triazol-5-yl)-<i>N</i>-(4-chlorophenethyl)-<i>N</i>-(oxetan-3-yl)piperidin-4-amine (<b>18</b>)</h4><div class="NLM_p last">It was obtained from oxetan-3-amine hydrochloride in two steps according to general procedures A (yield 44%) and C (yield 30%). The final compound (18 mg, 0.04 mmol) was obtained as a dihydrochloride salt after reversed-phase purification and lyophilization from 0.1 M HCl solution. LC–MS (ES+) <i>m</i>/<i>z</i>: 377.0/379.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, 348 K): δ 7.32 (d, <i>J</i> = 8.4 Hz, 1H), 7.28 (d, <i>J</i> = 8.4 Hz, 1H), 4.64–4.59 (m, 4H), 4.46–4.44 (m, 1H), 3.84 (brd, <i>J</i> = 13.1 Hz, 2H), 3.12–3.05 (m, 3H), 2.82–2.80 (m, 2H), 2.76 (td, <i>J</i> = 13.0, 2.1 Hz, 2H), 1.77 (d, <i>J</i> = 11.9 Hz, 2H), 1.48 (qd, <i>J</i> = 12.0, 4.1 Hz, 2H).</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 1-(3-Amino-4<i>H</i>-1,2,4-triazol-5-yl)-<i>N</i>-(4-chlorophenethyl)-<i>N</i>-((tetrahydrofuran-2-yl)methyl)piperidin-4-amine Bis-2,2,2-trifluoroacetate (<b>19</b>)</h4><div class="NLM_p last">It was obtained from 2-(aminomethyl)tetrahydrofuran in two steps according to general procedures A (yield 79%) and C (yield 40%). The final compound (93 mg, 0.15 mmol) was obtained as a bis-trifluoroacetate salt after reversed-phase purification. LC–MS (ES+) <i>m</i>/<i>z</i>: 421.0/423.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, 348 K): δ 7.36 (d, <i>J</i> = 8.5 Hz, 2H), 7.31 (d, <i>J</i> = 8.5 Hz, 2H), 4.25–4.20 (m, 1H), 3.89–3.85 (m, 2H), 3.83 (dt, <i>J</i> = 8.2, 7.0 Hz, 1H), 3.75 (td, <i>J</i> = 7.9, 6.1 Hz, 1H), 3.60 (tt, <i>J</i> = 12.2, 3.4 Hz, 1H), 3.37 (t, <i>J</i> = 8.5 Hz, 2H), 3.33 (brd, <i>J</i> = 12.6 Hz, 1H), 3.21–3.14 (m, 1H), 3.07–3.00 (m, 2H), 2.94–2.88 (m, 2H), 2.11–2.03 (m, 3H), 1.93–1.81 (m, 2H), 1.74 (pd, <i>J</i> = 12.2, 4.4 Hz, 2H), 1.56 (ddt, <i>J</i> = 12.4, 8.6, 7.1 Hz, 1H).</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 1-(3-Amino-4<i>H</i>-1,2,4-triazol-5-yl)-<i>N</i>-(4-chlorophenethyl)-<i>N</i>-((tetrahydro-2<i>H</i>-pyran-2-yl)methyl)piperidin-4-amine Bis-2,2,2-trifluoroacetate (<b>20</b>)</h4><div class="NLM_p last">It was obtained from tetrahydropyran-2-ylmethylamine in two steps according to general procedures A (yield 88%) and C (yield 55%). The final compound (141 mg, 0.22 mmol) was obtained as a bis-trifluoroacetate salt after reversed-phase purification. LC–MS (ES+) <i>m</i>/<i>z</i>: 419.1/421.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, 348 K): δ 7.36 (d, <i>J</i> = 8.4 Hz, 2H), 7.30 (d, <i>J</i> = 8.4 Hz, 2H), 3.94–3.90 (m, 1H), 3.89–3.84 (m, 2H), 3.70–3.65 (m, 1H), 3.56 (tt, <i>J</i> = 12.0, 3.5 Hz, 1H), 3.43–3.39 (m, 1H, overlapping with water signal), 3.36–3.31 (m, 2H), 3.26–3.14 (m, 2H), 3.04–3.00 (m, 2H), 2.91 (tt, <i>J</i> = 12.8, 3.1 Hz, 2H), 2.07–1.99 (m, 2H), 1.82–1.67 (m, 3H), 1.60 (d, <i>J</i> = 12.9 Hz, 1H), 1.53–1.43 (m, 3H), 1.25–1.19 (m, 1H).</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 5-(4-(3-(4-Chlorophenyl)pyrrolidin-1-yl)piperidin-1-yl)-1<i>H</i>-1,2,4-triazol-3-amine Bis-2,2,2-trifluoroacetate (<b>21</b>)</h4><div class="NLM_p last">It was obtained from 3-(4-chlorophenyl)pyrrolidine in two steps according to general procedures B (yield 45%) and C (yield 55%). The final compound (19 mg, 0.03 mmol) was obtained as a bis-trifluoroacetate salt after reversed-phase purification. LC–MS (ES+) <i>m</i>/<i>z</i>: 346.9/348.9 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, 348 K): δ 7.40–7.37 (m, 2H), 7.37–7.33 (m, 2H), 3.85 (dq, <i>J</i> = 11.6, 2.6 Hz, 3H), 3.71–3.49 (m, 3H), 3.46–3.39 (m, 2H), 2.90 (dddd, <i>J</i> = 15.1, 13.2, 5.8, 2.6 Hz, 2H), 2.49–2.38 (m, 1H), 2.17–2.10 (m, 2H), 2.09–1.95 (m, 1H), 1.65 (qt, <i>J</i> = 12.2, 4.3 Hz, 2H).</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 5-(3-(4-Chlorophenyl)-[1,4′-bipiperidin]-1′-yl)-1<i>H</i>-1,2,4-triazol-3-amine Bis-2,2,2-trifluoroacetate (<b>22</b>)</h4><div class="NLM_p last">It was obtained from 3-(4-chlorophenyl)piperidine in two steps according to general procedures B (yield 23%) and C (yield 14%). The final compound (8 mg, 0.01 mmol) was obtained as a bis-trifluoroacetate salt after reversed-phase purification. LC–MS (ES+) <i>m</i>/<i>z</i>: 360.9/362.9 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O): δ 7.42–7.37 (m, 2H), 7.35–7.31 (m, 2H), 3.50–3.44 (m, 1H), 3.45–3.38 (m, 2H), 3.10 (t, <i>J</i> = 12.0 Hz, 1H), 3.07–2.97 (m, 2H), 2.97–2.90 (m, 2H), 2.12–2.04 (m, 2H), 2.03–1.97 (m, 1H), 1.90–1.78 (m, 2H), 1.76–1.62 (m, 3H), 2 protons overlapping with water signal.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (<i>R</i>)-3-(4-(2-(4-Chlorobenzyl)pyrrolidin-1-yl)piperidin-1-yl)-4<i>H</i>-1,2,4-triazol-5-amine Bis-2,2,2-trifluoroacetate (<b>23</b>)</h4><div id="sec4_1_23_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> Step 1: Synthesis of <i>tert</i>-Butyl (<i>R</i>)-2-(Methoxy(methyl)carbamoyl)pyrrolidine-1-carboxylate (<b>37</b>)</h5><div class="NLM_p last">To a solution of <i>N</i>-Boc-<span class="smallcaps smallerCapital">d</span>-proline (10 g, 46.5 mmol) in DCM (200 mL), carbonyldiimidazole (11.3 g, 69.7 mmol) was added. After 30 min of activation of the carboxylic group, <i>N</i>,<i>O</i>-dimethylhydroxylamine (6.8 g, 69.7 mmol) was added and reaction was stirred overnight. The reaction mixture was washed with 1 M HCl, 5% solution of NaHCO<sub>3</sub> and brine. The organic layer was dried over MgSO<sub>4</sub> and concentrated. The product was purified by column chromatography in hexanes/AcOEt (4:1) to afford <b>37</b> as a colorless oil (6.19 g, 52%). LC–MS (ES+) <i>m</i>/<i>z</i>: 259.1 [M + H]<sup>+</sup>, 281.0 [M + Na]<sup>+</sup>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>; two rotamers in 1:1 ratio): δ 4.73–4.55 (m, 1H), 3.78 (s, first rotamer), 3.72 (s, second rotamer; signals at 3.78 and 3.72 summarizing to 3H), 3.63–3.52 (m, 1H), 3.51–3.44 (m, 1H, rotamer), 3.44–3.35 (m, 1H, rotamer), 3.19 (s, 3H), 2.26–2.10 (m, 1H), 2.04–1.92 (m, 1H), 1.92–1.77 (m, 2H), 1.46 (s, first rotamer), 1.41 (s, second rotamer; signals at 1.46 and 1.41 summarizing to 9H).</div></div><div id="sec4_1_23_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> Step 2: Synthesis of <i>tert</i>-Butyl (<i>R</i>)-2-(4-Chlorobenzoyl)pyrrolidine-1-carboxylate (<b>38</b>)</h5><div class="NLM_p last">Amide <b>37</b> (3.0 g, 11.61 mmol) was dissolved in dry diethyl ether (30 mL) under an atmosphere of argon and cooled to −70 °C. <i>p</i>-Chlorophenylmagnesium bromide, previously generated from magnesium (875 mg, 36.0 mmol) and <i>p</i>-bromochlorobenzene (6.67 g, 34.8 mmol) in 150 mL of diethyl ether, was added dropwise to the solution of amide <b>37</b> at −70 °C. After addition of Grignard reagent, reaction was allowed to warm to room temperature and stirred for 2 h more. The reaction was quenched with saturated NH<sub>4</sub>Cl solution and extracted with diethyl ether. The organic layer was washed with 1 M HCl and brine. Solvent was evaporated and oily residue was purified by column chromatography in hexanes/EtOAc (10:1) affording compound <b>38</b> as a white crystalline solid (2.47 g, 69%). LC–MS (ES+) <i>m</i>/<i>z</i>: 310.0/312.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>; two rotamers in 1:3 ratio): δ 7.96–7.92 (m, 2H, minor rotamer), 7.92–7.88 (m, 2H, major rotamer), 7.49–7.45 (m, 2H, major rotamer), 7.45–7.42 (m, 2H, minor rotamer), 5.28 (dd, <i>J</i> = 9.2, 3.6 Hz, 1H, minor rotamer), 5.14 (dd, <i>J</i> = 9.1, 4.0 Hz, 1H, major rotamer), 3.74–3.65 (m, 1H, major rotamer), 3.66–3.59 (m, 1H, minor rotamer), 3.60–3.52 (m, 1H, major rotamer), 3.52–3.44 (m, 1H, minor rotamer), 2.39–2.23 (m, 1H), 2.01–1.84 (m, 3H), 1.46 (s, 9H, minor rotamer), 1.26 (s, 9H, major rotamer).</div></div><div id="sec4_1_23_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> Step 3: Synthesis of (<i>R</i>)-2-(4-Chlorobenzyl)pyrrolidine (<b>39</b>)</h5><div class="NLM_p last">To a solution of ketone <b>38</b> (1 g, 3.23 mmol) in DCM, anhydrous aluminum chloride (1.29 g, 9.68 mmol) and triethylsilane (1.55 mL, 9.68 mmol) were added. After 1 h of stirring, LC–MS indicated completion of reaction. The reaction was quenched with a mixture of 4 M NaOH and brine. The aqueous phase was extracted with DCM, dried over MgSO<sub>4</sub>, filtered, and concentrated to afford <b>39</b> as a yellow oil (632 mg, 99%) that was used without further purification in the next step. LC–MS (ES+) <i>m</i>/<i>z</i>: 195.9/197.9 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_23_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> Step 4: Synthesis of <i>tert</i>-Butyl (<i>R</i>)-4-(2-(4-Chlorobenzyl)pyrrolidin-1-yl)piperidine-1-carboxylate (<b>68</b>)</h5><div class="NLM_p last"><i>N</i>-Boc-4-piperidone (0.74 g, 3.17 mmol) was reductively aminated with 0.62 g (3.17 mmol) of (<i>R</i>)-2-(4-chlorobenzyl)pyrrolidine (<b>39</b>) according to the general procedure B. The product was purified by flash chromatography using the DCM/MeOH (50:1) solvent system affording <b>68</b> as a yellow oil (540 mg, 45%). LC–MS (ES+) <i>m</i>/<i>z</i>: 379.1/381.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.26–7.22 (m, 2H), 7.13–7.09 (m, 2H), 4.29–4.03 (m, 3H), 3.07–3.00 (m, 1H), 2.98–2.89 (m, 1H), 2.90–2.81 (m, 1H), 2.81–2.63 (m, 3H), 2.63–2.54 (m, 1H), 2.48–2.37 (m, 1H), 1.92–1.81 (m, 1H), 1.81–1.75 (m, 1H), 1.75–1.59 (m, 3H), 1.59–1.47 (m, 2H), 1.47 (s, 9H).</div></div><div id="sec4_1_23_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> Step 5: Synthesis of (<i>R</i>)-3-(4-(2-(4-Chlorobenzyl)pyrrolidin-1-yl)piperidin-1-yl)-4<i>H</i>-1,2,4-triazol-5-amine Bis-2,2,2-trifluoroacetate (<b>23</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>68</b> according to the general procedure C and was purified by preparative reversed-phase chromatography. Compound <b>23</b> (201 mg, 0.34 mmol) was obtained in the form of bis-trifluoroacetate salt. LC–MS (ES+) <i>m</i>/<i>z</i>: 361.0/363.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O): δ 7.40–7.37 (m, 2H), 7.36–7.32 (m, 2H), 3.89–3.789 (m, 3H, overlapping with water signal), 3.54–3.48 (m, 1H), 3.42 (dt, <i>J</i> = 11.6, 5.9 Hz, 1H), 3.24–3.15 (m, 2H), 2.89 (q, <i>J</i> = 11.9 Hz, 2H), 2.75 (dd, <i>J</i> = 13.4, 11.3 Hz, 1H), 2.12 (d, <i>J</i> = 12.3 Hz, 1H), 2.04 (d, <i>J</i> = 12.2 Hz, 1H), 1.94–1.83 (m, 3H), 1.75–1.69 (m, 1H), 1.65 (qd, <i>J</i> = 12.6, 5.3 Hz, 2H).</div></div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (<i>R</i>)-3-(2-(4-Chlorobenzyl)-[1,4′-bipiperidin]-1′-yl)-4<i>H</i>-1,2,4-triazol-5-amine Bis-2,2,2-trifluoroacetate (<b>24</b>)</h4><div id="sec4_1_24_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> Step 1: Synthesis of (<i>S</i>)-<i>N</i>-((<i>R</i>)-1-(4-Chlorophenyl)pent-4-en-2-yl)-2-methylpropane-2-sulfinamide (<b>42</b>)</h5><div class="NLM_p last">A solution of <i>p</i>-chlorophenylacetaldehyde (6.5 g, 42 mmol), (<i>S</i>)-2-methyl-2-propanesulfinamide (5.09 g, 42 mmol), and Ti(OEt)<sub>4</sub> (9.2 mL, 84 mmol) in anhydrous DCM (85 mL) was refluxed for 2 h, then slightly heated (ca. 30 °C) overnight with stirring. MgSO<sub>4</sub> was added, and after 15 min, the reaction was filtered through a pad of Celite. The filtrate was cooled to −20 °C, and a solution of allyl magnesium bromide (63 mL, 63 mmol, 1 M in diethyl ether) was added dropwise. Upon completion of the addition, the cooling bath was removed, and the reaction was allowed to warm to room temperature. After this, the reaction mixture was poured into a saturated solution of NH<sub>4</sub>Cl and extracted three times with diethyl ether. Combined organic extracts were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was purified by column chromatography in the hexanes/AcOEt (4:1) solvent system affording compound <b>42</b> as yellow oil (5.0 g, 23%). LC–MS (ES+) <i>m</i>/<i>z</i>: 300.1/302.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.24–7.21 (m, 2H), 7.11–7.07 (m, 2H), 5.81–5.71 (m, 1H), 5.18–5.10 (m, 2H), 3.54–3.46 (m, 1H), 3.33–3.28 (m, 1H), 2.78 (dd, <i>J</i> = 7.1, 13.7 Hz, 1H), 2.69 (dd, <i>J</i> = 6.4, 13.7 Hz, 1H), 2.40–2.32 (m, 1H), 2.31–2.23 (m, 1H), 1.08 (s, 9H).</div></div><div id="sec4_1_24_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> Step 2: Synthesis of (<i>S</i>)-<i>N</i>-Allyl-<i>N</i>-((<i>R</i>)-1-(4-chlorophenyl)pent-4-en-2-yl)-2-methylpropane-2-sulfinamide (<b>43</b>)</h5><div class="NLM_p last">To a solution of sulfinamide <b>24</b> (1 g, 3.33 mmol) in DMF (10 mL), sodium hydride (0.32 g, 6.66 mmol) was added. After 20 min, a solution of allyl bromide (0.57 mL, 6.66 mmol) in DMF (12 mL) was added dropwise, and the reaction mixture was allowed to stir for 1 h. After this time, the reaction mixture was poured into a saturated solution of NH<sub>4</sub>Cl and extracted several times with diethyl ether. Combined organic extracts were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was purified by column chromatography in hexanes/AcOEt (3:1) gave title compound <b>43</b> (0.78 g, 71%). LC–MS (ES+) <i>m</i>/<i>z</i>: 340.2/342.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, 348 K): δ 7.30–7.27 (m, 2H), 7.24–7.22 (m, 2H), 5.86–5.77 (m, 1H), 5.74–5.65 (m, 1H), 5.23 (dq, <i>J</i> = 17.2, 1.6 Hz, 1H), 5.16 (dq, <i>J</i> = 10.2, 1.5 Hz, 1H), 5.01–4.93 (m, 2H), 3.80 (ddt, <i>J</i> = 16.5, 5.4, 1.7 Hz, 1H), 3.36 (tt, <i>J</i> = 8.2, 5.7 Hz, 1H), 3.22 (dd, <i>J</i> = 16.5, 7.0 Hz, 1H), 2.99 (dd, <i>J</i> = 13.8, 5.7 Hz, 1H), 2.78 (dd, <i>J</i> = 13.8, 8.3 Hz, 1H), 2.38–2.30 (m, 1H), 2.23–2.15 (m, 1H), 1.07 (s, 9H).</div></div><div id="sec4_1_24_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> Step 3: Synthesis of (<i>R</i>)-1-((<i>S</i>)-<i>tert</i>-Butylsulfinyl)-2-(4-chlorobenzyl)-1,2,3,6-tetrahydropyridine (<b>44</b>)</h5><div class="NLM_p last">A solution of starting diene <b>43</b> (0.78 g, 2.29 mmol) and Grubbs catalyst first generation (90 mg, 0.1 mmol) in DCM (40 mL) was refluxed for 1.5 h. After this time, the reaction mixture was cooled down and concentrated. The desired product was isolated by silica-gel column chromatography in hexanes/AcOEt (10:1) providing <b>44</b> (0.67 g, 94%). LC–MS (ES+) <i>m</i>/<i>z</i>: 312.2/314.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, 348 K): δ 7.35–7.32 (m, 2H), 7.32–7.29 (m, 2H), 5.76–5.68 (m, 2H), 3.77–3.72 (m, 1H), 3.63 (dt, <i>J</i> = 8.9, 6.2 Hz, 1H), 3.49–3.42 (m, 1H), 2.91 (dd, <i>J</i> = 13.6, 9.1 Hz, 1H), 2.75 (dd, <i>J</i> = 13.6, 6.3 Hz, 1H), 2.37–2.29 (m, 1H), 1.93–1.88 (m, 1H), 0.80 (s, 9H).</div></div><div id="sec4_1_24_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> Step 4: Synthesis of (<i>R</i>)-1-((<i>S</i>)-<i>tert</i>-Butylsulfinyl)-2-(4-chlorobenzyl)piperidine (<b>45</b>)</h5><div class="NLM_p last">To a solution of olefin <b>44</b> (0.62 g, 1.98 mmol) in MeOH (5 mL), a catalytic amount of 10% palladium on activated carbon was added. The reaction mixture was stirred under hydrogen overnight. After this time, the catalyst was filtered off through a Celite pad, and the filtrate was concentrated to dryness and purified by column chromatography using hexanes/AcOEt (4:1), affording piperidine <b>45</b> (0.48 g, 77%). LC–MS (ES+) <i>m</i>/<i>z</i>: 314.2/316.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, 348 K): δ 7.32–7.26 (m, 2H), 7.26–7.20 (m, 2H), 3.53–3.47 (m, 1H), 3.17–3.11 (m, 2H), 3.04 (dd, <i>J</i> = 13.6, 6.6 Hz, 1H), 2.84 (dd, <i>J</i> = 13.6, 8.5 Hz, 1H), 1.75–1.66 (m, 1H), 1.60–1.52 (m, 1H), 1.54–1.45 (m, 3H), 1.44–1.37 (m, 1H), 0.97 (s, 9H).</div></div><div id="sec4_1_24_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> Step 5: Synthesis of (<i>R</i>)-2-(4-Chlorobenzyl)piperidine (<b>46</b>)</h5><div class="NLM_p last">Compound <b>45</b> (0.48 g, 1.5 mmol) was treated with 2 M HCl (gas) in MeOH at room temperature for 1 h, and then the reaction was concentrated to dryness. The residue was taken between DCM and 1 M NaOH and phases were separated. The aqueous phase was extracted with DCM, and the organics were combined, dried, and concentrated to give unprotected piperidine <b>46</b> (0.23 g, 72%). LC–MS (ES+) <i>m</i>/<i>z</i>: 210.2/212.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.27–7.21 (m, 2H), 7.14–7.08 (m, 2H), 3.00 (dq, <i>J</i> = 11.8, 2.0 Hz, 1H), 2.71–2.60 (m, 2H), 2.54 (m, 2H), 1.80–1.73 (m, 1H), 1.66 (s, 1H), 1.61–1.53 (m, 1H), 1.43 (m, 1H), 1.34–1.23 (m, 1H), 1.22–1.13 (m, 1H).</div></div><div id="sec4_1_24_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> Step 6: Synthesis of <i>tert</i>-Butyl (<i>R</i>)-2-(4-Chlorobenzyl)-[1,4′-bipiperidine]-1′-carboxylate (<b>69</b>)</h5><div class="NLM_p last"><i>N</i>-Boc-4-piperidone (<b>31</b>) was reductively aminated with (<i>R</i>)-2-(4-chlorobenzyl)piperidine (<b>46</b>) according to the general procedure B. The product was purified by column chromatography using hexanes/AcOEt (4:1), providing <b>69</b> (0.17 g, 40%). LC–MS (ES+) <i>m</i>/<i>z</i>: 393.1/395.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_24_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> Step 7: Synthesis of (<i>R</i>)-3-(2-(4-Chlorobenzyl)-[1,4′-bipiperidin]-1′-yl)-4<i>H</i>-1,2,4-triazol-5-amine Bis-2,2,2-trifluoroacetate (<b>24</b>)</h5><div class="NLM_p last">The title compound was prepared according to the general procedure C and purified by preparative HPLC to give <b>24</b> as a bis-trifluoroacetate salt (40 mg, 28%). LC–MS (ES+) <i>m</i>/<i>z</i>: 375.1/377.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.42–7.38 (m, 2H), 7.35–7.28 (m, 2H), 3.65–3.56 (m, 1H), 3.56–3.48 (m, 1H), 3.45–3.33 (m, 1H), 3.15–3.02 (m, 1H), 3.02–2.86 (m, 2H), 2.88–2.80 (m, 1H), 2.71 (dd, <i>J</i> = 13.7, 9.8 Hz, 1H), 2.27–2.15 (m, 1H), 1.98–1.92 (m, 1H), 1.92–1.76 (m, 2H), 1.69–1.56 (m, 4H), 1.50–1.40 (m, 1H), 1.40–1.31 (m, 1H), 2 protons overlapping with water signal.</div></div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 3-(4-((2<i>S</i>,3<i>S</i>)-2-(4-Chlorobenzyl)-3-methoxyazetidin-1-yl)piperidin-1-yl)-4<i>H</i>-1,2,4-triazol-5-amine 2,2,2-Trifluoroacetate (<b>25</b>)</h4><div id="sec4_1_25_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> Step 1: (<i>S</i>)-(1-(4-Chlorophenyl)-4-diazo-3-oxobutan-2-yl)carbamate (<b>48</b>)</h5><div class="NLM_p last">To a solution of (<i>S</i>)-2-((<i>tert</i>-butoxycarbonyl)amino)-3-(4-chlorophenyl)propanoic acid (17.2 g, 57 mmol) in THF (200 mL) was added TEA (17 mL, 120 mmol) and methyl chloroformate (4.87 mL, 63 mmol) at −10 °C. After 15 min, a solution of diazomethane (342 mmol) in diethyl ether (400 mL) was added at −30 °C. The reaction mixture was allowed to warm and stirred overnight at room temperature. The excess of diazomethane was destroyed by a dropwise addition of AcOH (15 mL). The mixture was diluted with diethyl ether and washed with 5% NaHCO<sub>3</sub>, saturated NH<sub>4</sub>Cl, and brine. The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure to give title product <b>48</b> as an orange solid (18.0 g, 96%). LC–MS (ES+) <i>m</i>/<i>z</i>: 325.8/327.8 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>) 7.28 (d, <i>J</i> = 8.4 Hz, 2H), 7.13 (d, <i>J</i> = 8.3 Hz, 2H), 5.26 (br s, 1H), 5.07 (br s, 1H), 4.40 (br s, 1H), 3.03 (dd, <i>J</i> = 14.0, 7.0 Hz, 1H), 2.97 (dd, <i>J</i> = 13.5, 6.1 Hz, 1H), 1.42 (s, 9H).</div></div><div id="sec4_1_25_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> Step 2: <i>tert</i>-Butyl (<i>S</i>)-2-(4-Chlorobenzyl)-3-oxoazetidine-1-carboxylate (<b>49</b>)</h5><div class="NLM_p last">To a solution of compound <b>48</b> (3.6 g, 11 mmol) in DCM (55 mL), triethylamine (16 μL, 0.11 mmol) was added. The reaction mixture was cooled to 0 °C and rhodium acetate (25 mg, 0.056 mmol) was added. The cooling bath was removed, and the reaction was stirred at room temperature overnight. The mixture was diluted with water (50 mL), phases were separated, and the aqueous layer was extracted with DCM. The combined organics were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude residue was purified by flash chromatography using hexanes/AcOEt (15:1) solvent system to give title product <b>49</b> as colorless oil (1.5 g, 46%). LC–MS (ES+) <i>m</i>/<i>z</i>: 296.1/298.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.28–7.23 (m, 2H), 7.14–7.09 (m, 2H), 5.10 (dt, <i>J</i> = 6.4, 4.2 Hz, 1H), 4.55 (d, <i>J</i> = 16.6 Hz, 1H), 4.07 (dd, <i>J</i> = 16.6, 4.4 Hz, 1H), 3.16 (dd, <i>J</i> = 14.4, 6.4 Hz, 1H), 3.07 (dd, <i>J</i> = 14.3, 4.1 Hz, 1H), 1.47 (s, 9H).</div></div><div id="sec4_1_25_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> Step 3: <i>tert</i>-Butyl (2<i>S</i>,3<i>S</i>)-2-(4-Chlorobenzyl)-3-hydroxyazetidine-1-carboxylate (<b>50</b>)</h5><div class="NLM_p last">Boc-protected azetidinone <b>49</b> (1.5 g, 5.07 mmol) was dissolved in MeOH (20 mL), and sodium borohydride (0.23 g, 6.1 mmol) was added at 0 °C. The reaction mixture was allowed to warm and stirred at room temperature for 1 h, after which time it was quenched with 15 mL of 1 M NaOH. MeOH was evaporated under reduced pressure, and the aqueous layer was extracted with AcOEt. The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude residue was purified by flash chromatography using the hexanes/AcOEt (5:1) solvent system yielding a mixture of diastereoisomers in a 10:1 ratio. Minor diasteroisomer was rejected by crystallization from DCM/hexanes to give the title product <b>50</b> (1.3 g, 86%). LC–MS (ES+) <i>m</i>/<i>z</i>: 320.2/322.2 [M + Na]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>): δ 7.26–7.24 (m, 2H), 7.21 (d, <i>J</i> = 8.1 Hz, 2H), 4.59 (qd, <i>J</i> = 6.6, 4.0 Hz, 1H), 4.45–4.39 (m, 1H), 4.14 (dd, <i>J</i> = 9.8, 7.0 Hz, 1H), 3.70 (ddd, <i>J</i> = 9.8, 4.0, 1.1 Hz, 1H), 3.20 (dd, <i>J</i> = 13.9, 9.6 Hz, 1H), 3.14 (br s, 1H), 1.83 (d, <i>J</i> = 5.8 Hz, 1H), 1.41 (s, 9H).</div></div><div id="sec4_1_25_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> Step 4: <i>tert</i>-Butyl (2<i>S</i>,3<i>S</i>)-2-(4-Chlorobenzyl)-3-methoxyazetidine-1-carboxylate (<b>51</b>)</h5><div class="NLM_p last">To a solution of compound <b>50</b> (0.4 g, 1.34 mmol) in DMF (4 mL) was added sodium hydride (0.16 g, 4.04 mmol). The mixture was stirred for 5 min, and then methyl iodide (250 μL, 4.04 mmol) was added and stirring was continued at room temperature for 1 h, after which time the reaction mixture was diluted with water (15 mL) and extracted several times with diethyl ether. The combined organic layers were washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated under reduced pressure to give title product <b>51</b> as colorless oil (418 mg, 100%). LC–MS (ES+) <i>m</i>/<i>z</i>: 334.1/336.1 [M + Na]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>): δ 7.25–7.21 (m, 2H), 7.19 (d, <i>J</i> = 8.1 Hz, 2H), 4.54–4.33 (m, 1H), 4.09 (q, <i>J</i> = 6.1 Hz, 1H), 4.02 (t, <i>J</i> = 8.1 Hz, 1H), 3.75 (ddd, <i>J</i> = 9.5, 4.2, 1.0 Hz, 1H), 3.23 (s, 3H), 3.17 (dd, <i>J</i> = 13.8, 9.1 Hz, 1H), 3.06 (d, <i>J</i> = 14.0 Hz, 1H), 1.39 (s, 9H).</div></div><div id="sec4_1_25_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> Step 5: (2<i>S</i>,3<i>S</i>)-2-(4-Chlorobenzyl)-3-methoxyazetidine Hydrochloride (<b>52</b>)</h5><div class="NLM_p last">Compound <b>51</b> (418 mg, 1.34 mmol) was treated with 4 M HCl (gas) in 1,4-dioxane (2.2 mL, 8.8 mmol). The reaction mixture was stirred for 1 h at room temperature. The volatiles were evaporated under reduced pressure, and the residue was triturated with diethyl ether to give title product <b>52</b> as a white solid in a form of hydrochloride salt (256 mg, 77%). LC–MS (ES+) <i>m</i>/<i>z</i>: 212.1/214.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O): δ 7.36–7.33 (m, 2H), 7.30–7.27 (m, 2H), 4.74 (dt, <i>J</i> = 8.5, 6.5 Hz, 1H), 4.24 (td, <i>J</i> = 6.1, 3.5 Hz, 1H), 4.10 (dd, <i>J</i> = 11.5, 5.9 Hz, 1H), 3.70 (dd, <i>J</i> = 11.5, 3.5 Hz, 1H), 3.26 (s, 3H), 3.18 (dd, <i>J</i> = 14.8, 6.8 Hz, 1H), 3.08 (dd, <i>J</i> = 14.9, 8.7 Hz, 1H).</div></div><div id="sec4_1_25_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> Step 6: <i>tert</i>-Butyl 4-((2<i>S</i>,3<i>S</i>)-2-(4-Chlorobenzyl)-3-methoxyazetidin-1-yl)piperidine-1′-carboxylate (<b>70</b>)</h5><div class="NLM_p last">The title compound was prepared according to the general procedure B starting from 250 mg (1 mmol) of azetidine <b>52</b>. The crude post-reaction residue was loaded on silica gel and eluted with the hexanes/AcOEt (1:1) solvent system yielding 209 mg (0.53 mmol, 53%) of pure compound <b>70</b> in a form of colorless oil. LC–MS (ES+) <i>m</i>/<i>z</i>: 395.1/397.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, CDCl<sub>3</sub>): δ 7.24–7.20 (m, 2H), 7.15–7.11 (m, 2H), 4.08–3.91 (m, 2H), 3.82 (td, <i>J</i> = 5.6, 1.3 Hz, 1H), 3.44 (d, <i>J</i> = 8.8 Hz, 1H), 3.38–3.31 (m, 2H), 3.30 (s, 3H), 2.84 (dd, <i>J</i> = 8.8, 5.4 Hz, 1H), 2.79–2.72 (m, 2H), 2.59 (dd, <i>J</i> = 12.8, 2.4 Hz, 1H), 2.24 (tt, <i>J</i> = 10.1, 3.8 Hz, 1H), 1.72 (d, <i>J</i> = 12.3 Hz, 1H), 1.60 (d, <i>J</i> = 12.7 Hz, 1H), 1.45 (s, 9H), 1.41–1.32 (m, 1H), 1.30–1.22 (m, 1H).</div></div><div id="sec4_1_25_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i68" class="anchor-spacer"></div><h5 class="article-section__title" id="_i68"> Step 7: 3-(4-((2<i>S</i>,3<i>S</i>)-2-(4-Chlorobenzyl)-3-methoxyazetidin-1-yl)piperidin-1-yl)-4<i>H</i>-1,2,4-triazol-5-amine 2,2,2-Trifluoroacetate (<b>25</b>)</h5><div class="NLM_p last">The title compound was prepared according to the general procedure C and purified by preparative HPLC to give <b>25</b> as a bis-trifluoroacetate salt (80 mg, 25%). LC–MS (ES+) <i>m</i>/<i>z</i>: 377.0/378.9 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O): δ 7.39–7.35 (m, 2H), 7.33–7.27 (m, 2H), 4.84 (dt, <i>J</i> = 10.9, 5.5 Hz, 1H), 4.13–4.05 (m, 2H), 3.96 (dd, <i>J</i> = 11.4, 2.0 Hz, 1H), 3.75–3.71 (m, 2H), 3.41–3.30 (m, 2H), 3.26 (s, 3H), 2.95 (dd, <i>J</i> = 14.0, 5.0 Hz, 1H), 2.82 (dddd, <i>J</i> = 13.0, 10.3, 7.6, 2.7 Hz, 2H), 1.96–1.86 (m, 2H), 1.36 (dqd, <i>J</i> = 20.1, 12.1, 4.5 Hz, 2H).</div></div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> (3<i>S</i>,5<i>S</i>)-1-(1-(3-Amino-4<i>H</i>-1,2,4-triazol-5-yl)piperidin-4-yl)-5-(4-chlorobenzyl)pyrrolidin-3-ol 2,2,2-Trifluoroacetate (<b>26</b>)</h4><div id="sec4_1_26_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70"> Step 1: Synthesis of <i>tert</i>-Butyl (2<i>R</i>,4<i>S</i>)-4-Hydroxy-2-(methoxy(methyl)carbamoyl)pyrrolidine-1-carboxylate (<b>54</b>)</h5><div class="NLM_p last">The title compound was prepared by a similar procedure as that used for compound <b>37</b> starting from Boc-<span class="smallcaps smallerCapital">d</span>-hydroxyproline. Purification by column chromatography (hexanes/AcOEt, 2:1) provided <b>54</b> as a colorless oil (4.15 g, 49%). LC–MS (ES+) <i>m</i>/<i>z</i>: 274.9. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, 348 K): δ 4.67 (t, <i>J</i> = 7.3 Hz, 1H), 4.28–4.23 (m, 1H), 3.68 (s, 3H), 3.41–3.36 (m, 1H), 3.29 (dt, <i>J</i> = 11.2, 1.9 Hz, 1H), 3.10 (s, 3H), 2.18–2.06 (m, 1H), 1.87–1.79 (m, 1H), 1.37 (s), 1.32 (s) (integrations of signals at 1.37 and 1.32 ppm summarize to 9H).</div></div><div id="sec4_1_26_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> Step 2: Synthesis of <i>tert</i>-Butyl (2<i>R</i>,4<i>S</i>)-4-((<i>tert</i>-Butyldimethylsilyl)oxy)-2-(methoxy(methyl)carbamoyl)pyrrolidine-1-carboxylate (<b>55</b>)</h5><div class="NLM_p last">To a solution of compound <b>54</b> (5 g, 18.22 mmol) in DMF (60 mL), imidazole (6.2 g, 91.13 mmol) was added followed by TBDMSCl (4.1 g, 27.33 mmol), and the reaction mixture was stirred overnight. After this time, the reaction mixture was diluted with water (250 mL) and extracted several times with AcOEt. Combined organics were washed with water, brine, dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated. The crude product was purified by column chromatography (hexanes/AcOEt, 8:1) to give 6.50 g of <b>55</b> as a colorless oil (16.7 mmol, 92%). LC–MS (ES+) <i>m</i>/<i>z</i>: 289.7 [M – Boc + H]<sup>+</sup>, 411.1 [M + Na]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, 348 K): δ 4.70–4.63 (m, 1H), 4.42 (qd, <i>J</i> = 4.2, 1.7 Hz, 1H), 3.44–3.41 (m, 4H), 3.31–3.24 (m, 1H), 3.10 (s, 3H), 2.13–2.05 (m, 1H), 1.90–1.83 (m, 1H), 1.35 (br s), 1.31 (br s) (integrations of signals at 1.35 and 1.31 ppm summarize to 9H), 0.84 (s, 9H), 0.04 (s, 6H).</div></div><div id="sec4_1_26_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i72" class="anchor-spacer"></div><h5 class="article-section__title" id="_i72"> Step 3: Synthesis of (2<i>R</i>,4<i>S</i>)-<i>tert</i>-Butyl 4-((<i>tert</i>-Butyldimethylsilyl)oxy)-2-(4-chlorobenzoyl)pyrrolidine-1-carboxylate (<b>56</b>)</h5><div class="NLM_p last">The title compound was prepared by a similar procedure as that used for compound <b>38</b> and purified by column chromatography (hexanes/AcOEt, 10:1) to give <b>56</b> as a colorless oil (970 mg, 86%). LC–MS (ES+) <i>m</i>/<i>z</i>: 340.0/341.9 [M – Boc + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, presence of 2 rotamers): δ 7.97–7.95 (m, 2H), 7.61–7.59 (m, 2H), 5.27–5.22 (m, 1H), 4.44–4.39 (m, 1H), 3.52 (dd, <i>J</i> = 11.4, 4.4 Hz, 1H, rotamer), 3.48 (dd, <i>J</i> = 11.4, 4.4 Hz, 1H, rotamer), 3.34 (m, 1H, rotamer), 3.30 (m, 1H, rotamer), 2.24–2.19 (m, 1H), 1.92 (ddd, <i>J</i> = 12.9, 7.8, 4.8 Hz, 1H, rotamer), 1.85 (ddd, <i>J</i> = 13.0, 7.7, 4.8 Hz, 1H, rotamer), 1.34 (s, 9H, rotamer), 1.11 (s, 9H, rotamer), 0.83 (s, 9H), 0.04 (s, 6H, rotamer), 0.03 (s, 6H, rotamer).</div></div><div id="sec4_1_26_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i73" class="anchor-spacer"></div><h5 class="article-section__title" id="_i73"> Step 4: Synthesis of (3<i>S</i>,5<i>S</i>)-5-(4-Chlorobenzyl)pyrrolidin-3-ol (<b>57</b>)</h5><div class="NLM_p last">Starting from 883 mg (2 mmol) of <b>56</b>, the title compound was prepared by a similar procedure as that used for compound <b>39</b>. Crude <b>57</b> (0.35 g, 1.65 mmol, 81%) was obtained in the form of a yellowish oil that was sufficiently pure to be used in the next step without further purification. LC–MS (ES+) <i>m</i>/<i>z</i>: 212.0/213.9 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_26_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i74" class="anchor-spacer"></div><h5 class="article-section__title" id="_i74"> Step 5: Synthesis of <i>tert</i>-Butyl 4-((2<i>S</i>,4<i>S</i>)-2-(4-Chlorobenzyl)-4-hydroxypyrrolidin-1-yl)piperidine-1-carboxylate (<b>71</b>)</h5><div class="NLM_p last">The title compound was prepared according to the general procedure B starting from 176 mg (0.83 mmol) of <b>57</b>. It was purified by silica-gel column chromatography using the hexanes/AcOEt (4:1) solvent system yielding 147 mg of <b>70</b> (0.37 mmol, 45%). LC–MS (ES+) <i>m</i>/<i>z</i>: 295.4/297.3 [M – Boc + 1]<sup>+</sup>, 395.4/397.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, 348 K): δ 7.29–7.26 (m, 2H), 7.21–7.18 (m, 2H), 4.08–4.02 (m, 1H), 3.97–3.91 (m, 2H), 2.99 (dd, <i>J</i> = 9.7, 5.8 Hz, 1H), 2.82 (dd, <i>J</i> = 13.4, 4.3 Hz, 1H), 2.80–2.73 (m, 1H), 2.72–2.62 (m, 2H), 2.43 (dd, <i>J</i> = 9.6, 4.7 Hz, 1H), 2.42–2.38 (m, 2H), 1.74–1.67 (m, 2H), 1.58 (dt, <i>J</i> = 13.0, 6.6 Hz, 1H), 1.53–1.46 (m, 1H), 1.38 (s, 9H), 1.35–1.21 (m, 2H).</div></div><div id="sec4_1_26_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i75" class="anchor-spacer"></div><h5 class="article-section__title" id="_i75"> Step 6: Synthesis of (3<i>S</i>,5<i>S</i>)-1-(1-(3-Amino-1<i>H</i>-1,2,4-triazol-5-yl)piperidin-4-yl)-5-(4-chlorobenzyl)pyrrolidin-3-ol Bis-2,2,2-trifluoroacetate (<b>26</b>)</h5><div class="NLM_p last">The title compound was prepared according to the general procedure C and purified by preparative HPLC to give <b>26</b> as a bis-trifluoroacetate salt (80 mg, 44%). LC–MS (ES+) <i>m</i>/<i>z</i>: 377.2/379.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O): δ 7.40–7.38 (m, 2H), 7.34 (d, <i>J</i> = 8.4 Hz, 2H), 4.33 (s, 1H), 4.02–3.94 (m, 1H), 3.64–3.56 (m, 1H), 3.48 (dd, <i>J</i> = 12.8, 4.3 Hz, 1H), 3.31 (dd, <i>J</i> = 12.9, 4.0 Hz, 1H), 3.23 (d, <i>J</i> = 12.7 Hz, 1H), 2.90 (t, <i>J</i> = 11.9 Hz, 2H), 2.79 (t, <i>J</i> = 12.0 Hz, 1H), 2.10–2.03 (m, 2H), 1.85–1.78 (m, 1H), 1.77–1.72 (m, 1H), 1.72–1.60 (m, 2H).</div></div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 5-(4-((2<i>S</i>,4<i>S</i>)-2-(4-Chlorobenzyl)-4-methoxypyrrolidin-1-yl)piperidin-1-yl)-4<i>H</i>-1,2,4-triazol-3-amine 2,2,2-Trifluoroacetate (<b>27</b>)</h4><div id="sec4_1_27_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i77" class="anchor-spacer"></div><h5 class="article-section__title" id="_i77"> Step 1: Synthesis of <i>tert</i>-Butyl 4-((2<i>S</i>,4<i>S</i>)-2-(4-Chlorobenzyl)-4-methoxypyrrolidin-1-yl)piperidine-1-carboxylate (<b>74</b>)</h5><div class="NLM_p last">Starting from 101 mg of compound <b>71</b> (0.25 mmol), the title compound was prepared by a similar procedure as that used for compound <b>50</b>. Purification by column chromatography (hexanes/AcOEt, 1:1) gave 120 mg of <b>73</b> as a yellowish oil (0.24 mmol, 95%). LC–MS (ES+) <i>m</i>/<i>z</i>: 409.1/411.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, 348 K): δ 7.31–7.28 (m, 2H), 7.22–7.19 (m, 2H), 3.98–3.89 (m, 2H), 3.76–3.70 (m, 1H), 3.11–3.07 (m, 1H), 3.08 (s, 3H), 2.99 (dt, <i>J</i> = 9.0, 4.5 Hz, 1H), 2.85 (dd, <i>J</i> = 13.2, 4.1 Hz, 1H), 2.78 (td, <i>J</i> = 11.7, 10.9, 5.6 Hz, 1H), 2.75–2.55 (m, 2H), 2.47 (dd, <i>J</i> = 9.6, 3.9 Hz, 1H), 2.34 (dd, <i>J</i> = 13.2, 9.2 Hz, 1H), 1.72–1.65 (m, 2H), 1.58–1.51 (m, 1H), 1.53–1.46 (m, 1H), 1.37 (s, 9H), 1.33–1.24 (m, 1H), 1.23–1.16 (m, 1H).</div></div><div id="sec4_1_27_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i78" class="anchor-spacer"></div><h5 class="article-section__title" id="_i78"> Step 2: Synthesis of 5-(4-((2<i>S</i>,4<i>S</i>)-2-(4-Chlorobenzyl)-4-methoxypyrrolidin-1-yl)piperidin-1-yl)-1<i>H</i>-1,2,4-triazol-3-amine Bis-2,2,2-trifluoroacetate (<b>27</b>)</h5><div class="NLM_p last">The title compound was prepared according to the general procedure C and purified by preparative HPLC to give <b>27</b> as a bis-trifluoroacetate salt (11 mg, 8%). LC–MS (ES+) <i>m</i>/<i>z</i>: 391.2/393.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O): δ 7.40 (d, <i>J</i> = 8.5 Hz, 2H), 7.35 (d, <i>J</i> = 8.5 Hz, 2H), 4.01 (s, 1H), 3.94–3.80 (m, 3H), 3.56–3.41 (m, 3H), 3.31 (d, <i>J</i> = 10.9 Hz, 1H), 3.17 (s, 3H), 2.89–2.77 (m, 3H), 2.02 (br s, 2H), 1.92 (br s, 1H), 1.83–1.76 (m, 1H), 1.65 (dd, <i>J</i> = 5.1, 9.7 Hz, 2H).</div></div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> (3<i>R</i>,5<i>S</i>)-1-(1-(3-Amino-1<i>H</i>-1,2,4-triazol-5-yl)piperidin-4-yl)-5-(4-chlorobenzyl)pyrrolidin-3-ol 2,2,2-Trifluoroacetate (<b>28</b>)</h4><div id="sec4_1_28_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i80" class="anchor-spacer"></div><h5 class="article-section__title" id="_i80"> Step 1: Synthesis of (2<i>R</i>,4<i>R</i>)-1-<i>tert</i>-Butyl 2-Methyl 4-(<i>tert</i>-Butoxy)pyrrolidine-1,2-dicarboxylate (<b>59</b>)</h5><div class="NLM_p last">To a solution of 16.06 g (65.5 mmol) of 1-<i>tert</i>-butyl 2-methyl (2<i>R</i>,4<i>R</i>)-4-hydroxypyrrolidine-1,2-dicarboxylate (<b>58</b>) in DCM (100 mL), Mg(ClO<sub>4</sub>)<sub>2</sub> (1.46 g, 6.55 mmol) was added, followed by Boc<sub>2</sub>O (32.87 g, 150.6 mmol), and the reaction mixture was stirred overnight. The following day, another portions of Mg(ClO<sub>4</sub>)<sub>2</sub> (1.46 g, 6.55 mmol) and Boc<sub>2</sub>O (44.30 g, 203 mmol) were added, and the reaction mixture was stirred overnight, after which time LC–MS control indicated completion of the reaction. The reaction mixture was filtrated and evaporated to dryness. Purification by column chromatography (hexanes/AcOEt, 9:1) afforded 13.51 g (44.8 mmol, 68%) of compound <b>59</b> as a white crystalline solid. LC–MS (ES+) <i>m</i>/<i>z</i>: 302.4 [M + H]<sup>+</sup>, 324.3 [M + Na]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, presence of 2 rotamers in 2:1 ratio): δ 4.24–4.19 (m, 1H), 4.17–4.13 (m, 1H), 3.61 (s, 3H, major rotamer), 3.58 (s, 3H, minor rotamer), 3.54–3.51 (m, 1H), 2.99–2.94 (m, 1H), 2.38–2.30 (m, 1H), 1.75–1.71 (m, 1H), 1.36 (s, 9H, minor rotamer), 1.29 (s, 9H, major rotamer), 1.08 (s, 9H, major rotamer), 1.07 (s, 9H, minor rotamer).</div></div><div id="sec4_1_28_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i81" class="anchor-spacer"></div><h5 class="article-section__title" id="_i81"> Step 2: Synthesis of (2<i>R</i>,4<i>R</i>)-4-(<i>tert</i>-Butoxy)-1-(<i>tert</i>-butoxycarbonyl)pyrrolidine-2-carboxylic Acid (<b>60</b>)</h5><div class="NLM_p last">Compound <b>59</b> (13.5 g, 44.8 mmol) was dissolved in a mixture of 200 mL of THF and 100 mL of MeOH. Solution of lithium hydroxide hydrate in 100 mL of water was added to the reaction mixture and the resulting mixture was stirred overnight. After LC–MS control had indicated completion of the reaction, the reaction mixture was concentrated and the aqueous residue was carefully acidified to pH 4 by dropwise addition of 2 M HCl at 0 °C and the product was extracted with AcOEt. The organic layer was washed with brine, dried over MgSO<sub>4</sub>, filtered, and evaporated, affording 12.1 g (42.1 mmol, 94%) of the title compound <b>60</b> as a yellowish oil, which was used in the next step without further purification. LC–MS (ES+) <i>m</i>/<i>z</i>: 310.3 [M + Na]<sup>+</sup>, 286.0 [M – H]<sup>−</sup>.</div></div><div id="sec4_1_28_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i82" class="anchor-spacer"></div><h5 class="article-section__title" id="_i82"> Step 3: Synthesis of (2<i>R</i>,4<i>R</i>)-<i>tert</i>-Butyl 4-(<i>tert</i>-Butoxy)-2-(methoxy(methyl)carbamoyl)pyrrolidine-1-carboxylate (<b>61</b>)</h5><div class="NLM_p last">Starting from 12.1 g (42.2 mmol) of the crude carboxylic acid <b>60</b>, the title compound was prepared by a similar procedure as that used for compound <b>37</b>. Purification by column chromatography (hexanes/AcOEt, 5:1) afforded 9.34 g of <b>61</b> as a white crystalline solid (28.3 mmol, 67%). LC–MS (ES+) <i>m</i>/<i>z</i>: 331.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, 348 K): δ 4.49 (t, <i>J</i> = 8.4 Hz, 1H), 4.20 (q, <i>J</i> = 7.7 Hz, 1H), 3.66–3.63 (m, 4H), 3.09 (s, 3H), 2.91 (br s, 1H), 2.47 (dt, <i>J</i> = 2.3, 7.9 Hz, 1H), 1.54–1.50 (m, 1H), 1.31 (br s, 9H), 1.11 (s, 9H).</div></div><div id="sec4_1_28_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i83" class="anchor-spacer"></div><h5 class="article-section__title" id="_i83"> Step 4: Synthesis of (2<i>R</i>,4<i>R</i>)-<i>tert</i>-Butyl 4-(<i>tert</i>-Butoxy)-2-(4-chlorobenzoyl)pyrrolidine-1-carboxylate (<b>62</b>)</h5><div class="NLM_p last">Starting from 4.55 g (13.8 mmol) of the Weinreb amide <b>61</b>, the title compound was prepared by a similar procedure as that used for compound <b>38</b>. Purification by column chromatography (hexanes/AcOEt, 9:1) afforded 2.11 g of <b>62</b> (5.52 mmol, 40%) as a white solid. LC–MS (ES+) <i>m</i>/<i>z</i>: 326.3/328.3 [M – <sup><i>t</i></sup>Bu + 1]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, presence of two rotamers in 1:1 ratio): δ 7.96–7.86 (m, 2H), 7.59–7.53 (m, 2H), 5.13–5.06 (m, 1H), 4.30–4.22 (m, 1H), 3.67–3.59 (m, 1H), 3.04–2.97 (m, 1H), 2.62–2.53 (m, 1H), 1.57–1.49 (m, 1H), 1.33 (s, 3H, rotamer), 1.11 (s, 6H, rotamer), 1.04 (s, 6H, rotamer), 1.01 (s, 3H, rotamer).</div></div><div id="sec4_1_28_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i84" class="anchor-spacer"></div><h5 class="article-section__title" id="_i84"> Step 5: Synthesis of (3<i>R</i>,5<i>S</i>)-5-(4-Chlorobenzyl)pyrrolidin-3-ol (<b>63</b>)</h5><div class="NLM_p last">Starting from 359 mg (0.94 mmol) of the ketone <b>62</b>, the title compound was prepared by a similar procedure as that used for <b>39</b> to give 195 mg of crude <b>63</b> (0.92 mmol, 98%) as a yellow oil that was used in the following reductive amination step without further purification. LC–MS (ES+) <i>m</i>/<i>z</i>: 212.2/214.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_28_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i85" class="anchor-spacer"></div><h5 class="article-section__title" id="_i85"> Step 6: Synthesis of <i>tert</i>-Butyl 4-((2<i>S</i>,4<i>R</i>)-2-(4-Chlorobenzyl)-4-hydroxypyrrolidin-1-yl)piperidine-1-carboxylate (<b>72</b>)</h5><div class="NLM_p last">The title compound was prepared according to the general procedure B starting from compound <b>63</b> obtained in the previous step. It was purified by silica-gel column chromatography using the hexanes/AcOEt (4:1) solvent system yielding 146 mg of <b>70</b> (0.37 mmol, 40%). LC–MS (ES+) <i>m</i>/<i>z</i>: 295.4/297.3 [M – Boc + 1]<sup>+</sup>, 395.4/397.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, 348 K): δ 7.28–7.23 (m, 2H), 7.20–7.16 (m, 2H), 4.08–4.02 (m, 1H), 3.92–3.86 (m, 2H), 3.03–2.97 (m, 2H), 2.84 (dd, <i>J</i> = 13.3, 4.5 Hz, 1H), 2.75 (dd, <i>J</i> = 10.1, 6.1 Hz, 1H), 2.71–2.60 (m, 4H), 2.55 (dd, <i>J</i> = 13.3, 9.1 Hz, 1H), 1.84–1.76 (m, 1H), 1.70–1.61 (m, 2H), 1.36 (s, 9H), 1.31–1.12 (m, 2H).</div></div><div id="sec4_1_28_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i86" class="anchor-spacer"></div><h5 class="article-section__title" id="_i86"> Step 7: Synthesis of (3<i>R</i>,5<i>S</i>)-1-(1-(3-Amino-1<i>H</i>-1,2,4-triazol-3-yl)piperidin-5-yl)-5-(4-chlorobenzyl)pyrrolidin-3-ol Bis-2,2,2-trifluoroacetate (<b>28</b>)</h5><div class="NLM_p last">The title compound was prepared according to the general procedure C and purified by preparative HPLC to give <b>28</b> as a bis-trifluoroacetate salt (105 mg, 33%). LC–MS (ES+) <i>m</i>/<i>z</i>: 377.4/379.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, 348 K): δ 7.39–7.36 (m, 2H), 7.33–7.30 (m, 2H), 4.44–4.39 (m, 1H), 4.02–3.95 (m, 1H), 3.91–3.83 (m, 2H), 3.56–3.46 (m, 1H), 3.43–3.37 (m, 1H), 3.37–3.28 (m, 1H), 3.25 (dd, <i>J</i> = 13.5, 4.4 Hz, 1H), 3.04 (dd, <i>J</i> = 13.5, 11.3 Hz, 1H), 2.94–2.85 (m, 2H), 2.22–2.17 (m, 1H), 2.17–2.09 (m, 1H), 2.07–2.00 (m, 1H), 1.84–1.68 (m, 3H).</div></div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> 5-(4-((2<i>S</i>,4<i>R</i>)-2-(4-Chlorobenzyl)-4-methoxypyrrolidin-1-yl)piperidin-1-yl)-1<i>H</i>-1,2,4-triazol-3-amine 2,2,2-Trifluoroacetate (<b>29</b>)</h4><div id="sec4_1_29_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i88" class="anchor-spacer"></div><h5 class="article-section__title" id="_i88"> Step 1: Synthesis of <i>tert</i>-Butyl 4-((2<i>S</i>,4<i>R</i>)-2-(4-Chlorobenzyl)-4-methoxypyrrolidin-1-yl)piperidine-1-carboxylate (<b>75</b>)</h5><div class="NLM_p last">Starting from 50 mg of compound <b>72</b> (0.13 mmol), the title compound was prepared in a similar methylation procedure as that used for <b>50</b>. Purification by column chromatography (hexanes/AcOEt, 1:1) gave 41 mg (0.10 mmol, 77%) of <b>75</b> in a form of pale yellow oil. LC–MS (ES+) <i>m</i>/<i>z</i>: 409.4/411.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.28–7.24 (m, 2H), 7.18–7.15 (m, 2H), 3.92–3.86 (m, 2H), 3.75–3.70 (m, 1H), 3.13 (s, 3H), 3.05–2.99 (m, 1H), 2.82 (dd, <i>J</i> = 13.3, 4.5 Hz, 1H), 2.78–2.72 (m, 2H), 2.72–2.61 (m, 4H), 2.49–2.44 (m, 8H), 1.79 (dt, <i>J</i> = 13.2, 7.1 Hz, 1H), 1.70–1.63 (m, 2H), 1.43–1.38 (m, 1H), 1.36 (s, 10H), 1.32–1.23 (m, 1H), 1.24–1.17 (m, 1H).</div></div><div id="sec4_1_29_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i89" class="anchor-spacer"></div><h5 class="article-section__title" id="_i89"> Step 2: Synthesis of 5-(4-((2<i>S</i>,4<i>R</i>)-2-(4-Chlorobenzyl)-4-methoxypyrrolidin-1-yl)piperidin-1-yl)-1<i>H</i>-1,2,4-triazol-3-amine Bis-2,2,2-trifluoroacetate (<b>29</b>)</h5><div class="NLM_p last">The title compound was prepared according to the general procedure C and purified by preparative HPLC to give 21 mg of <b>29</b> as a bis-trifluoroacetate salt (0.034 mmol, 34%). LC–MS (ES+) <i>m</i>/<i>z</i>: 391.4/393.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, 348 K): δ 7.39–7.34 (m, 2H), 7.30–7.26 (m, 2H), 4.07–4.03 (m, 1H), 4.03–3.96 (m, 1H), 3.89–3.82 (m, 2H), 3.56 (d, <i>J</i> = 12.4 Hz, 1H), 3.52–3.46 (m, 1H) 3.36–3.28 (m, 1H), 3.27 (s, 3H), 3.21 (dd, <i>J</i> = 13.5, 4.5 Hz, 1H), 2.92–2.80 (m, 3H), 2.18–2.08 (m, 2H), 2.03–1.98 (m, 1H), 1.83–1.77 (m, 1H), 1.79–1.65 (m, 2H).</div></div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> (<i>S</i>)-5-(4-(3-(4-Chlorobenzyl)morpholino)piperidin-1-yl)-4<i>H</i>-1,2,4-triazol-3-amine (<b>30</b>)</h4><div id="sec4_1_30_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i91" class="anchor-spacer"></div><h5 class="article-section__title" id="_i91"> Step 1: Synthesis of 2-Chloro-<i>N</i>-[(1<i>S</i>)-1-(4-chlorobenzyl)-2-hydroxyethyl]acetamide (<b>65</b>)</h5><div class="NLM_p last">To a solution of amino alcohol <b>64</b> (5.0 g, 27.09 mmol) in THF (162 mL), TEA (4.6 mL, 32.50 mmol) was added, and the solution was cooled to 0 °C. Chloroacetyl chloride (2.1 mL, 27.09 mmol) was added slowly in such a manner that the internal temperature of the reaction was below 5 °C. The cooling bath was then removed, and the mixture was stirred for further 20 min. Diethyl ether was then added, and the whole reaction mixture was sequentially washed with 1 M HCl, 1 M NaOH, and brine, dried over MgSO<sub>4</sub>, filtered, and evaporated to dryness to give the crude product. Crystallization from hot diethyl ether gave compound <b>65</b> (6.0 g, 85%). LC–MS (ES+) <i>m</i>/<i>z</i>: 262.2/264.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.05 (d, <i>J</i> = 8.5 Hz, 1H), 7.33–7.25 (m, 2H), 7.23–7.14 (m, 2H), 4.85 (t, <i>J</i> = 5.5 Hz, 1H), 3.95 (s, 2H), 3.90–3.78 (m, 1H), 3.38–3.25 (m, 3H), 2.80 (dd, <i>J</i> = 13.7, 5.4 Hz, 1H), 2.60 (dd, <i>J</i> = 13.7, 8.6 Hz, 1H).</div></div><div id="sec4_1_30_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i92" class="anchor-spacer"></div><h5 class="article-section__title" id="_i92"> Step 2: Synthesis of (5<i>S</i>)-5-(4-Chlorobenzyl)morpholin-3-one (<b>66</b>)</h5><div class="NLM_p last">To a solution of 5.1 g of compound <b>65</b> (19.45 mmol) in THF (195 mL), sodium hydride 50% in mineral oil (2.8 g, 58.35 mmol) was added all at once at 0 °C, and the reaction mixture was allowed to stir at room temperature for 2 h. The excess of sodium hydride was then carefully quenched by dropwise addition of brine and then additional volume of brine was added causing phase separation. The organic layer was separated, and the aqueous layer was additionally extracted with diethyl ether. Combined organic extracts were then dried over MgSO<sub>4</sub> and filtered, and the solvents were evaporated. The crude product was sufficiently pure to be used in the next step without any additional purification (2.6 g, 59%). LC–MS (ES+) <i>m</i>/<i>z</i>: 226.2/228.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.33–7.28 (m, 2H), 7.14–7.07 (m, 2H), 6.10 (br s, 1H), 4.20–4.09 (m, 2H), 3.87 (dd, <i>J</i> = 11.8, 3.7 Hz, 1H), 3.74–3.65 (m, 1H), 3.55 (dd, <i>J</i> = 11.8, 6.2 Hz, 1H), 2.90–2.80 (m, 1H), 2.71 (dd, <i>J</i> = 13.6, 8.5 Hz, 1H).</div></div><div id="sec4_1_30_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i93" class="anchor-spacer"></div><h5 class="article-section__title" id="_i93"> Step 3: Synthesis of (5<i>S</i>)-5-(4-Chlorobenzyl)morpholine (<b>67</b>)</h5><div class="NLM_p last">To a solution of morpholin-3-one <b>66</b> (2.3 g, 10.36 mmol) in THF (30 mL) BH<sub>3</sub>·DMS complex (3.1 mL, 31.08 mmol) was added, and the reaction mixture was refluxed for 3 h, after which time the TLC control showed complete consumption of the starting material. The reaction mixture was cooled to room temperature, and 2 M HCl was cautiously added (30 mL). The resulting reaction mixture was refluxed for 2 h and cooled back to room temperature. The pH of the solution was then made strongly alkaline (∼10) by a dropwise addition of 4 M NaOH. The organic layer was separated, and the aqueous layer was additionally extracted with diethyl ether. Combined organic extracts were then dried over MgSO<sub>4</sub> and filtered, and the solvents were evaporated. The crude morpholine <b>67</b> was sufficiently pure to be used in the next step without any additional purification (1.6 g, 7.54 mmol, 73%). LC–MS (ES+) <i>m</i>/<i>z</i>: 212.2/214.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.28 (d, <i>J</i> = 8.3 Hz, 2H), 7.11 (d, <i>J</i> = 8.3 Hz, 2H), 3.81–3.75 (m, 2H), 3.55–3.49 (m, 1H), 3.24 (t, <i>J</i> = 10 Hz, 1H), 3.0–2.98 (m, 1H), 2.89–2.8 (m, 2H), 2.62 (dd, <i>J</i> = 4.9, 13.5 Hz, 1H), 2.44 (dd, <i>J</i> = 9.2, 13.5 Hz, 1H).</div></div><div id="sec4_1_30_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i94" class="anchor-spacer"></div><h5 class="article-section__title" id="_i94"> Step 4: Synthesis of <i>tert</i>-Butyl (<i>R</i>)-4-(2-(4-Chlorobenzyl)morpholin-1-yl)piperidine-1-carboxylate (<b>73</b>)</h5><div class="NLM_p last">The title compound was prepared according to the general procedure B starting from morpholine <b>67</b>. Product was purified by silica-gel chromatography (elution with hexanes/AcOEt; 1:1) yielding 1.58 g (4.0 mmol, 53%) of pure compound <b>73</b>. LC–MS (ES+) <i>m</i>/<i>z</i>: 395.1/397.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.33–7.29 (m, 2H), 7.25–7.20 (m, 2H), 3.92 (t, <i>J</i> = 14.8 Hz, 2H), 3.68–3.58 (m, 2H), 3.31 (dd, <i>J</i> = 11.6, 5.5 Hz, 1H), 3.11–2.97 (m, 2H), 2.91 (d, <i>J</i> = 13.8 Hz, 1H), 2.79–2.69 (m, 3H), 2.69–2.62 (m, 2H), 1.79–1.75 (m, 1H), 1.76–1.71 (m, 1H), 1.38 (s, 9H), 1.36–1.21 (m, 2H), one proton overlapping with water signal.</div></div><div id="sec4_1_30_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i95" class="anchor-spacer"></div><h5 class="article-section__title" id="_i95"> Step 5: Synthesis of (<i>S</i>)-5-(4-(3-(4-Chlorobenzyl)morpholino)piperidin-1-yl)-4<i>H</i>-1,2,4-triazol-3-amine (<b>30</b>)</h5><div class="NLM_p last">The title compound was prepared according to the general procedure C and purified by crystallization from hot acetonitrile. <b>30</b> (694 mg, 1.84 mmol, 46% over three steps) was obtained. HRMS calculated for C<sub>18</sub>H<sub>26</sub>ClN<sub>6</sub>O [M + H]<sup>+</sup>, 377.1851; HRMS found, 377.1851. <sup>1</sup>H NMR (700 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O, 348 K): δ 7.35–7.31 (m, 2H), 7.28–7.19 (m, 2H), 5.68 (br s, 2H), 4.89–4.65 (m, 1H), 3.87–3.69 (m, 3H), 3.63–3.48 (m, 3H), 3.37–3.32 (m, 2H), 3.23 (dd, <i>J</i> = 11.1, 5.4 Hz, 1H), 2.94–2.76 (m, 3H), 2.71–2.59 (m, 2H), 1.75 (d, <i>J</i> = 12.4 Hz, 1H), 1.67 (d, <i>J</i> = 12.4 Hz, 1H), 1.47 (qd, <i>J</i> = 12.0, 4.1 Hz, 1H), 1.34 (qd, <i>J</i> = 12.0, 4.2 Hz, 1H).</div></div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> 5-(4-(3-(4-Chlorobenzyl)morpholino)piperidin-1-yl)-4<i>H</i>-1,2,4-triazol-3-amine (<b><i>rac</i>-30</b>)</h4><div class="NLM_p last">This compound was synthesized for the purpose of assessment of the optical purity of compound <b>30</b> (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00681/suppl_file/jm9b00681_si_001.pdf" class="ext-link">Supporting Information</a>). Starting from racemic 2-amino-3-(4-chlorphenyl)propan-1-ol, the synthesis was accomplished exactly in the same manner as for compound <b>30</b>. <b><i>rac-</i>30</b> (105 mg) was obtained.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> Biological Methods (In Vitro)</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> Enzymatic Assays: IC<sub>50</sub> Determination toward Human and Mouse AMCase and Human and Mouse CHIT1</h4><div class="NLM_p last">Human and mouse AMCase and human and mouse CHIT1 recombinant proteins were produced in CHO-K1 cells after transient transfection with plasmid coding full-length protein with C-terminal His-tag. The proteins were purified by nickel-affinity chromatography. Chitinolytic activity of recombinant enzymes was measured using standard assay as previously described.<a onclick="showRef(event, 'ref21 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref21 ref27 ref28">(21,27,28)</a> For determination of enzymatic activity, 103 μM 4-methylumbelliferyl β-<span class="smallcaps smallerCapital">d</span>-<i>N</i>,<i>N</i>-diacetylchitobioside hydrate and 5.2 ng per well of hAMCase, 46 μM 4-methylumbelliferyl β-<span class="smallcaps smallerCapital">d</span>-<i>N</i>,<i>N</i>′-diacetylchitobioside hydrate and 3 ng per well of mAMCase, 5 μM 4-methylumbelliferyl β-<span class="smallcaps smallerCapital">d</span>-<i>N</i>,<i>N</i>′,<i>N</i>″-triacetylchitotrioside and 0.2 ng per well of hCHIT1, or 20 μM 4-methylumbelliferyl β-<span class="smallcaps smallerCapital">d</span>-<i>N</i>,<i>N</i>′,<i>N</i>″-triacetylchitotrioside and 2 ng per well of mCHIT1 were used. Appropriate substrate, enzyme, and varying concentrations of compounds in assay buffer (0.1 M citrate, 0.2 M dibasic phosphate, 1 mg/mL bovine serum albumin) were incubated in a 96-well black microtiter plate with shaking in the dark at 37 °C for 60 min followed by addition of stop solution (0.3 M glycine/NaOH buffer, pH 10.5). Substrate hydrolysis product 4-methlyumbelliferone was measured fluorometrically using a Spark M10 (Tecan) microplate reader (excitation 355 nm/emission 460 nm). IC<sub>50</sub> values of all inhibitors against AMCase and CHIT1 were determined from dose–response sigmoidal curves of the % of inhibition versus log(inhibitor concentration) using GraphPad Prism version 6.0. Experiments were performed in duplicate.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> hERG Binding Assay</h4><div class="NLM_p last">To characterize the affinity of compounds to the hERG channel, the Predictor hERG fluorescence polarization assay kit (Invitrogen) was used according to the manufacturer’s protocol.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> Biological Methods (In Vivo)</h3><div class="NLM_p">All in vivo experiments were performed in accordance with the guidelines of the Institute for Animal Care and Use Committee in Poland, and all protocols were approved by Local Ethic Committee, Warsaw, Poland.</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> Pharmacokinetic Measurements in Mice</h4><div class="NLM_p last">The PK properties of compound 30 were evaluated in female BALB/c mice following single intravenous bolus (3 mg/kg) or oral (10 mg/kg) administration. Compound <b>30</b> was prepared in a 30% PEG400/70% water vehicle for intravenous bolus and oral administrations at 5 mL/kg, respectively, and administered to 2 mice/group per time point with samples collected out to 24 h post-dose. Blood collection was performed by cardiac puncture under anesthesia with sampling of blood into K<sub>2</sub>EDTA anticoagulant tubes, followed by centrifugation to obtain plasma. Samples were stored frozen at −80 °C or lower prior to compound extraction and LC/MS/MS analysis. Pharmacokinetic parameters of compound <b>30</b> in mice were calculated by standard noncompartmental modeling from the systemic plasma concentration–time profile.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> Pharmacokinetic Measurements in Rats</h4><div class="NLM_p last">The PK properties of compound <b>30</b> were evaluated in male Sprague–Dawley rats following single intravenous bolus (3 mg/kg) or oral (10 mg/kg) administration. Compound <b>30</b> was prepared in a 10% solutol/10% ethanol/5% glucose in a saline vehicle for intravenous bolus and oral administrations at 1.5 or 5 mL/kg, respectively. Blood collection was performed at 5 min (IV only), 15 min, 30 min, 1 h, 2 h, 4 h, 6 h, and 12 h post compound <b>30</b> administration (<i>n</i> = 2) serially from same animal by tail vein puncture without anesthesia. Blood was collected into K<sub>2</sub>EDTA anticoagulant tubes and followed by centrifugation to obtain plasma. Plasma samples snap frozen and stored at −80 °C or lower prior to compound extraction and LC/MS/MS analysis. Pharmacokinetic parameters of compound <b>30</b> in rats were calculated by standard noncompartmental modeling from the systemic plasma concentration–time profile.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> Measurement of Compound <b>30</b> Concentration in the Brain</h4><div class="NLM_p last">In order to assess the concentration of compound <b>30</b> present in the brain at the steady state in relation to that in blood, compound <b>30</b> was administered to female BALB/c mice following single oral administration at 10 mg/kg dose. Compound <b>30</b> was prepared in a 10% ethanol/10% solutol/5% glucose in a saline vehicle at 5 mL/kg and administered to 2 mice/group per time point. Blood and brain were collected at 30 min, 2 h, and 4 h post administration. First, blood collection was performed by a cardiac puncture under anesthesia with sampling of blood into K<sub>2</sub>EDTA anticoagulant tubes, followed by centrifugation to obtain plasma. Then, the brain was dissected, weighted, and homogenized in 10% ethanol in water. The samples were stored frozen at −80 °C prior to compound extraction and LC/MS/MS analysis. The relative brain bioavailability was calculated as <i>F</i><sub>rel(brain/plasma)</sub> = AUC<sub>brain(p.o.)</sub>/AUC<sub>plasma(p.o.)</sub> × 100%.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> HDM Mouse Model of Allergic Pulmonary Inflammation</h4><div class="NLM_p last">Determination of the therapeutic efficacy of compound <b>30</b> was carried in 3 week-long exposure HDM-induced mouse model of allergic inflammation. Briefly, 2 groups (<i>n</i> = 8; HDM with or without compound <b>30</b> treatment) of age-matched 8-week-old female C57BL/6 mice (Charles River, Germany) were subjected to intranasal exposure of 40 μg of HDM extract (Greer, Lenoir, NC) in 25 μL PBS solution 5 times per week for 19 days. In addition, naive mice were subjected to PBS intranasal challenges at times of HMD challenges (<i>n</i> = 8). Compound <b>30</b> was administered orally (20 μL/g) in a dose of 50 mg/kg starting on day 7 onward, representing a therapeutic treatment scheme as compared to vehicle-treated controls. The mice were allowed to rest 24 h post last HDM and compound <b>30</b> administration, and on day 19, animals were euthanized by lethal Morbital injection (sodium pentobarbital 26.7 mg/mL, pentobarbital 133.3 mg/mL; Biovet, Poland), and material was collected for subsequent assessment of pulmonary inflammation. Briefly, lungs were washed via trachea using 1 mL of PBS to collect BALf. The BALf was centrifuged (10 min, 2000 rpm, 4 °C), and the cell pellet was resuspended in 300 μL of PBS and subsequently used for FACS analysis for CD45-positive leukocyte population identification.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> Pulmonary Inflammation Assessment</h4><div class="NLM_p last">The inflammatory cells influx was analyzed in BALf. Total BALf cells were counted manually using a Burker chamber and were further characterized with flow cytometry (FACSAria, BD) to determine total leukocyte (CD45-positive) total numbers in BALf.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> Molecular Modeling</h4><div class="NLM_p last">The initial conformation of compound <b>2</b> was taken from the experimentally solved structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NR8">5NR8</a>). The three-dimensional structure of compound <b>30</b> was built using the structure of <b>2</b> and OpenBabel,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and further refined using MOPAC7 with the PM3 method.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Molecular docking was performed using rDock with desolvation scoring function<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> to AMCase (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RM4">3RM4</a>) and CHIT1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NR8">5NR8</a>). For each ligand, 100 poses were generated, and 10 top scoring models were inspected visually. Poses with a binding mode most similar to the native ligands were accepted for the further analysis.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i107"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00681" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65747" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65747" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00681" class="ext-link">10.1021/acs.jmedchem.9b00681</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H NMR spectra and HPLC profiles for compounds <b>4–30</b>, chiral HPLC profiles for compounds <b>30</b> and <b><i>rac-</i>30</b>, crystallographic information for compound <b>50</b>, analysis of Trp99 side-chain orientation in published AMCase crystallographic structures, comparison of human and murine AMCase sequences and their binding sites (experimentally solved and homology model, respectively), and comparison of human and murine CHIT1 sequences and their binding sites (experimentally solved and homology model, respectively) (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00681/suppl_file/jm9b00681_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings, IC<sub>50</sub> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00681/suppl_file/jm9b00681_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Computational model of hAMCase with compound <b>2</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00681/suppl_file/jm9b00681_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Computational model of hAMCase with compound <b>30</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00681/suppl_file/jm9b00681_si_004.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Computational model of hCHIT1 with compound <b>30</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00681/suppl_file/jm9b00681_si_005.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00681/suppl_file/jm9b00681_si_001.pdf">jm9b00681_si_001.pdf (5.27 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00681/suppl_file/jm9b00681_si_002.csv">jm9b00681_si_002.csv (3.28 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00681/suppl_file/jm9b00681_si_003.pdb">jm9b00681_si_003.pdb (470.3 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00681/suppl_file/jm9b00681_si_004.pdb">jm9b00681_si_004.pdb (470.61 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00681/suppl_file/jm9b00681_si_005.pdb">jm9b00681_si_005.pdb (499.96 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates have been deposited in the CCDC with accession code for compound <b>50</b>: CCDC 1901012. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via <a href="http://www.ccdc.cam.ac.uk/structures" class="extLink">www.ccdc.cam.ac.uk/structures</a>.</p><div class="testing" data-doi="10.1021/acs.jmedchem.9b00681" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82785" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82785" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacek Olczak</span> - <span class="hlFld-Affiliation affiliation">OncoArendi
Therapeutics SA, Żwirki
i Wigury 101, 02-089 Warsaw, Poland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9932-2373" title="Orcid link">http://orcid.org/0000-0001-9932-2373</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#99f3b7f6f5fae3f8f2d9f6f7faf6f8ebfcf7fdf0b7faf6f4"><span class="__cf_email__" data-cfemail="b1db9fdeddd2cbd0daf1dedfd2ded0c3d4dfd5d89fd2dedc">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marzena Mazur</span> - <span class="hlFld-Affiliation affiliation">OncoArendi
Therapeutics SA, Żwirki
i Wigury 101, 02-089 Warsaw, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barbara Dymek</span> - <span class="hlFld-Affiliation affiliation">OncoArendi
Therapeutics SA, Żwirki
i Wigury 101, 02-089 Warsaw, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Koralewski</span> - <span class="hlFld-Affiliation affiliation">OncoArendi
Therapeutics SA, Żwirki
i Wigury 101, 02-089 Warsaw, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Piotr Sklepkiewicz</span> - <span class="hlFld-Affiliation affiliation">OncoArendi
Therapeutics SA, Żwirki
i Wigury 101, 02-089 Warsaw, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sylwia Olejniczak</span> - <span class="hlFld-Affiliation affiliation">OncoArendi
Therapeutics SA, Żwirki
i Wigury 101, 02-089 Warsaw, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marcin Mazurkiewicz</span> - <span class="hlFld-Affiliation affiliation">OncoArendi
Therapeutics SA, Żwirki
i Wigury 101, 02-089 Warsaw, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michał Piotrowicz</span> - <span class="hlFld-Affiliation affiliation">OncoArendi
Therapeutics SA, Żwirki
i Wigury 101, 02-089 Warsaw, Poland</span>; 
    <span>Present Address:
                        Department of Organic Chemistry, Faculty of Chemistry, University of Łódź, Tamka 12, 91-403 Łódź, Poland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7214-858X" title="Orcid link">http://orcid.org/0000-0001-7214-858X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Magdalena Salamon</span> - <span class="hlFld-Affiliation affiliation">OncoArendi
Therapeutics SA, Żwirki
i Wigury 101, 02-089 Warsaw, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karol Jędrzejczak</span> - <span class="hlFld-Affiliation affiliation">OncoArendi
Therapeutics SA, Żwirki
i Wigury 101, 02-089 Warsaw, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Agnieszka Zagozdzon</span> - <span class="hlFld-Affiliation affiliation">OncoArendi
Therapeutics SA, Żwirki
i Wigury 101, 02-089 Warsaw, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wojciech Czestkowski</span> - <span class="hlFld-Affiliation affiliation">OncoArendi
Therapeutics SA, Żwirki
i Wigury 101, 02-089 Warsaw, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Krzysztof Matyszewski</span> - <span class="hlFld-Affiliation affiliation">OncoArendi
Therapeutics SA, Żwirki
i Wigury 101, 02-089 Warsaw, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bartłomiej Borek</span> - <span class="hlFld-Affiliation affiliation">OncoArendi
Therapeutics SA, Żwirki
i Wigury 101, 02-089 Warsaw, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Agnieszka Bartoszewicz</span> - <span class="hlFld-Affiliation affiliation">OncoArendi
Therapeutics SA, Żwirki
i Wigury 101, 02-089 Warsaw, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elżbieta Pluta</span> - <span class="hlFld-Affiliation affiliation">OncoArendi
Therapeutics SA, Żwirki
i Wigury 101, 02-089 Warsaw, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aleksandra Rymaszewska</span> - <span class="hlFld-Affiliation affiliation">OncoArendi
Therapeutics SA, Żwirki
i Wigury 101, 02-089 Warsaw, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Witold Mozga</span> - <span class="hlFld-Affiliation affiliation">OncoArendi
Therapeutics SA, Żwirki
i Wigury 101, 02-089 Warsaw, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Filip Stefaniak</span> - <span class="hlFld-Affiliation affiliation">OncoArendi
Therapeutics SA, Żwirki
i Wigury 101, 02-089 Warsaw, Poland</span>; 
    <span class="hlFld-Affiliation affiliation">Laboratory
of Bioinformatics and Protein Engineering, International Institute of Molecular and Cell Biology in Warsaw, Ks. Trojdena 4, 02-109 Warsaw, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paweł Dobrzański</span> - <span class="hlFld-Affiliation affiliation">OncoArendi
Therapeutics SA, Żwirki
i Wigury 101, 02-089 Warsaw, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karolina Dzwonek</span> - <span class="hlFld-Affiliation affiliation">OncoArendi
Therapeutics SA, Żwirki
i Wigury 101, 02-089 Warsaw, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jakub Golab</span> - <span class="hlFld-Affiliation affiliation">OncoArendi
Therapeutics SA, Żwirki
i Wigury 101, 02-089 Warsaw, Poland</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Immunology, Medical University of Warsaw, Nielubowicza 5, 02-097 Warsaw, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adam Golebiowski</span> - <span class="hlFld-Affiliation affiliation">OncoArendi
Therapeutics SA, Żwirki
i Wigury 101, 02-089 Warsaw, Poland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5960-2995" title="Orcid link">http://orcid.org/0000-0001-5960-2995</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): Some of the authors are current employees of OncoArendi Therapeutics S.A. and own company stocks.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i111">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60143" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60143" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Studies were supported by two projects: (1) “Development of a first-in-class small molecule drug candidate for treatment of idiopathic pulmonary fibrosis through chitotriosidase inhibition” (POIR.01.01.01-00-0551/15), acronym IPF and (2) “Preclinical research and clinical trials of a first-in-class development candidate in therapy of asthma and inflammatory bowel disease” (POIR.01.01.01-00-0168/15), acronym IBD—both cofinanced by the National Centre for Research and Development in the framework of European Funds Smart Growth. We thank Dr. Damian Trzybiński and Prof. Krzysztof Woźniak for collecting and analyzing the crystallographic data. This research was carried out at the Biological and Chemical Research Centre, University of Warsaw, co-financed from the European Regional Development Fund. The data were collected at the Core Facility for Crystallographic and Biophysical Research to support the development of medicinal products sponsored by the Foundation for Polish Science (FNP).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">COPD</td><td class="NLM_def"><p class="first last">chronic obstructive pulmonary disease</p></td></tr><tr><td class="NLM_term">CHIT1</td><td class="NLM_def"><p class="first last">chitotriosidase</p></td></tr><tr><td class="NLM_term">hCHIT1</td><td class="NLM_def"><p class="first last">human chitotriosidase</p></td></tr><tr><td class="NLM_term">mCHIT1</td><td class="NLM_def"><p class="first last">mouse chitotriosidase</p></td></tr><tr><td class="NLM_term">AMCase</td><td class="NLM_def"><p class="first last">acidic mammalian chitinase</p></td></tr><tr><td class="NLM_term">hAMCase</td><td class="NLM_def"><p class="first last">human acidic mammalian chitinase</p></td></tr><tr><td class="NLM_term">mAMCase</td><td class="NLM_def"><p class="first last">mouse acidic mammalian chitinase</p></td></tr><tr><td class="NLM_term">IL-13</td><td class="NLM_def"><p class="first last">interleukin-13</p></td></tr><tr><td class="NLM_term">Th2</td><td class="NLM_def"><p class="first last">type 2 helper T cell</p></td></tr><tr><td class="NLM_term">HDM</td><td class="NLM_def"><p class="first last">house dust mite</p></td></tr><tr><td class="NLM_term">TGFβ</td><td class="NLM_def"><p class="first last">transforming growth factor beta</p></td></tr><tr><td class="NLM_term">DAT</td><td class="NLM_def"><p class="first last">dopamine active transporter</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">AUC<sub>0–inf</sub></td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">peak plasma concentration of a drug after administration</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>max</sub></td><td class="NLM_def"><p class="first last">time to reach <i>C</i><sub>max</sub></p></td></tr><tr><td class="NLM_term"><i>F</i></td><td class="NLM_def"><p class="first last">bioavailability</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term">BALf</td><td class="NLM_def"><p class="first last">bronchoalveolar lavage fluid</p></td></tr><tr><td class="NLM_term">ILD</td><td class="NLM_def"><p class="first last">interstitial lung disease</p></td></tr><tr><td class="NLM_term">IPF</td><td class="NLM_def"><p class="first last">idiopathic pulmonary fibrosis</p></td></tr><tr><td class="NLM_term">FACS</td><td class="NLM_def"><p class="first last">fluorescence-activated cell sorting</p></td></tr><tr><td class="NLM_term">CHO-K1</td><td class="NLM_def"><p class="first last">Chinese hamster ovarian cell, K1 type</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>R</sub></td><td class="NLM_def"><p class="first last">retention time</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i113">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64226" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64226" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 39 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brightling, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddel, H. K.</span></span> <span> </span><span class="NLM_article-title">Asthma</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>391</i></span>,  <span class="NLM_fpage">783</span>– <span class="NLM_lpage">800</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(17)33311-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1016%2Fs0140-6736%2817%2933311-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=29273246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A280%3ADC%252BC1Mzks12htQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=391&publication_year=2018&pages=783-800&author=A.+Papiauthor=C.+Brightlingauthor=S.+E.+Pedersenauthor=H.+K.+Reddel&title=Asthma&doi=10.1016%2Fs0140-6736%2817%2933311-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Asthma</span></div><div class="casAuthors">Papi Alberto; Brightling Christopher; Pedersen Soren E; Reddel Helen K</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">391</span>
        (<span class="NLM_cas:issue">10122</span>),
    <span class="NLM_cas:pages">783-800</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Asthma-one of the most common chronic, non-communicable diseases in children and adults-is characterised by variable respiratory symptoms and variable airflow limitation.  Asthma is a consequence of complex gene-environment interactions, with heterogeneity in clinical presentation and the type and intensity of airway inflammation and remodelling.  The goal of asthma treatment is to achieve good asthma control-ie, to minimise symptom burden and risk of exacerbations.  Anti-inflammatory and bronchodilator treatments are the mainstay of asthma therapy and are used in a stepwise approach.  Pharmacological treatment is based on a cycle of assessment and re-evaluation of symptom control, risk factors, comorbidities, side-effects, and patient satisfaction by means of shared decisions.  Asthma is classed as severe when requiring high-intensity treatment to keep it under control, or if it remains uncontrolled despite treatment.  New biological therapies for treatment of severe asthma, together with developments in biomarkers, present opportunities for phenotype-specific interventions and realisation of more personalised treatment.  In this Seminar, we provide a clinically focused overview of asthma, including epidemiology, pathophysiology, clinical diagnosis, asthma phenotypes, severe asthma, acute exacerbations, and clinical management of disease in adults and children older than 5 years.  Emerging therapies, controversies, and uncertainties in asthma management are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTkkwaIXLDBxb5XHngOXiV_fW6udTcc2eYkXyHdFtBTf7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mzks12htQ%253D%253D&md5=32a89bd095eebe078f563cf7cf64fadd</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fs0140-6736%2817%2933311-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0140-6736%252817%252933311-1%26sid%3Dliteratum%253Aachs%26aulast%3DPapi%26aufirst%3DA.%26aulast%3DBrightling%26aufirst%3DC.%26aulast%3DPedersen%26aufirst%3DS.%2BE.%26aulast%3DReddel%26aufirst%3DH.%2BK.%26atitle%3DAsthma%26jtitle%3DLancet%26date%3D2018%26volume%3D391%26spage%3D783%26epage%3D800%26doi%3D10.1016%2Fs0140-6736%2817%2933311-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pavord, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beasley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agusti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brusselle, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullinan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Custovic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ducharme, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahy, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frey, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heaney, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humbert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sly, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Mutius, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zar, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, A.</span></span> <span> </span><span class="NLM_article-title">After asthma: redefining airways diseases</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>391</i></span>,  <span class="NLM_fpage">350</span>– <span class="NLM_lpage">400</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(17)30879-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1016%2Fs0140-6736%2817%2930879-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=28911920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A280%3ADC%252BC1cboslSquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=391&publication_year=2018&pages=350-400&author=I.+D.+Pavordauthor=R.+Beasleyauthor=A.+Agustiauthor=G.+P.+Andersonauthor=E.+Belauthor=G.+Brusselleauthor=P.+Cullinanauthor=A.+Custovicauthor=F.+M.+Ducharmeauthor=J.+V.+Fahyauthor=U.+Freyauthor=P.+Gibsonauthor=L.+G.+Heaneyauthor=P.+G.+Holtauthor=M.+Humbertauthor=C.+M.+Lloydauthor=G.+Marksauthor=F.+D.+Martinezauthor=P.+D.+Slyauthor=E.+von+Mutiusauthor=S.+Wenzelauthor=H.+J.+Zarauthor=A.+Bush&title=After+asthma%3A+redefining+airways+diseases&doi=10.1016%2Fs0140-6736%2817%2930879-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">After asthma: redefining airways diseases</span></div><div class="casAuthors">Pavord Ian D; Beasley Richard; Agusti Alvar; Anderson Gary P; Bel Elisabeth; Brusselle Guy; Cullinan Paul; Lloyd Clare M; Custovic Adnan; Ducharme Francine M; Fahy John V; Frey Urs; Gibson Peter; Heaney Liam G; Holt Patrick G; Humbert Marc; Marks Guy; Martinez Fernando D; Sly Peter D; von Mutius Erika; Wenzel Sally; Zar Heather J; Bush Andy</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">391</span>
        (<span class="NLM_cas:issue">10118</span>),
    <span class="NLM_cas:pages">350-400</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS2Ycwv3QW8_Vf1XRtfYM0dfW6udTcc2eYbpLakrsvj9rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cboslSquw%253D%253D&md5=9cf7c2ef0ed69dcb9ac8d4d88b59b63c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fs0140-6736%2817%2930879-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0140-6736%252817%252930879-6%26sid%3Dliteratum%253Aachs%26aulast%3DPavord%26aufirst%3DI.%2BD.%26aulast%3DBeasley%26aufirst%3DR.%26aulast%3DAgusti%26aufirst%3DA.%26aulast%3DAnderson%26aufirst%3DG.%2BP.%26aulast%3DBel%26aufirst%3DE.%26aulast%3DBrusselle%26aufirst%3DG.%26aulast%3DCullinan%26aufirst%3DP.%26aulast%3DCustovic%26aufirst%3DA.%26aulast%3DDucharme%26aufirst%3DF.%2BM.%26aulast%3DFahy%26aufirst%3DJ.%2BV.%26aulast%3DFrey%26aufirst%3DU.%26aulast%3DGibson%26aufirst%3DP.%26aulast%3DHeaney%26aufirst%3DL.%2BG.%26aulast%3DHolt%26aufirst%3DP.%2BG.%26aulast%3DHumbert%26aufirst%3DM.%26aulast%3DLloyd%26aufirst%3DC.%2BM.%26aulast%3DMarks%26aufirst%3DG.%26aulast%3DMartinez%26aufirst%3DF.%2BD.%26aulast%3DSly%26aufirst%3DP.%2BD.%26aulast%3Dvon%2BMutius%26aufirst%3DE.%26aulast%3DWenzel%26aufirst%3DS.%26aulast%3DZar%26aufirst%3DH.%2BJ.%26aulast%3DBush%26aufirst%3DA.%26atitle%3DAfter%2520asthma%253A%2520redefining%2520airways%2520diseases%26jtitle%3DLancet%26date%3D2018%26volume%3D391%26spage%3D350%26epage%3D400%26doi%3D10.1016%2Fs0140-6736%2817%2930879-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, A. N. J.</span></span> <span> </span><span class="NLM_article-title">TH2 cell development and function</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1038/nri.2017.118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1038%2Fnri.2017.118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=29082915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslehtr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=121-133&author=J.+A.+Walkerauthor=A.+N.+J.+McKenzie&title=TH2+cell+development+and+function&doi=10.1038%2Fnri.2017.118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">TH2 cell development and function</span></div><div class="casAuthors">Walker, Jennifer A.; McKenzie, Andrew N. J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-133</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">T helper 2 (TH2) cells orchestrate protective type 2 immune responses, such as those that target helminths and facilitate tissue repair, but also contribute to chronic inflammatory diseases, such as asthma and allergy.  Here, we review recent insights into how diverse mol. signals from cellular sources, including dendritic cells, innate lymphoid cells and the epithelium, are integrated by T cells to guide the transcriptional and epigenetic changes necessary for TH2 cell differentiation.  Our improved understanding of these pathways has opened new avenues for therapeutically targeting TH2 cells in asthma and allergy.  The advent of comprehensive single-cell transcriptomics along with improvements in single-cell proteomics and the generation of novel in vivo cell fate mapping techniques promise to expand our understanding of T cell diversity and offer new insight into disease-related heterogeneity and plasticity of TH cell responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoohegyijwGWbVg90H21EOLACvtfcHk0ljyWlNYrCyHQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslehtr%252FM&md5=b3235a2458de52cd51863a1a73aed2dd</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnri.2017.118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri.2017.118%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DJ.%2BA.%26aulast%3DMcKenzie%26aufirst%3DA.%2BN.%2BJ.%26atitle%3DTH2%2520cell%2520development%2520and%2520function%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2018%26volume%3D18%26spage%3D121%26epage%3D133%26doi%3D10.1038%2Fnri.2017.118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duru, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yüceege, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ardiç, S.</span></span> <span> </span><span class="NLM_article-title">Chitinases and lung diseases</span>. <i>Tuberk. ve Toraks</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.5578/tt.3773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.5578%2Ftt.3773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=23581271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A280%3ADC%252BC3srltFSgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2013&pages=71-75&author=S.+Duruauthor=M.+Y%C3%BCceegeauthor=S.+Ardi%C3%A7&title=Chitinases+and+lung+diseases&doi=10.5578%2Ftt.3773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Chitinases and lung diseases</span></div><div class="casAuthors">Duru Serap; Yuceege Melike; Ardic Sadik</div><div class="citationInfo"><span class="NLM_cas:title">Tuberkuloz ve toraks</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-5</span>
        ISSN:<span class="NLM_cas:issn">0494-1373</span>.
    </div><div class="casAbstract">Chitinase enzymes that hydrolize chitin and some articficial substrates are expressed in human despite lacking of the endogenous chitin within the body.  Chitinases phatophysiological functions within human are not fully known.  Recent evidence revealed that chitinases may have role into some processes of immune responses and inflammatory system.  In this review, we discuss the role of chitinases in lung diseases based on the available information from the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTyayyJCFhHV8ScOqQTSkOffW6udTcc2eYbpLakrsvj9rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3srltFSgtQ%253D%253D&md5=843632da002810409623b3eb536b18a7</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.5578%2Ftt.3773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5578%252Ftt.3773%26sid%3Dliteratum%253Aachs%26aulast%3DDuru%26aufirst%3DS.%26aulast%3DY%25C3%25BCceege%26aufirst%3DM.%26aulast%3DArdi%25C3%25A7%26aufirst%3DS.%26atitle%3DChitinases%2520and%2520lung%2520diseases%26jtitle%3DTuberk.%2520ve%2520Toraks%26date%3D2013%26volume%3D61%26spage%3D71%26epage%3D75%26doi%3D10.5578%2Ftt.3773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koller, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Silva, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flavell, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elias, J. A.</span></span> <span> </span><span class="NLM_article-title">Acidic mammalian chitinase regulates epithelial cell apoptosis via a chitinolytic-independent mechanism</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>182</i></span>,  <span class="NLM_fpage">5098</span>– <span class="NLM_lpage">5106</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.0803446</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.4049%2Fjimmunol.0803446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=19342690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFOisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2009&pages=5098-5106&author=D.+Hartlauthor=C.+H.+Heauthor=B.+Kollerauthor=C.+A.+Da+Silvaauthor=Y.+Kobayashiauthor=C.+G.+Leeauthor=R.+A.+Flavellauthor=J.+A.+Elias&title=Acidic+mammalian+chitinase+regulates+epithelial+cell+apoptosis+via+a+chitinolytic-independent+mechanism&doi=10.4049%2Fjimmunol.0803446"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Acidic Mammalian Chitinase Regulates Epithelial Cell Apoptosis via a Chitinolytic-Independent Mechanism</span></div><div class="casAuthors">Hartl, Dominik; He, Chuan Hua; Koller, Babara; Da Silva, Carla A.; Kobayashi, Yasushi; Lee, Chun Geun; Flavell, Richard A.; Elias, Jack A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">5098-5106</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Acidic mammalian chitinase (AMCase) is produced during and plays an important role in the pathogenesis of Th2-mediated diseases and antiparasite responses.  However, the effector responses of AMCase in these settings have not been adequately defined and the relationship(s) between its chitinolytic and other biol. properties have not been investigated.  In these studies, we demonstrate that AMCase protects airway epithelial cells from Fas ligand- and growth factor withdrawal-induced apoptosis.  This cytoprotection was assocd. with Akt phosphorylation and abrogated when the PI3K/Akt pathway was inhibited.  Comparable cytoprotection was also seen in expts. comparing wild-type AMCase and mutant AMCase that lacked chitinolytic activity.  Importantly, the apoptosis-inhibiting effect of enzymically active and inactive AMCase was abrogated by treatment with allosamidin.  These studies demonstrate that secreted AMCase feeds back in an autocrine and/or paracrine manner to protect pulmonary epithelial cells from growth factor withdrawal- and Fas ligand-induced apoptosis.  They also demonstrate that the cytoprotection is mediated via a PI3K/Akt-dependent and allosamidin-sensitive pathway that is independent of the chitinolytic activity of this chitinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZVFoVH-1ht7Vg90H21EOLACvtfcHk0ljyWlNYrCyHQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFOisbY%253D&md5=b2bfc2927826f81ee1de5fb35f40bb51</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0803446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0803446%26sid%3Dliteratum%253Aachs%26aulast%3DHartl%26aufirst%3DD.%26aulast%3DHe%26aufirst%3DC.%2BH.%26aulast%3DKoller%26aufirst%3DB.%26aulast%3DDa%2BSilva%26aufirst%3DC.%2BA.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DC.%2BG.%26aulast%3DFlavell%26aufirst%3DR.%2BA.%26aulast%3DElias%26aufirst%3DJ.%2BA.%26atitle%3DAcidic%2520mammalian%2520chitinase%2520regulates%2520epithelial%2520cell%2520apoptosis%2520via%2520a%2520chitinolytic-independent%2520mechanism%26jtitle%3DJ.%2520Immunol.%26date%3D2009%26volume%3D182%26spage%3D5098%26epage%3D5106%26doi%3D10.4049%2Fjimmunol.0803446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">James, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinius, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kupczyk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ono, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izuhara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kere, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Söderhäll, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlén, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boot, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlén, S.-E.</span></span> <span> </span><span class="NLM_article-title">Increased YKL-40 and Chitotriosidase in Asthma and Chronic Obstructive Pulmonary Disease</span>. <i>Am. J. Respir. Crit. Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>193</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1164/rccm.201504-0760oc</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1164%2Frccm.201504-0760oc" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=26372680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFWmtr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2016&pages=131-142&author=A.+J.+Jamesauthor=L.+E.+Reiniusauthor=M.+Verhoekauthor=A.+Gomesauthor=M.+Kupczykauthor=U.+Hammarauthor=J.+Onoauthor=S.+Ohtaauthor=K.+Izuharaauthor=E.+Belauthor=J.+Kereauthor=C.+S%C3%B6derh%C3%A4llauthor=B.+Dahl%C3%A9nauthor=R.+G.+Bootauthor=S.-E.+Dahl%C3%A9n&title=Increased+YKL-40+and+Chitotriosidase+in+Asthma+and+Chronic+Obstructive+Pulmonary+Disease&doi=10.1164%2Frccm.201504-0760oc"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Increased YKL-40 and chitotriosidase in asthma and chronic obstructive pulmonary disease</span></div><div class="casAuthors">James, Anna J.; Reinius, Lovisa E.; Verhoek, Marri; Gomes, Anna; Kupczyk, Maciej; Hammar, Ulf; Ono, Junya; Ohta, Shoichiro; Izuhara, Kenji; Bel, Elisabeth; Kere, Juha; Soederhaell, Cilla; Dahlen, Barbro; Boot, Rolf G.; Dahlen, Sven-Erik</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-142</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: Serum chitinases may be novel biomarkers of airway inflammation and remodeling, but less is known about factors regulating their levels.  Objectives: To examine serum chitotriosidase activity and YKL-40 levels in patients with asthma and chronic obstructive pulmonary disease (COPD) and evaluate clin. relevant factors that may affect chitinase levels, including genetic variability, corticosteroid treatment, disease exacerbations, and allergen exposure.  Methods: Serum chitotriosidase (CHIT1) activity and YKL-40 (CHI3L1) levels, as well as the CHIT1 rs3831317 and CHI3L1 rs4950928 genotypes, were examd. in subsets of patients with mild to moderate asthma (n = 76), severe asthma (n = 93), and COPD (n = 64) taking part in the European multicenter BIOAIR (Longitudinal Assessment of Clin. Course and Biomarkers in Severe Chronic Airway Disease) study.  Blood was obtained at baseline, before and after a 2-wk oral steroid intervention, up to six times during a 1-yr period, and during exacerbations.  Baseline chitinase levels were also measured in 72 healthy control subjects.  The effect of allergen inhalation on blood and sputum YKL-40 levels was measured in two sep. groups of patients with mild atopic asthma; one group underwent repeated low-dose allergen challenge (n = 15), and the other underwent high-dose allergen challenge (n = 16).  Measurements and Main Results: Serum chitotriosidase and YKL-40 were significantly elevated in patients with asthma and those with COPD compared with healthy control subjects.  Genotype and age strongly affected both YKL-40 and chitotriosidase activity, but assocns. with disease remained following adjustment for these factors.  Correlations were obsd. with lung function but not with other biomarkers, including exhaled nitric oxide, blood eosinophils, periostin, and IgE.  Generally, acute exacerbations, allergen-induced airway obstruction, and corticosteroid treatment did not affect circulating chitinase levels.  Conclusions: YKL-40 and chitotriosidase are increased in asthma and more so in COPD.  The data in the present study support these substances as being relatively steroid-insensitive, non-T-helper cell type 2-type biomarkers distinctly related to chronic inflammatory disease processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonCASXwXqcILVg90H21EOLACvtfcHk0lgtQHV9N-FIeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFWmtr3F&md5=c100bfde5a107d31befe55bdb42455bb</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1164%2Frccm.201504-0760oc&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.201504-0760oc%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DA.%2BJ.%26aulast%3DReinius%26aufirst%3DL.%2BE.%26aulast%3DVerhoek%26aufirst%3DM.%26aulast%3DGomes%26aufirst%3DA.%26aulast%3DKupczyk%26aufirst%3DM.%26aulast%3DHammar%26aufirst%3DU.%26aulast%3DOno%26aufirst%3DJ.%26aulast%3DOhta%26aufirst%3DS.%26aulast%3DIzuhara%26aufirst%3DK.%26aulast%3DBel%26aufirst%3DE.%26aulast%3DKere%26aufirst%3DJ.%26aulast%3DS%25C3%25B6derh%25C3%25A4ll%26aufirst%3DC.%26aulast%3DDahl%25C3%25A9n%26aufirst%3DB.%26aulast%3DBoot%26aufirst%3DR.%2BG.%26aulast%3DDahl%25C3%25A9n%26aufirst%3DS.-E.%26atitle%3DIncreased%2520YKL-40%2520and%2520Chitotriosidase%2520in%2520Asthma%2520and%2520Chronic%2520Obstructive%2520Pulmonary%2520Disease%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2016%26volume%3D193%26spage%3D131%26epage%3D142%26doi%3D10.1164%2Frccm.201504-0760oc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homer, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohn, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamid, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elias, J. A.</span></span> <span> </span><span class="NLM_article-title">Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>304</i></span>,  <span class="NLM_fpage">1678</span>– <span class="NLM_lpage">1682</span>, <span class="refDoi"> DOI: 10.1126/science.1095336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1126%2Fscience.1095336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=15192232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BD2cXks1Cgsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2004&pages=1678-1682&author=Z.+Zhuauthor=T.+Zhengauthor=R.+J.+Homerauthor=Y.+K.+Kimauthor=N.+Y.+Chenauthor=L.+Cohnauthor=Q.+Hamidauthor=J.+A.+Elias&title=Acidic+mammalian+chitinase+in+asthmatic+Th2+inflammation+and+IL-13+pathway+activation&doi=10.1126%2Fscience.1095336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Acidic Mammalian Chitinase in Asthmatic Th2 Inflammation and IL-13 Pathway Activation</span></div><div class="casAuthors">Zhu, Zhou; Zheng, Tao; Homer, Robert J.; Kim, Yoon-Keun; Chen, Ning Yuan; Cohn, Lauren; Hamid, Qutayba; Elias, Jack A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">5677</span>),
    <span class="NLM_cas:pages">1678-1682</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Chitin is a surface component of parasites and insects, and chitinases are induced in lower life forms during infections with these agents.  Although chitin itself does not exist in humans, chitinases are present in the human genome.  We show here that acidic mammalian chitinase (AMCase) is induced via a T helper-2 (Th2)-specific, interleukin-13 (IL-13)-mediated pathway in epithelial cells and macrophages in an aeroallergen asthma model and expressed in exaggerated quantities in human asthma.  AMCase neutralization ameliorated Th2 inflammation and airway hyperresponsiveness, in part by inhibiting IL-13 pathway activation and chemokine induction.  AMCase may thus be an important mediator of IL-13-induced responses in Th2-dominated disorders such as asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr11ubUlNbNs7Vg90H21EOLACvtfcHk0lgtQHV9N-FIeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXks1Cgsr0%253D&md5=4358d813c473ef0d9b788a9dceb0f7f2</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.1095336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1095336%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DZheng%26aufirst%3DT.%26aulast%3DHomer%26aufirst%3DR.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BK.%26aulast%3DChen%26aufirst%3DN.%2BY.%26aulast%3DCohn%26aufirst%3DL.%26aulast%3DHamid%26aufirst%3DQ.%26aulast%3DElias%26aufirst%3DJ.%2BA.%26atitle%3DAcidic%2520mammalian%2520chitinase%2520in%2520asthmatic%2520Th2%2520inflammation%2520and%2520IL-13%2520pathway%2520activation%26jtitle%3DScience%26date%3D2004%26volume%3D304%26spage%3D1678%26epage%3D1682%26doi%3D10.1126%2Fscience.1095336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agapov, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battaile, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidwell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hachem, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzman, M. J.</span></span> <span> </span><span class="NLM_article-title">Macrophage chitinase 1 stratifies chronic obstructive lung disease</span>. <i>Am. J. Respir. Cell Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">384</span>, <span class="refDoi"> DOI: 10.1165/2009-0122r</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1165%2F2009-0122r" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=19491341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Squ7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=379-384&author=E.+Agapovauthor=J.+T.+Battaileauthor=R.+Tidwellauthor=R.+Hachemauthor=G.+A.+Pattersonauthor=R.+A.+Pierceauthor=J.+J.+Atkinsonauthor=M.+J.+Holtzman&title=Macrophage+chitinase+1+stratifies+chronic+obstructive+lung+disease&doi=10.1165%2F2009-0122r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage chitinase 1 stratifies chronic obstructive lung disease</span></div><div class="casAuthors">Agapov, Eugene; Battaile, John T.; Tidwell, Rose; Hachem, Ramsey; Patterson, G. Alexander; Pierce, Richard A.; Atkinson, Jeffrey J.; Holtzman, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">379-384</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Diagnosis and therapy of chronic inflammatory lung disease is limited by the need for individualized biomarkers that provide insight into pathogenesis.  Herein we show that mouse models of chronic obstructive lung disease exhibit an increase in lung chitinase prodn. but cannot predict which chitinase family member may be equivalently increased in humans with corresponding lung disease.  Moreover, we demonstrate that lung macrophage prodn. of chitinase 1 is selectively increased in a subset of subjects with severe chronic obstructive pulmonary disease, and this increase is reflected in plasma levels.  The findings provide a means to noninvasively track alternatively activated macrophages in chronic lung disease and thereby better differentiate mol. phenotypes in heterogeneous patient populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBj7y8qo-5RrVg90H21EOLACvtfcHk0lgtQHV9N-FIeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Squ7bK&md5=c1da83cca202ed5bf33b5420a65cde91</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1165%2F2009-0122r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252F2009-0122r%26sid%3Dliteratum%253Aachs%26aulast%3DAgapov%26aufirst%3DE.%26aulast%3DBattaile%26aufirst%3DJ.%2BT.%26aulast%3DTidwell%26aufirst%3DR.%26aulast%3DHachem%26aufirst%3DR.%26aulast%3DPatterson%26aufirst%3DG.%2BA.%26aulast%3DPierce%26aufirst%3DR.%2BA.%26aulast%3DAtkinson%26aufirst%3DJ.%2BJ.%26aulast%3DHoltzman%26aufirst%3DM.%2BJ.%26atitle%3DMacrophage%2520chitinase%25201%2520stratifies%2520chronic%2520obstructive%2520lung%2520disease%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2009%26volume%3D41%26spage%3D379%26epage%3D384%26doi%3D10.1165%2F2009-0122r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aminuddin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akhabir, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanowicz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paré, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connett, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthonisen, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahy, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibold, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burchard, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulsvik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakke, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litonjua, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomas, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaty, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crapo, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandford, A. J.</span></span> <span> </span><span class="NLM_article-title">Genetic association between human chitinases and lung function in COPD</span>. <i>Hum. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">1105</span>– <span class="NLM_lpage">1114</span>, <span class="refDoi"> DOI: 10.1007/s00439-011-1127-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1007%2Fs00439-011-1127-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=22200767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos1yku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2012&pages=1105-1114&author=F.+Aminuddinauthor=L.+Akhabirauthor=D.+Stefanowiczauthor=P.+D.+Par%C3%A9author=J.+E.+Connettauthor=N.+R.+Anthonisenauthor=J.+V.+Fahyauthor=M.+A.+Seiboldauthor=E.+G.+Burchardauthor=C.+Engauthor=A.+Gulsvikauthor=P.+Bakkeauthor=M.+H.+Choauthor=A.+Litonjuaauthor=D.+A.+Lomasauthor=W.+H.+Andersonauthor=T.+H.+Beatyauthor=J.+D.+Crapoauthor=E.+K.+Silvermanauthor=A.+J.+Sandford&title=Genetic+association+between+human+chitinases+and+lung+function+in+COPD&doi=10.1007%2Fs00439-011-1127-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic association between human chitinases and lung function in COPD</span></div><div class="casAuthors">Aminuddin, F.; Akhabir, L.; Stefanowicz, D.; Pare, P. D.; Connett, J. E.; Anthonisen, N. R.; Fahy, J. V.; Seibold, M. A.; Burchard, E. G.; Eng, C.; Gulsvik, A.; Bakke, P.; Cho, M. H.; Litonjua, A.; Lomas, D. A.; Anderson, W. H.; Beaty, T. H.; Crapo, J. D.; Silverman, E. K.; Sandford, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Human Genetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1105-1114</span>CODEN:
                <span class="NLM_cas:coden">HUGEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6717</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Two primary chitinases have been identified in humans-acid mammalian chitinase (AMCase) and chitotriosidase (CHIT1).  Mammalian chitinases have been obsd. to affect the host's immune response.  The aim of this study was to test for assocn. between genetic variation in the chitinases and phenotypes related to chronic obstructive pulmonary disease (COPD).  Polymorphisms in the chitinase genes were selected based on previous assocns. with respiratory diseases.  Polymorphisms that were assocd. with lung function level or rate of decline in the Lung Health Study (LHS) cohort were analyzed for assocn. with COPD affection status in four other COPD case-control populations.  Chitinase activity and protein levels were also related to genotypes.  In the caucasian LHS population, the baseline forced expiratory vol. in one second (FEV1) was significantly different between the AA and GG genotypic groups of the AMCase rs3818822 polymorphism.  Subjects with the GG genotype had higher AMCase protein and chitinase activity compared with AA homozygotes.  For CHIT1 rs2494303, a significant assocn. was obsd. between rate of decline in FEV1 and the different genotypes.  In the African American LHS population, CHIT1 rs2494303 and AMCase G339T genotypes were assocd. with rate of decline in FEV1.  Although a significant effect of chitinase gene alleles was found on lung function level and decline in the LHS, we were unable to replicate the assocns. with COPD affection status in the other COPD study groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-AEqXKz06TrVg90H21EOLACvtfcHk0lhKxiCX7A_bWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos1yku7w%253D&md5=e3fb8142a8a2d245baa03581e7662769</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs00439-011-1127-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00439-011-1127-1%26sid%3Dliteratum%253Aachs%26aulast%3DAminuddin%26aufirst%3DF.%26aulast%3DAkhabir%26aufirst%3DL.%26aulast%3DStefanowicz%26aufirst%3DD.%26aulast%3DPar%25C3%25A9%26aufirst%3DP.%2BD.%26aulast%3DConnett%26aufirst%3DJ.%2BE.%26aulast%3DAnthonisen%26aufirst%3DN.%2BR.%26aulast%3DFahy%26aufirst%3DJ.%2BV.%26aulast%3DSeibold%26aufirst%3DM.%2BA.%26aulast%3DBurchard%26aufirst%3DE.%2BG.%26aulast%3DEng%26aufirst%3DC.%26aulast%3DGulsvik%26aufirst%3DA.%26aulast%3DBakke%26aufirst%3DP.%26aulast%3DCho%26aufirst%3DM.%2BH.%26aulast%3DLitonjua%26aufirst%3DA.%26aulast%3DLomas%26aufirst%3DD.%2BA.%26aulast%3DAnderson%26aufirst%3DW.%2BH.%26aulast%3DBeaty%26aufirst%3DT.%2BH.%26aulast%3DCrapo%26aufirst%3DJ.%2BD.%26aulast%3DSilverman%26aufirst%3DE.%2BK.%26aulast%3DSandford%26aufirst%3DA.%2BJ.%26atitle%3DGenetic%2520association%2520between%2520human%2520chitinases%2520and%2520lung%2520function%2520in%2520COPD%26jtitle%3DHum.%2520Genet.%26date%3D2012%26volume%3D131%26spage%3D1105%26epage%3D1114%26doi%3D10.1007%2Fs00439-011-1127-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Artieda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cenarro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gañán, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jericó, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalvo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casado, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitoria, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puzo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pocoví, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Civeira, F.</span></span> <span> </span><span class="NLM_article-title">Serum chitotriosidase activity is increased in subjects with atherosclerosis disease</span>. <i>Arterioscler., Thromb., Vasc. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1645</span>– <span class="NLM_lpage">1652</span>, <span class="refDoi"> DOI: 10.1161/01.atv.0000089329.09061.07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1161%2F01.atv.0000089329.09061.07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=12893688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVWrt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=1645-1652&author=M.+Artiedaauthor=A.+Cenarroauthor=A.+Ga%C3%B1%C3%A1nauthor=I.+Jeric%C3%B3author=C.+Gonzalvoauthor=J.+M.+Casadoauthor=I.+Vitoriaauthor=J.+Puzoauthor=M.+Pocov%C3%ADauthor=F.+Civeira&title=Serum+chitotriosidase+activity+is+increased+in+subjects+with+atherosclerosis+disease&doi=10.1161%2F01.atv.0000089329.09061.07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Serum chitotriosidase activity is increased in subjects With atherosclerosis disease</span></div><div class="casAuthors">Artieda, Marta; Cenarro, Ana; Ganan, Alberto; Jerico, Ivonne; Gonzalvo, Carmen; Casado, Juan M.; Vitoria, Isabel; Puzo, Jose; Pocovi, Miguel; Civeira, Fernando</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1645-1652</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective- This study was undertaken to analyze the relation between serum activity of chitotriosidase enzyme, a protein synthesized exclusively by activated macrophages, and atherosclerotic lesion extent in subjects with atherothrombotic stroke (ATS) and in subjects with ischemic heart disease (IHD).  Methods and Results- We assayed the serum chitotriosidase activity and a common chitotriosidase gene polymorphism that causes deficiency in chitotriosidase activity in 3 Spanish populations, ATS (n=153), IHD (n=124), and control (n=148) subjects.  Statistical differences were found in serum chitotriosidase activity between ATS (88.1±4.6 nmol/mL · h, P<0.0001) and IHD subjects (79.0±6.3, P=0.002) vs. control group (70.9±5.2).  These obsd. differences were not attributable to a distinct allelic or genotype distribution.  The extension of the atherosclerotic lesion in carotids of ATS subjects was measured by duplex sonog.  Chitotriosidase activities were 66.9±9.6, 88.7±8.3, and 107.7±11.8 for subjects with carotid stenosis ≤30%, 31% to 60%, and >60%, resp.  Statistical differences were obsd. between subjects with major and intermediate stenosis grade compared with subjects with minor stenosis, P=0.005 and P=0.016, resp.  Conclusions- Serum chitotriosidase activity is significantly increased in individuals suffering from atherosclerosis disease and is related to the severity of the atherosclerotic lesion, suggesting a possible role as atherosclerotic extent marker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjfaHPeIda2LVg90H21EOLACvtfcHk0lhKxiCX7A_bWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVWrt7o%253D&md5=f060955236f7d0f0c317c335f521eb6f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1161%2F01.atv.0000089329.09061.07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.atv.0000089329.09061.07%26sid%3Dliteratum%253Aachs%26aulast%3DArtieda%26aufirst%3DM.%26aulast%3DCenarro%26aufirst%3DA.%26aulast%3DGa%25C3%25B1%25C3%25A1n%26aufirst%3DA.%26aulast%3DJeric%25C3%25B3%26aufirst%3DI.%26aulast%3DGonzalvo%26aufirst%3DC.%26aulast%3DCasado%26aufirst%3DJ.%2BM.%26aulast%3DVitoria%26aufirst%3DI.%26aulast%3DPuzo%26aufirst%3DJ.%26aulast%3DPocov%25C3%25AD%26aufirst%3DM.%26aulast%3DCiveira%26aufirst%3DF.%26atitle%3DSerum%2520chitotriosidase%2520activity%2520is%2520increased%2520in%2520subjects%2520with%2520atherosclerosis%2520disease%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2003%26volume%3D23%26spage%3D1645%26epage%3D1652%26doi%3D10.1161%2F01.atv.0000089329.09061.07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bargagli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggiorelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Sipio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margollicci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottoli, P.</span></span> <span> </span><span class="NLM_article-title">Human chitotriosidase: a sensitive biomarker of sarcoidosis</span>. <i>J. Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">264</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1007/s10875-012-9754-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1007%2Fs10875-012-9754-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=22878841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslamsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=264-270&author=E.+Bargagliauthor=D.+Bennettauthor=C.+Maggiorelliauthor=P.+Di+Sipioauthor=M.+Margollicciauthor=N.+Bianchiauthor=P.+Rottoli&title=Human+chitotriosidase%3A+a+sensitive+biomarker+of+sarcoidosis&doi=10.1007%2Fs10875-012-9754-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Human Chitotriosidase: a Sensitive Biomarker of Sarcoidosis</span></div><div class="casAuthors">Bargagli, Elena; Bennett, David; Maggiorelli, Claudia; Sipio, Pasquale; Margollicci, Maria; Bianchi, Nicola; Rottoli, Paola</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">264-270</span>CODEN:
                <span class="NLM_cas:coden">JCIMDO</span>;
        ISSN:<span class="NLM_cas:issn">0271-9142</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Background Sarcoidosis is a multisystem granulomatous disease of unknown etiol.  No suitable biomarkers are available to evaluate the evolution of this disease, which still has an unpredictable clin. course.  Some years ago our research group proposed chitotriosidase as a potential biomarker with prognostic value, that however needed to be validated.  Aims and methods The aims of this study were to evaluate the sensitivity and specificity of chitotriosidase in a population of 232 sarcoidosis patients under the observation of our Sarcoidosis Regional Referral Center in Siena and to analyze enzyme concns. in different disease phenotypes (as defined by the recently published COS classification) to define its prognostic value.  Results Serum chitotriosidase concns. were significantly higher in patients than in healthy controls (p < 0.0001) and were directly correlated with ACE levels (r = 0.25, p < 0.0001).  ROC curve anal. revealed 88.6 % sensitivity and 92.8 % specificity.  Enzyme concns. were significantly higher in stage 3 sarcoidosis than in stage 0 (p = 0.02).  The lowest concns. of chitotriosidase were found in untreated patients in remission (COS-1), while the highest enzyme concns. were found in symptomatic patients with persistent disease on steroids and with functional deterioration in the last year (COS-9).  In COS-9 subgroup, chitotriosidase decreased significantly after the increasing of steroid dose or the introduction of a new immunosuppressant therapy (p < 0.01).  Conclusion Chitotriosidase proved to be a biomarker with good sensitivity and specificity that is easily detected in serum.  It can be proposed in clin. practice to identify progressive patients requiring close follow-up, to detect relapses and to evaluate the effects of therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwMt2Gnk9Wo7Vg90H21EOLACvtfcHk0lhKxiCX7A_bWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslamsLc%253D&md5=d6b36d32e6fa4c0ec6e54382c1d7e04c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs10875-012-9754-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10875-012-9754-4%26sid%3Dliteratum%253Aachs%26aulast%3DBargagli%26aufirst%3DE.%26aulast%3DBennett%26aufirst%3DD.%26aulast%3DMaggiorelli%26aufirst%3DC.%26aulast%3DDi%2BSipio%26aufirst%3DP.%26aulast%3DMargollicci%26aufirst%3DM.%26aulast%3DBianchi%26aufirst%3DN.%26aulast%3DRottoli%26aufirst%3DP.%26atitle%3DHuman%2520chitotriosidase%253A%2520a%2520sensitive%2520biomarker%2520of%2520sarcoidosis%26jtitle%3DJ.%2520Clin.%2520Immunol.%26date%3D2013%26volume%3D33%26spage%3D264%26epage%3D270%26doi%3D10.1007%2Fs10875-012-9754-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bargagli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margollicci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luddi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikiforakis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grazia Perari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosso, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottoli, P.</span></span> <span> </span><span class="NLM_article-title">Chitotriosidase activity in patients with interstitial lung diseases</span>. <i>Respir. Med.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">2176</span>– <span class="NLM_lpage">2181</span>, <span class="refDoi"> DOI: 10.1016/j.rmed.2007.05.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1016%2Fj.rmed.2007.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=17631992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A280%3ADC%252BD2sritl2ksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=2176-2181&author=E.+Bargagliauthor=M.+Margollicciauthor=A.+Luddiauthor=N.+Nikiforakisauthor=M.+Grazia+Perariauthor=S.+Grossoauthor=A.+Perroneauthor=P.+Rottoli&title=Chitotriosidase+activity+in+patients+with+interstitial+lung+diseases&doi=10.1016%2Fj.rmed.2007.05.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Chitotriosidase activity in patients with interstitial lung diseases</span></div><div class="casAuthors">Bargagli Elena; Margollicci Maria; Luddi Alice; Nikiforakis Nicolaos; Perari Maria Grazia; Grosso Salvatore; Perrone Anna; Rottoli Paola</div><div class="citationInfo"><span class="NLM_cas:title">Respiratory medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2176-81</span>
        ISSN:<span class="NLM_cas:issn">0954-6111</span>.
    </div><div class="casAbstract">BACKGROUND:  In previous papers, we found significantly higher activity of chitotriosidase, a macrophage derived enzyme, in serum and BAL of patients with sarcoidosis, especially in those with progressing disease and lung involvement, than in controls.  Locally and systemically produced chitotriosidase activity was correlated with radiological stage and also with degree of lung infiltration, suggesting that this enzyme may play a role in the pathogenesis of sarcoidosis and may be used as a marker of disease severity.  AIM:  To analyse chitotriosidase activity in serum and bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis and pulmonary fibrosis associated with systemic sclerosis and to compare it with chitotriosidase activity in controls and sarcoidosis patients.  METHODS:  Chitotriosidase activity was determined by a fluorometric assay.  RESULTS:  The results showed that serum chitotriosidase activity was only elevated in sarcoidosis patients; in patients with idiopathic pulmonary fibrosis and pulmonary fibrosis associated with systemic sclerosis it was in the normal range.  On the contrary, in BAL of sarcoidosis and idiopathic pulmonary fibrosis patients the activity was significantly higher than in controls.  CONCLUSION:  Serum chitotriosidase is a potential marker of sarcoidosis severity; it increases in sarcoidosis in relation to radiological stage and degree of lung infiltration.  The increase in chitotriosidase activity in BAL of sarcoidosis and idiopathic pulmonary fibrosis patients suggests that the enzyme could be involved in fibrogenesis in diffuse lung diseases.  Further research is needed to understand the role of chitotriosidase in the pathogenesis of sarcoidosis and its involvement in fibrotic remodelling in certain diffuse lung diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRBlIG9FNlwQGlSCSgBhwJFfW6udTcc2eYqMNkz-3owhbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sritl2ksA%253D%253D&md5=03bd6b3a9e02431da7a31eb2a269a279</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.rmed.2007.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.rmed.2007.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DBargagli%26aufirst%3DE.%26aulast%3DMargollicci%26aufirst%3DM.%26aulast%3DLuddi%26aufirst%3DA.%26aulast%3DNikiforakis%26aufirst%3DN.%26aulast%3DGrazia%2BPerari%26aufirst%3DM.%26aulast%3DGrosso%26aufirst%3DS.%26aulast%3DPerrone%26aufirst%3DA.%26aulast%3DRottoli%26aufirst%3DP.%26atitle%3DChitotriosidase%2520activity%2520in%2520patients%2520with%2520interstitial%2520lung%2520diseases%26jtitle%3DRespir.%2520Med.%26date%3D2007%26volume%3D101%26spage%3D2176%26epage%3D2181%26doi%3D10.1016%2Fj.rmed.2007.05.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harlander, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salobir, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zupancic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tercelj, M.</span></span> <span> </span><span class="NLM_article-title">Bronchoalveolar lavage chitotriosidase activity as a biomarker of sarcoidosis</span>. <i>Sarcoidosis Vasc. Diffuse Lung Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">317</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=26847098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A280%3ADC%252BC28notVGmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2016&pages=313-317&author=M.+Harlanderauthor=B.+Salobirauthor=M.+Zupancicauthor=M.+Tercelj&title=Bronchoalveolar+lavage+chitotriosidase+activity+as+a+biomarker+of+sarcoidosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Bronchoalveolar lavage chitotriosidase activity as a biomarker of sarcoidosis</span></div><div class="casAuthors">Harlander Matevz; Salobir Barbara; Zupancic Mirjana; Tercelj Marjeta</div><div class="citationInfo"><span class="NLM_cas:title">Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">313-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Chitotriosidase (CTO) was shown to be a good biomarker of sarcoidosis.  Increased levels in bronchoalveolar lavage fluid (BALF) were reported and associated with more severe forms of the disease.  OBJECTIVES:  The aim of the study was to evaluate the value of CTO in BALF as a routine biomarker of sarcoidosis.  METHODS:  The study included 85 patients in 9 control subjects in whom serum and BALF CTO were measured.  RESULTS:  Significantly higher CTO levels were detected in BALF of sarcoidosis patients than in control subjects (p < 0.001).  There was good correlation between serum and BALF CTO levels in sarcoidosis patients (Spearman's Rho 0.481, p < 0.001).  Serum but not BALF CTO had good correlation with clinical parameters.  Only in a group of patients with BALF CTO above upper normal range there was association of BALF CTO with impaired FVC (p = 0.020) and chest radiograph score (0-2 vs. 3-4, p = 0.016).  CONCLUSIONS:  In comparison to serum CTO no additional benefit of determining CTO in BAL for routine sarcoidosis workup was shown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSExZkDUL6o1WZyxfu64m4ffW6udTcc2eYqMNkz-3owhbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28notVGmsw%253D%253D&md5=643c4d3534932b395e05dd5fea33fd23</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarlander%26aufirst%3DM.%26aulast%3DSalobir%26aufirst%3DB.%26aulast%3DZupancic%26aufirst%3DM.%26aulast%3DTercelj%26aufirst%3DM.%26atitle%3DBronchoalveolar%2520lavage%2520chitotriosidase%2520activity%2520as%2520a%2520biomarker%2520of%2520sarcoidosis%26jtitle%3DSarcoidosis%2520Vasc.%2520Diffuse%2520Lung%2520Dis.%26date%3D2016%26volume%3D32%26spage%3D313%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hector, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chotirmall, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavelle, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirković, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eichler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ralhan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berenbrinker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mack, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ensenauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riethmüller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graepler-Mainka, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElvaney, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartl, D.</span></span> <span> </span><span class="NLM_article-title">Chitinase activation in patients with fungus-associated cystic fibrosis lung disease</span>. <i>J. Allergy Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">1183</span>, <span class="refDoi"> DOI: 10.1016/j.jaci.2016.01.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1016%2Fj.jaci.2016.01.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=27056270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A280%3ADC%252BC28fnvFSgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=1183&author=A.+Hectorauthor=S.+H.+Chotirmallauthor=G.+M.+Lavelleauthor=B.+Mirkovi%C4%87author=D.+Horanauthor=L.+Eichlerauthor=M.+Mezgerauthor=A.+Singhauthor=A.+Ralhanauthor=S.+Berenbrinkerauthor=I.+Mackauthor=R.+Ensenauerauthor=J.+Riethm%C3%BCllerauthor=U.+Graepler-Mainkaauthor=M.+A.+Murrayauthor=M.+Grieseauthor=N.+G.+McElvaneyauthor=D.+Hartl&title=Chitinase+activation+in+patients+with+fungus-associated+cystic+fibrosis+lung+disease&doi=10.1016%2Fj.jaci.2016.01.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Chitinase activation in patients with fungus-associated cystic fibrosis lung disease</span></div><div class="casAuthors">Hector Andreas; Eichler Laura; Mezger Markus; Singh Anurag; Ralhan Anjai; Berenbrinker Sina; Riethmuller Joachim; Graepler-Mainka Ute; Chotirmall Sanjay H; Lavelle Gillian M; Mirkovic Bojana; Horan Deirdre; Murray Michelle A; McElvaney N Gerry; Mack Ines; Ensenauer Regina; Griese Matthias; Hartl Dominik</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of allergy and clinical immunology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1183-1189.e4</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Chitinases have recently gained attention in the field of pulmonary diseases, particularly in asthma and chronic obstructive pulmonary disease, but their potential role in patients with cystic fibrosis (CF)-associated lung disease remains unclear.  OBJECTIVE:  The aim of this study was to assess chitinase activity systemically and in the airways of patients with CF and asthma compared with healthy subjects.  Additionally, we assessed factors that regulate chitinase activity within the lungs of patients with CF.  METHODS:  Chitinase activities were quantified in serum and bronchoalveolar lavage fluid from patients with CF, asthmatic patients, and healthy control subjects.  Mechanistically, the role of CF airway proteases and genetic chitinase deficiency was assessed.  RESULTS:  Chitinase activity was systemically increased in patients with CF compared with that in healthy control subjects and asthmatic patients.  Further stratification showed that chitinase activity was enhanced in patients with CF colonized with Candida albicans compared with that in noncolonized patients.  CF proteases degraded chitinases in the airway microenvironment of patients with CF.  Genetic chitinase deficiency was associated with C albicans colonization in patients with CF.  CONCLUSION:  Patients with CF have enhanced chitinase activation associated with C albicans colonization.  Therefore chitinases might represent a novel biomarker and therapeutic target for CF-associated fungal disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnkbMAaoN8wcScOqQTSkOffW6udTcc2eYqMNkz-3owhbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fnvFSgtQ%253D%253D&md5=22cf21a34fd46a73dd75274daf38c3c3</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2016.01.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2016.01.031%26sid%3Dliteratum%253Aachs%26aulast%3DHector%26aufirst%3DA.%26aulast%3DChotirmall%26aufirst%3DS.%2BH.%26aulast%3DLavelle%26aufirst%3DG.%2BM.%26aulast%3DMirkovi%25C4%2587%26aufirst%3DB.%26aulast%3DHoran%26aufirst%3DD.%26aulast%3DEichler%26aufirst%3DL.%26aulast%3DMezger%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DRalhan%26aufirst%3DA.%26aulast%3DBerenbrinker%26aufirst%3DS.%26aulast%3DMack%26aufirst%3DI.%26aulast%3DEnsenauer%26aufirst%3DR.%26aulast%3DRiethm%25C3%25BCller%26aufirst%3DJ.%26aulast%3DGraepler-Mainka%26aufirst%3DU.%26aulast%3DMurray%26aufirst%3DM.%2BA.%26aulast%3DGriese%26aufirst%3DM.%26aulast%3DMcElvaney%26aufirst%3DN.%2BG.%26aulast%3DHartl%26aufirst%3DD.%26atitle%3DChitinase%2520activation%2520in%2520patients%2520with%2520fungus-associated%2520cystic%2520fibrosis%2520lung%2520disease%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2016%26volume%3D138%26spage%3D1183%26doi%3D10.1016%2Fj.jaci.2016.01.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herzog, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahangari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulati, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feghali-Bostwick, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varga, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elias, J. A.</span></span> <span> </span><span class="NLM_article-title">Chitinase 1 is a biomarker for and therapeutic target in scleroderma-associated interstitial lung disease that augments TGF-beta1 signaling</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>189</i></span>,  <span class="NLM_fpage">2635</span>– <span class="NLM_lpage">2644</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1201115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.4049%2Fjimmunol.1201115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=22826322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1aksrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2012&pages=2635-2644&author=C.+G.+Leeauthor=E.+L.+Herzogauthor=F.+Ahangariauthor=Y.+Zhouauthor=M.+Gulatiauthor=C.-M.+Leeauthor=X.+Pengauthor=C.+Feghali-Bostwickauthor=S.+A.+Jimenezauthor=J.+Vargaauthor=J.+A.+Elias&title=Chitinase+1+is+a+biomarker+for+and+therapeutic+target+in+scleroderma-associated+interstitial+lung+disease+that+augments+TGF-beta1+signaling&doi=10.4049%2Fjimmunol.1201115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Chitinase 1 Is a Biomarker for and Therapeutic Target in Scleroderma-Associated Interstitial Lung Disease That Augments TGF-β1 Signaling</span></div><div class="casAuthors">Lee, Chun Geun; Herzog, Erica L.; Ahangari, Farida; Zhou, Yang; Gulati, Mridu; Lee, Chang-Min; Peng, Xueyan; Feghali-Bostwick, Carol; Jimenez, Sergio A.; Varga, John; Elias, Jack A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">189</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2635-2644</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Interstitial lung disease (ILD) with pulmonary fibrosis is an important manifestation in systemic sclerosis (SSc, scleroderma) where it portends a poor prognosis.  However, biomarkers that predict the development and or severity of SSc-ILD have not been validated, and the pathogenetic mechanisms that engender this pulmonary response are poorly understood.  In this study, we demonstrate in two different patient cohorts that the levels of chitotriosidase (Chit1) bioactivity and protein are significantly increased in the circulation and lungs of SSc patients compared with demog. matched controls.  We also demonstrate that, compared with patients without lung involvement, patients with ILD show high levels of circulating Chit1 activity that correlate with disease severity.  Murine modeling shows that in comparison with wild-type mice, bleomycin-induced pulmonary fibrosis was significantly reduced in Chit1-/- mice and significantly enhanced in lungs from Chit1 overexpressing transgenic animals.  In vitro studies also demonstrated that Chit1 interacts with TGF-β1 to augment fibroblast TGF-β receptors 1 and 2 expression and TGF-β-induced Smad and MAPK/ERK activation.  These studies indicate that Chit1 is potential biomarker for ILD in SSc and a therapeutic target in SSc-assocd. lung fibrosis and demonstrate that Chit1 augments TGF-β1 effects by increasing receptor expression and canonical and noncanonical TGF-β1 signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLePPAHVnYN7Vg90H21EOLACvtfcHk0liDrVEXF-HL6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1aksrfN&md5=43ba51fe854b550a13ab0c90ba9ba084</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1201115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1201115%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.%2BG.%26aulast%3DHerzog%26aufirst%3DE.%2BL.%26aulast%3DAhangari%26aufirst%3DF.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DGulati%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DC.-M.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DFeghali-Bostwick%26aufirst%3DC.%26aulast%3DJimenez%26aufirst%3DS.%2BA.%26aulast%3DVarga%26aufirst%3DJ.%26aulast%3DElias%26aufirst%3DJ.%2BA.%26atitle%3DChitinase%25201%2520is%2520a%2520biomarker%2520for%2520and%2520therapeutic%2520target%2520in%2520scleroderma-associated%2520interstitial%2520lung%2520disease%2520that%2520augments%2520TGF-beta1%2520signaling%26jtitle%3DJ.%2520Immunol.%26date%3D2012%26volume%3D189%26spage%3D2635%26epage%3D2644%26doi%3D10.4049%2Fjimmunol.1201115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenbarth, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elias, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eynon, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flavell, R. A.</span></span> <span> </span><span class="NLM_article-title">AMCase is a crucial regulator of type 2 immune responses to inhaled house dust mites</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">E2891</span>– <span class="NLM_lpage">E2899</span>, <span class="refDoi"> DOI: 10.1073/pnas.1507393112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1073%2Fpnas.1507393112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=26038565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosVKrtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=E2891-E2899&author=L.+K.+Kimauthor=R.+Moritaauthor=Y.+Kobayashiauthor=S.+C.+Eisenbarthauthor=C.+G.+Leeauthor=J.+Eliasauthor=E.+E.+Eynonauthor=R.+A.+Flavell&title=AMCase+is+a+crucial+regulator+of+type+2+immune+responses+to+inhaled+house+dust+mites&doi=10.1073%2Fpnas.1507393112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">AMCase is a crucial regulator of type 2 immune responses to inhaled house dust mites</span></div><div class="casAuthors">Kim, Lark Kyun; Morita, Rimpei; Kobayashi, Yasushi; Eisenbarth, Stephanie C.; Lee, Chun Geun; Elias, Jack; Eynon, Elizabeth E.; Flavell, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">E2891-E2899</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Chitinases are enzymes that cleave chitin, a component of the exoskeleton of many organisms including the house dust mite (HDM).  Here we show that knockin mice expressing an enzymically inactive acidic mammalian chitinase (AMCase), the dominant true chitinase in mouse lung, showed enhanced type 2 immune responses to inhaled HDM.  We found that uncleaved chitin promoted the release of IL-33, whereas cleaved chitin could be phagocytosed and could induce the activation of caspase-1 and subsequent activation of caspase-7; this results in the resoln. of type 2 immune responses, probably by promoting the inactivation of IL-33.  These data suggest that AMCase is a crucial regulator of type 2 immune responses to inhaled chitin-contg. aeroallergens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqexp0_1nUUdLVg90H21EOLACvtfcHk0liDrVEXF-HL6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosVKrtLk%253D&md5=bfae4eaba25d18054d9a9664f91d880d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1507393112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1507393112%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DL.%2BK.%26aulast%3DMorita%26aufirst%3DR.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DEisenbarth%26aufirst%3DS.%2BC.%26aulast%3DLee%26aufirst%3DC.%2BG.%26aulast%3DElias%26aufirst%3DJ.%26aulast%3DEynon%26aufirst%3DE.%2BE.%26aulast%3DFlavell%26aufirst%3DR.%2BA.%26atitle%3DAMCase%2520is%2520a%2520crucial%2520regulator%2520of%2520type%25202%2520immune%2520responses%2520to%2520inhaled%2520house%2520dust%2520mites%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2015%26volume%3D112%26spage%3DE2891%26epage%3DE2899%26doi%3D10.1073%2Fpnas.1507393112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Silva, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dela Cruz, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahangari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takyar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elias, J. A.</span></span> <span> </span><span class="NLM_article-title">Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury</span>. <i>Annu. Rev. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">479</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1146/annurev-physiol-012110-142250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1146%2Fannurev-physiol-012110-142250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=21054166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVKjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2011&pages=479-501&author=C.+G.+Leeauthor=C.+A.+Da+Silvaauthor=C.+S.+Dela+Cruzauthor=F.+Ahangariauthor=B.+Maauthor=M.-J.+Kangauthor=C.-H.+Heauthor=S.+Takyarauthor=J.+A.+Elias&title=Role+of+chitin+and+chitinase%2Fchitinase-like+proteins+in+inflammation%2C+tissue+remodeling%2C+and+injury&doi=10.1146%2Fannurev-physiol-012110-142250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury</span></div><div class="casAuthors">Lee, Chun Geun; Da Silva, Carla A.; Dela Cruz, Charles S.; Ahangari, Farida; Ma, Bing; Kang, Min-Jong; He, Chuan-Hua; Takyar, Seyedtaghi; Elias, Jack A.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Physiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">479-501</span>CODEN:
                <span class="NLM_cas:coden">ARPHAD</span>;
        ISSN:<span class="NLM_cas:issn">0066-4278</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The 18 glycosyl hydrolase family of chitinases is an ancient gene family that is widely expressed from prokaryotes to eukaryotes.  In mammals, despite the absence of endogenous chitin, a no. of chitinases and chitinase-like proteins (C/CLPs) were identified.  However, their roles have only recently begun to be elucidated.  Acidic mammalian chitinase (AMCase) inhibits chitin-induced innate inflammation; augments chitin-free, allergen-induced Th2 inflammation; and mediates effector functions of IL-13.  The CLPs BRP-39/YKL-40 (also termed chitinase 3-like 1) inhibit oxidant-induced lung injury, augments adaptive Th2 immunity, regulates apoptosis, stimulates alternative macrophage activation, and contributes to fibrosis and wound healing.  In accord with these findings, levels of YKL-40 in the lung and serum are increased in asthma and other inflammatory and remodeling disorders and often correlate with disease severity.  Our understanding of the roles of C/CLPs in inflammation, tissue remodeling, and tissue injury in health and disease is reviewed below.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowzHNOTFA9GrVg90H21EOLACvtfcHk0liDrVEXF-HL6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVKjurg%253D&md5=b43e39234c46e82a305f8052123ab996</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1146%2Fannurev-physiol-012110-142250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-physiol-012110-142250%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.%2BG.%26aulast%3DDa%2BSilva%26aufirst%3DC.%2BA.%26aulast%3DDela%2BCruz%26aufirst%3DC.%2BS.%26aulast%3DAhangari%26aufirst%3DF.%26aulast%3DMa%26aufirst%3DB.%26aulast%3DKang%26aufirst%3DM.-J.%26aulast%3DHe%26aufirst%3DC.-H.%26aulast%3DTakyar%26aufirst%3DS.%26aulast%3DElias%26aufirst%3DJ.%2BA.%26atitle%3DRole%2520of%2520chitin%2520and%2520chitinase%252Fchitinase-like%2520proteins%2520in%2520inflammation%252C%2520tissue%2520remodeling%252C%2520and%2520injury%26jtitle%3DAnnu.%2520Rev.%2520Physiol.%26date%3D2011%26volume%3D73%26spage%3D479%26epage%3D501%26doi%3D10.1146%2Fannurev-physiol-012110-142250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mack, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hector, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballbach, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlhaufl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mall, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartl, D.</span></span> <span> </span><span class="NLM_article-title">The role of chitin, chitinases, and chitinase-like proteins in pediatric lung diseases</span>. <i>Mol. Cell. Pediatr.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">3</span>, <span class="refDoi"> DOI: 10.1186/s40348-015-0014-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1186%2Fs40348-015-0014-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=26542293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A280%3ADC%252BC28zpslWisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2015&pages=3&author=I.+Mackauthor=A.+Hectorauthor=M.+Ballbachauthor=J.+Kohlhauflauthor=K.+J.+Fuchsauthor=A.+Weberauthor=M.+A.+Mallauthor=D.+Hartl&title=The+role+of+chitin%2C+chitinases%2C+and+chitinase-like+proteins+in+pediatric+lung+diseases&doi=10.1186%2Fs40348-015-0014-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The role of chitin, chitinases, and chitinase-like proteins in pediatric lung diseases</span></div><div class="casAuthors">Mack Ines; Hector Andreas; Ballbach Marlene; Kohlhaufl Julius; Hartl Dominik; Fuchs Katharina J; Weber Alexander; Mall Marcus A</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and cellular pediatrics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3</span>
        ISSN:<span class="NLM_cas:issn">2194-7791</span>.
    </div><div class="casAbstract">Chitin, after cellulose, the second most abundant biopolymer on earth, is a key component of insects, fungi, and house-dust mites.  Lower life forms are endowed with chitinases to defend themselves against chitin-bearing pathogens.  Unexpectedly, humans were also found to express chitinases as well as chitinase-like proteins that modulate immune responses.  Particularly, increased levels of the chitinase-like protein YKL-40 have been associated with severe asthma, cystic fibrosis, and other inflammatory disease conditions.  Here, we summarize and discuss the potential role of chitin, chitinases, and chitinase-like proteins in pediatric lung diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRevA87LZB6CApJitSxOdIlfW6udTcc2ebfM6XeWPoc17ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zpslWisQ%253D%253D&md5=9b4b0676b4c22374fba9c8bceb92d004</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1186%2Fs40348-015-0014-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40348-015-0014-6%26sid%3Dliteratum%253Aachs%26aulast%3DMack%26aufirst%3DI.%26aulast%3DHector%26aufirst%3DA.%26aulast%3DBallbach%26aufirst%3DM.%26aulast%3DKohlhaufl%26aufirst%3DJ.%26aulast%3DFuchs%26aufirst%3DK.%2BJ.%26aulast%3DWeber%26aufirst%3DA.%26aulast%3DMall%26aufirst%3DM.%2BA.%26aulast%3DHartl%26aufirst%3DD.%26atitle%3DThe%2520role%2520of%2520chitin%252C%2520chitinases%252C%2520and%2520chitinase-like%2520proteins%2520in%2520pediatric%2520lung%2520diseases%26jtitle%3DMol.%2520Cell.%2520Pediatr.%26date%3D2015%26volume%3D2%26spage%3D3%26doi%3D10.1186%2Fs40348-015-0014-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boot, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blommaart, E. F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swart, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghauharali-van
der Vlugt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bijl, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moe, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Place, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aerts, J. M. F. G.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel acidic mammalian chitinase distinct from chitotriosidase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">6770</span>– <span class="NLM_lpage">6778</span>, <span class="refDoi"> DOI: 10.1074/jbc.m009886200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1074%2Fjbc.m009886200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=11085997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslSgsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=6770-6778&author=R.+G.+Bootauthor=E.+F.+C.+Blommaartauthor=E.+Swartauthor=K.+Ghauharali-van%0Ader+Vlugtauthor=N.+Bijlauthor=C.+Moeauthor=A.+Placeauthor=J.+M.+F.+G.+Aerts&title=Identification+of+a+novel+acidic+mammalian+chitinase+distinct+from+chitotriosidase&doi=10.1074%2Fjbc.m009886200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel acidic mammalian chitinase distinct from chitotriosidase</span></div><div class="casAuthors">Boot, Rolf G.; Blommaart, Edward F. C.; Swart, Erwin; Ghuharali-Van der Vlugt, Karen; Bijl, Nora; Moe, Cassandra; Place, Allen; Aerts, Johannes M. F. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">6770-6778</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Chitinases are ubiquitous chitin-fragmenting hydrolases.  Recently we discovered the first human chitinase, named chitotriosidase, that is specifically expressed by phagocytes.  We here report the identification, purifn., and subsequent cloning of a second mammalian chitinase.  This enzyme is characterized by an acidic isoelec. point and therefore named acidic mammalian chitinase (AMCase).  In rodents and man the enzyme is relatively abundant in the gastrointestinal tract and is found to a lesser extent in the lung.  Like chitotriosidase, AMCase is synthesized as a 50-kDa protein contg. a 39-kDa N-terminal catalytic domain, a hinge region, and a C-terminal chitin-binding domain.  In contrast to chitotriosidase, the enzyme is extremely acid stable and shows a distinct second pH optimum around pH 2.  AMCase is capable of cleaving artificial chitin-like substrates as well as crab shell chitin and chitin as present in the fungal cell wall.  Our study has revealed the existence of a chitinolytic enzyme in the gastrointestinal tract and lung that may play a role in digestion and/or defense.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK9zza8yUykLVg90H21EOLACvtfcHk0lh6eZtGr-hihQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslSgsrs%253D&md5=cb1d31ccbf699384de3cb00105259993</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m009886200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m009886200%26sid%3Dliteratum%253Aachs%26aulast%3DBoot%26aufirst%3DR.%2BG.%26aulast%3DBlommaart%26aufirst%3DE.%2BF.%2BC.%26aulast%3DSwart%26aufirst%3DE.%26aulast%3DGhauharali-van%2Bder%2BVlugt%26aufirst%3DK.%26aulast%3DBijl%26aufirst%3DN.%26aulast%3DMoe%26aufirst%3DC.%26aulast%3DPlace%26aufirst%3DA.%26aulast%3DAerts%26aufirst%3DJ.%2BM.%2BF.%2BG.%26atitle%3DIdentification%2520of%2520a%2520novel%2520acidic%2520mammalian%2520chitinase%2520distinct%2520from%2520chitotriosidase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D6770%26epage%3D6778%26doi%3D10.1074%2Fjbc.m009886200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garth, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackel, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeder, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackburn, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunaway, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matalon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steele, C.</span></span> <span> </span><span class="NLM_article-title">Acidic mammalian chitinase negatively affects immune responses during acute and chronic Aspergillus fumigatus exposure</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">e00944</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1128/IAI.00944-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1128%2FIAI.00944-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=29712728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvV2ms7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2018&pages=e00944-17&author=J.+M.+Garthauthor=J.+J.+Mackelauthor=K.+M.+Reederauthor=J.+P.+Blackburnauthor=C.+W.+Dunawayauthor=Z.+Yuauthor=S.+Matalonauthor=L.+Fitzauthor=C.+Steele&title=Acidic+mammalian+chitinase+negatively+affects+immune+responses+during+acute+and+chronic+Aspergillus+fumigatus+exposure&doi=10.1128%2FIAI.00944-17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Acidic mammalian chitinase negatively affects immune responses during acute and chronic Aspergillus fumigatus exposure</span></div><div class="casAuthors">Garth, Jaleesa M.; Mackel, Joseph J.; Reeder, Kristen M.; Blackburn, Jonathan P.; Dunaway, Chad W.; Yu, Zhihong; Matalon, Sadis; Fitz, Lori; Steele, Chad</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e00944-17/1-e00944-17/14</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">1098-5522</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Here, we detd. the impact of acidic mammalian chitinase (AMCase) (Chia) deficiency on host defense during acute exposure to the fungal pathogen Aspergillus fumigatus as well as its contribution to A. fumigatus-assocd. allergic asthma.  We demonstrate that chitin in the fungal cell wall was detected at low levels in A. fumigatus conidia, which emerged at the highest level during hyphal transition.  In response to acute A. fumigatus challenge, Chia-/- mice unexpectedly demonstrated lower A. fumigatus lung burdens at 2 days postchallenge.  The lower fungal burden correlated with decreased lung interleukin-33 (IL-33) levels yet increased IL-1β and prostaglandin E2 (PGE2) prodn., a phenotype that we reported previously to promote the induction of IL-17A and IL-22.  During chronic A. fumigatus exposure, AMCase deficiency resulted in lower dynamic and airway lung resistance than in wild-type mice.  Improved lung physiol. correlated with attenuated levels of the proallergic chemokines CCL17 and CCL22.  Surprisingly, examn. of inflammatory responses during chronic exposure revealed attenuated IL-17A and IL-22 responses, but not type 2 responses, in the absence of AMCase.  Collectively, these data suggest that AMCase functions as a neg. regulator of immune responses during acute fungal exposure and is a contributor to fungal asthma severity, putatively via the induction of proinflammatory responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCMQwKBOCcrLVg90H21EOLACvtfcHk0lh6eZtGr-hihQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvV2ms7%252FF&md5=1650a55df583e4c508e3b4e7e28d5561</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1128%2FIAI.00944-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.00944-17%26sid%3Dliteratum%253Aachs%26aulast%3DGarth%26aufirst%3DJ.%2BM.%26aulast%3DMackel%26aufirst%3DJ.%2BJ.%26aulast%3DReeder%26aufirst%3DK.%2BM.%26aulast%3DBlackburn%26aufirst%3DJ.%2BP.%26aulast%3DDunaway%26aufirst%3DC.%2BW.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DMatalon%26aufirst%3DS.%26aulast%3DFitz%26aufirst%3DL.%26aulast%3DSteele%26aufirst%3DC.%26atitle%3DAcidic%2520mammalian%2520chitinase%2520negatively%2520affects%2520immune%2520responses%2520during%2520acute%2520and%2520chronic%2520Aspergillus%2520fumigatus%2520exposure%26jtitle%3DInfect.%2520Immun.%26date%3D2018%26volume%3D86%26spage%3De00944%26epage%3D17%26doi%3D10.1128%2FIAI.00944-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mazur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olczak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koralewski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czestkowski, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jedrzejczak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golab, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzwonek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dymek, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sklepkiewicz, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagozdzon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noonan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahboubi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheeler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckett, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hungerford, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podjarny, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitschler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cousido-Siah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golebiowski, A.</span></span> <span> </span><span class="NLM_article-title">Targeting Acidic Mammalian chitinase Is Effective in Animal Model of Asthma</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">695</span>– <span class="NLM_lpage">710</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01051</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01051" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVCms7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=695-710&author=M.+Mazurauthor=J.+Olczakauthor=S.+Olejniczakauthor=R.+Koralewskiauthor=W.+Czestkowskiauthor=A.+Jedrzejczakauthor=J.+Golabauthor=K.+Dzwonekauthor=B.+Dymekauthor=P.+L.+Sklepkiewiczauthor=A.+Zagozdzonauthor=T.+Noonanauthor=K.+Mahboubiauthor=B.+Conwayauthor=R.+Sheelerauthor=P.+Beckettauthor=W.+M.+Hungerfordauthor=A.+Podjarnyauthor=A.+Mitschlerauthor=A.+Cousido-Siahauthor=F.+Fadelauthor=A.+Golebiowski&title=Targeting+Acidic+Mammalian+chitinase+Is+Effective+in+Animal+Model+of+Asthma&doi=10.1021%2Facs.jmedchem.7b01051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Acidic Mammalian chitinase Is Effective in Animal Model of Asthma</span></div><div class="casAuthors">Mazur, Marzena; Olczak, Jacek; Olejniczak, Sylwia; Koralewski, Robert; Czestkowski, Wojciech; Jedrzejczak, Anna; Golab, Jakub; Dzwonek, Karolina; Dymek, Barbara; Sklepkiewicz, Piotr L.; Zagozdzon, Agnieszka; Noonan, Tom; Mahboubi, Keyvan; Conway, Bruce; Sheeler, Ryan; Beckett, Paul; Hungerford, William M.; Podjarny, Alberto; Mitschler, Andre; Cousido-Siah, Alexandra; Fadel, Firas; Golebiowski, Adam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">695-710</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This article highlights the authors' work toward the identification of a potent, selective, and efficacious acidic mammalian chitinase (AMCase) inhibitor.  Rational design, guided by x-ray anal. of several inhibitors bound to human chitotriosidase (hCHIT1), led to the identification of compd. 7f (1-(3-amino-1H-1,2,4-triazol-5-yl)-N-(4-chlorophenethyl)-N-isobutylpiperidin-4-amine) as a highly potent AMCase inhibitor (IC50 values of 14 and 19 nM against human and mouse enzyme, resp.) and selective (>150× against mCHIT1) with very good PK properties.  This compd. dosed once daily at 30 mg/kg po showed significant anti-inflammatory efficacy in HDM-induced allergic airway inflammation in mice, reducing inflammatory cell influx in the BALF and total IgE concn. in plasma, which correlated with decrease of chitinolytic activity.  Therapeutic efficacy of compd. 7f in the clin. relevant aero-allergen-induced acute asthma model in mice provides a rationale for developing AMCase inhibitor for the treatment of asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9n2hO0hKVarVg90H21EOLACvtfcHk0lhuTuEyF_to4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVCms7nJ&md5=d93c7add7d10a66f03419a6c7fe59bfc</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01051%26sid%3Dliteratum%253Aachs%26aulast%3DMazur%26aufirst%3DM.%26aulast%3DOlczak%26aufirst%3DJ.%26aulast%3DOlejniczak%26aufirst%3DS.%26aulast%3DKoralewski%26aufirst%3DR.%26aulast%3DCzestkowski%26aufirst%3DW.%26aulast%3DJedrzejczak%26aufirst%3DA.%26aulast%3DGolab%26aufirst%3DJ.%26aulast%3DDzwonek%26aufirst%3DK.%26aulast%3DDymek%26aufirst%3DB.%26aulast%3DSklepkiewicz%26aufirst%3DP.%2BL.%26aulast%3DZagozdzon%26aufirst%3DA.%26aulast%3DNoonan%26aufirst%3DT.%26aulast%3DMahboubi%26aufirst%3DK.%26aulast%3DConway%26aufirst%3DB.%26aulast%3DSheeler%26aufirst%3DR.%26aulast%3DBeckett%26aufirst%3DP.%26aulast%3DHungerford%26aufirst%3DW.%2BM.%26aulast%3DPodjarny%26aufirst%3DA.%26aulast%3DMitschler%26aufirst%3DA.%26aulast%3DCousido-Siah%26aufirst%3DA.%26aulast%3DFadel%26aufirst%3DF.%26aulast%3DGolebiowski%26aufirst%3DA.%26atitle%3DTargeting%2520Acidic%2520Mammalian%2520chitinase%2520Is%2520Effective%2520in%2520Animal%2520Model%2520of%2520Asthma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D695%26epage%3D710%26doi%3D10.1021%2Facs.jmedchem.7b01051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Corman, M. L.</span>; <span class="NLM_string-name">Hungerford, W. M.</span>; <span class="NLM_string-name">Golebiowski, A.</span>; <span class="NLM_string-name">Beckett, R. P.</span>; <span class="NLM_string-name">Mazur, M.</span>; <span class="NLM_string-name">Olejniczak, S.</span>; <span class="NLM_string-name">Olczak, J.</span></span> <span> </span><span class="NLM_article-title">Substituted Amino Triazoles</span>. WO Patent <span class="NLM_patent">WO 2015/095701 A1</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=M.+L.+Corman&author=W.+M.+Hungerford&author=A.+Golebiowski&author=R.+P.+Beckett&author=M.+Mazur&author=S.+Olejniczak&author=J.+Olczak&title=Substituted+Amino+Triazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCorman%26aufirst%3DM.%2BL.%26atitle%3DSubstituted%2520Amino%2520Triazoles%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, M.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, C.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, T.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.-R.</span></span> <span> </span><span class="NLM_article-title">Inhibition of acidic mammalian chitinase by RNA interference suppresses ovalbumin-sensitized allergic asthma</span>. <i>Hum. Gene Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1597</span>– <span class="NLM_lpage">1606</span>, <span class="refDoi"> DOI: 10.1089/hum.2008.092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1089%2Fhum.2008.092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=19548841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1WhtL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=1597-1606&author=C.-J.+Yangauthor=Y.-K.+Liuauthor=C.-L.+Liuauthor=C.-N.+Shenauthor=M.-L.+Kuoauthor=C.-C.+Suauthor=C.-P.+Tsengauthor=T.-C.+Yenauthor=C.-R.+Shen&title=Inhibition+of+acidic+mammalian+chitinase+by+RNA+interference+suppresses+ovalbumin-sensitized+allergic+asthma&doi=10.1089%2Fhum.2008.092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of acidic mammalian chitinase by RNA interference suppresses ovalbumin-sensitized allergic asthma</span></div><div class="casAuthors">Yang, Ching-Jen; Liu, Yu-Kuo; Liu, Chao-Lin; Shen, Chia-Ning; Kuo, Ming-Ling; Su, Chien-Chang; Tseng, Ching-Ping; Yen, Tzu-Chen; Shen, Chia-Rui</div><div class="citationInfo"><span class="NLM_cas:title">Human Gene Therapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1597-1606</span>CODEN:
                <span class="NLM_cas:coden">HGTHE3</span>;
        ISSN:<span class="NLM_cas:issn">1043-0342</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Asthma, a chronic helper T cell type 2-mediated inflammatory disease, is characterized by airway hyperresponsiveness and inflammation.  Growing evidence suggests that increased expression of acidic mammalian chitinase (AMCase) may play a role in the pathogenesis of asthma.  In the present study, we sought to develop an RNA interference approach to suppress allergic asthma in mice through silencing of AMCase expression.  Mice sensitized with ovalbumin (OVA) were intratracheally administered a recombinant adeno-assocd. virus expressing short hairpin RNA (rAAV-shRNA) against AMCase.  In OVA-sensitized mice, the development of allergic symptoms was significantly assocd. with elevated AMCase expression.  After administration of rAAV-shRNA, there was a significant redn. of AMCase expression in the lung and in bronchoalveolar lavage fluid (BALF) cells of sensitized mice.  Sensitized mice receiving rAAV-shRNA showed a significant improvement in allergic symptoms, including airway hyperresponsiveness (AHR), eosinophil infiltration, eotaxin, interleukin-13 secretion in BALF, and serum OVA-specific IgE level.  Our data suggest the hyperexpression of AMCase in asthma can be suppressed by rAAV-mediated shRNA.  Silencing AMCase expression by shRNA may be a promising therapeutic strategy in asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyU9pcjbg2rLVg90H21EOLACvtfcHk0lhuTuEyF_to4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1WhtL%252FI&md5=ad60a3b1cdd8089e340a15455e19747c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1089%2Fhum.2008.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fhum.2008.092%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DC.-J.%26aulast%3DLiu%26aufirst%3DY.-K.%26aulast%3DLiu%26aufirst%3DC.-L.%26aulast%3DShen%26aufirst%3DC.-N.%26aulast%3DKuo%26aufirst%3DM.-L.%26aulast%3DSu%26aufirst%3DC.-C.%26aulast%3DTseng%26aufirst%3DC.-P.%26aulast%3DYen%26aufirst%3DT.-C.%26aulast%3DShen%26aufirst%3DC.-R.%26atitle%3DInhibition%2520of%2520acidic%2520mammalian%2520chitinase%2520by%2520RNA%2520interference%2520suppresses%2520ovalbumin-sensitized%2520allergic%2520asthma%26jtitle%3DHum.%2520Gene%2520Ther.%26date%3D2009%26volume%3D20%26spage%3D1597%26epage%3D1606%26doi%3D10.1089%2Fhum.2008.092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vannella, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramalingam, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Queiroz
Prado, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciurba, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barron, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borthwick, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mentink-Kane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheever, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitz, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, J. F.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynn, T. A.</span></span> <span> </span><span class="NLM_article-title">Acidic chitinase primes the protective immune response to gastrointestinal nematodes</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">538</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1038/ni.3417</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1038%2Fni.3417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=27043413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC28Xltleisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=538-544&author=K.+M.+Vannellaauthor=T.+R.+Ramalingamauthor=K.+M.+Hartauthor=R.+de+Queiroz%0APradoauthor=J.+Sciurbaauthor=L.+Barronauthor=L.+A.+Borthwickauthor=A.+D.+Smithauthor=M.+Mentink-Kaneauthor=S.+Whiteauthor=R.+W.+Thompsonauthor=A.+W.+Cheeverauthor=K.+Bockauthor=I.+Mooreauthor=L.+J.+Fitzauthor=J.+F.+Urbanauthor=T.+A.+Wynn&title=Acidic+chitinase+primes+the+protective+immune+response+to+gastrointestinal+nematodes&doi=10.1038%2Fni.3417"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Acidic chitinase primes the protective immune response to gastrointestinal nematodes</span></div><div class="casAuthors">Vannella, Kevin M.; Ramalingam, Thirumalai R.; Hart, Kevin M.; Prado, Rafael de Queiroz; Sciurba, Joshua; Barron, Luke; Borthwick, Lee A.; Smith, Allen D.; Mentink-Kane, Margaret; White, Sandra; Thompson, Robert W.; Cheever, Allen W.; Bock, Kevin; Moore, Ian; Fitz, Lori J.; Urban, Joseph F., Jr.; Wynn, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">538-544</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Acidic mammalian chitinase (AMCase) is known to be induced by allergens and helminths, yet its role in immunity is unclear.  Using AMCase-deficient mice, we show that AMCase deficiency reduced the no. of group 2 innate lymphoid cells during allergen challenge but was not required for establishment of type 2 inflammation in the lung in response to allergens or helminths.  In contrast, AMCase-deficient mice showed a profound defect in type 2 immunity following infection with the chitin-contg. gastrointestinal nematodes Nippostrongylus brasiliensis and Heligmosomoides polygyrus bakeri.  The impaired immunity was assocd. with reduced mucus prodn. and decreased intestinal expression of the signature type 2 response genes Il13, Chil3, Retnlb, and Clca1.  CD103+ dendritic cells, which regulate T cell homing, were also reduced in mesenteric lymph nodes of infected AMCase-deficient mice.  Thus, AMCase functions as a crit. initiator of protective type 2 responses to intestinal nematodes but is largely dispensable for allergic responses in the lung.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr84VjQEDBCdLVg90H21EOLACvtfcHk0lhZGWwHFXVQng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xltleisb8%253D&md5=303a01b3d17006ba0848a7c1c67ac478</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fni.3417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.3417%26sid%3Dliteratum%253Aachs%26aulast%3DVannella%26aufirst%3DK.%2BM.%26aulast%3DRamalingam%26aufirst%3DT.%2BR.%26aulast%3DHart%26aufirst%3DK.%2BM.%26aulast%3Dde%2BQueiroz%2BPrado%26aufirst%3DR.%26aulast%3DSciurba%26aufirst%3DJ.%26aulast%3DBarron%26aufirst%3DL.%26aulast%3DBorthwick%26aufirst%3DL.%2BA.%26aulast%3DSmith%26aufirst%3DA.%2BD.%26aulast%3DMentink-Kane%26aufirst%3DM.%26aulast%3DWhite%26aufirst%3DS.%26aulast%3DThompson%26aufirst%3DR.%2BW.%26aulast%3DCheever%26aufirst%3DA.%2BW.%26aulast%3DBock%26aufirst%3DK.%26aulast%3DMoore%26aufirst%3DI.%26aulast%3DFitz%26aufirst%3DL.%2BJ.%26aulast%3DUrban%26aufirst%3DJ.%2BF.%26aulast%3DWynn%26aufirst%3DT.%2BA.%26atitle%3DAcidic%2520chitinase%2520primes%2520the%2520protective%2520immune%2520response%2520to%2520gastrointestinal%2520nematodes%26jtitle%3DNat.%2520Immunol.%26date%3D2016%26volume%3D17%26spage%3D538%26epage%3D544%26doi%3D10.1038%2Fni.3417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seibold, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodruff, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boot, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burchard, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahy, J. V.</span></span> <span> </span><span class="NLM_article-title">Chitotriosidase is the primary active chitinase in the human lung and is modulated by genotype and smoking habit</span>. <i>J. Allergy Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">944</span>, <span class="refDoi"> DOI: 10.1016/j.jaci.2008.08.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1016%2Fj.jaci.2008.08.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=18845328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlGgsr3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2008&pages=944&author=M.+A.+Seiboldauthor=S.+Donnellyauthor=M.+Solonauthor=A.+Innesauthor=P.+G.+Woodruffauthor=R.+G.+Bootauthor=E.+G.+Burchardauthor=J.+V.+Fahy&title=Chitotriosidase+is+the+primary+active+chitinase+in+the+human+lung+and+is+modulated+by+genotype+and+smoking+habit&doi=10.1016%2Fj.jaci.2008.08.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Chitotriosidase is the primary active chitinase in the human lung and is modulated by genotype and smoking habit</span></div><div class="casAuthors">Seibold, Max A.; Donnelly, Samantha; Solon, Margaret; Innes, Anh; Woodruff, Prescott G.; Boot, Rolf G.; Burchard, Esteban Gonzalez; Fahy, John V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">944-950</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Chitinolytic enzymes play important roles in the pathophysiol. of allergic airway responses in mouse models of asthma.  Acidic mammalian chitinase (AMCase) and chitotriosidase (CHIT1) have chitinolytic activity, but relatively little is known about their expression in human asthma.  We sought to det. the expression and activity of AMCase and CHIT1 in healthy subjects, subjects with asthma, and habitual smokers, taking account of the null 24-bp duplication in the CHIT1 gene.  We measured chitinase activity in bronchoalveolar lavage (BAL) fluid at multiple pHs by using a synthetic chitin substrate.  We also detd. AMCase and CHIT1 gene expression in epithelial brushings and BAL fluid macrophages by means of real time RT-PCR.  Paired DNA samples were genotyped for the CHIT1 duplication.  In all subgroups the pH profile of chitinase activity in BAL fluid matched that of CHIT1, but not AMCase, and chitinase activity was absent in subjects genetically deficient in active CHIT1.  Although AMCase protein was detectable in lavage fluid, AMCase transcripts in macrophages were consistent with an isoform lacking enzymic activity.  Median chitinase activity in BAL fluid tended to be lower than normal in asthmatic subjects but was increased 7-fold in habitual smokers, where CHIT1 gene expression in macrophages was increased.  Chitinase activity in the lung is the result of CHIT1 activity.  Although AMCase protein is detectable in the lung, our data indicate that it is inactive.  Chitinase activity is not increased in subjects with asthma and in fact tends to be decreased.  The high levels of chitinase activity in habitual smokers result from upregulation of CHIT1 gene expression, esp. in macrophages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgOiEW5aOPqLVg90H21EOLACvtfcHk0lhZGWwHFXVQng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlGgsr3O&md5=711bac9ca3fb813b5783a6fa36aa2b8d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2008.08.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2008.08.023%26sid%3Dliteratum%253Aachs%26aulast%3DSeibold%26aufirst%3DM.%2BA.%26aulast%3DDonnelly%26aufirst%3DS.%26aulast%3DSolon%26aufirst%3DM.%26aulast%3DInnes%26aufirst%3DA.%26aulast%3DWoodruff%26aufirst%3DP.%2BG.%26aulast%3DBoot%26aufirst%3DR.%2BG.%26aulast%3DBurchard%26aufirst%3DE.%2BG.%26aulast%3DFahy%26aufirst%3DJ.%2BV.%26atitle%3DChitotriosidase%2520is%2520the%2520primary%2520active%2520chitinase%2520in%2520the%2520human%2520lung%2520and%2520is%2520modulated%2520by%2520genotype%2520and%2520smoking%2520habit%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2008%26volume%3D122%26spage%3D944%26doi%3D10.1016%2Fj.jaci.2008.08.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bargagli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margollicci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikiforakis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luddi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosso, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottoli, P.</span></span> <span> </span><span class="NLM_article-title">Chitotriosidase Activity in the Serum of Patients with Sarcoidosis and Pulmonary Tuberculosis</span>. <i>Respiration</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">548</span>– <span class="NLM_lpage">552</span>, <span class="refDoi"> DOI: 10.1159/000100555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1159%2F000100555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=17347558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosVemurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2007&pages=548-552&author=E.+Bargagliauthor=M.+Margollicciauthor=N.+Nikiforakisauthor=A.+Luddiauthor=A.+Perroneauthor=S.+Grossoauthor=P.+Rottoli&title=Chitotriosidase+Activity+in+the+Serum+of+Patients+with+Sarcoidosis+and+Pulmonary+Tuberculosis&doi=10.1159%2F000100555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Chitotriosidase Activity in the Serum of Patients with Sarcoidosis and Pulmonary Tuberculosis</span></div><div class="casAuthors">Bargagli, Elena; Margollicci, Maria; Nikiforakis, Nikolaos; Luddi, Alice; Perrone, Anna; Grosso, Salvatore; Rottoli, Paola</div><div class="citationInfo"><span class="NLM_cas:title">Respiration</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">548-552</span>CODEN:
                <span class="NLM_cas:coden">RESPBD</span>;
        ISSN:<span class="NLM_cas:issn">0025-7931</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background: Human chitotriosidase is a chitinase selectively expressed by activated macrophages.  An increase in chitotriosidase activity was previously described by us in the serum and bronchoalveolar lavage of sarcoidosis patients.  Objective: The aim of the present study was to analyze serum chitotriosidase activity in a larger no. of sarcoidosis patients to verify the reported increase with respect to controls and to compare serum chitotriosidase levels in patients with sarcoidosis and tuberculosis, two granulomatous disorders of different etiol.  Methods: Chitotriosidase activity was measured in the serum of 96 sarcoidosis patients, 15 pulmonary tuberculosis patients and 30 healthy controls.  Results: We found significantly higher serum chitotriosidase activity in sarcoidosis patients than controls (p < 0.01) and in sarcoidosis patients than tuberculosis patients (p < 0.01), confirming a striking elevation of chitotriosidase activity (>10 times greater than normal) in pulmonary sarcoidosis patients.  This is the first time that chitotriosidase activity has been analyzed in the serum of patients with pulmonary tuberculosis; it was found to be significantly lower than in sarcoidosis patients and not significantly greater than in controls.  Conclusion: Although the mechanisms leading to the increase in chitotriosidase activity in sarcoidosis are still unknown, this enzyme may be specifically involved in the pathogenesis of the disease.  Further studies with a greater no. of patients are needed to confirm these results and to det. whether chitotriosidase could be a marker with diagnostic or prognostic value in sarcoidosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLAFTVqLTfDrVg90H21EOLACvtfcHk0lhZGWwHFXVQng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosVemurk%253D&md5=0d64b3a03003c0ad06d721b1cac57f43</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1159%2F000100555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000100555%26sid%3Dliteratum%253Aachs%26aulast%3DBargagli%26aufirst%3DE.%26aulast%3DMargollicci%26aufirst%3DM.%26aulast%3DNikiforakis%26aufirst%3DN.%26aulast%3DLuddi%26aufirst%3DA.%26aulast%3DPerrone%26aufirst%3DA.%26aulast%3DGrosso%26aufirst%3DS.%26aulast%3DRottoli%26aufirst%3DP.%26atitle%3DChitotriosidase%2520Activity%2520in%2520the%2520Serum%2520of%2520Patients%2520with%2520Sarcoidosis%2520and%2520Pulmonary%2520Tuberculosis%26jtitle%3DRespiration%26date%3D2007%26volume%3D74%26spage%3D548%26epage%3D552%26doi%3D10.1159%2F000100555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cakir, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gumus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ucar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozkoparan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akgul, E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karaman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deniz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurt, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozkan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilgic, H.</span></span> <span> </span><span class="NLM_article-title">Serum chitotriosidase activity in pulmonary tuberculosis: response to treatment and correlations with clinical parameters</span>. <i>Ann. Lab. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.3343/alm.2012.32.3.184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.3343%2Falm.2012.32.3.184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=22563552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFSis7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=184-189&author=G.+Cakirauthor=S.+Gumusauthor=E.+Ucarauthor=H.+Kayaauthor=E.+Tozkoparanauthor=E.+O.+Akgulauthor=B.+Karamanauthor=O.+Denizauthor=I.+Kurtauthor=M.+Ozkanauthor=H.+Bilgic&title=Serum+chitotriosidase+activity+in+pulmonary+tuberculosis%3A+response+to+treatment+and+correlations+with+clinical+parameters&doi=10.3343%2Falm.2012.32.3.184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Serum chitotriosidase activity in pulmonary tuberculosis: response to treatment and correlations with clinical parameters</span></div><div class="casAuthors">Cakir, Gulhan; Gumus, Seyfettin; Ucar, Ergun; Kaya, Hatice; Tozkoparan, Ergun; Akgul, Emin Ozgur; Karaman, Bulent; Deniz, Omer; Kurt, Ismail; Ozkan, Metin; Bilgic, Hayati</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Laboratory Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">184-189</span>CODEN:
                <span class="NLM_cas:coden">ALMNCA</span>;
        ISSN:<span class="NLM_cas:issn">2234-3806</span>.
    
            (<span class="NLM_cas:orgname">Korean Society for Laboratory Medicine</span>)
        </div><div class="casAbstract">Background: Chitotriosidase is an accepted marker of macrophage activation.  In this study, we investigated serum chitotriosidase levels in pulmonary tuberculosis (PTB).  Methods: Forth-two patients with PTB and 30 healthy subjects were enrolled in the study.  The radiol. extent of PTB, radiol. sequela after treatment, and the degree of smear positivity were assessed.  Chitotriosidase levels were measured by a fluorometric method.  Results: The serum chitotriosidase levels of the PTB patients were significantly higher than those of the control subjects (39.73±24.97 vs. 9.63±4.55 nmol/mL/h, P<0.001).  After completion of the std. 6-mo antituberculous treatment, chitotriosidase levels in PTB patients significantly decreased (10.47±4.54 nmol/mL/h, P<0.001).  Chitotriosidase levels correlated significantly with the radiol. extent of PTB, degree of smear positivity, and post-treatment radiol. sequela score (r=0.439, r=0.449, and r=0.337, resp.).  Conclusions: This study demonstrated that serum chitotriosidase levels increase in PTB; therefore, chitotriosidase can be used as a marker of disease activity, severity, and response to treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Sr1bQdd1WbVg90H21EOLACvtfcHk0lhRuTA-CqMKwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFSis7nP&md5=e560962ffd260e431c729ec0df2bc70a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.3343%2Falm.2012.32.3.184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3343%252Falm.2012.32.3.184%26sid%3Dliteratum%253Aachs%26aulast%3DCakir%26aufirst%3DG.%26aulast%3DGumus%26aufirst%3DS.%26aulast%3DUcar%26aufirst%3DE.%26aulast%3DKaya%26aufirst%3DH.%26aulast%3DTozkoparan%26aufirst%3DE.%26aulast%3DAkgul%26aufirst%3DE.%2BO.%26aulast%3DKaraman%26aufirst%3DB.%26aulast%3DDeniz%26aufirst%3DO.%26aulast%3DKurt%26aufirst%3DI.%26aulast%3DOzkan%26aufirst%3DM.%26aulast%3DBilgic%26aufirst%3DH.%26atitle%3DSerum%2520chitotriosidase%2520activity%2520in%2520pulmonary%2520tuberculosis%253A%2520response%2520to%2520treatment%2520and%2520correlations%2520with%2520clinical%2520parameters%26jtitle%3DAnn.%2520Lab.%2520Med.%26date%3D2012%26volume%3D32%26spage%3D184%26epage%3D189%26doi%3D10.3343%2Falm.2012.32.3.184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cole, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olland, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursavich, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czerwinski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeClercq, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph-McCarthy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellingboe, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Presman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strand, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, C. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsao, D. H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitz, L. J.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of acidic mammalian chitinase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6122</span>– <span class="NLM_lpage">6128</span>, <span class="refDoi"> DOI: 10.1021/jm100533p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100533p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVChtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6122-6128&author=D.+C.+Coleauthor=A.+M.+Ollandauthor=J.+Jacobauthor=J.+Brooksauthor=M.+G.+Bursavichauthor=R.+Czerwinskiauthor=C.+DeClercqauthor=M.+Johnsonauthor=D.+Joseph-McCarthyauthor=J.+W.+Ellingboeauthor=L.+Linauthor=P.+Nowakauthor=E.+Presmanauthor=J.+Strandauthor=A.+Tamauthor=C.+M.+M.+Williamsauthor=S.+Yaoauthor=D.+H.+H.+Tsaoauthor=L.+J.+Fitz&title=Identification+and+characterization+of+acidic+mammalian+chitinase+inhibitors&doi=10.1021%2Fjm100533p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Characterization of Acidic Mammalian Chitinase Inhibitors</span></div><div class="casAuthors">Cole, Derek C.; Olland, Andrea M.; Jacob, Jaison; Brooks, Jon; Bursavich, Matthew G.; Czerwinski, Robert; De Clercq, Charlene; Johnson, Mark; Joseph-McCarthy, Diane; Ellingboe, John W.; Lin, Laura; Nowak, Pawel; Presman, Ella; Strand, James; Tam, Amy; Williams, Cara M. M.; Yao, Shihua; Tsao, Desiree H. H.; Fitz, Lori J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6122-6128</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acidic mammalian chitinase (AMCase) is a member of the glycosyl hydrolase 18 family (EC 3.2.1.14) that has been implicated in the pathophysiol. of allergic airway disease such as asthma.  Small mol. inhibitors of AMCase were identified using a combination of high-throughput screening, fragment screening, and virtual screening techniques and characterized by enzyme inhibition and NMR and Biacore binding expts.  X-ray structures of the inhibitors in complex with AMCase revealed that the larger more potent HTS hits, e.g. 5-(4-(2-(4-bromophenoxy)ethyl)piperazine-1-yl)-1H-1,2,4-triazol-3-amine 1, spanned from the active site pocket to a hydrophobic pocket.  Smaller fragments identified by FBS occupy both these pockets independently and suggest potential strategies for linking fragments.  Compd. 1 is a 200 nM AMCase inhibitor which reduced AMCase enzymic activity in the bronchoalveolar lavage fluid in allergen-challenged mice after oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq3-AOdwYs2LVg90H21EOLACvtfcHk0lhRuTA-CqMKwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVChtL8%253D&md5=47d5010b73151d1ad4f641c47c3fb100</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm100533p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100533p%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DOlland%26aufirst%3DA.%2BM.%26aulast%3DJacob%26aufirst%3DJ.%26aulast%3DBrooks%26aufirst%3DJ.%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DCzerwinski%26aufirst%3DR.%26aulast%3DDeClercq%26aufirst%3DC.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DJoseph-McCarthy%26aufirst%3DD.%26aulast%3DEllingboe%26aufirst%3DJ.%2BW.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DPresman%26aufirst%3DE.%26aulast%3DStrand%26aufirst%3DJ.%26aulast%3DTam%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DC.%2BM.%2BM.%26aulast%3DYao%26aufirst%3DS.%26aulast%3DTsao%26aufirst%3DD.%2BH.%2BH.%26aulast%3DFitz%26aufirst%3DL.%2BJ.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520acidic%2520mammalian%2520chitinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6122%26epage%3D6128%26doi%3D10.1021%2Fjm100533p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggleston, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maizels, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Aalten, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. E.</span></span> <span> </span><span class="NLM_article-title">Analyzing Airway Inflammation with Chemical Biology: Dissection of Acidic Mammalian Chitinase Function with a Selective Drug-like Inhibitor</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">569</span>– <span class="NLM_lpage">579</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2011.02.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1016%2Fj.chembiol.2011.02.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=21609838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmslOksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=569-579&author=T.+E.+Sutherlandauthor=O.+A.+Andersenauthor=M.+Betouauthor=I.+M.+Egglestonauthor=R.+M.+Maizelsauthor=D.+van+Aaltenauthor=J.+E.+Allen&title=Analyzing+Airway+Inflammation+with+Chemical+Biology%3A+Dissection+of+Acidic+Mammalian+Chitinase+Function+with+a+Selective+Drug-like+Inhibitor&doi=10.1016%2Fj.chembiol.2011.02.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Analyzing Airway Inflammation with Chemical Biology: Dissection of Acidic Mammalian Chitinase Function with a Selective Drug-like Inhibitor</span></div><div class="casAuthors">Sutherland, Tara E.; Andersen, Ole A.; Betou, Marie; Eggleston, Ian M.; Maizels, Rick M.; van Aalten, Daan; Allen, Judith E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">569-579</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Acidic mammalian chitinase (AMCase) is produced in the lung during allergic inflammation and asthma, and inhibition of enzymic activity has been considered as a therapeutic strategy.  However, most chitinase inhibitors are nonselective, addnl. inhibiting chitotriosidase activity.  Here, we describe bisdionin F, a competitive AMCase inhibitor with 20-fold selectivity for AMCase over chitotriosidase, designed by utilizing the AMCase crystal structure and dicaffeine scaffold.  In a murine model of allergic inflammation, bisdionin F-treatment attenuated chitinase activity and alleviated the primary features of allergic inflammation including eosinophilia.  However, selective AMCase inhibition by bisdionin F also caused dramatic and unexpected neutrophilia in the lungs.  This class of inhibitor will be a powerful tool to dissect the functions of mammalian chitinases in disease and represents a synthetically accessible scaffold to optimize inhibitory properties in terms of airway inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlYJOOAc9ksbVg90H21EOLACvtfcHk0liolQK2bmdS7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmslOksL4%253D&md5=3b082d80515694618da2dd966c25a6f9</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.02.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.02.017%26sid%3Dliteratum%253Aachs%26aulast%3DSutherland%26aufirst%3DT.%2BE.%26aulast%3DAndersen%26aufirst%3DO.%2BA.%26aulast%3DBetou%26aufirst%3DM.%26aulast%3DEggleston%26aufirst%3DI.%2BM.%26aulast%3DMaizels%26aufirst%3DR.%2BM.%26aulast%3Dvan%2BAalten%26aufirst%3DD.%26aulast%3DAllen%26aufirst%3DJ.%2BE.%26atitle%3DAnalyzing%2520Airway%2520Inflammation%2520with%2520Chemical%2520Biology%253A%2520Dissection%2520of%2520Acidic%2520Mammalian%2520Chitinase%2520Function%2520with%2520a%2520Selective%2520Drug-like%2520Inhibitor%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D569%26epage%3D579%26doi%3D10.1016%2Fj.chembiol.2011.02.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="note"><p class="first last">See “hAMCase_+_compound_2.pdb” file in <a href="/doi/suppl/10.1021/acs.jmedchem.9b00681/suppl_file/jm9b00681_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jamieson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moir, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rankovic, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wishart, G.</span></span> <span> </span><span class="NLM_article-title">Medicinal Chemistry of hERG Optimizations: Highlights and Hang-Ups</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">5029</span>– <span class="NLM_lpage">5046</span>, <span class="refDoi"> DOI: 10.1021/jm060379l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060379l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5029-5046&author=C.+Jamiesonauthor=E.+M.+Moirauthor=Z.+Rankovicauthor=G.+Wishart&title=Medicinal+Chemistry+of+hERG+Optimizations%3A+Highlights+and+Hang-Ups&doi=10.1021%2Fjm060379l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30aR"><div class="casContent"><span class="casTitleNuber">30a</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of hERG optimizations: Highlights and hang-ups</span></div><div class="casAuthors">Jamieson, Craig; Moir, Elizabeth M.; Rankovic, Zoran; Wishart, Grant</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5029-5046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  A brief summary of the in silico, in vitro, and in vivo approaches employed to measure blockade of hERG and QT prolongation is detailed.  The discussion aims to summarize the approaches engaged to circumvent activity at hERG, identified through an extensive literature survey.  The optimizations are recorded as pairs of compds., which have been categorized in terms of the tactics employed to diminish hERG activity. Examn. of the properties of the compds. within each category has enabled formulation os some empirical guidelines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv6eM5w53KebVg90H21EOLACvtfcHk0liolQK2bmdS7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D&md5=117c84a010f877c835b7dbc945996b92</span></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.1021%2Fjm060379l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060379l%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMoir%26aufirst%3DE.%2BM.%26aulast%3DRankovic%26aufirst%3DZ.%26aulast%3DWishart%26aufirst%3DG.%26atitle%3DMedicinal%2520Chemistry%2520of%2520hERG%2520Optimizations%253A%2520Highlights%2520and%2520Hang-Ups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5029%26epage%3D5046%26doi%3D10.1021%2Fjm060379l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit30b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, M.</span></span> <span> </span><span class="NLM_article-title">A Risk Assessment of Human Ether-a-Go-Go-Related Gene Potassium Channel Inhibition by Using Lipophilicity and Basicity for Drug Discovery</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1110</span>– <span class="NLM_lpage">1116</span>, <span class="refDoi"> DOI: 10.1248/cpb.59.1110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1248%2Fcpb.59.1110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=21881254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlCgtbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2011&pages=1110-1116&author=Y.+Kawaiauthor=S.+Tsukamotoauthor=J.+Itoauthor=K.+Akimotoauthor=M.+Takahashi&title=A+Risk+Assessment+of+Human+Ether-a-Go-Go-Related+Gene+Potassium+Channel+Inhibition+by+Using+Lipophilicity+and+Basicity+for+Drug+Discovery&doi=10.1248%2Fcpb.59.1110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30bR"><div class="casContent"><span class="casTitleNuber">30b</span><div class="casTitle"><span class="NLM_cas:atitle">A risk assessment of human ether-a-go-go-related gene potassium channel inhibition by using lipophilicity and basicity for drug discovery</span></div><div class="casAuthors">Kawai, Yukinori; Tsukamoto, Shinsaku; Ito, Junko; Akimoto, Katsuya; Takahashi, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1110-1116</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">The blockade of human ether-a-go-go-related gene (hERG) potassium channels is widely regarded as the predominant cause of drug-induced QT prolongation.  The correlation anal. between the inhibition of the hERG channel (hERG inhibition) and physicochem. properties was investigated by use of inhouse quinolone antibiotics as model compds.  In order to establish a simple prediction model of hERG inhibition, we focused on the comprehensible physicochem. parameters such as lipophilicity (log P) and basicity (pKa).  At first, the risk assocd. with increasing log P and pKa was examd. by statistical anal.  It was demonstrated that the risk assocd. with increasing log P and pKa by one unit, resp., almost identically increased.  Consequently, equal attention should be paid to both parameters on hERG inhibition.  Next, a prediction model of hERG inhibition which was represented by log P and pKa was investigated.  As a result, we built the stepwise discriminant prediction model which took advantage of the risk judgment by zone classification.  In conclusion, the impact of log P and pKa on hERG inhibition was clarified relatively and quant.  The quant. risk assessment established based on both parameters, was considered to be a practical and useful tool in avoiding hERG inhibition and in the rational drug design for drug discovery, esp. in lead optimization.  Moreover, we also carried out a trend anal. using a different deriv. and demonstrated that both parameters were equally significant for hERG inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEKu_OZWyq1LVg90H21EOLACvtfcHk0liolQK2bmdS7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlCgtbrP&md5=d86268b2844bfcd471fc12a81b32e413</span></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.1248%2Fcpb.59.1110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.59.1110%26sid%3Dliteratum%253Aachs%26aulast%3DKawai%26aufirst%3DY.%26aulast%3DTsukamoto%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DJ.%26aulast%3DAkimoto%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DM.%26atitle%3DA%2520Risk%2520Assessment%2520of%2520Human%2520Ether-a-Go-Go-Related%2520Gene%2520Potassium%2520Channel%2520Inhibition%2520by%2520Using%2520Lipophilicity%2520and%2520Basicity%2520for%2520Drug%2520Discovery%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2011%26volume%3D59%26spage%3D1110%26epage%3D1116%26doi%3D10.1248%2Fcpb.59.1110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piper, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duff, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliason, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frazee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuerstenau-Sharp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jachec, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollok, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shekhani, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, S. D.</span></span> <span> </span><span class="NLM_article-title">Development of the predictor HERG fluorescence polarization assay using a membrane protein enrichment approach</span>. <i>Assay Drug Dev. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">223</span>, <span class="refDoi"> DOI: 10.1089/adt.2008.137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1089%2Fadt.2008.137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=18471075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BD1cXls1Kqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=213-223&author=D.+R.+Piperauthor=S.+R.+Duffauthor=H.+C.+Eliasonauthor=W.+J.+Frazeeauthor=E.+A.+Freyauthor=M.+Fuerstenau-Sharpauthor=C.+Jachecauthor=B.+D.+Marksauthor=B.+A.+Pollokauthor=M.+S.+Shekhaniauthor=D.+V.+Thompsonauthor=P.+Whitneyauthor=K.+W.+Vogelauthor=S.+D.+Hess&title=Development+of+the+predictor+HERG+fluorescence+polarization+assay+using+a+membrane+protein+enrichment+approach&doi=10.1089%2Fadt.2008.137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Development of the predictor hERG fluorescence polarization assay using a membrane protein enrichment approach</span></div><div class="casAuthors">Piper, David R.; Duff, Steve R.; Eliason, Hildegard C.; Frazee, W. Jack; Frey, Elizabeth A.; Fuerstenau-Sharp, Maya; Jachec, Christine; Marks, Bryan D.; Pollok, Brian A.; Shekhani, Mohammed Saleh; Thompson, David V.; Whitney, Pam; Vogel, Kurt W.; Hess, Stephen D.</div><div class="citationInfo"><span class="NLM_cas:title">Assay and Drug Development Technologies</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-223</span>CODEN:
                <span class="NLM_cas:coden">ADDTAR</span>;
        ISSN:<span class="NLM_cas:issn">1540-658X</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">The life-threatening consequences of acquired, or drug-induced, long QT syndrome due to block of the human ether-a-go-go-related gene (hERG) channel are well appreciated and have been the cause of several drugs being removed from the market in recent years because of patient death.  In the last decade, the propensity for block of the hERG channel by a diverse and expanding set of compds. has led to the requirement that all new drugs be tested for hERG channel block in a functional patch-clamp assay.  Because of the need to identify potential hERG blockers early in the discovery process, radiometric hERG binding assays are preferred over patch-clamp assays for compd. triage, because of relative advantages in speed and cost.  Even so, these radiometric binding assays are laborious and require dedicated instrumentation and infrastructure to cope with the regulatory and safety issues assocd. with the use of radiation.  To overcome these limitations, we developed a homogeneous, fluorescence polarization-based assay to identify and characterize the affinity of small mols. for the hERG channel and have demonstrated tight correlation with data obtained from either radioligand binding or patch-clamp assays.  Key to the development of this assay was a cell line that expressed highly elevated levels of hERG protein, which was generated by coupling expression of the hERG channel to that of a selectable cell surface marker.  A high-expressing clone was isolated by flow cytometry and used to generate membrane prepns. that contained >50-fold the typical d. of hERG channels measured by [3H]astemizole binding.  This strategy enabled the Predictor (Invitrogen, Carlsbad, CA) hERG fluorescence polarization assay and should be useful in the development of other fluorescence polarization-based assays that use membrane proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZM6EWKp8Hv7Vg90H21EOLACvtfcHk0liGEHXCqsEbyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXls1Kqurk%253D&md5=e7d8aad7c76722779653b38ca60ee242</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1089%2Fadt.2008.137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fadt.2008.137%26sid%3Dliteratum%253Aachs%26aulast%3DPiper%26aufirst%3DD.%2BR.%26aulast%3DDuff%26aufirst%3DS.%2BR.%26aulast%3DEliason%26aufirst%3DH.%2BC.%26aulast%3DFrazee%26aufirst%3DW.%2BJ.%26aulast%3DFrey%26aufirst%3DE.%2BA.%26aulast%3DFuerstenau-Sharp%26aufirst%3DM.%26aulast%3DJachec%26aufirst%3DC.%26aulast%3DMarks%26aufirst%3DB.%2BD.%26aulast%3DPollok%26aufirst%3DB.%2BA.%26aulast%3DShekhani%26aufirst%3DM.%2BS.%26aulast%3DThompson%26aufirst%3DD.%2BV.%26aulast%3DWhitney%26aufirst%3DP.%26aulast%3DVogel%26aufirst%3DK.%2BW.%26aulast%3DHess%26aufirst%3DS.%2BD.%26atitle%3DDevelopment%2520of%2520the%2520predictor%2520HERG%2520fluorescence%2520polarization%2520assay%2520using%2520a%2520membrane%2520protein%2520enrichment%2520approach%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2008%26volume%3D6%26spage%3D213%26epage%3D223%26doi%3D10.1089%2Fadt.2008.137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pristupa, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kish, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niznik, H. B.</span></span> <span> </span><span class="NLM_article-title">Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">135</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=8302271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADyaK2cXhsFemu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1994&pages=125-135&author=Z.+B.+Pristupaauthor=J.+M.+Wilsonauthor=B.+J.+Hoffmanauthor=S.+J.+Kishauthor=H.+B.+Niznik&title=Pharmacological+heterogeneity+of+the+cloned+and+native+human+dopamine+transporter%3A+disassociation+of+%5B3H%5DWIN+35%2C428+and+%5B3H%5DGBR+12%2C935+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding</span></div><div class="casAuthors">Pristupa, Zdenek B.; Wilson, Julie M.; Hoffman, Beth J.; Kish, Stephen J.; Niznik, Hyman B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-35</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">Controversy exists as to whether the functional state of the dopamine (DA) transporter is identical to sites mediating the specific binding of selective DA transporter radioligands.  Therefore, the authors compared the pharmacol. profile of numerous dopamine transport substrates and inhibitors on [3H]DA uptake with the binding of [3H]WIN 35,428 and [3H]GBR 12,935 to COS-7 cells transiently expressing the cloned human DA transporter.  [3H]DA uptake and [3H]WIN 35,428 binding was specific, saturable, and to a single class of binding sites with an estd. Km/Vmax of ∼2 μM and 6 pmol/min/105 cells for DA uptake and Kd/Bmax values of ∼10 nM and 113 fmol/105 cells for [3H]WIN 35,428.  [3H]DA uptake was inhibited in a concn.-dependent and uniphasic manner by dopaminergic agents with an appropriate rank order of potency for the DA transporter.  Although most uptake blockers inhibited [3H]WIN 35,428 binding in a uniphasic manner, WIN 35,428, Lu 19,005, D-amphetamine, and DA clearly displayed the presence of both high and low affinity components.  Comparison of the Ki values for the inhibition of [3H]DA uptake with [3H]WIN 35,428 binding reveals that, for uptake blockers and D-amphetamine, it is the high affinity component that shares pharmacol. identity with effects on DA uptake (r = 0.9985), whereas for DA it is the low affinity site.  In striking contrast, however, [3H]GBR 12,935 binding to COS-7 cells could not be made to exhibit a pharmacol. profile indicative of the DA transporter and suggests that the site regulating functional [3H]DA uptake may not be identical with sites labeled by [3H]GBR 12,935 in these cells.  Moreover, these sites appear unrelated to those previously described in native membranes as "piperazine acceptor" or P 450 proteins.  Comparison of Ki values and rank order of potency for the inhibition of [3H]WIN 35,428 or [3H]GBR 12,935 binding to human caudate membranes reveals pharmacol. homol., but not identity, with that of the cloned DA uptake process.  Taken together, these data suggest that 1) [3H]WIN 35,428 recognizes two sites of the DA transporter, of which only one appears to represent the functional state of the protein, and 2) [3H]WIN 35,428 and [3H]GBR 12,935 do not appear to bind the same functional form/state of the DA transporter.  Whether the nonidentity of binding sites is a manifestation of some post-translational regulatory event (e.g., phosphorylation/accessory binding protein) or caused by the existence of multiple mol. forms of the DA transporter is currently unknown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU2Vc8HuOAsLVg90H21EOLACvtfcHk0liGEHXCqsEbyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhsFemu7c%253D&md5=a6ce271aad17d6f7f282bd716bbd1ddf</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPristupa%26aufirst%3DZ.%2BB.%26aulast%3DWilson%26aufirst%3DJ.%2BM.%26aulast%3DHoffman%26aufirst%3DB.%2BJ.%26aulast%3DKish%26aufirst%3DS.%2BJ.%26aulast%3DNiznik%26aufirst%3DH.%2BB.%26atitle%3DPharmacological%2520heterogeneity%2520of%2520the%2520cloned%2520and%2520native%2520human%2520dopamine%2520transporter%253A%2520disassociation%2520of%2520%255B3H%255DWIN%252035%252C428%2520and%2520%255B3H%255DGBR%252012%252C935%2520binding%26jtitle%3DMol.%2520Pharmacol.%26date%3D1994%26volume%3D45%26spage%3D125%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maron, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ames, B. N.</span></span> <span> </span><span class="NLM_article-title">Revised methods for the Salmonella mutagenicity test</span>. <i>Mutat. Res.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">173</span>– <span class="NLM_lpage">215</span>, <span class="refDoi"> DOI: 10.1016/0165-1161(83)90010-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1016%2F0165-1161%2883%2990010-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=6341825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADyaL3sXhvFarsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1983&pages=173-215&author=D.+M.+Maronauthor=B.+N.+Ames&title=Revised+methods+for+the+Salmonella+mutagenicity+test&doi=10.1016%2F0165-1161%2883%2990010-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Revised methods for the Salmonella mutagenicity test</span></div><div class="casAuthors">Maron, Dorothy M.; Ames, Bruce N.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Environmental Mutagenesis and Related Subjects </span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">173-215</span>CODEN:
                <span class="NLM_cas:coden">MEMSE8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A revision of methods for detecting carcinogens and mutagens with the Salmonella mutagenicity test (A. et al., 1975b) is described.  Two new tester strains, a frameshift strain (TA 97) and a strain carrying an ochre mutation on a multicopy plasmid (TA 102), are added to the std. tester set.  TA 97 replaces TA 1537.  TA 1535 and 1538 are removed from the recommended set, but can be retained at the option of the investigator.  TA 98 and 100 are retained.  Other special purpose strains are discussed and minor changes in procedure, (principally in the growth, storage, and preservation of the tester strains) are presented.  Two substitutions are made in diagnostic mutagens to eliminate MNNG and 9-aminoacridine.  Some test modifications are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzIjKbxaVZYrVg90H21EOLACvtfcHk0liGEHXCqsEbyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXhvFarsb4%253D&md5=415285947b98c9ddbbd79bbe000c9dca</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2F0165-1161%2883%2990010-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1161%252883%252990010-9%26sid%3Dliteratum%253Aachs%26aulast%3DMaron%26aufirst%3DD.%2BM.%26aulast%3DAmes%26aufirst%3DB.%2BN.%26atitle%3DRevised%2520methods%2520for%2520the%2520Salmonella%2520mutagenicity%2520test%26jtitle%3DMutat.%2520Res.%26date%3D1983%26volume%3D113%26spage%3D173%26epage%3D215%26doi%3D10.1016%2F0165-1161%2883%2990010-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span> </span><span class="NLM_article-title">Panel composed of 96 binding and enzyme
assays</span>. <a href="https://www.eurofinsdiscoveryservices.com/catalogmanagement/viewitem/Diversity-Panel/P9#testingInfo" class="extLink">https://www.eurofinsdiscoveryservices.com/catalogmanagement/viewitem/Diversity-Panel/P9#testingInfo</a> (accessed March 19, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Panel+composed+of+96+binding+and+enzyme%0Aassays.+https%3A%2F%2Fwww.eurofinsdiscoveryservices.com%2Fcatalogmanagement%2Fviewitem%2FDiversity-Panel%2FP9%23testingInfo+%28accessed+March+19%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DPanel%2520composed%2520of%252096%2520binding%2520and%2520enzyme%250Aassays%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span> </span><span class="NLM_article-title">Commercially available assay</span>. <a href="https://www.eurofinsdiscoveryservices.com/catalogmanagement/viewitem/hERG-Human-Potassium-Ion-Channel-Cell-Based-Automated-Patch-Clamp-CiPA-Assay-5-Conc/CYL8038QP2DR" class="extLink">https://www.eurofinsdiscoveryservices.com/catalogmanagement/viewitem/hERG-Human-Potassium-Ion-Channel-Cell-Based-Automated-Patch-Clamp-CiPA-Assay-5-Conc/CYL8038QP2DR</a> (accessed March 19, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Commercially+available+assay.+https%3A%2F%2Fwww.eurofinsdiscoveryservices.com%2Fcatalogmanagement%2Fviewitem%2FhERG-Human-Potassium-Ion-Channel-Cell-Based-Automated-Patch-Clamp-CiPA-Assay-5-Conc%2FCYL8038QP2DR+%28accessed+March+19%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DCommercially%2520available%2520assay%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span> </span><span class="NLM_article-title">Commercially available assay</span>. <a href="https://www.eurofinsdiscoveryservices.com/catalogmanagement/viewitem/DAT-Rat-Dopamine-Transporter-Functional-Antagonist-Uptake-Assay-Cerep/394" class="extLink">https://www.eurofinsdiscoveryservices.com/catalogmanagement/viewitem/DAT-Rat-Dopamine-Transporter-Functional-Antagonist-Uptake-Assay-Cerep/394</a> (accessed March 19, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Commercially+available+assay.+https%3A%2F%2Fwww.eurofinsdiscoveryservices.com%2Fcatalogmanagement%2Fviewitem%2FDAT-Rat-Dopamine-Transporter-Functional-Antagonist-Uptake-Assay-Cerep%2F394+%28accessed+March+19%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DCommercially%2520available%2520assay%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Boyle, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banck, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandermeersch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchison, G. R.</span></span> <span> </span><span class="NLM_article-title">Open Babel: An open chemical toolbox</span>. <i>J. Cheminf.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">33</span>, <span class="refDoi"> DOI: 10.1186/1758-2946-3-33</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1186%2F1758-2946-3-33" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=21982300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVWjurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=33&author=N.+M.+O%E2%80%99Boyleauthor=M.+Banckauthor=C.+A.+Jamesauthor=C.+Morleyauthor=T.+Vandermeerschauthor=G.+R.+Hutchison&title=Open+Babel%3A+An+open+chemical+toolbox&doi=10.1186%2F1758-2946-3-33"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Open Babel: an open chemical toolbox</span></div><div class="casAuthors">O'Boyle, Noel M.; Banck, Michael; James, Craig A.; Morley, Chris; Vandermeersch, Tim; Hutchison, Geoffrey R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cheminformatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">33</span>CODEN:
                <span class="NLM_cas:coden">JCOHB3</span>;
        ISSN:<span class="NLM_cas:issn">1758-2946</span>.
    
            (<span class="NLM_cas:orgname">Chemistry Central Ltd.</span>)
        </div><div class="casAbstract">Background: A frequent problem in computational modeling is the interconversion of chem. structures between different formats.  While std. interchange formats exist (for example, Chem. Markup Language) and de facto stds. have arisen (for example, SMILES format), the need to interconvert formats is a continuing problem due to the multitude of different application areas for chem. data, differences in the data stored by different formats (0D vs. 3D, for example), and competition between software along with a lack of vendor-neutral formats.  Results: We discuss, for the first time, Open Babel, an open-source chem. toolbox that speaks the many languages of chem. data.  Open Babel version 2.3 interconverts over 110 formats.  The need to represent such a wide variety of chem. and mol. data requires a library that implements a wide range of cheminformatics algorithms, from partial charge assignment and aromaticity detection, to bond order perception and canonicalization.  We detail the implementation of Open Babel, describe key advances in the 2.3 release, and outline a variety of uses both in terms of software products and scientific research, including applications far beyond simple format interconversion.  Conclusions: Open Babel presents a soln. to the proliferation of multiple chem. file formats.  In addn., it provides a variety of useful utilities from conformer searching and 2D depiction, to filtering, batch conversion, and substructure and similarity searching.  For developers, it can be used as a programming library to handle chem. data in areas such as org. chem., drug design, materials science, and computational chem.  It is freely available under an open-source license.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfQ1lvaS5767Vg90H21EOLACvtfcHk0lhB7L2_LZSidw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVWjurbF&md5=74e4f19b7f87417f916d57f7abcfb761</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1186%2F1758-2946-3-33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1758-2946-3-33%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DN.%2BM.%26aulast%3DBanck%26aufirst%3DM.%26aulast%3DJames%26aufirst%3DC.%2BA.%26aulast%3DMorley%26aufirst%3DC.%26aulast%3DVandermeersch%26aufirst%3DT.%26aulast%3DHutchison%26aufirst%3DG.%2BR.%26atitle%3DOpen%2520Babel%253A%2520An%2520open%2520chemical%2520toolbox%26jtitle%3DJ.%2520Cheminf.%26date%3D2011%26volume%3D3%26spage%3D33%26doi%3D10.1186%2F1758-2946-3-33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, J. J. P.</span></span> <span> </span><span class="NLM_article-title">MOPAC: A semiempirical molecular orbital program</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1007/BF00128336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1007%2FBF00128336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=2197373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADyaK3cXksFyjurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1990&pages=1-103&author=J.+J.+P.+Stewart&title=MOPAC%3A+A+semiempirical+molecular+orbital+program&doi=10.1007%2FBF00128336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">MOPAC:  a semiempirical molecular orbital program</span></div><div class="casAuthors">Stewart, James J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-105</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    </div><div class="casAbstract">An overview is presented of MOPAC, a semiempirical MO program for the study of chem. reactions involving mols., ions, and linear polymers.  The program implements the semiempirical Hamiltonians MNDO, AM1, MINDO/3, and MNDO-PM3 and combines the calcns. of vibrational spectra, thermodn. quantities, isotopic substitution effects, and force consts. in a fully integrated program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr44czad1cLAbVg90H21EOLACvtfcHk0lhB7L2_LZSidw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXksFyjurc%253D&md5=983366b4ba2797f0fd8a91aec6d366ed</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2FBF00128336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00128336%26sid%3Dliteratum%253Aachs%26aulast%3DStewart%26aufirst%3DJ.%2BJ.%2BP.%26atitle%3DMOPAC%253A%2520A%2520semiempirical%2520molecular%2520orbital%2520program%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D1990%26volume%3D4%26spage%3D1%26epage%3D103%26doi%3D10.1007%2FBF00128336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Carmona, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Garcia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foloppe, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garmendia-Doval, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juhos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidtke, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morley, S. D.</span></span> <span> </span><span class="NLM_article-title">rDock: A Fast, Versatile and Open Source Program for Docking Ligands to Proteins and Nucleic Acids</span>. <i>PLoS Comput. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e1003571</span>, <span class="refDoi"> DOI: 10.1371/journal.pcbi.1003571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1371%2Fjournal.pcbi.1003571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=24722481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGlsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=e1003571&author=S.+Ruiz-Carmonaauthor=D.+Alvarez-Garciaauthor=N.+Foloppeauthor=A.+B.+Garmendia-Dovalauthor=S.+Juhosauthor=P.+Schmidtkeauthor=X.+Barrilauthor=R.+E.+Hubbardauthor=S.+D.+Morley&title=rDock%3A+A+Fast%2C+Versatile+and+Open+Source+Program+for+Docking+Ligands+to+Proteins+and+Nucleic+Acids&doi=10.1371%2Fjournal.pcbi.1003571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">rDock: a fast, versatile and open source program for docking ligands to proteins and nucleic acids</span></div><div class="casAuthors">Ruiz-Carmona, Sergio; Alvarez-Garcia, Daniel; Foloppe, Nicolas; Garmendia-Doval, A. Beatriz; Juhos, Szilveszter; Schmidtke, Peter; Barril, Xavier; Hubbard, Roderick E.; Morley, S. David</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Computational Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e1003571/1-e1003571/7, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">PCBLBG</span>;
        ISSN:<span class="NLM_cas:issn">1553-7358</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Identification of chem. compds. with specific biol. activities is an important step in both chem. biol. and drug discovery.  When the structure of the intended target is available, one approach is to use mol. docking programs to assess the chem. complementarity of small mols. with the target; such calcns. provide a qual. measure of affinity that can be used in virtual screening (VS) to rank order a list of compds. according to their potential to be active. rDock is a mol. docking program developed at Vernalis for high-throughput VS (HTVS) applications.  Evolved from RiboDock, the program can be used against proteins and nucleic acids, is designed to be computationally very efficient and allows the user to incorporate addnl. constraints and information as a bias to guide docking.  This article provides an overview of the program structure and features and compares rDock to two ref. programs, AutoDock Vina (open source) and Schrodinger's Glide (com.).  In terms of computational speed for VS, rDock is faster than Vina and comparable to Glide.  For binding mode prediction, rDock and Vina are superior to Glide.  The VS performance of rDock is significantly better than Vina, but inferior to Glide for most systems unless pharmacophore constraints are used; in that case rDock and Glide are of equal performance.  The program is released under the Lesser General Public License and is freely available for download, together with the manuals, example files and the complete test sets, at online.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL0qXwzBNIxLVg90H21EOLACvtfcHk0lhB7L2_LZSidw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGlsL%252FO&md5=e4cb786d6567fdc7f2a46f64955a9992</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pcbi.1003571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pcbi.1003571%26sid%3Dliteratum%253Aachs%26aulast%3DRuiz-Carmona%26aufirst%3DS.%26aulast%3DAlvarez-Garcia%26aufirst%3DD.%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DGarmendia-Doval%26aufirst%3DA.%2BB.%26aulast%3DJuhos%26aufirst%3DS.%26aulast%3DSchmidtke%26aufirst%3DP.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DMorley%26aufirst%3DS.%2BD.%26atitle%3DrDock%253A%2520A%2520Fast%252C%2520Versatile%2520and%2520Open%2520Source%2520Program%2520for%2520Docking%2520Ligands%2520to%2520Proteins%2520and%2520Nucleic%2520Acids%26jtitle%3DPLoS%2520Comput.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3De1003571%26doi%3D10.1371%2Fjournal.pcbi.1003571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21a','cit21b'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':[],'ref30':['cit30a','cit30b'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 9 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Robert Koralewski, Barbara Dymek, Marzena Mazur, Piotr Sklepkiewicz, Sylwia Olejniczak, Wojciech Czestkowski, Krzysztof Matyszewski, Gleb Andryianau, Piotr Niedziejko, Michal Kowalski, Mariusz Gruza, Bartłomiej Borek, Karol Jedrzejczak, Agnieszka Bartoszewicz, Elżbieta Pluta, Aleksandra Rymaszewska, Magdalena Kania, Tomasz Rejczak, Sylwia Piasecka, Michal Mlacki, Marcin Mazurkiewicz, Michał Piotrowicz, Magdalena Salamon, Agnieszka Zagozdzon, Agnieszka Napiorkowska-Gromadzka, Aneta Bartlomiejczak, Witold Mozga, Paweł Dobrzański, Karolina Dzwonek, Jakub Golab, Marcin Nowotny, Jacek Olczak, <span class="NLM_string-name hlFld-ContribAuthor">Adam Golebiowski</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of OATD-01, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (24)
                                     , 15527-15540. <a href="https://doi.org/10.1021/acs.jmedchem.0c01179" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01179</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01179%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BOATD-01%25252C%252Ba%252BFirst-in-Class%252BChitinase%252BInhibitor%252Bas%252BPotential%252BNew%252BTherapeutics%252Bfor%252BIdiopathic%252BPulmonary%252BFibrosis%26aulast%3DKoralewski%26aufirst%3DRobert%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D07072020%26date%3D20102020%26volume%3D63%26issue%3D24%26spage%3D15527%26epage%3D15540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gleb Andryianau, Michal Kowalski, Michal C. Piotrowicz, Adam A. Rajkiewicz, Barbara Dymek, Piotr L. Sklepkiewicz, Elzbieta Pluta, Filip Stefaniak, Wojciech Czestkowski, Sylwia Olejniczak, Marzena Mazur, Piotr Niedziejko, Robert Koralewski, Krzysztof Matyszewski, Mariusz Gruza, Agnieszka Zagozdzon, Magdalena Salamon, Aleksandra Rymaszewska, Mikolaj Welzer, Karolina Dzwonek, Jakub Golab, Jacek Olczak, Agnieszka Bartoszewicz, <span class="NLM_string-name hlFld-ContribAuthor">Adam Golebiowski</span>. </span><span class="cited-content_cbyCitation_article-title">Benzoxazepine-Derived Selective, Orally Bioavailable Inhibitor of Human Acidic Mammalian Chitinase. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (6)
                                     , 1228-1235. <a href="https://doi.org/10.1021/acsmedchemlett.0c00092" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00092%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBenzoxazepine-Derived%252BSelective%25252C%252BOrally%252BBioavailable%252BInhibitor%252Bof%252BHuman%252BAcidic%252BMammalian%252BChitinase%26aulast%3DAndryianau%26aufirst%3DGleb%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D21022020%26date%3D24042020%26date%3D01052020%26date%3D24042020%26volume%3D11%26issue%3D6%26spage%3D1228%26epage%3D1235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marzena  Mazur</span>, <span class="hlFld-ContribAuthor ">Anna  Zielińska</span>, <span class="hlFld-ContribAuthor ">Marcin M.  Grzybowski</span>, <span class="hlFld-ContribAuthor ">Jacek  Olczak</span>, <span class="hlFld-ContribAuthor ">Jakub  Fichna</span>. </span><span class="cited-content_cbyCitation_article-title">Chitinases and Chitinase-Like Proteins as Therapeutic Targets in Inflammatory Diseases, with a Special Focus on Inflammatory Bowel Diseases. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (13)
                                     , 6966. <a href="https://doi.org/10.3390/ijms22136966" title="DOI URL">https://doi.org/10.3390/ijms22136966</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22136966&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22136966%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DChitinases%252Band%252BChitinase-Like%252BProteins%252Bas%252BTherapeutic%252BTargets%252Bin%252BInflammatory%252BDiseases%25252C%252Bwith%252Ba%252BSpecial%252BFocus%252Bon%252BInflammatory%252BBowel%252BDiseases%26aulast%3DMazur%26aufirst%3DMarzena%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D13%26spage%3D6966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saravut  Satitsri</span>, <span class="hlFld-ContribAuthor ">Chatchai  Muanprasat</span>. </span><span class="cited-content_cbyCitation_article-title">Chitin and Chitosan Derivatives as Biomaterial Resources for Biological and Biomedical Applications. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (24)
                                     , 5961. <a href="https://doi.org/10.3390/molecules25245961" title="DOI URL">https://doi.org/10.3390/molecules25245961</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25245961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25245961%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DChitin%252Band%252BChitosan%252BDerivatives%252Bas%252BBiomaterial%252BResources%252Bfor%252BBiological%252Band%252BBiomedical%252BApplications%26aulast%3DSatitsri%26aufirst%3DSaravut%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D24%26spage%3D5961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Xi  Jiang</span>, <span class="hlFld-ContribAuthor ">Qing  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Glycoside hydrolase family 18 chitinases: The known and the unknown. </span><span class="cited-content_cbyCitation_journal-name">Biotechnology Advances</span><span> <strong>2020,</strong> <em>43 </em>, 107553. <a href="https://doi.org/10.1016/j.biotechadv.2020.107553" title="DOI URL">https://doi.org/10.1016/j.biotechadv.2020.107553</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biotechadv.2020.107553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biotechadv.2020.107553%26sid%3Dliteratum%253Aachs%26jtitle%3DBiotechnology%2520Advances%26atitle%3DGlycoside%252Bhydrolase%252Bfamily%252B18%252Bchitinases%25253A%252BThe%252Bknown%252Band%252Bthe%252Bunknown%26aulast%3DChen%26aufirst%3DWei%26date%3D2020%26volume%3D43%26spage%3D107553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenhua  Zhu</span>, <span class="hlFld-ContribAuthor ">Erik  Lönnblom</span>, <span class="hlFld-ContribAuthor ">Michael  Förster</span>, <span class="hlFld-ContribAuthor ">Martina  Johannesson</span>, <span class="hlFld-ContribAuthor ">Pei  Tao</span>, <span class="hlFld-ContribAuthor ">Liesu  Meng</span>, <span class="hlFld-ContribAuthor ">Shemin  Lu</span>, <span class="hlFld-ContribAuthor ">Rikard  Holmdahl</span>. </span><span class="cited-content_cbyCitation_article-title">Natural polymorphism of Ym1 regulates pneumonitis through alternative activation of macrophages. </span><span class="cited-content_cbyCitation_journal-name">Science Advances</span><span> <strong>2020,</strong> <em>6 </em>
                                    (43)
                                     , eaba9337. <a href="https://doi.org/10.1126/sciadv.aba9337" title="DOI URL">https://doi.org/10.1126/sciadv.aba9337</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/sciadv.aba9337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fsciadv.aba9337%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Advances%26atitle%3DNatural%252Bpolymorphism%252Bof%252BYm1%252Bregulates%252Bpneumonitis%252Bthrough%252Balternative%252Bactivation%252Bof%252Bmacrophages%26aulast%3DZhu%26aufirst%3DWenhua%26date%3D2020%26date%3D2020%26volume%3D6%26issue%3D43%26spage%3Deaba9337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eden  Silva e Souza</span>, <span class="hlFld-ContribAuthor ">Vanessa de Abreu  Barcellos</span>, <span class="hlFld-ContribAuthor ">Nicolau  Sbaraini</span>, <span class="hlFld-ContribAuthor ">Júlia Catarina Vieira  Reuwsaat</span>, <span class="hlFld-ContribAuthor ">Rafael de Oliveira  Schneider</span>, <span class="hlFld-ContribAuthor ">Adriana Corrêa  da Silva</span>, <span class="hlFld-ContribAuthor ">Ane Wichine Acosta  Garcia</span>, <span class="hlFld-ContribAuthor ">Gilsane Lino  von Poser</span>, <span class="hlFld-ContribAuthor ">Euzébio Guimarães  Barbosa</span>, <span class="hlFld-ContribAuthor ">João Paulo Matos Santos  Lima</span>, <span class="hlFld-ContribAuthor ">Marilene Henning  Vainstein</span>. </span><span class="cited-content_cbyCitation_article-title">A Plumieridine-Rich Fraction From Allamanda polyantha Inhibits Chitinolytic Activity and Exhibits Antifungal Properties Against Cryptococcus neoformans. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Microbiology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fmicb.2020.02058" title="DOI URL">https://doi.org/10.3389/fmicb.2020.02058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmicb.2020.02058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmicb.2020.02058%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Microbiology%26atitle%3DA%252BPlumieridine-Rich%252BFraction%252BFrom%252BAllamanda%252Bpolyantha%252BInhibits%252BChitinolytic%252BActivity%252Band%252BExhibits%252BAntifungal%252BProperties%252BAgainst%252BCryptococcus%252Bneoformans%26aulast%3DSilva%2Be%2BSouza%26aufirst%3DEden%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amanda  Garrido</span>, <span class="hlFld-ContribAuthor ">Alban  Lepailleur</span>, <span class="hlFld-ContribAuthor ">Serge M.  Mignani</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>. </span><span class="cited-content_cbyCitation_article-title">hERG toxicity assessment: Useful guidelines for drug design. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>195 </em>, 112290. <a href="https://doi.org/10.1016/j.ejmech.2020.112290" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112290</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112290%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DhERG%252Btoxicity%252Bassessment%25253A%252BUseful%252Bguidelines%252Bfor%252Bdrug%252Bdesign%26aulast%3DGarrido%26aufirst%3DAmanda%26date%3D2020%26volume%3D195%26spage%3D112290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ida  Mogensen</span>, <span class="hlFld-ContribAuthor ">Anna  James</span>, <span class="hlFld-ContribAuthor ">Andrei  Malinovschi</span>. </span><span class="cited-content_cbyCitation_article-title">Systemic and breath biomarkers for asthma: an update. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Allergy & Clinical Immunology</span><span> <strong>2020,</strong> <em>20 </em>
                                    (1)
                                     , 71-79. <a href="https://doi.org/10.1097/ACI.0000000000000599" title="DOI URL">https://doi.org/10.1097/ACI.0000000000000599</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/ACI.0000000000000599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FACI.0000000000000599%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Allergy%2520%2526%2520Clinical%2520Immunology%26atitle%3DSystemic%252Band%252Bbreath%252Bbiomarkers%252Bfor%252Basthma%25253A%252Ban%252Bupdate%26aulast%3DMogensen%26aufirst%3DIda%26date%3D2020%26volume%3D20%26issue%3D1%26spage%3D71%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Early optimization of Wyeth 1—moderately potent dual chitinase inhibitor (replacement of bromine by the chlorine atom in the phenyl ring has no major impact on inhibitory potency).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Docking of compound <b>2</b> to the binding pocket of hAMCase (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RM4">3RM4</a><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a>) and (B) structure of the hCHIT1–compound <b>2</b> complex (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NR8">5NR8</a>). For ligands, carbon atoms are colored in green, nitrogen atoms in blue, oxygen atoms in red, sulfur atoms in yellow, and bromine atoms in dark red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Two possible modes of cyclization of two linear N-substituents leading to (A) more and (B) less rigidified (4-chlorophenyl)-<i>N</i>-heterocycles.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Binding site of hCHIT1 complexed with compound <b>2</b> (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NR8">5NR8</a>); homobenzylic hydrogens marked as H<sub>A</sub> and H<sub>B</sub>. H<sub>A</sub> can be substituted by the incoming alkyl linker joining the homobenzylic position with the <i>N</i>-methyl group (the resulting 2-(4-chlorobenzyl)pyrrolidine of the <i>R</i> configuration shown). On the other hand, H<sub>B</sub> cannot be displaced in the same way without disrupting conformation of the <i>p</i>-halophenetyl substituent.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Plasma total concentration–time course for compound <b>30</b> after 3 mg/kg IV bolus and after 10 mg/kg oral administration (PO) to female BALB/c mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Plasma and brain total concentrations of <b>30</b> after 10 mg/kg oral administration in female BALB/c mice compared to the observed off-target activities.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Dual AMCase/CHIT1 inhibition with compound <b>30</b> results in significant anti-inflammatory effects in the HDM-induced asthma mouse model. Flow cytometry analysis of total infiltrating leukocytes numbers in BALf recovered from naive mice challenged with PBS or HDM with or without compound <b>30</b> (50 mg/kg; PO; qd) or dexamethasone (10 mg/kg, IP, qd) treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Compound <b>30</b> docked to the hAMCase [PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RM4">3RM4</a>, panes (A,C)] and hCHIT1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NR8">5NR8</a>, panes (B,D)) binding pockets. Upper panes (A,B) show key residues forming the binding pockets of both proteins. Bottom panes (C,D) show a sphere representation of binding pockets of proteins; distinct residues (269 and 300) and Trp99 are shown as sticks. For ligands, carbon atoms are colored in green, nitrogen atoms in blue, oxygen atoms in red, and sulfur atoms in yellow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of Compounds <b>4–20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) R<sub>1</sub>–NH<sub>2</sub>, NaBH(OAc)<sub>3</sub>, DCE, rt; then (b) 4-chlorophenylacetaldehyde, NaBH(OAc)<sub>3</sub>, DCE, rt, 45–88% over 2 steps (c) HCl, AcOEt, rt; (d) <i>S</i>,<i>S</i>′-dimethyl <i>N</i>-cyanodithioiminocarbonate, K<sub>2</sub>CO<sub>3</sub>, MeCN, 82 °C; (e) hydrazine, MeCN, 82 °C, 15–55% over 3 steps; (f) NaOH, H<sub>2</sub>O, reflux, 10%.</p></p></figure><figure data-id="sch2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Analogues <b>21</b> and <b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 3-(4-chlorophenyl)pyrrolidine (for <b>34</b>) or 3-(4-chlorophenyl)piperidine (for <b>35</b>), NaBH(OAc)<sub>3</sub>, AcOH, DCE, rt, 45 and 23% for <b>34</b> and <b>35</b>, respectively; (b) HCl, AcOEt, rt; (c) <i>S</i>,<i>S</i>′-dimethyl <i>N</i>-cyanodithioiminocarbonate, K<sub>2</sub>CO<sub>3</sub>, MeCN, 82 °C; (d) hydrazine, MeCN, 82 °C, 55 and 14% over 3 steps for <b>21</b> and <b>22</b>, respectively.</p></p></figure><figure data-id="sch3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of (<i>R</i>)-2-(4-Chlorobenzyl)pyrrolidine <b>39</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HN(Me)OMe, CDI, DCM, rt, 52%; (b) 4-chlorophenymagnesium bromide, Et<sub>2</sub>O, −70 °C to rt, 69%; (c) AlCl<sub>3</sub>, Et<sub>3</sub>SiH, DCM, 0 °C to rt, 99%; (d) <i>N</i>-Boc-piperid-4-one, NaBH(OAc)<sub>3</sub>, AcOH, DCE, rt, 45%; (e) HCl, AcOEt, rt; (f) <i>S</i>,<i>S</i>′-dimethyl <i>N</i>-cyanodithioiminocarbonate, K<sub>2</sub>CO<sub>3</sub>, MeCN, 82 °C; (g) hydrazine, MeCN, 82 °C, 39% over 3 steps.</p></p></figure><figure data-id="sch4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of (<i>R</i>)-2-(4-Chlorobenzyl)piperidine <b>46</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 4-chlorophenylacetaldehyde, Ti(OEt)<sub>4</sub>, DCM, reflux, then rt; (b) allylmagnesium bromide, −20 °C to rt, 23% over two steps; (c) allyl bromide, NaH, DMF, rt, 71%; (d) Grubbs catalyst first generation, DCM, reflux, 94%; (e) H<sub>2</sub>, Pd/C (cat.), MeOH, rt, 77%; (f) HCl, MeOH, rt, 72%.</p></p></figure><figure data-id="sch5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of (2<i>S</i>,3<i>S</i>)-2-(4-Chlorobenzyl)-3-methoxyazetidine <b>52</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) methyl chloroformate, Et<sub>3</sub>N, THF, −15 °C, then CH<sub>2</sub>N<sub>2</sub> solution in Et<sub>2</sub>O, −30 °C to rt, 96%; (b) Rh<sub>2</sub>(OAc)<sub>4</sub> (0.5% mol), Et<sub>3</sub>N (1% mol), DCM, 0 °C to rt, 46%; (c) NaBH<sub>4</sub>, MeOH, 0 °C to rt, 86%; (d) NaH, MeI, DMF, rt, 100%; (e) HCl, 1,4-dioxane, rt, 77%.</p></p></figure><figure data-id="sch6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of (2<i>S</i>,4<i>S</i>)-2-(4-Chlorobenzyl)-4-hydroxypyrrolidine <b>57</b> and (2<i>S</i>,4<i>R</i>)-2-(4-Chlorobenzyl)-4-hydroxypyrrolidine <b>63</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HN(Me)OMe, CDI, DCM, rt, 49% for <b>54</b>, 67% for <b>61</b>; (b) TBSCl, imidazole, DMF, rt, 92%; (c) 4-chlorophenymagnesium bromide, Et<sub>2</sub>O, −70 °C to rt, 86% for <b>56</b>, 40% for <b>62</b>; (d) AlCl<sub>3</sub>, Et<sub>3</sub>SiH, DCM, 0 °C to rt, 81% for <b>57</b>, 98% for <b>63</b>; (e) Boc<sub>2</sub>O, Mg(ClO<sub>4</sub>)<sub>2</sub>, DCM, reflux, 68%; (f) LiOH, THF/MeOH/H<sub>2</sub>O, rt, 94%.</p></p></figure><figure data-id="sch7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of (<i>S</i>)-3-(4-Chlorobenzyl)morpholine <b>67</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) chloroacetyl chloride, Et<sub>3</sub>N, THF, 0 °C, 85%; (b) NaH, THF, 0 °C to rt, 59%; (c) BH<sub>3</sub>·DMS complex, THF, reflux, 73%.</p></p></figure><figure data-id="sch8" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/medium/jm-2019-00681p_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. General Synthesis of Compounds <b>23–30</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00681/20190801/images/large/jm-2019-00681p_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00681&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>N</i>-Boc-piperid-4-one <b>31</b>, NaBH(OAc)<sub>3</sub>, AcOH, DCE, rt, 45–85%; (b) MeI, NaH, DMF, rt, 95 and 77% for <b>74</b> and <b>75</b>, respectively; (c) HCl, AcOEt, rt; (d) <i>S</i>,<i>S</i>′-dimethyl <i>N</i>-cyanodithioiminocarbonate, K<sub>2</sub>CO<sub>3</sub>, MeCN, 82 °C; (e) hydrazine, MeCN, 82 °C, 15–84% over three steps.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i113">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23758" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23758" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 39 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brightling, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddel, H. K.</span></span> <span> </span><span class="NLM_article-title">Asthma</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>391</i></span>,  <span class="NLM_fpage">783</span>– <span class="NLM_lpage">800</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(17)33311-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1016%2Fs0140-6736%2817%2933311-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=29273246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A280%3ADC%252BC1Mzks12htQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=391&publication_year=2018&pages=783-800&author=A.+Papiauthor=C.+Brightlingauthor=S.+E.+Pedersenauthor=H.+K.+Reddel&title=Asthma&doi=10.1016%2Fs0140-6736%2817%2933311-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Asthma</span></div><div class="casAuthors">Papi Alberto; Brightling Christopher; Pedersen Soren E; Reddel Helen K</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">391</span>
        (<span class="NLM_cas:issue">10122</span>),
    <span class="NLM_cas:pages">783-800</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Asthma-one of the most common chronic, non-communicable diseases in children and adults-is characterised by variable respiratory symptoms and variable airflow limitation.  Asthma is a consequence of complex gene-environment interactions, with heterogeneity in clinical presentation and the type and intensity of airway inflammation and remodelling.  The goal of asthma treatment is to achieve good asthma control-ie, to minimise symptom burden and risk of exacerbations.  Anti-inflammatory and bronchodilator treatments are the mainstay of asthma therapy and are used in a stepwise approach.  Pharmacological treatment is based on a cycle of assessment and re-evaluation of symptom control, risk factors, comorbidities, side-effects, and patient satisfaction by means of shared decisions.  Asthma is classed as severe when requiring high-intensity treatment to keep it under control, or if it remains uncontrolled despite treatment.  New biological therapies for treatment of severe asthma, together with developments in biomarkers, present opportunities for phenotype-specific interventions and realisation of more personalised treatment.  In this Seminar, we provide a clinically focused overview of asthma, including epidemiology, pathophysiology, clinical diagnosis, asthma phenotypes, severe asthma, acute exacerbations, and clinical management of disease in adults and children older than 5 years.  Emerging therapies, controversies, and uncertainties in asthma management are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTkkwaIXLDBxb5XHngOXiV_fW6udTcc2eaW-TMTpm2u7rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mzks12htQ%253D%253D&md5=32a89bd095eebe078f563cf7cf64fadd</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fs0140-6736%2817%2933311-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0140-6736%252817%252933311-1%26sid%3Dliteratum%253Aachs%26aulast%3DPapi%26aufirst%3DA.%26aulast%3DBrightling%26aufirst%3DC.%26aulast%3DPedersen%26aufirst%3DS.%2BE.%26aulast%3DReddel%26aufirst%3DH.%2BK.%26atitle%3DAsthma%26jtitle%3DLancet%26date%3D2018%26volume%3D391%26spage%3D783%26epage%3D800%26doi%3D10.1016%2Fs0140-6736%2817%2933311-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pavord, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beasley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agusti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brusselle, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullinan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Custovic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ducharme, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahy, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frey, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heaney, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humbert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sly, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Mutius, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zar, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, A.</span></span> <span> </span><span class="NLM_article-title">After asthma: redefining airways diseases</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>391</i></span>,  <span class="NLM_fpage">350</span>– <span class="NLM_lpage">400</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(17)30879-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1016%2Fs0140-6736%2817%2930879-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=28911920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A280%3ADC%252BC1cboslSquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=391&publication_year=2018&pages=350-400&author=I.+D.+Pavordauthor=R.+Beasleyauthor=A.+Agustiauthor=G.+P.+Andersonauthor=E.+Belauthor=G.+Brusselleauthor=P.+Cullinanauthor=A.+Custovicauthor=F.+M.+Ducharmeauthor=J.+V.+Fahyauthor=U.+Freyauthor=P.+Gibsonauthor=L.+G.+Heaneyauthor=P.+G.+Holtauthor=M.+Humbertauthor=C.+M.+Lloydauthor=G.+Marksauthor=F.+D.+Martinezauthor=P.+D.+Slyauthor=E.+von+Mutiusauthor=S.+Wenzelauthor=H.+J.+Zarauthor=A.+Bush&title=After+asthma%3A+redefining+airways+diseases&doi=10.1016%2Fs0140-6736%2817%2930879-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">After asthma: redefining airways diseases</span></div><div class="casAuthors">Pavord Ian D; Beasley Richard; Agusti Alvar; Anderson Gary P; Bel Elisabeth; Brusselle Guy; Cullinan Paul; Lloyd Clare M; Custovic Adnan; Ducharme Francine M; Fahy John V; Frey Urs; Gibson Peter; Heaney Liam G; Holt Patrick G; Humbert Marc; Marks Guy; Martinez Fernando D; Sly Peter D; von Mutius Erika; Wenzel Sally; Zar Heather J; Bush Andy</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">391</span>
        (<span class="NLM_cas:issue">10118</span>),
    <span class="NLM_cas:pages">350-400</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS2Ycwv3QW8_Vf1XRtfYM0dfW6udTcc2eaW-TMTpm2u7rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cboslSquw%253D%253D&md5=9cf7c2ef0ed69dcb9ac8d4d88b59b63c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fs0140-6736%2817%2930879-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0140-6736%252817%252930879-6%26sid%3Dliteratum%253Aachs%26aulast%3DPavord%26aufirst%3DI.%2BD.%26aulast%3DBeasley%26aufirst%3DR.%26aulast%3DAgusti%26aufirst%3DA.%26aulast%3DAnderson%26aufirst%3DG.%2BP.%26aulast%3DBel%26aufirst%3DE.%26aulast%3DBrusselle%26aufirst%3DG.%26aulast%3DCullinan%26aufirst%3DP.%26aulast%3DCustovic%26aufirst%3DA.%26aulast%3DDucharme%26aufirst%3DF.%2BM.%26aulast%3DFahy%26aufirst%3DJ.%2BV.%26aulast%3DFrey%26aufirst%3DU.%26aulast%3DGibson%26aufirst%3DP.%26aulast%3DHeaney%26aufirst%3DL.%2BG.%26aulast%3DHolt%26aufirst%3DP.%2BG.%26aulast%3DHumbert%26aufirst%3DM.%26aulast%3DLloyd%26aufirst%3DC.%2BM.%26aulast%3DMarks%26aufirst%3DG.%26aulast%3DMartinez%26aufirst%3DF.%2BD.%26aulast%3DSly%26aufirst%3DP.%2BD.%26aulast%3Dvon%2BMutius%26aufirst%3DE.%26aulast%3DWenzel%26aufirst%3DS.%26aulast%3DZar%26aufirst%3DH.%2BJ.%26aulast%3DBush%26aufirst%3DA.%26atitle%3DAfter%2520asthma%253A%2520redefining%2520airways%2520diseases%26jtitle%3DLancet%26date%3D2018%26volume%3D391%26spage%3D350%26epage%3D400%26doi%3D10.1016%2Fs0140-6736%2817%2930879-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, A. N. J.</span></span> <span> </span><span class="NLM_article-title">TH2 cell development and function</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1038/nri.2017.118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1038%2Fnri.2017.118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=29082915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslehtr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=121-133&author=J.+A.+Walkerauthor=A.+N.+J.+McKenzie&title=TH2+cell+development+and+function&doi=10.1038%2Fnri.2017.118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">TH2 cell development and function</span></div><div class="casAuthors">Walker, Jennifer A.; McKenzie, Andrew N. J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-133</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">T helper 2 (TH2) cells orchestrate protective type 2 immune responses, such as those that target helminths and facilitate tissue repair, but also contribute to chronic inflammatory diseases, such as asthma and allergy.  Here, we review recent insights into how diverse mol. signals from cellular sources, including dendritic cells, innate lymphoid cells and the epithelium, are integrated by T cells to guide the transcriptional and epigenetic changes necessary for TH2 cell differentiation.  Our improved understanding of these pathways has opened new avenues for therapeutically targeting TH2 cells in asthma and allergy.  The advent of comprehensive single-cell transcriptomics along with improvements in single-cell proteomics and the generation of novel in vivo cell fate mapping techniques promise to expand our understanding of T cell diversity and offer new insight into disease-related heterogeneity and plasticity of TH cell responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoohegyijwGWbVg90H21EOLACvtfcHk0lgVGq3BsVQGDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslehtr%252FM&md5=b3235a2458de52cd51863a1a73aed2dd</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnri.2017.118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri.2017.118%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DJ.%2BA.%26aulast%3DMcKenzie%26aufirst%3DA.%2BN.%2BJ.%26atitle%3DTH2%2520cell%2520development%2520and%2520function%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2018%26volume%3D18%26spage%3D121%26epage%3D133%26doi%3D10.1038%2Fnri.2017.118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duru, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yüceege, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ardiç, S.</span></span> <span> </span><span class="NLM_article-title">Chitinases and lung diseases</span>. <i>Tuberk. ve Toraks</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.5578/tt.3773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.5578%2Ftt.3773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=23581271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A280%3ADC%252BC3srltFSgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2013&pages=71-75&author=S.+Duruauthor=M.+Y%C3%BCceegeauthor=S.+Ardi%C3%A7&title=Chitinases+and+lung+diseases&doi=10.5578%2Ftt.3773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Chitinases and lung diseases</span></div><div class="casAuthors">Duru Serap; Yuceege Melike; Ardic Sadik</div><div class="citationInfo"><span class="NLM_cas:title">Tuberkuloz ve toraks</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-5</span>
        ISSN:<span class="NLM_cas:issn">0494-1373</span>.
    </div><div class="casAbstract">Chitinase enzymes that hydrolize chitin and some articficial substrates are expressed in human despite lacking of the endogenous chitin within the body.  Chitinases phatophysiological functions within human are not fully known.  Recent evidence revealed that chitinases may have role into some processes of immune responses and inflammatory system.  In this review, we discuss the role of chitinases in lung diseases based on the available information from the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTyayyJCFhHV8ScOqQTSkOffW6udTcc2eY9-PvKk7vawbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3srltFSgtQ%253D%253D&md5=843632da002810409623b3eb536b18a7</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.5578%2Ftt.3773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5578%252Ftt.3773%26sid%3Dliteratum%253Aachs%26aulast%3DDuru%26aufirst%3DS.%26aulast%3DY%25C3%25BCceege%26aufirst%3DM.%26aulast%3DArdi%25C3%25A7%26aufirst%3DS.%26atitle%3DChitinases%2520and%2520lung%2520diseases%26jtitle%3DTuberk.%2520ve%2520Toraks%26date%3D2013%26volume%3D61%26spage%3D71%26epage%3D75%26doi%3D10.5578%2Ftt.3773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koller, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Silva, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flavell, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elias, J. A.</span></span> <span> </span><span class="NLM_article-title">Acidic mammalian chitinase regulates epithelial cell apoptosis via a chitinolytic-independent mechanism</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>182</i></span>,  <span class="NLM_fpage">5098</span>– <span class="NLM_lpage">5106</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.0803446</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.4049%2Fjimmunol.0803446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=19342690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFOisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2009&pages=5098-5106&author=D.+Hartlauthor=C.+H.+Heauthor=B.+Kollerauthor=C.+A.+Da+Silvaauthor=Y.+Kobayashiauthor=C.+G.+Leeauthor=R.+A.+Flavellauthor=J.+A.+Elias&title=Acidic+mammalian+chitinase+regulates+epithelial+cell+apoptosis+via+a+chitinolytic-independent+mechanism&doi=10.4049%2Fjimmunol.0803446"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Acidic Mammalian Chitinase Regulates Epithelial Cell Apoptosis via a Chitinolytic-Independent Mechanism</span></div><div class="casAuthors">Hartl, Dominik; He, Chuan Hua; Koller, Babara; Da Silva, Carla A.; Kobayashi, Yasushi; Lee, Chun Geun; Flavell, Richard A.; Elias, Jack A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">5098-5106</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Acidic mammalian chitinase (AMCase) is produced during and plays an important role in the pathogenesis of Th2-mediated diseases and antiparasite responses.  However, the effector responses of AMCase in these settings have not been adequately defined and the relationship(s) between its chitinolytic and other biol. properties have not been investigated.  In these studies, we demonstrate that AMCase protects airway epithelial cells from Fas ligand- and growth factor withdrawal-induced apoptosis.  This cytoprotection was assocd. with Akt phosphorylation and abrogated when the PI3K/Akt pathway was inhibited.  Comparable cytoprotection was also seen in expts. comparing wild-type AMCase and mutant AMCase that lacked chitinolytic activity.  Importantly, the apoptosis-inhibiting effect of enzymically active and inactive AMCase was abrogated by treatment with allosamidin.  These studies demonstrate that secreted AMCase feeds back in an autocrine and/or paracrine manner to protect pulmonary epithelial cells from growth factor withdrawal- and Fas ligand-induced apoptosis.  They also demonstrate that the cytoprotection is mediated via a PI3K/Akt-dependent and allosamidin-sensitive pathway that is independent of the chitinolytic activity of this chitinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZVFoVH-1ht7Vg90H21EOLACvtfcHk0lgVGq3BsVQGDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFOisbY%253D&md5=b2bfc2927826f81ee1de5fb35f40bb51</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0803446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0803446%26sid%3Dliteratum%253Aachs%26aulast%3DHartl%26aufirst%3DD.%26aulast%3DHe%26aufirst%3DC.%2BH.%26aulast%3DKoller%26aufirst%3DB.%26aulast%3DDa%2BSilva%26aufirst%3DC.%2BA.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DC.%2BG.%26aulast%3DFlavell%26aufirst%3DR.%2BA.%26aulast%3DElias%26aufirst%3DJ.%2BA.%26atitle%3DAcidic%2520mammalian%2520chitinase%2520regulates%2520epithelial%2520cell%2520apoptosis%2520via%2520a%2520chitinolytic-independent%2520mechanism%26jtitle%3DJ.%2520Immunol.%26date%3D2009%26volume%3D182%26spage%3D5098%26epage%3D5106%26doi%3D10.4049%2Fjimmunol.0803446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">James, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinius, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kupczyk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ono, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izuhara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kere, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Söderhäll, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlén, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boot, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlén, S.-E.</span></span> <span> </span><span class="NLM_article-title">Increased YKL-40 and Chitotriosidase in Asthma and Chronic Obstructive Pulmonary Disease</span>. <i>Am. J. Respir. Crit. Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>193</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1164/rccm.201504-0760oc</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1164%2Frccm.201504-0760oc" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=26372680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFWmtr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2016&pages=131-142&author=A.+J.+Jamesauthor=L.+E.+Reiniusauthor=M.+Verhoekauthor=A.+Gomesauthor=M.+Kupczykauthor=U.+Hammarauthor=J.+Onoauthor=S.+Ohtaauthor=K.+Izuharaauthor=E.+Belauthor=J.+Kereauthor=C.+S%C3%B6derh%C3%A4llauthor=B.+Dahl%C3%A9nauthor=R.+G.+Bootauthor=S.-E.+Dahl%C3%A9n&title=Increased+YKL-40+and+Chitotriosidase+in+Asthma+and+Chronic+Obstructive+Pulmonary+Disease&doi=10.1164%2Frccm.201504-0760oc"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Increased YKL-40 and chitotriosidase in asthma and chronic obstructive pulmonary disease</span></div><div class="casAuthors">James, Anna J.; Reinius, Lovisa E.; Verhoek, Marri; Gomes, Anna; Kupczyk, Maciej; Hammar, Ulf; Ono, Junya; Ohta, Shoichiro; Izuhara, Kenji; Bel, Elisabeth; Kere, Juha; Soederhaell, Cilla; Dahlen, Barbro; Boot, Rolf G.; Dahlen, Sven-Erik</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-142</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: Serum chitinases may be novel biomarkers of airway inflammation and remodeling, but less is known about factors regulating their levels.  Objectives: To examine serum chitotriosidase activity and YKL-40 levels in patients with asthma and chronic obstructive pulmonary disease (COPD) and evaluate clin. relevant factors that may affect chitinase levels, including genetic variability, corticosteroid treatment, disease exacerbations, and allergen exposure.  Methods: Serum chitotriosidase (CHIT1) activity and YKL-40 (CHI3L1) levels, as well as the CHIT1 rs3831317 and CHI3L1 rs4950928 genotypes, were examd. in subsets of patients with mild to moderate asthma (n = 76), severe asthma (n = 93), and COPD (n = 64) taking part in the European multicenter BIOAIR (Longitudinal Assessment of Clin. Course and Biomarkers in Severe Chronic Airway Disease) study.  Blood was obtained at baseline, before and after a 2-wk oral steroid intervention, up to six times during a 1-yr period, and during exacerbations.  Baseline chitinase levels were also measured in 72 healthy control subjects.  The effect of allergen inhalation on blood and sputum YKL-40 levels was measured in two sep. groups of patients with mild atopic asthma; one group underwent repeated low-dose allergen challenge (n = 15), and the other underwent high-dose allergen challenge (n = 16).  Measurements and Main Results: Serum chitotriosidase and YKL-40 were significantly elevated in patients with asthma and those with COPD compared with healthy control subjects.  Genotype and age strongly affected both YKL-40 and chitotriosidase activity, but assocns. with disease remained following adjustment for these factors.  Correlations were obsd. with lung function but not with other biomarkers, including exhaled nitric oxide, blood eosinophils, periostin, and IgE.  Generally, acute exacerbations, allergen-induced airway obstruction, and corticosteroid treatment did not affect circulating chitinase levels.  Conclusions: YKL-40 and chitotriosidase are increased in asthma and more so in COPD.  The data in the present study support these substances as being relatively steroid-insensitive, non-T-helper cell type 2-type biomarkers distinctly related to chronic inflammatory disease processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonCASXwXqcILVg90H21EOLACvtfcHk0lgHiPKTm0R71g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFWmtr3F&md5=c100bfde5a107d31befe55bdb42455bb</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1164%2Frccm.201504-0760oc&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.201504-0760oc%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DA.%2BJ.%26aulast%3DReinius%26aufirst%3DL.%2BE.%26aulast%3DVerhoek%26aufirst%3DM.%26aulast%3DGomes%26aufirst%3DA.%26aulast%3DKupczyk%26aufirst%3DM.%26aulast%3DHammar%26aufirst%3DU.%26aulast%3DOno%26aufirst%3DJ.%26aulast%3DOhta%26aufirst%3DS.%26aulast%3DIzuhara%26aufirst%3DK.%26aulast%3DBel%26aufirst%3DE.%26aulast%3DKere%26aufirst%3DJ.%26aulast%3DS%25C3%25B6derh%25C3%25A4ll%26aufirst%3DC.%26aulast%3DDahl%25C3%25A9n%26aufirst%3DB.%26aulast%3DBoot%26aufirst%3DR.%2BG.%26aulast%3DDahl%25C3%25A9n%26aufirst%3DS.-E.%26atitle%3DIncreased%2520YKL-40%2520and%2520Chitotriosidase%2520in%2520Asthma%2520and%2520Chronic%2520Obstructive%2520Pulmonary%2520Disease%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2016%26volume%3D193%26spage%3D131%26epage%3D142%26doi%3D10.1164%2Frccm.201504-0760oc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homer, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohn, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamid, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elias, J. A.</span></span> <span> </span><span class="NLM_article-title">Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>304</i></span>,  <span class="NLM_fpage">1678</span>– <span class="NLM_lpage">1682</span>, <span class="refDoi"> DOI: 10.1126/science.1095336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1126%2Fscience.1095336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=15192232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BD2cXks1Cgsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2004&pages=1678-1682&author=Z.+Zhuauthor=T.+Zhengauthor=R.+J.+Homerauthor=Y.+K.+Kimauthor=N.+Y.+Chenauthor=L.+Cohnauthor=Q.+Hamidauthor=J.+A.+Elias&title=Acidic+mammalian+chitinase+in+asthmatic+Th2+inflammation+and+IL-13+pathway+activation&doi=10.1126%2Fscience.1095336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Acidic Mammalian Chitinase in Asthmatic Th2 Inflammation and IL-13 Pathway Activation</span></div><div class="casAuthors">Zhu, Zhou; Zheng, Tao; Homer, Robert J.; Kim, Yoon-Keun; Chen, Ning Yuan; Cohn, Lauren; Hamid, Qutayba; Elias, Jack A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">5677</span>),
    <span class="NLM_cas:pages">1678-1682</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Chitin is a surface component of parasites and insects, and chitinases are induced in lower life forms during infections with these agents.  Although chitin itself does not exist in humans, chitinases are present in the human genome.  We show here that acidic mammalian chitinase (AMCase) is induced via a T helper-2 (Th2)-specific, interleukin-13 (IL-13)-mediated pathway in epithelial cells and macrophages in an aeroallergen asthma model and expressed in exaggerated quantities in human asthma.  AMCase neutralization ameliorated Th2 inflammation and airway hyperresponsiveness, in part by inhibiting IL-13 pathway activation and chemokine induction.  AMCase may thus be an important mediator of IL-13-induced responses in Th2-dominated disorders such as asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr11ubUlNbNs7Vg90H21EOLACvtfcHk0lgHiPKTm0R71g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXks1Cgsr0%253D&md5=4358d813c473ef0d9b788a9dceb0f7f2</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.1095336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1095336%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DZheng%26aufirst%3DT.%26aulast%3DHomer%26aufirst%3DR.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BK.%26aulast%3DChen%26aufirst%3DN.%2BY.%26aulast%3DCohn%26aufirst%3DL.%26aulast%3DHamid%26aufirst%3DQ.%26aulast%3DElias%26aufirst%3DJ.%2BA.%26atitle%3DAcidic%2520mammalian%2520chitinase%2520in%2520asthmatic%2520Th2%2520inflammation%2520and%2520IL-13%2520pathway%2520activation%26jtitle%3DScience%26date%3D2004%26volume%3D304%26spage%3D1678%26epage%3D1682%26doi%3D10.1126%2Fscience.1095336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agapov, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battaile, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidwell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hachem, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzman, M. J.</span></span> <span> </span><span class="NLM_article-title">Macrophage chitinase 1 stratifies chronic obstructive lung disease</span>. <i>Am. J. Respir. Cell Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">384</span>, <span class="refDoi"> DOI: 10.1165/2009-0122r</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1165%2F2009-0122r" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=19491341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Squ7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=379-384&author=E.+Agapovauthor=J.+T.+Battaileauthor=R.+Tidwellauthor=R.+Hachemauthor=G.+A.+Pattersonauthor=R.+A.+Pierceauthor=J.+J.+Atkinsonauthor=M.+J.+Holtzman&title=Macrophage+chitinase+1+stratifies+chronic+obstructive+lung+disease&doi=10.1165%2F2009-0122r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage chitinase 1 stratifies chronic obstructive lung disease</span></div><div class="casAuthors">Agapov, Eugene; Battaile, John T.; Tidwell, Rose; Hachem, Ramsey; Patterson, G. Alexander; Pierce, Richard A.; Atkinson, Jeffrey J.; Holtzman, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">379-384</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Diagnosis and therapy of chronic inflammatory lung disease is limited by the need for individualized biomarkers that provide insight into pathogenesis.  Herein we show that mouse models of chronic obstructive lung disease exhibit an increase in lung chitinase prodn. but cannot predict which chitinase family member may be equivalently increased in humans with corresponding lung disease.  Moreover, we demonstrate that lung macrophage prodn. of chitinase 1 is selectively increased in a subset of subjects with severe chronic obstructive pulmonary disease, and this increase is reflected in plasma levels.  The findings provide a means to noninvasively track alternatively activated macrophages in chronic lung disease and thereby better differentiate mol. phenotypes in heterogeneous patient populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBj7y8qo-5RrVg90H21EOLACvtfcHk0lgHiPKTm0R71g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Squ7bK&md5=c1da83cca202ed5bf33b5420a65cde91</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1165%2F2009-0122r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252F2009-0122r%26sid%3Dliteratum%253Aachs%26aulast%3DAgapov%26aufirst%3DE.%26aulast%3DBattaile%26aufirst%3DJ.%2BT.%26aulast%3DTidwell%26aufirst%3DR.%26aulast%3DHachem%26aufirst%3DR.%26aulast%3DPatterson%26aufirst%3DG.%2BA.%26aulast%3DPierce%26aufirst%3DR.%2BA.%26aulast%3DAtkinson%26aufirst%3DJ.%2BJ.%26aulast%3DHoltzman%26aufirst%3DM.%2BJ.%26atitle%3DMacrophage%2520chitinase%25201%2520stratifies%2520chronic%2520obstructive%2520lung%2520disease%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2009%26volume%3D41%26spage%3D379%26epage%3D384%26doi%3D10.1165%2F2009-0122r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aminuddin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akhabir, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanowicz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paré, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connett, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthonisen, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahy, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibold, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burchard, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulsvik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakke, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litonjua, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomas, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaty, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crapo, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandford, A. J.</span></span> <span> </span><span class="NLM_article-title">Genetic association between human chitinases and lung function in COPD</span>. <i>Hum. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">1105</span>– <span class="NLM_lpage">1114</span>, <span class="refDoi"> DOI: 10.1007/s00439-011-1127-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1007%2Fs00439-011-1127-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=22200767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos1yku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2012&pages=1105-1114&author=F.+Aminuddinauthor=L.+Akhabirauthor=D.+Stefanowiczauthor=P.+D.+Par%C3%A9author=J.+E.+Connettauthor=N.+R.+Anthonisenauthor=J.+V.+Fahyauthor=M.+A.+Seiboldauthor=E.+G.+Burchardauthor=C.+Engauthor=A.+Gulsvikauthor=P.+Bakkeauthor=M.+H.+Choauthor=A.+Litonjuaauthor=D.+A.+Lomasauthor=W.+H.+Andersonauthor=T.+H.+Beatyauthor=J.+D.+Crapoauthor=E.+K.+Silvermanauthor=A.+J.+Sandford&title=Genetic+association+between+human+chitinases+and+lung+function+in+COPD&doi=10.1007%2Fs00439-011-1127-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic association between human chitinases and lung function in COPD</span></div><div class="casAuthors">Aminuddin, F.; Akhabir, L.; Stefanowicz, D.; Pare, P. D.; Connett, J. E.; Anthonisen, N. R.; Fahy, J. V.; Seibold, M. A.; Burchard, E. G.; Eng, C.; Gulsvik, A.; Bakke, P.; Cho, M. H.; Litonjua, A.; Lomas, D. A.; Anderson, W. H.; Beaty, T. H.; Crapo, J. D.; Silverman, E. K.; Sandford, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Human Genetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1105-1114</span>CODEN:
                <span class="NLM_cas:coden">HUGEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6717</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Two primary chitinases have been identified in humans-acid mammalian chitinase (AMCase) and chitotriosidase (CHIT1).  Mammalian chitinases have been obsd. to affect the host's immune response.  The aim of this study was to test for assocn. between genetic variation in the chitinases and phenotypes related to chronic obstructive pulmonary disease (COPD).  Polymorphisms in the chitinase genes were selected based on previous assocns. with respiratory diseases.  Polymorphisms that were assocd. with lung function level or rate of decline in the Lung Health Study (LHS) cohort were analyzed for assocn. with COPD affection status in four other COPD case-control populations.  Chitinase activity and protein levels were also related to genotypes.  In the caucasian LHS population, the baseline forced expiratory vol. in one second (FEV1) was significantly different between the AA and GG genotypic groups of the AMCase rs3818822 polymorphism.  Subjects with the GG genotype had higher AMCase protein and chitinase activity compared with AA homozygotes.  For CHIT1 rs2494303, a significant assocn. was obsd. between rate of decline in FEV1 and the different genotypes.  In the African American LHS population, CHIT1 rs2494303 and AMCase G339T genotypes were assocd. with rate of decline in FEV1.  Although a significant effect of chitinase gene alleles was found on lung function level and decline in the LHS, we were unable to replicate the assocns. with COPD affection status in the other COPD study groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-AEqXKz06TrVg90H21EOLACvtfcHk0lhHnvz-xChUVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos1yku7w%253D&md5=e3fb8142a8a2d245baa03581e7662769</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs00439-011-1127-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00439-011-1127-1%26sid%3Dliteratum%253Aachs%26aulast%3DAminuddin%26aufirst%3DF.%26aulast%3DAkhabir%26aufirst%3DL.%26aulast%3DStefanowicz%26aufirst%3DD.%26aulast%3DPar%25C3%25A9%26aufirst%3DP.%2BD.%26aulast%3DConnett%26aufirst%3DJ.%2BE.%26aulast%3DAnthonisen%26aufirst%3DN.%2BR.%26aulast%3DFahy%26aufirst%3DJ.%2BV.%26aulast%3DSeibold%26aufirst%3DM.%2BA.%26aulast%3DBurchard%26aufirst%3DE.%2BG.%26aulast%3DEng%26aufirst%3DC.%26aulast%3DGulsvik%26aufirst%3DA.%26aulast%3DBakke%26aufirst%3DP.%26aulast%3DCho%26aufirst%3DM.%2BH.%26aulast%3DLitonjua%26aufirst%3DA.%26aulast%3DLomas%26aufirst%3DD.%2BA.%26aulast%3DAnderson%26aufirst%3DW.%2BH.%26aulast%3DBeaty%26aufirst%3DT.%2BH.%26aulast%3DCrapo%26aufirst%3DJ.%2BD.%26aulast%3DSilverman%26aufirst%3DE.%2BK.%26aulast%3DSandford%26aufirst%3DA.%2BJ.%26atitle%3DGenetic%2520association%2520between%2520human%2520chitinases%2520and%2520lung%2520function%2520in%2520COPD%26jtitle%3DHum.%2520Genet.%26date%3D2012%26volume%3D131%26spage%3D1105%26epage%3D1114%26doi%3D10.1007%2Fs00439-011-1127-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Artieda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cenarro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gañán, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jericó, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalvo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casado, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitoria, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puzo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pocoví, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Civeira, F.</span></span> <span> </span><span class="NLM_article-title">Serum chitotriosidase activity is increased in subjects with atherosclerosis disease</span>. <i>Arterioscler., Thromb., Vasc. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1645</span>– <span class="NLM_lpage">1652</span>, <span class="refDoi"> DOI: 10.1161/01.atv.0000089329.09061.07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1161%2F01.atv.0000089329.09061.07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=12893688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVWrt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=1645-1652&author=M.+Artiedaauthor=A.+Cenarroauthor=A.+Ga%C3%B1%C3%A1nauthor=I.+Jeric%C3%B3author=C.+Gonzalvoauthor=J.+M.+Casadoauthor=I.+Vitoriaauthor=J.+Puzoauthor=M.+Pocov%C3%ADauthor=F.+Civeira&title=Serum+chitotriosidase+activity+is+increased+in+subjects+with+atherosclerosis+disease&doi=10.1161%2F01.atv.0000089329.09061.07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Serum chitotriosidase activity is increased in subjects With atherosclerosis disease</span></div><div class="casAuthors">Artieda, Marta; Cenarro, Ana; Ganan, Alberto; Jerico, Ivonne; Gonzalvo, Carmen; Casado, Juan M.; Vitoria, Isabel; Puzo, Jose; Pocovi, Miguel; Civeira, Fernando</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1645-1652</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective- This study was undertaken to analyze the relation between serum activity of chitotriosidase enzyme, a protein synthesized exclusively by activated macrophages, and atherosclerotic lesion extent in subjects with atherothrombotic stroke (ATS) and in subjects with ischemic heart disease (IHD).  Methods and Results- We assayed the serum chitotriosidase activity and a common chitotriosidase gene polymorphism that causes deficiency in chitotriosidase activity in 3 Spanish populations, ATS (n=153), IHD (n=124), and control (n=148) subjects.  Statistical differences were found in serum chitotriosidase activity between ATS (88.1±4.6 nmol/mL · h, P<0.0001) and IHD subjects (79.0±6.3, P=0.002) vs. control group (70.9±5.2).  These obsd. differences were not attributable to a distinct allelic or genotype distribution.  The extension of the atherosclerotic lesion in carotids of ATS subjects was measured by duplex sonog.  Chitotriosidase activities were 66.9±9.6, 88.7±8.3, and 107.7±11.8 for subjects with carotid stenosis ≤30%, 31% to 60%, and >60%, resp.  Statistical differences were obsd. between subjects with major and intermediate stenosis grade compared with subjects with minor stenosis, P=0.005 and P=0.016, resp.  Conclusions- Serum chitotriosidase activity is significantly increased in individuals suffering from atherosclerosis disease and is related to the severity of the atherosclerotic lesion, suggesting a possible role as atherosclerotic extent marker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjfaHPeIda2LVg90H21EOLACvtfcHk0lhHnvz-xChUVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVWrt7o%253D&md5=f060955236f7d0f0c317c335f521eb6f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1161%2F01.atv.0000089329.09061.07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.atv.0000089329.09061.07%26sid%3Dliteratum%253Aachs%26aulast%3DArtieda%26aufirst%3DM.%26aulast%3DCenarro%26aufirst%3DA.%26aulast%3DGa%25C3%25B1%25C3%25A1n%26aufirst%3DA.%26aulast%3DJeric%25C3%25B3%26aufirst%3DI.%26aulast%3DGonzalvo%26aufirst%3DC.%26aulast%3DCasado%26aufirst%3DJ.%2BM.%26aulast%3DVitoria%26aufirst%3DI.%26aulast%3DPuzo%26aufirst%3DJ.%26aulast%3DPocov%25C3%25AD%26aufirst%3DM.%26aulast%3DCiveira%26aufirst%3DF.%26atitle%3DSerum%2520chitotriosidase%2520activity%2520is%2520increased%2520in%2520subjects%2520with%2520atherosclerosis%2520disease%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2003%26volume%3D23%26spage%3D1645%26epage%3D1652%26doi%3D10.1161%2F01.atv.0000089329.09061.07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bargagli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggiorelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Sipio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margollicci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottoli, P.</span></span> <span> </span><span class="NLM_article-title">Human chitotriosidase: a sensitive biomarker of sarcoidosis</span>. <i>J. Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">264</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1007/s10875-012-9754-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1007%2Fs10875-012-9754-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=22878841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslamsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=264-270&author=E.+Bargagliauthor=D.+Bennettauthor=C.+Maggiorelliauthor=P.+Di+Sipioauthor=M.+Margollicciauthor=N.+Bianchiauthor=P.+Rottoli&title=Human+chitotriosidase%3A+a+sensitive+biomarker+of+sarcoidosis&doi=10.1007%2Fs10875-012-9754-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Human Chitotriosidase: a Sensitive Biomarker of Sarcoidosis</span></div><div class="casAuthors">Bargagli, Elena; Bennett, David; Maggiorelli, Claudia; Sipio, Pasquale; Margollicci, Maria; Bianchi, Nicola; Rottoli, Paola</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">264-270</span>CODEN:
                <span class="NLM_cas:coden">JCIMDO</span>;
        ISSN:<span class="NLM_cas:issn">0271-9142</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Background Sarcoidosis is a multisystem granulomatous disease of unknown etiol.  No suitable biomarkers are available to evaluate the evolution of this disease, which still has an unpredictable clin. course.  Some years ago our research group proposed chitotriosidase as a potential biomarker with prognostic value, that however needed to be validated.  Aims and methods The aims of this study were to evaluate the sensitivity and specificity of chitotriosidase in a population of 232 sarcoidosis patients under the observation of our Sarcoidosis Regional Referral Center in Siena and to analyze enzyme concns. in different disease phenotypes (as defined by the recently published COS classification) to define its prognostic value.  Results Serum chitotriosidase concns. were significantly higher in patients than in healthy controls (p < 0.0001) and were directly correlated with ACE levels (r = 0.25, p < 0.0001).  ROC curve anal. revealed 88.6 % sensitivity and 92.8 % specificity.  Enzyme concns. were significantly higher in stage 3 sarcoidosis than in stage 0 (p = 0.02).  The lowest concns. of chitotriosidase were found in untreated patients in remission (COS-1), while the highest enzyme concns. were found in symptomatic patients with persistent disease on steroids and with functional deterioration in the last year (COS-9).  In COS-9 subgroup, chitotriosidase decreased significantly after the increasing of steroid dose or the introduction of a new immunosuppressant therapy (p < 0.01).  Conclusion Chitotriosidase proved to be a biomarker with good sensitivity and specificity that is easily detected in serum.  It can be proposed in clin. practice to identify progressive patients requiring close follow-up, to detect relapses and to evaluate the effects of therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwMt2Gnk9Wo7Vg90H21EOLACvtfcHk0lhHnvz-xChUVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslamsLc%253D&md5=d6b36d32e6fa4c0ec6e54382c1d7e04c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs10875-012-9754-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10875-012-9754-4%26sid%3Dliteratum%253Aachs%26aulast%3DBargagli%26aufirst%3DE.%26aulast%3DBennett%26aufirst%3DD.%26aulast%3DMaggiorelli%26aufirst%3DC.%26aulast%3DDi%2BSipio%26aufirst%3DP.%26aulast%3DMargollicci%26aufirst%3DM.%26aulast%3DBianchi%26aufirst%3DN.%26aulast%3DRottoli%26aufirst%3DP.%26atitle%3DHuman%2520chitotriosidase%253A%2520a%2520sensitive%2520biomarker%2520of%2520sarcoidosis%26jtitle%3DJ.%2520Clin.%2520Immunol.%26date%3D2013%26volume%3D33%26spage%3D264%26epage%3D270%26doi%3D10.1007%2Fs10875-012-9754-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bargagli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margollicci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luddi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikiforakis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grazia Perari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosso, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottoli, P.</span></span> <span> </span><span class="NLM_article-title">Chitotriosidase activity in patients with interstitial lung diseases</span>. <i>Respir. Med.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">2176</span>– <span class="NLM_lpage">2181</span>, <span class="refDoi"> DOI: 10.1016/j.rmed.2007.05.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1016%2Fj.rmed.2007.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=17631992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A280%3ADC%252BD2sritl2ksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=2176-2181&author=E.+Bargagliauthor=M.+Margollicciauthor=A.+Luddiauthor=N.+Nikiforakisauthor=M.+Grazia+Perariauthor=S.+Grossoauthor=A.+Perroneauthor=P.+Rottoli&title=Chitotriosidase+activity+in+patients+with+interstitial+lung+diseases&doi=10.1016%2Fj.rmed.2007.05.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Chitotriosidase activity in patients with interstitial lung diseases</span></div><div class="casAuthors">Bargagli Elena; Margollicci Maria; Luddi Alice; Nikiforakis Nicolaos; Perari Maria Grazia; Grosso Salvatore; Perrone Anna; Rottoli Paola</div><div class="citationInfo"><span class="NLM_cas:title">Respiratory medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2176-81</span>
        ISSN:<span class="NLM_cas:issn">0954-6111</span>.
    </div><div class="casAbstract">BACKGROUND:  In previous papers, we found significantly higher activity of chitotriosidase, a macrophage derived enzyme, in serum and BAL of patients with sarcoidosis, especially in those with progressing disease and lung involvement, than in controls.  Locally and systemically produced chitotriosidase activity was correlated with radiological stage and also with degree of lung infiltration, suggesting that this enzyme may play a role in the pathogenesis of sarcoidosis and may be used as a marker of disease severity.  AIM:  To analyse chitotriosidase activity in serum and bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis and pulmonary fibrosis associated with systemic sclerosis and to compare it with chitotriosidase activity in controls and sarcoidosis patients.  METHODS:  Chitotriosidase activity was determined by a fluorometric assay.  RESULTS:  The results showed that serum chitotriosidase activity was only elevated in sarcoidosis patients; in patients with idiopathic pulmonary fibrosis and pulmonary fibrosis associated with systemic sclerosis it was in the normal range.  On the contrary, in BAL of sarcoidosis and idiopathic pulmonary fibrosis patients the activity was significantly higher than in controls.  CONCLUSION:  Serum chitotriosidase is a potential marker of sarcoidosis severity; it increases in sarcoidosis in relation to radiological stage and degree of lung infiltration.  The increase in chitotriosidase activity in BAL of sarcoidosis and idiopathic pulmonary fibrosis patients suggests that the enzyme could be involved in fibrogenesis in diffuse lung diseases.  Further research is needed to understand the role of chitotriosidase in the pathogenesis of sarcoidosis and its involvement in fibrotic remodelling in certain diffuse lung diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRBlIG9FNlwQGlSCSgBhwJFfW6udTcc2eYxz005tdDE-7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sritl2ksA%253D%253D&md5=03bd6b3a9e02431da7a31eb2a269a279</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.rmed.2007.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.rmed.2007.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DBargagli%26aufirst%3DE.%26aulast%3DMargollicci%26aufirst%3DM.%26aulast%3DLuddi%26aufirst%3DA.%26aulast%3DNikiforakis%26aufirst%3DN.%26aulast%3DGrazia%2BPerari%26aufirst%3DM.%26aulast%3DGrosso%26aufirst%3DS.%26aulast%3DPerrone%26aufirst%3DA.%26aulast%3DRottoli%26aufirst%3DP.%26atitle%3DChitotriosidase%2520activity%2520in%2520patients%2520with%2520interstitial%2520lung%2520diseases%26jtitle%3DRespir.%2520Med.%26date%3D2007%26volume%3D101%26spage%3D2176%26epage%3D2181%26doi%3D10.1016%2Fj.rmed.2007.05.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harlander, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salobir, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zupancic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tercelj, M.</span></span> <span> </span><span class="NLM_article-title">Bronchoalveolar lavage chitotriosidase activity as a biomarker of sarcoidosis</span>. <i>Sarcoidosis Vasc. Diffuse Lung Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">317</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=26847098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A280%3ADC%252BC28notVGmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2016&pages=313-317&author=M.+Harlanderauthor=B.+Salobirauthor=M.+Zupancicauthor=M.+Tercelj&title=Bronchoalveolar+lavage+chitotriosidase+activity+as+a+biomarker+of+sarcoidosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Bronchoalveolar lavage chitotriosidase activity as a biomarker of sarcoidosis</span></div><div class="casAuthors">Harlander Matevz; Salobir Barbara; Zupancic Mirjana; Tercelj Marjeta</div><div class="citationInfo"><span class="NLM_cas:title">Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">313-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Chitotriosidase (CTO) was shown to be a good biomarker of sarcoidosis.  Increased levels in bronchoalveolar lavage fluid (BALF) were reported and associated with more severe forms of the disease.  OBJECTIVES:  The aim of the study was to evaluate the value of CTO in BALF as a routine biomarker of sarcoidosis.  METHODS:  The study included 85 patients in 9 control subjects in whom serum and BALF CTO were measured.  RESULTS:  Significantly higher CTO levels were detected in BALF of sarcoidosis patients than in control subjects (p < 0.001).  There was good correlation between serum and BALF CTO levels in sarcoidosis patients (Spearman's Rho 0.481, p < 0.001).  Serum but not BALF CTO had good correlation with clinical parameters.  Only in a group of patients with BALF CTO above upper normal range there was association of BALF CTO with impaired FVC (p = 0.020) and chest radiograph score (0-2 vs. 3-4, p = 0.016).  CONCLUSIONS:  In comparison to serum CTO no additional benefit of determining CTO in BAL for routine sarcoidosis workup was shown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSExZkDUL6o1WZyxfu64m4ffW6udTcc2eYxz005tdDE-7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28notVGmsw%253D%253D&md5=643c4d3534932b395e05dd5fea33fd23</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarlander%26aufirst%3DM.%26aulast%3DSalobir%26aufirst%3DB.%26aulast%3DZupancic%26aufirst%3DM.%26aulast%3DTercelj%26aufirst%3DM.%26atitle%3DBronchoalveolar%2520lavage%2520chitotriosidase%2520activity%2520as%2520a%2520biomarker%2520of%2520sarcoidosis%26jtitle%3DSarcoidosis%2520Vasc.%2520Diffuse%2520Lung%2520Dis.%26date%3D2016%26volume%3D32%26spage%3D313%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hector, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chotirmall, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavelle, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirković, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eichler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ralhan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berenbrinker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mack, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ensenauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riethmüller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graepler-Mainka, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElvaney, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartl, D.</span></span> <span> </span><span class="NLM_article-title">Chitinase activation in patients with fungus-associated cystic fibrosis lung disease</span>. <i>J. Allergy Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">1183</span>, <span class="refDoi"> DOI: 10.1016/j.jaci.2016.01.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1016%2Fj.jaci.2016.01.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=27056270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A280%3ADC%252BC28fnvFSgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=1183&author=A.+Hectorauthor=S.+H.+Chotirmallauthor=G.+M.+Lavelleauthor=B.+Mirkovi%C4%87author=D.+Horanauthor=L.+Eichlerauthor=M.+Mezgerauthor=A.+Singhauthor=A.+Ralhanauthor=S.+Berenbrinkerauthor=I.+Mackauthor=R.+Ensenauerauthor=J.+Riethm%C3%BCllerauthor=U.+Graepler-Mainkaauthor=M.+A.+Murrayauthor=M.+Grieseauthor=N.+G.+McElvaneyauthor=D.+Hartl&title=Chitinase+activation+in+patients+with+fungus-associated+cystic+fibrosis+lung+disease&doi=10.1016%2Fj.jaci.2016.01.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Chitinase activation in patients with fungus-associated cystic fibrosis lung disease</span></div><div class="casAuthors">Hector Andreas; Eichler Laura; Mezger Markus; Singh Anurag; Ralhan Anjai; Berenbrinker Sina; Riethmuller Joachim; Graepler-Mainka Ute; Chotirmall Sanjay H; Lavelle Gillian M; Mirkovic Bojana; Horan Deirdre; Murray Michelle A; McElvaney N Gerry; Mack Ines; Ensenauer Regina; Griese Matthias; Hartl Dominik</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of allergy and clinical immunology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1183-1189.e4</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Chitinases have recently gained attention in the field of pulmonary diseases, particularly in asthma and chronic obstructive pulmonary disease, but their potential role in patients with cystic fibrosis (CF)-associated lung disease remains unclear.  OBJECTIVE:  The aim of this study was to assess chitinase activity systemically and in the airways of patients with CF and asthma compared with healthy subjects.  Additionally, we assessed factors that regulate chitinase activity within the lungs of patients with CF.  METHODS:  Chitinase activities were quantified in serum and bronchoalveolar lavage fluid from patients with CF, asthmatic patients, and healthy control subjects.  Mechanistically, the role of CF airway proteases and genetic chitinase deficiency was assessed.  RESULTS:  Chitinase activity was systemically increased in patients with CF compared with that in healthy control subjects and asthmatic patients.  Further stratification showed that chitinase activity was enhanced in patients with CF colonized with Candida albicans compared with that in noncolonized patients.  CF proteases degraded chitinases in the airway microenvironment of patients with CF.  Genetic chitinase deficiency was associated with C albicans colonization in patients with CF.  CONCLUSION:  Patients with CF have enhanced chitinase activation associated with C albicans colonization.  Therefore chitinases might represent a novel biomarker and therapeutic target for CF-associated fungal disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnkbMAaoN8wcScOqQTSkOffW6udTcc2eZKxG57NDH2A7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fnvFSgtQ%253D%253D&md5=22cf21a34fd46a73dd75274daf38c3c3</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2016.01.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2016.01.031%26sid%3Dliteratum%253Aachs%26aulast%3DHector%26aufirst%3DA.%26aulast%3DChotirmall%26aufirst%3DS.%2BH.%26aulast%3DLavelle%26aufirst%3DG.%2BM.%26aulast%3DMirkovi%25C4%2587%26aufirst%3DB.%26aulast%3DHoran%26aufirst%3DD.%26aulast%3DEichler%26aufirst%3DL.%26aulast%3DMezger%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DRalhan%26aufirst%3DA.%26aulast%3DBerenbrinker%26aufirst%3DS.%26aulast%3DMack%26aufirst%3DI.%26aulast%3DEnsenauer%26aufirst%3DR.%26aulast%3DRiethm%25C3%25BCller%26aufirst%3DJ.%26aulast%3DGraepler-Mainka%26aufirst%3DU.%26aulast%3DMurray%26aufirst%3DM.%2BA.%26aulast%3DGriese%26aufirst%3DM.%26aulast%3DMcElvaney%26aufirst%3DN.%2BG.%26aulast%3DHartl%26aufirst%3DD.%26atitle%3DChitinase%2520activation%2520in%2520patients%2520with%2520fungus-associated%2520cystic%2520fibrosis%2520lung%2520disease%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2016%26volume%3D138%26spage%3D1183%26doi%3D10.1016%2Fj.jaci.2016.01.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herzog, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahangari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulati, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feghali-Bostwick, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varga, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elias, J. A.</span></span> <span> </span><span class="NLM_article-title">Chitinase 1 is a biomarker for and therapeutic target in scleroderma-associated interstitial lung disease that augments TGF-beta1 signaling</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>189</i></span>,  <span class="NLM_fpage">2635</span>– <span class="NLM_lpage">2644</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1201115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.4049%2Fjimmunol.1201115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=22826322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1aksrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2012&pages=2635-2644&author=C.+G.+Leeauthor=E.+L.+Herzogauthor=F.+Ahangariauthor=Y.+Zhouauthor=M.+Gulatiauthor=C.-M.+Leeauthor=X.+Pengauthor=C.+Feghali-Bostwickauthor=S.+A.+Jimenezauthor=J.+Vargaauthor=J.+A.+Elias&title=Chitinase+1+is+a+biomarker+for+and+therapeutic+target+in+scleroderma-associated+interstitial+lung+disease+that+augments+TGF-beta1+signaling&doi=10.4049%2Fjimmunol.1201115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Chitinase 1 Is a Biomarker for and Therapeutic Target in Scleroderma-Associated Interstitial Lung Disease That Augments TGF-β1 Signaling</span></div><div class="casAuthors">Lee, Chun Geun; Herzog, Erica L.; Ahangari, Farida; Zhou, Yang; Gulati, Mridu; Lee, Chang-Min; Peng, Xueyan; Feghali-Bostwick, Carol; Jimenez, Sergio A.; Varga, John; Elias, Jack A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">189</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2635-2644</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Interstitial lung disease (ILD) with pulmonary fibrosis is an important manifestation in systemic sclerosis (SSc, scleroderma) where it portends a poor prognosis.  However, biomarkers that predict the development and or severity of SSc-ILD have not been validated, and the pathogenetic mechanisms that engender this pulmonary response are poorly understood.  In this study, we demonstrate in two different patient cohorts that the levels of chitotriosidase (Chit1) bioactivity and protein are significantly increased in the circulation and lungs of SSc patients compared with demog. matched controls.  We also demonstrate that, compared with patients without lung involvement, patients with ILD show high levels of circulating Chit1 activity that correlate with disease severity.  Murine modeling shows that in comparison with wild-type mice, bleomycin-induced pulmonary fibrosis was significantly reduced in Chit1-/- mice and significantly enhanced in lungs from Chit1 overexpressing transgenic animals.  In vitro studies also demonstrated that Chit1 interacts with TGF-β1 to augment fibroblast TGF-β receptors 1 and 2 expression and TGF-β-induced Smad and MAPK/ERK activation.  These studies indicate that Chit1 is potential biomarker for ILD in SSc and a therapeutic target in SSc-assocd. lung fibrosis and demonstrate that Chit1 augments TGF-β1 effects by increasing receptor expression and canonical and noncanonical TGF-β1 signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLePPAHVnYN7Vg90H21EOLACvtfcHk0lj7FVn6V-JLcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1aksrfN&md5=43ba51fe854b550a13ab0c90ba9ba084</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1201115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1201115%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.%2BG.%26aulast%3DHerzog%26aufirst%3DE.%2BL.%26aulast%3DAhangari%26aufirst%3DF.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DGulati%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DC.-M.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DFeghali-Bostwick%26aufirst%3DC.%26aulast%3DJimenez%26aufirst%3DS.%2BA.%26aulast%3DVarga%26aufirst%3DJ.%26aulast%3DElias%26aufirst%3DJ.%2BA.%26atitle%3DChitinase%25201%2520is%2520a%2520biomarker%2520for%2520and%2520therapeutic%2520target%2520in%2520scleroderma-associated%2520interstitial%2520lung%2520disease%2520that%2520augments%2520TGF-beta1%2520signaling%26jtitle%3DJ.%2520Immunol.%26date%3D2012%26volume%3D189%26spage%3D2635%26epage%3D2644%26doi%3D10.4049%2Fjimmunol.1201115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenbarth, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elias, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eynon, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flavell, R. A.</span></span> <span> </span><span class="NLM_article-title">AMCase is a crucial regulator of type 2 immune responses to inhaled house dust mites</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">E2891</span>– <span class="NLM_lpage">E2899</span>, <span class="refDoi"> DOI: 10.1073/pnas.1507393112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1073%2Fpnas.1507393112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=26038565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosVKrtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=E2891-E2899&author=L.+K.+Kimauthor=R.+Moritaauthor=Y.+Kobayashiauthor=S.+C.+Eisenbarthauthor=C.+G.+Leeauthor=J.+Eliasauthor=E.+E.+Eynonauthor=R.+A.+Flavell&title=AMCase+is+a+crucial+regulator+of+type+2+immune+responses+to+inhaled+house+dust+mites&doi=10.1073%2Fpnas.1507393112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">AMCase is a crucial regulator of type 2 immune responses to inhaled house dust mites</span></div><div class="casAuthors">Kim, Lark Kyun; Morita, Rimpei; Kobayashi, Yasushi; Eisenbarth, Stephanie C.; Lee, Chun Geun; Elias, Jack; Eynon, Elizabeth E.; Flavell, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">E2891-E2899</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Chitinases are enzymes that cleave chitin, a component of the exoskeleton of many organisms including the house dust mite (HDM).  Here we show that knockin mice expressing an enzymically inactive acidic mammalian chitinase (AMCase), the dominant true chitinase in mouse lung, showed enhanced type 2 immune responses to inhaled HDM.  We found that uncleaved chitin promoted the release of IL-33, whereas cleaved chitin could be phagocytosed and could induce the activation of caspase-1 and subsequent activation of caspase-7; this results in the resoln. of type 2 immune responses, probably by promoting the inactivation of IL-33.  These data suggest that AMCase is a crucial regulator of type 2 immune responses to inhaled chitin-contg. aeroallergens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqexp0_1nUUdLVg90H21EOLACvtfcHk0lj7FVn6V-JLcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosVKrtLk%253D&md5=bfae4eaba25d18054d9a9664f91d880d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1507393112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1507393112%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DL.%2BK.%26aulast%3DMorita%26aufirst%3DR.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DEisenbarth%26aufirst%3DS.%2BC.%26aulast%3DLee%26aufirst%3DC.%2BG.%26aulast%3DElias%26aufirst%3DJ.%26aulast%3DEynon%26aufirst%3DE.%2BE.%26aulast%3DFlavell%26aufirst%3DR.%2BA.%26atitle%3DAMCase%2520is%2520a%2520crucial%2520regulator%2520of%2520type%25202%2520immune%2520responses%2520to%2520inhaled%2520house%2520dust%2520mites%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2015%26volume%3D112%26spage%3DE2891%26epage%3DE2899%26doi%3D10.1073%2Fpnas.1507393112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Silva, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dela Cruz, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahangari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takyar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elias, J. A.</span></span> <span> </span><span class="NLM_article-title">Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury</span>. <i>Annu. Rev. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">479</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1146/annurev-physiol-012110-142250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1146%2Fannurev-physiol-012110-142250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=21054166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVKjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2011&pages=479-501&author=C.+G.+Leeauthor=C.+A.+Da+Silvaauthor=C.+S.+Dela+Cruzauthor=F.+Ahangariauthor=B.+Maauthor=M.-J.+Kangauthor=C.-H.+Heauthor=S.+Takyarauthor=J.+A.+Elias&title=Role+of+chitin+and+chitinase%2Fchitinase-like+proteins+in+inflammation%2C+tissue+remodeling%2C+and+injury&doi=10.1146%2Fannurev-physiol-012110-142250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury</span></div><div class="casAuthors">Lee, Chun Geun; Da Silva, Carla A.; Dela Cruz, Charles S.; Ahangari, Farida; Ma, Bing; Kang, Min-Jong; He, Chuan-Hua; Takyar, Seyedtaghi; Elias, Jack A.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Physiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">479-501</span>CODEN:
                <span class="NLM_cas:coden">ARPHAD</span>;
        ISSN:<span class="NLM_cas:issn">0066-4278</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The 18 glycosyl hydrolase family of chitinases is an ancient gene family that is widely expressed from prokaryotes to eukaryotes.  In mammals, despite the absence of endogenous chitin, a no. of chitinases and chitinase-like proteins (C/CLPs) were identified.  However, their roles have only recently begun to be elucidated.  Acidic mammalian chitinase (AMCase) inhibits chitin-induced innate inflammation; augments chitin-free, allergen-induced Th2 inflammation; and mediates effector functions of IL-13.  The CLPs BRP-39/YKL-40 (also termed chitinase 3-like 1) inhibit oxidant-induced lung injury, augments adaptive Th2 immunity, regulates apoptosis, stimulates alternative macrophage activation, and contributes to fibrosis and wound healing.  In accord with these findings, levels of YKL-40 in the lung and serum are increased in asthma and other inflammatory and remodeling disorders and often correlate with disease severity.  Our understanding of the roles of C/CLPs in inflammation, tissue remodeling, and tissue injury in health and disease is reviewed below.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowzHNOTFA9GrVg90H21EOLACvtfcHk0lj7FVn6V-JLcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVKjurg%253D&md5=b43e39234c46e82a305f8052123ab996</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1146%2Fannurev-physiol-012110-142250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-physiol-012110-142250%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.%2BG.%26aulast%3DDa%2BSilva%26aufirst%3DC.%2BA.%26aulast%3DDela%2BCruz%26aufirst%3DC.%2BS.%26aulast%3DAhangari%26aufirst%3DF.%26aulast%3DMa%26aufirst%3DB.%26aulast%3DKang%26aufirst%3DM.-J.%26aulast%3DHe%26aufirst%3DC.-H.%26aulast%3DTakyar%26aufirst%3DS.%26aulast%3DElias%26aufirst%3DJ.%2BA.%26atitle%3DRole%2520of%2520chitin%2520and%2520chitinase%252Fchitinase-like%2520proteins%2520in%2520inflammation%252C%2520tissue%2520remodeling%252C%2520and%2520injury%26jtitle%3DAnnu.%2520Rev.%2520Physiol.%26date%3D2011%26volume%3D73%26spage%3D479%26epage%3D501%26doi%3D10.1146%2Fannurev-physiol-012110-142250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mack, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hector, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballbach, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlhaufl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mall, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartl, D.</span></span> <span> </span><span class="NLM_article-title">The role of chitin, chitinases, and chitinase-like proteins in pediatric lung diseases</span>. <i>Mol. Cell. Pediatr.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">3</span>, <span class="refDoi"> DOI: 10.1186/s40348-015-0014-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1186%2Fs40348-015-0014-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=26542293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A280%3ADC%252BC28zpslWisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2015&pages=3&author=I.+Mackauthor=A.+Hectorauthor=M.+Ballbachauthor=J.+Kohlhauflauthor=K.+J.+Fuchsauthor=A.+Weberauthor=M.+A.+Mallauthor=D.+Hartl&title=The+role+of+chitin%2C+chitinases%2C+and+chitinase-like+proteins+in+pediatric+lung+diseases&doi=10.1186%2Fs40348-015-0014-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The role of chitin, chitinases, and chitinase-like proteins in pediatric lung diseases</span></div><div class="casAuthors">Mack Ines; Hector Andreas; Ballbach Marlene; Kohlhaufl Julius; Hartl Dominik; Fuchs Katharina J; Weber Alexander; Mall Marcus A</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and cellular pediatrics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3</span>
        ISSN:<span class="NLM_cas:issn">2194-7791</span>.
    </div><div class="casAbstract">Chitin, after cellulose, the second most abundant biopolymer on earth, is a key component of insects, fungi, and house-dust mites.  Lower life forms are endowed with chitinases to defend themselves against chitin-bearing pathogens.  Unexpectedly, humans were also found to express chitinases as well as chitinase-like proteins that modulate immune responses.  Particularly, increased levels of the chitinase-like protein YKL-40 have been associated with severe asthma, cystic fibrosis, and other inflammatory disease conditions.  Here, we summarize and discuss the potential role of chitin, chitinases, and chitinase-like proteins in pediatric lung diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRevA87LZB6CApJitSxOdIlfW6udTcc2ebLjEae2dZgZrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zpslWisQ%253D%253D&md5=9b4b0676b4c22374fba9c8bceb92d004</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1186%2Fs40348-015-0014-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40348-015-0014-6%26sid%3Dliteratum%253Aachs%26aulast%3DMack%26aufirst%3DI.%26aulast%3DHector%26aufirst%3DA.%26aulast%3DBallbach%26aufirst%3DM.%26aulast%3DKohlhaufl%26aufirst%3DJ.%26aulast%3DFuchs%26aufirst%3DK.%2BJ.%26aulast%3DWeber%26aufirst%3DA.%26aulast%3DMall%26aufirst%3DM.%2BA.%26aulast%3DHartl%26aufirst%3DD.%26atitle%3DThe%2520role%2520of%2520chitin%252C%2520chitinases%252C%2520and%2520chitinase-like%2520proteins%2520in%2520pediatric%2520lung%2520diseases%26jtitle%3DMol.%2520Cell.%2520Pediatr.%26date%3D2015%26volume%3D2%26spage%3D3%26doi%3D10.1186%2Fs40348-015-0014-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boot, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blommaart, E. F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swart, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghauharali-van
der Vlugt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bijl, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moe, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Place, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aerts, J. M. F. G.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel acidic mammalian chitinase distinct from chitotriosidase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">6770</span>– <span class="NLM_lpage">6778</span>, <span class="refDoi"> DOI: 10.1074/jbc.m009886200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1074%2Fjbc.m009886200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=11085997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslSgsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=6770-6778&author=R.+G.+Bootauthor=E.+F.+C.+Blommaartauthor=E.+Swartauthor=K.+Ghauharali-van%0Ader+Vlugtauthor=N.+Bijlauthor=C.+Moeauthor=A.+Placeauthor=J.+M.+F.+G.+Aerts&title=Identification+of+a+novel+acidic+mammalian+chitinase+distinct+from+chitotriosidase&doi=10.1074%2Fjbc.m009886200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel acidic mammalian chitinase distinct from chitotriosidase</span></div><div class="casAuthors">Boot, Rolf G.; Blommaart, Edward F. C.; Swart, Erwin; Ghuharali-Van der Vlugt, Karen; Bijl, Nora; Moe, Cassandra; Place, Allen; Aerts, Johannes M. F. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">6770-6778</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Chitinases are ubiquitous chitin-fragmenting hydrolases.  Recently we discovered the first human chitinase, named chitotriosidase, that is specifically expressed by phagocytes.  We here report the identification, purifn., and subsequent cloning of a second mammalian chitinase.  This enzyme is characterized by an acidic isoelec. point and therefore named acidic mammalian chitinase (AMCase).  In rodents and man the enzyme is relatively abundant in the gastrointestinal tract and is found to a lesser extent in the lung.  Like chitotriosidase, AMCase is synthesized as a 50-kDa protein contg. a 39-kDa N-terminal catalytic domain, a hinge region, and a C-terminal chitin-binding domain.  In contrast to chitotriosidase, the enzyme is extremely acid stable and shows a distinct second pH optimum around pH 2.  AMCase is capable of cleaving artificial chitin-like substrates as well as crab shell chitin and chitin as present in the fungal cell wall.  Our study has revealed the existence of a chitinolytic enzyme in the gastrointestinal tract and lung that may play a role in digestion and/or defense.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK9zza8yUykLVg90H21EOLACvtfcHk0lj6EtGYLJsmTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslSgsrs%253D&md5=cb1d31ccbf699384de3cb00105259993</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m009886200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m009886200%26sid%3Dliteratum%253Aachs%26aulast%3DBoot%26aufirst%3DR.%2BG.%26aulast%3DBlommaart%26aufirst%3DE.%2BF.%2BC.%26aulast%3DSwart%26aufirst%3DE.%26aulast%3DGhauharali-van%2Bder%2BVlugt%26aufirst%3DK.%26aulast%3DBijl%26aufirst%3DN.%26aulast%3DMoe%26aufirst%3DC.%26aulast%3DPlace%26aufirst%3DA.%26aulast%3DAerts%26aufirst%3DJ.%2BM.%2BF.%2BG.%26atitle%3DIdentification%2520of%2520a%2520novel%2520acidic%2520mammalian%2520chitinase%2520distinct%2520from%2520chitotriosidase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D6770%26epage%3D6778%26doi%3D10.1074%2Fjbc.m009886200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garth, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackel, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeder, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackburn, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunaway, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matalon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steele, C.</span></span> <span> </span><span class="NLM_article-title">Acidic mammalian chitinase negatively affects immune responses during acute and chronic Aspergillus fumigatus exposure</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">e00944</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1128/IAI.00944-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1128%2FIAI.00944-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=29712728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvV2ms7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2018&pages=e00944-17&author=J.+M.+Garthauthor=J.+J.+Mackelauthor=K.+M.+Reederauthor=J.+P.+Blackburnauthor=C.+W.+Dunawayauthor=Z.+Yuauthor=S.+Matalonauthor=L.+Fitzauthor=C.+Steele&title=Acidic+mammalian+chitinase+negatively+affects+immune+responses+during+acute+and+chronic+Aspergillus+fumigatus+exposure&doi=10.1128%2FIAI.00944-17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Acidic mammalian chitinase negatively affects immune responses during acute and chronic Aspergillus fumigatus exposure</span></div><div class="casAuthors">Garth, Jaleesa M.; Mackel, Joseph J.; Reeder, Kristen M.; Blackburn, Jonathan P.; Dunaway, Chad W.; Yu, Zhihong; Matalon, Sadis; Fitz, Lori; Steele, Chad</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e00944-17/1-e00944-17/14</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">1098-5522</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Here, we detd. the impact of acidic mammalian chitinase (AMCase) (Chia) deficiency on host defense during acute exposure to the fungal pathogen Aspergillus fumigatus as well as its contribution to A. fumigatus-assocd. allergic asthma.  We demonstrate that chitin in the fungal cell wall was detected at low levels in A. fumigatus conidia, which emerged at the highest level during hyphal transition.  In response to acute A. fumigatus challenge, Chia-/- mice unexpectedly demonstrated lower A. fumigatus lung burdens at 2 days postchallenge.  The lower fungal burden correlated with decreased lung interleukin-33 (IL-33) levels yet increased IL-1β and prostaglandin E2 (PGE2) prodn., a phenotype that we reported previously to promote the induction of IL-17A and IL-22.  During chronic A. fumigatus exposure, AMCase deficiency resulted in lower dynamic and airway lung resistance than in wild-type mice.  Improved lung physiol. correlated with attenuated levels of the proallergic chemokines CCL17 and CCL22.  Surprisingly, examn. of inflammatory responses during chronic exposure revealed attenuated IL-17A and IL-22 responses, but not type 2 responses, in the absence of AMCase.  Collectively, these data suggest that AMCase functions as a neg. regulator of immune responses during acute fungal exposure and is a contributor to fungal asthma severity, putatively via the induction of proinflammatory responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCMQwKBOCcrLVg90H21EOLACvtfcHk0lj6EtGYLJsmTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvV2ms7%252FF&md5=1650a55df583e4c508e3b4e7e28d5561</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1128%2FIAI.00944-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.00944-17%26sid%3Dliteratum%253Aachs%26aulast%3DGarth%26aufirst%3DJ.%2BM.%26aulast%3DMackel%26aufirst%3DJ.%2BJ.%26aulast%3DReeder%26aufirst%3DK.%2BM.%26aulast%3DBlackburn%26aufirst%3DJ.%2BP.%26aulast%3DDunaway%26aufirst%3DC.%2BW.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DMatalon%26aufirst%3DS.%26aulast%3DFitz%26aufirst%3DL.%26aulast%3DSteele%26aufirst%3DC.%26atitle%3DAcidic%2520mammalian%2520chitinase%2520negatively%2520affects%2520immune%2520responses%2520during%2520acute%2520and%2520chronic%2520Aspergillus%2520fumigatus%2520exposure%26jtitle%3DInfect.%2520Immun.%26date%3D2018%26volume%3D86%26spage%3De00944%26epage%3D17%26doi%3D10.1128%2FIAI.00944-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mazur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olczak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koralewski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czestkowski, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jedrzejczak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golab, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzwonek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dymek, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sklepkiewicz, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagozdzon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noonan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahboubi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheeler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckett, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hungerford, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podjarny, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitschler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cousido-Siah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golebiowski, A.</span></span> <span> </span><span class="NLM_article-title">Targeting Acidic Mammalian chitinase Is Effective in Animal Model of Asthma</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">695</span>– <span class="NLM_lpage">710</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01051</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01051" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVCms7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=695-710&author=M.+Mazurauthor=J.+Olczakauthor=S.+Olejniczakauthor=R.+Koralewskiauthor=W.+Czestkowskiauthor=A.+Jedrzejczakauthor=J.+Golabauthor=K.+Dzwonekauthor=B.+Dymekauthor=P.+L.+Sklepkiewiczauthor=A.+Zagozdzonauthor=T.+Noonanauthor=K.+Mahboubiauthor=B.+Conwayauthor=R.+Sheelerauthor=P.+Beckettauthor=W.+M.+Hungerfordauthor=A.+Podjarnyauthor=A.+Mitschlerauthor=A.+Cousido-Siahauthor=F.+Fadelauthor=A.+Golebiowski&title=Targeting+Acidic+Mammalian+chitinase+Is+Effective+in+Animal+Model+of+Asthma&doi=10.1021%2Facs.jmedchem.7b01051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Acidic Mammalian chitinase Is Effective in Animal Model of Asthma</span></div><div class="casAuthors">Mazur, Marzena; Olczak, Jacek; Olejniczak, Sylwia; Koralewski, Robert; Czestkowski, Wojciech; Jedrzejczak, Anna; Golab, Jakub; Dzwonek, Karolina; Dymek, Barbara; Sklepkiewicz, Piotr L.; Zagozdzon, Agnieszka; Noonan, Tom; Mahboubi, Keyvan; Conway, Bruce; Sheeler, Ryan; Beckett, Paul; Hungerford, William M.; Podjarny, Alberto; Mitschler, Andre; Cousido-Siah, Alexandra; Fadel, Firas; Golebiowski, Adam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">695-710</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This article highlights the authors' work toward the identification of a potent, selective, and efficacious acidic mammalian chitinase (AMCase) inhibitor.  Rational design, guided by x-ray anal. of several inhibitors bound to human chitotriosidase (hCHIT1), led to the identification of compd. 7f (1-(3-amino-1H-1,2,4-triazol-5-yl)-N-(4-chlorophenethyl)-N-isobutylpiperidin-4-amine) as a highly potent AMCase inhibitor (IC50 values of 14 and 19 nM against human and mouse enzyme, resp.) and selective (>150× against mCHIT1) with very good PK properties.  This compd. dosed once daily at 30 mg/kg po showed significant anti-inflammatory efficacy in HDM-induced allergic airway inflammation in mice, reducing inflammatory cell influx in the BALF and total IgE concn. in plasma, which correlated with decrease of chitinolytic activity.  Therapeutic efficacy of compd. 7f in the clin. relevant aero-allergen-induced acute asthma model in mice provides a rationale for developing AMCase inhibitor for the treatment of asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9n2hO0hKVarVg90H21EOLACvtfcHk0ljTRxm_JR_5cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVCms7nJ&md5=d93c7add7d10a66f03419a6c7fe59bfc</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01051%26sid%3Dliteratum%253Aachs%26aulast%3DMazur%26aufirst%3DM.%26aulast%3DOlczak%26aufirst%3DJ.%26aulast%3DOlejniczak%26aufirst%3DS.%26aulast%3DKoralewski%26aufirst%3DR.%26aulast%3DCzestkowski%26aufirst%3DW.%26aulast%3DJedrzejczak%26aufirst%3DA.%26aulast%3DGolab%26aufirst%3DJ.%26aulast%3DDzwonek%26aufirst%3DK.%26aulast%3DDymek%26aufirst%3DB.%26aulast%3DSklepkiewicz%26aufirst%3DP.%2BL.%26aulast%3DZagozdzon%26aufirst%3DA.%26aulast%3DNoonan%26aufirst%3DT.%26aulast%3DMahboubi%26aufirst%3DK.%26aulast%3DConway%26aufirst%3DB.%26aulast%3DSheeler%26aufirst%3DR.%26aulast%3DBeckett%26aufirst%3DP.%26aulast%3DHungerford%26aufirst%3DW.%2BM.%26aulast%3DPodjarny%26aufirst%3DA.%26aulast%3DMitschler%26aufirst%3DA.%26aulast%3DCousido-Siah%26aufirst%3DA.%26aulast%3DFadel%26aufirst%3DF.%26aulast%3DGolebiowski%26aufirst%3DA.%26atitle%3DTargeting%2520Acidic%2520Mammalian%2520chitinase%2520Is%2520Effective%2520in%2520Animal%2520Model%2520of%2520Asthma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D695%26epage%3D710%26doi%3D10.1021%2Facs.jmedchem.7b01051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Corman, M. L.</span>; <span class="NLM_string-name">Hungerford, W. M.</span>; <span class="NLM_string-name">Golebiowski, A.</span>; <span class="NLM_string-name">Beckett, R. P.</span>; <span class="NLM_string-name">Mazur, M.</span>; <span class="NLM_string-name">Olejniczak, S.</span>; <span class="NLM_string-name">Olczak, J.</span></span> <span> </span><span class="NLM_article-title">Substituted Amino Triazoles</span>. WO Patent <span class="NLM_patent">WO 2015/095701 A1</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=M.+L.+Corman&author=W.+M.+Hungerford&author=A.+Golebiowski&author=R.+P.+Beckett&author=M.+Mazur&author=S.+Olejniczak&author=J.+Olczak&title=Substituted+Amino+Triazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCorman%26aufirst%3DM.%2BL.%26atitle%3DSubstituted%2520Amino%2520Triazoles%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, M.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, C.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, T.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.-R.</span></span> <span> </span><span class="NLM_article-title">Inhibition of acidic mammalian chitinase by RNA interference suppresses ovalbumin-sensitized allergic asthma</span>. <i>Hum. Gene Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1597</span>– <span class="NLM_lpage">1606</span>, <span class="refDoi"> DOI: 10.1089/hum.2008.092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1089%2Fhum.2008.092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=19548841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1WhtL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=1597-1606&author=C.-J.+Yangauthor=Y.-K.+Liuauthor=C.-L.+Liuauthor=C.-N.+Shenauthor=M.-L.+Kuoauthor=C.-C.+Suauthor=C.-P.+Tsengauthor=T.-C.+Yenauthor=C.-R.+Shen&title=Inhibition+of+acidic+mammalian+chitinase+by+RNA+interference+suppresses+ovalbumin-sensitized+allergic+asthma&doi=10.1089%2Fhum.2008.092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of acidic mammalian chitinase by RNA interference suppresses ovalbumin-sensitized allergic asthma</span></div><div class="casAuthors">Yang, Ching-Jen; Liu, Yu-Kuo; Liu, Chao-Lin; Shen, Chia-Ning; Kuo, Ming-Ling; Su, Chien-Chang; Tseng, Ching-Ping; Yen, Tzu-Chen; Shen, Chia-Rui</div><div class="citationInfo"><span class="NLM_cas:title">Human Gene Therapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1597-1606</span>CODEN:
                <span class="NLM_cas:coden">HGTHE3</span>;
        ISSN:<span class="NLM_cas:issn">1043-0342</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Asthma, a chronic helper T cell type 2-mediated inflammatory disease, is characterized by airway hyperresponsiveness and inflammation.  Growing evidence suggests that increased expression of acidic mammalian chitinase (AMCase) may play a role in the pathogenesis of asthma.  In the present study, we sought to develop an RNA interference approach to suppress allergic asthma in mice through silencing of AMCase expression.  Mice sensitized with ovalbumin (OVA) were intratracheally administered a recombinant adeno-assocd. virus expressing short hairpin RNA (rAAV-shRNA) against AMCase.  In OVA-sensitized mice, the development of allergic symptoms was significantly assocd. with elevated AMCase expression.  After administration of rAAV-shRNA, there was a significant redn. of AMCase expression in the lung and in bronchoalveolar lavage fluid (BALF) cells of sensitized mice.  Sensitized mice receiving rAAV-shRNA showed a significant improvement in allergic symptoms, including airway hyperresponsiveness (AHR), eosinophil infiltration, eotaxin, interleukin-13 secretion in BALF, and serum OVA-specific IgE level.  Our data suggest the hyperexpression of AMCase in asthma can be suppressed by rAAV-mediated shRNA.  Silencing AMCase expression by shRNA may be a promising therapeutic strategy in asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyU9pcjbg2rLVg90H21EOLACvtfcHk0ljTRxm_JR_5cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1WhtL%252FI&md5=ad60a3b1cdd8089e340a15455e19747c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1089%2Fhum.2008.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fhum.2008.092%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DC.-J.%26aulast%3DLiu%26aufirst%3DY.-K.%26aulast%3DLiu%26aufirst%3DC.-L.%26aulast%3DShen%26aufirst%3DC.-N.%26aulast%3DKuo%26aufirst%3DM.-L.%26aulast%3DSu%26aufirst%3DC.-C.%26aulast%3DTseng%26aufirst%3DC.-P.%26aulast%3DYen%26aufirst%3DT.-C.%26aulast%3DShen%26aufirst%3DC.-R.%26atitle%3DInhibition%2520of%2520acidic%2520mammalian%2520chitinase%2520by%2520RNA%2520interference%2520suppresses%2520ovalbumin-sensitized%2520allergic%2520asthma%26jtitle%3DHum.%2520Gene%2520Ther.%26date%3D2009%26volume%3D20%26spage%3D1597%26epage%3D1606%26doi%3D10.1089%2Fhum.2008.092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vannella, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramalingam, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Queiroz
Prado, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciurba, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barron, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borthwick, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mentink-Kane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheever, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitz, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, J. F.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynn, T. A.</span></span> <span> </span><span class="NLM_article-title">Acidic chitinase primes the protective immune response to gastrointestinal nematodes</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">538</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1038/ni.3417</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1038%2Fni.3417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=27043413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC28Xltleisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=538-544&author=K.+M.+Vannellaauthor=T.+R.+Ramalingamauthor=K.+M.+Hartauthor=R.+de+Queiroz%0APradoauthor=J.+Sciurbaauthor=L.+Barronauthor=L.+A.+Borthwickauthor=A.+D.+Smithauthor=M.+Mentink-Kaneauthor=S.+Whiteauthor=R.+W.+Thompsonauthor=A.+W.+Cheeverauthor=K.+Bockauthor=I.+Mooreauthor=L.+J.+Fitzauthor=J.+F.+Urbanauthor=T.+A.+Wynn&title=Acidic+chitinase+primes+the+protective+immune+response+to+gastrointestinal+nematodes&doi=10.1038%2Fni.3417"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Acidic chitinase primes the protective immune response to gastrointestinal nematodes</span></div><div class="casAuthors">Vannella, Kevin M.; Ramalingam, Thirumalai R.; Hart, Kevin M.; Prado, Rafael de Queiroz; Sciurba, Joshua; Barron, Luke; Borthwick, Lee A.; Smith, Allen D.; Mentink-Kane, Margaret; White, Sandra; Thompson, Robert W.; Cheever, Allen W.; Bock, Kevin; Moore, Ian; Fitz, Lori J.; Urban, Joseph F., Jr.; Wynn, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">538-544</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Acidic mammalian chitinase (AMCase) is known to be induced by allergens and helminths, yet its role in immunity is unclear.  Using AMCase-deficient mice, we show that AMCase deficiency reduced the no. of group 2 innate lymphoid cells during allergen challenge but was not required for establishment of type 2 inflammation in the lung in response to allergens or helminths.  In contrast, AMCase-deficient mice showed a profound defect in type 2 immunity following infection with the chitin-contg. gastrointestinal nematodes Nippostrongylus brasiliensis and Heligmosomoides polygyrus bakeri.  The impaired immunity was assocd. with reduced mucus prodn. and decreased intestinal expression of the signature type 2 response genes Il13, Chil3, Retnlb, and Clca1.  CD103+ dendritic cells, which regulate T cell homing, were also reduced in mesenteric lymph nodes of infected AMCase-deficient mice.  Thus, AMCase functions as a crit. initiator of protective type 2 responses to intestinal nematodes but is largely dispensable for allergic responses in the lung.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr84VjQEDBCdLVg90H21EOLACvtfcHk0liHzzSFhFmQ_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xltleisb8%253D&md5=303a01b3d17006ba0848a7c1c67ac478</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fni.3417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.3417%26sid%3Dliteratum%253Aachs%26aulast%3DVannella%26aufirst%3DK.%2BM.%26aulast%3DRamalingam%26aufirst%3DT.%2BR.%26aulast%3DHart%26aufirst%3DK.%2BM.%26aulast%3Dde%2BQueiroz%2BPrado%26aufirst%3DR.%26aulast%3DSciurba%26aufirst%3DJ.%26aulast%3DBarron%26aufirst%3DL.%26aulast%3DBorthwick%26aufirst%3DL.%2BA.%26aulast%3DSmith%26aufirst%3DA.%2BD.%26aulast%3DMentink-Kane%26aufirst%3DM.%26aulast%3DWhite%26aufirst%3DS.%26aulast%3DThompson%26aufirst%3DR.%2BW.%26aulast%3DCheever%26aufirst%3DA.%2BW.%26aulast%3DBock%26aufirst%3DK.%26aulast%3DMoore%26aufirst%3DI.%26aulast%3DFitz%26aufirst%3DL.%2BJ.%26aulast%3DUrban%26aufirst%3DJ.%2BF.%26aulast%3DWynn%26aufirst%3DT.%2BA.%26atitle%3DAcidic%2520chitinase%2520primes%2520the%2520protective%2520immune%2520response%2520to%2520gastrointestinal%2520nematodes%26jtitle%3DNat.%2520Immunol.%26date%3D2016%26volume%3D17%26spage%3D538%26epage%3D544%26doi%3D10.1038%2Fni.3417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seibold, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodruff, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boot, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burchard, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahy, J. V.</span></span> <span> </span><span class="NLM_article-title">Chitotriosidase is the primary active chitinase in the human lung and is modulated by genotype and smoking habit</span>. <i>J. Allergy Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">944</span>, <span class="refDoi"> DOI: 10.1016/j.jaci.2008.08.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1016%2Fj.jaci.2008.08.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=18845328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlGgsr3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2008&pages=944&author=M.+A.+Seiboldauthor=S.+Donnellyauthor=M.+Solonauthor=A.+Innesauthor=P.+G.+Woodruffauthor=R.+G.+Bootauthor=E.+G.+Burchardauthor=J.+V.+Fahy&title=Chitotriosidase+is+the+primary+active+chitinase+in+the+human+lung+and+is+modulated+by+genotype+and+smoking+habit&doi=10.1016%2Fj.jaci.2008.08.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Chitotriosidase is the primary active chitinase in the human lung and is modulated by genotype and smoking habit</span></div><div class="casAuthors">Seibold, Max A.; Donnelly, Samantha; Solon, Margaret; Innes, Anh; Woodruff, Prescott G.; Boot, Rolf G.; Burchard, Esteban Gonzalez; Fahy, John V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">944-950</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Chitinolytic enzymes play important roles in the pathophysiol. of allergic airway responses in mouse models of asthma.  Acidic mammalian chitinase (AMCase) and chitotriosidase (CHIT1) have chitinolytic activity, but relatively little is known about their expression in human asthma.  We sought to det. the expression and activity of AMCase and CHIT1 in healthy subjects, subjects with asthma, and habitual smokers, taking account of the null 24-bp duplication in the CHIT1 gene.  We measured chitinase activity in bronchoalveolar lavage (BAL) fluid at multiple pHs by using a synthetic chitin substrate.  We also detd. AMCase and CHIT1 gene expression in epithelial brushings and BAL fluid macrophages by means of real time RT-PCR.  Paired DNA samples were genotyped for the CHIT1 duplication.  In all subgroups the pH profile of chitinase activity in BAL fluid matched that of CHIT1, but not AMCase, and chitinase activity was absent in subjects genetically deficient in active CHIT1.  Although AMCase protein was detectable in lavage fluid, AMCase transcripts in macrophages were consistent with an isoform lacking enzymic activity.  Median chitinase activity in BAL fluid tended to be lower than normal in asthmatic subjects but was increased 7-fold in habitual smokers, where CHIT1 gene expression in macrophages was increased.  Chitinase activity in the lung is the result of CHIT1 activity.  Although AMCase protein is detectable in the lung, our data indicate that it is inactive.  Chitinase activity is not increased in subjects with asthma and in fact tends to be decreased.  The high levels of chitinase activity in habitual smokers result from upregulation of CHIT1 gene expression, esp. in macrophages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgOiEW5aOPqLVg90H21EOLACvtfcHk0liHzzSFhFmQ_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlGgsr3O&md5=711bac9ca3fb813b5783a6fa36aa2b8d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2008.08.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2008.08.023%26sid%3Dliteratum%253Aachs%26aulast%3DSeibold%26aufirst%3DM.%2BA.%26aulast%3DDonnelly%26aufirst%3DS.%26aulast%3DSolon%26aufirst%3DM.%26aulast%3DInnes%26aufirst%3DA.%26aulast%3DWoodruff%26aufirst%3DP.%2BG.%26aulast%3DBoot%26aufirst%3DR.%2BG.%26aulast%3DBurchard%26aufirst%3DE.%2BG.%26aulast%3DFahy%26aufirst%3DJ.%2BV.%26atitle%3DChitotriosidase%2520is%2520the%2520primary%2520active%2520chitinase%2520in%2520the%2520human%2520lung%2520and%2520is%2520modulated%2520by%2520genotype%2520and%2520smoking%2520habit%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2008%26volume%3D122%26spage%3D944%26doi%3D10.1016%2Fj.jaci.2008.08.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bargagli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margollicci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikiforakis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luddi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosso, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottoli, P.</span></span> <span> </span><span class="NLM_article-title">Chitotriosidase Activity in the Serum of Patients with Sarcoidosis and Pulmonary Tuberculosis</span>. <i>Respiration</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">548</span>– <span class="NLM_lpage">552</span>, <span class="refDoi"> DOI: 10.1159/000100555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1159%2F000100555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=17347558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosVemurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2007&pages=548-552&author=E.+Bargagliauthor=M.+Margollicciauthor=N.+Nikiforakisauthor=A.+Luddiauthor=A.+Perroneauthor=S.+Grossoauthor=P.+Rottoli&title=Chitotriosidase+Activity+in+the+Serum+of+Patients+with+Sarcoidosis+and+Pulmonary+Tuberculosis&doi=10.1159%2F000100555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Chitotriosidase Activity in the Serum of Patients with Sarcoidosis and Pulmonary Tuberculosis</span></div><div class="casAuthors">Bargagli, Elena; Margollicci, Maria; Nikiforakis, Nikolaos; Luddi, Alice; Perrone, Anna; Grosso, Salvatore; Rottoli, Paola</div><div class="citationInfo"><span class="NLM_cas:title">Respiration</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">548-552</span>CODEN:
                <span class="NLM_cas:coden">RESPBD</span>;
        ISSN:<span class="NLM_cas:issn">0025-7931</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background: Human chitotriosidase is a chitinase selectively expressed by activated macrophages.  An increase in chitotriosidase activity was previously described by us in the serum and bronchoalveolar lavage of sarcoidosis patients.  Objective: The aim of the present study was to analyze serum chitotriosidase activity in a larger no. of sarcoidosis patients to verify the reported increase with respect to controls and to compare serum chitotriosidase levels in patients with sarcoidosis and tuberculosis, two granulomatous disorders of different etiol.  Methods: Chitotriosidase activity was measured in the serum of 96 sarcoidosis patients, 15 pulmonary tuberculosis patients and 30 healthy controls.  Results: We found significantly higher serum chitotriosidase activity in sarcoidosis patients than controls (p < 0.01) and in sarcoidosis patients than tuberculosis patients (p < 0.01), confirming a striking elevation of chitotriosidase activity (>10 times greater than normal) in pulmonary sarcoidosis patients.  This is the first time that chitotriosidase activity has been analyzed in the serum of patients with pulmonary tuberculosis; it was found to be significantly lower than in sarcoidosis patients and not significantly greater than in controls.  Conclusion: Although the mechanisms leading to the increase in chitotriosidase activity in sarcoidosis are still unknown, this enzyme may be specifically involved in the pathogenesis of the disease.  Further studies with a greater no. of patients are needed to confirm these results and to det. whether chitotriosidase could be a marker with diagnostic or prognostic value in sarcoidosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLAFTVqLTfDrVg90H21EOLACvtfcHk0liHzzSFhFmQ_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosVemurk%253D&md5=0d64b3a03003c0ad06d721b1cac57f43</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1159%2F000100555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000100555%26sid%3Dliteratum%253Aachs%26aulast%3DBargagli%26aufirst%3DE.%26aulast%3DMargollicci%26aufirst%3DM.%26aulast%3DNikiforakis%26aufirst%3DN.%26aulast%3DLuddi%26aufirst%3DA.%26aulast%3DPerrone%26aufirst%3DA.%26aulast%3DGrosso%26aufirst%3DS.%26aulast%3DRottoli%26aufirst%3DP.%26atitle%3DChitotriosidase%2520Activity%2520in%2520the%2520Serum%2520of%2520Patients%2520with%2520Sarcoidosis%2520and%2520Pulmonary%2520Tuberculosis%26jtitle%3DRespiration%26date%3D2007%26volume%3D74%26spage%3D548%26epage%3D552%26doi%3D10.1159%2F000100555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cakir, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gumus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ucar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozkoparan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akgul, E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karaman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deniz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurt, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozkan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilgic, H.</span></span> <span> </span><span class="NLM_article-title">Serum chitotriosidase activity in pulmonary tuberculosis: response to treatment and correlations with clinical parameters</span>. <i>Ann. Lab. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.3343/alm.2012.32.3.184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.3343%2Falm.2012.32.3.184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=22563552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFSis7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=184-189&author=G.+Cakirauthor=S.+Gumusauthor=E.+Ucarauthor=H.+Kayaauthor=E.+Tozkoparanauthor=E.+O.+Akgulauthor=B.+Karamanauthor=O.+Denizauthor=I.+Kurtauthor=M.+Ozkanauthor=H.+Bilgic&title=Serum+chitotriosidase+activity+in+pulmonary+tuberculosis%3A+response+to+treatment+and+correlations+with+clinical+parameters&doi=10.3343%2Falm.2012.32.3.184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Serum chitotriosidase activity in pulmonary tuberculosis: response to treatment and correlations with clinical parameters</span></div><div class="casAuthors">Cakir, Gulhan; Gumus, Seyfettin; Ucar, Ergun; Kaya, Hatice; Tozkoparan, Ergun; Akgul, Emin Ozgur; Karaman, Bulent; Deniz, Omer; Kurt, Ismail; Ozkan, Metin; Bilgic, Hayati</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Laboratory Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">184-189</span>CODEN:
                <span class="NLM_cas:coden">ALMNCA</span>;
        ISSN:<span class="NLM_cas:issn">2234-3806</span>.
    
            (<span class="NLM_cas:orgname">Korean Society for Laboratory Medicine</span>)
        </div><div class="casAbstract">Background: Chitotriosidase is an accepted marker of macrophage activation.  In this study, we investigated serum chitotriosidase levels in pulmonary tuberculosis (PTB).  Methods: Forth-two patients with PTB and 30 healthy subjects were enrolled in the study.  The radiol. extent of PTB, radiol. sequela after treatment, and the degree of smear positivity were assessed.  Chitotriosidase levels were measured by a fluorometric method.  Results: The serum chitotriosidase levels of the PTB patients were significantly higher than those of the control subjects (39.73±24.97 vs. 9.63±4.55 nmol/mL/h, P<0.001).  After completion of the std. 6-mo antituberculous treatment, chitotriosidase levels in PTB patients significantly decreased (10.47±4.54 nmol/mL/h, P<0.001).  Chitotriosidase levels correlated significantly with the radiol. extent of PTB, degree of smear positivity, and post-treatment radiol. sequela score (r=0.439, r=0.449, and r=0.337, resp.).  Conclusions: This study demonstrated that serum chitotriosidase levels increase in PTB; therefore, chitotriosidase can be used as a marker of disease activity, severity, and response to treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Sr1bQdd1WbVg90H21EOLACvtfcHk0lirfRXqk4XE1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFSis7nP&md5=e560962ffd260e431c729ec0df2bc70a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.3343%2Falm.2012.32.3.184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3343%252Falm.2012.32.3.184%26sid%3Dliteratum%253Aachs%26aulast%3DCakir%26aufirst%3DG.%26aulast%3DGumus%26aufirst%3DS.%26aulast%3DUcar%26aufirst%3DE.%26aulast%3DKaya%26aufirst%3DH.%26aulast%3DTozkoparan%26aufirst%3DE.%26aulast%3DAkgul%26aufirst%3DE.%2BO.%26aulast%3DKaraman%26aufirst%3DB.%26aulast%3DDeniz%26aufirst%3DO.%26aulast%3DKurt%26aufirst%3DI.%26aulast%3DOzkan%26aufirst%3DM.%26aulast%3DBilgic%26aufirst%3DH.%26atitle%3DSerum%2520chitotriosidase%2520activity%2520in%2520pulmonary%2520tuberculosis%253A%2520response%2520to%2520treatment%2520and%2520correlations%2520with%2520clinical%2520parameters%26jtitle%3DAnn.%2520Lab.%2520Med.%26date%3D2012%26volume%3D32%26spage%3D184%26epage%3D189%26doi%3D10.3343%2Falm.2012.32.3.184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cole, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olland, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursavich, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czerwinski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeClercq, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph-McCarthy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellingboe, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Presman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strand, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, C. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsao, D. H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitz, L. J.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of acidic mammalian chitinase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6122</span>– <span class="NLM_lpage">6128</span>, <span class="refDoi"> DOI: 10.1021/jm100533p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100533p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVChtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6122-6128&author=D.+C.+Coleauthor=A.+M.+Ollandauthor=J.+Jacobauthor=J.+Brooksauthor=M.+G.+Bursavichauthor=R.+Czerwinskiauthor=C.+DeClercqauthor=M.+Johnsonauthor=D.+Joseph-McCarthyauthor=J.+W.+Ellingboeauthor=L.+Linauthor=P.+Nowakauthor=E.+Presmanauthor=J.+Strandauthor=A.+Tamauthor=C.+M.+M.+Williamsauthor=S.+Yaoauthor=D.+H.+H.+Tsaoauthor=L.+J.+Fitz&title=Identification+and+characterization+of+acidic+mammalian+chitinase+inhibitors&doi=10.1021%2Fjm100533p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Characterization of Acidic Mammalian Chitinase Inhibitors</span></div><div class="casAuthors">Cole, Derek C.; Olland, Andrea M.; Jacob, Jaison; Brooks, Jon; Bursavich, Matthew G.; Czerwinski, Robert; De Clercq, Charlene; Johnson, Mark; Joseph-McCarthy, Diane; Ellingboe, John W.; Lin, Laura; Nowak, Pawel; Presman, Ella; Strand, James; Tam, Amy; Williams, Cara M. M.; Yao, Shihua; Tsao, Desiree H. H.; Fitz, Lori J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6122-6128</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acidic mammalian chitinase (AMCase) is a member of the glycosyl hydrolase 18 family (EC 3.2.1.14) that has been implicated in the pathophysiol. of allergic airway disease such as asthma.  Small mol. inhibitors of AMCase were identified using a combination of high-throughput screening, fragment screening, and virtual screening techniques and characterized by enzyme inhibition and NMR and Biacore binding expts.  X-ray structures of the inhibitors in complex with AMCase revealed that the larger more potent HTS hits, e.g. 5-(4-(2-(4-bromophenoxy)ethyl)piperazine-1-yl)-1H-1,2,4-triazol-3-amine 1, spanned from the active site pocket to a hydrophobic pocket.  Smaller fragments identified by FBS occupy both these pockets independently and suggest potential strategies for linking fragments.  Compd. 1 is a 200 nM AMCase inhibitor which reduced AMCase enzymic activity in the bronchoalveolar lavage fluid in allergen-challenged mice after oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq3-AOdwYs2LVg90H21EOLACvtfcHk0lirfRXqk4XE1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVChtL8%253D&md5=47d5010b73151d1ad4f641c47c3fb100</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm100533p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100533p%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DOlland%26aufirst%3DA.%2BM.%26aulast%3DJacob%26aufirst%3DJ.%26aulast%3DBrooks%26aufirst%3DJ.%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DCzerwinski%26aufirst%3DR.%26aulast%3DDeClercq%26aufirst%3DC.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DJoseph-McCarthy%26aufirst%3DD.%26aulast%3DEllingboe%26aufirst%3DJ.%2BW.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DPresman%26aufirst%3DE.%26aulast%3DStrand%26aufirst%3DJ.%26aulast%3DTam%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DC.%2BM.%2BM.%26aulast%3DYao%26aufirst%3DS.%26aulast%3DTsao%26aufirst%3DD.%2BH.%2BH.%26aulast%3DFitz%26aufirst%3DL.%2BJ.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520acidic%2520mammalian%2520chitinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6122%26epage%3D6128%26doi%3D10.1021%2Fjm100533p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggleston, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maizels, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Aalten, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. E.</span></span> <span> </span><span class="NLM_article-title">Analyzing Airway Inflammation with Chemical Biology: Dissection of Acidic Mammalian Chitinase Function with a Selective Drug-like Inhibitor</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">569</span>– <span class="NLM_lpage">579</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2011.02.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1016%2Fj.chembiol.2011.02.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=21609838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmslOksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=569-579&author=T.+E.+Sutherlandauthor=O.+A.+Andersenauthor=M.+Betouauthor=I.+M.+Egglestonauthor=R.+M.+Maizelsauthor=D.+van+Aaltenauthor=J.+E.+Allen&title=Analyzing+Airway+Inflammation+with+Chemical+Biology%3A+Dissection+of+Acidic+Mammalian+Chitinase+Function+with+a+Selective+Drug-like+Inhibitor&doi=10.1016%2Fj.chembiol.2011.02.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Analyzing Airway Inflammation with Chemical Biology: Dissection of Acidic Mammalian Chitinase Function with a Selective Drug-like Inhibitor</span></div><div class="casAuthors">Sutherland, Tara E.; Andersen, Ole A.; Betou, Marie; Eggleston, Ian M.; Maizels, Rick M.; van Aalten, Daan; Allen, Judith E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">569-579</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Acidic mammalian chitinase (AMCase) is produced in the lung during allergic inflammation and asthma, and inhibition of enzymic activity has been considered as a therapeutic strategy.  However, most chitinase inhibitors are nonselective, addnl. inhibiting chitotriosidase activity.  Here, we describe bisdionin F, a competitive AMCase inhibitor with 20-fold selectivity for AMCase over chitotriosidase, designed by utilizing the AMCase crystal structure and dicaffeine scaffold.  In a murine model of allergic inflammation, bisdionin F-treatment attenuated chitinase activity and alleviated the primary features of allergic inflammation including eosinophilia.  However, selective AMCase inhibition by bisdionin F also caused dramatic and unexpected neutrophilia in the lungs.  This class of inhibitor will be a powerful tool to dissect the functions of mammalian chitinases in disease and represents a synthetically accessible scaffold to optimize inhibitory properties in terms of airway inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlYJOOAc9ksbVg90H21EOLACvtfcHk0lirfRXqk4XE1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmslOksL4%253D&md5=3b082d80515694618da2dd966c25a6f9</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.02.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.02.017%26sid%3Dliteratum%253Aachs%26aulast%3DSutherland%26aufirst%3DT.%2BE.%26aulast%3DAndersen%26aufirst%3DO.%2BA.%26aulast%3DBetou%26aufirst%3DM.%26aulast%3DEggleston%26aufirst%3DI.%2BM.%26aulast%3DMaizels%26aufirst%3DR.%2BM.%26aulast%3Dvan%2BAalten%26aufirst%3DD.%26aulast%3DAllen%26aufirst%3DJ.%2BE.%26atitle%3DAnalyzing%2520Airway%2520Inflammation%2520with%2520Chemical%2520Biology%253A%2520Dissection%2520of%2520Acidic%2520Mammalian%2520Chitinase%2520Function%2520with%2520a%2520Selective%2520Drug-like%2520Inhibitor%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D569%26epage%3D579%26doi%3D10.1016%2Fj.chembiol.2011.02.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="note"><p class="first last">See “hAMCase_+_compound_2.pdb” file in <a href="/doi/suppl/10.1021/acs.jmedchem.9b00681/suppl_file/jm9b00681_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jamieson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moir, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rankovic, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wishart, G.</span></span> <span> </span><span class="NLM_article-title">Medicinal Chemistry of hERG Optimizations: Highlights and Hang-Ups</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">5029</span>– <span class="NLM_lpage">5046</span>, <span class="refDoi"> DOI: 10.1021/jm060379l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060379l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5029-5046&author=C.+Jamiesonauthor=E.+M.+Moirauthor=Z.+Rankovicauthor=G.+Wishart&title=Medicinal+Chemistry+of+hERG+Optimizations%3A+Highlights+and+Hang-Ups&doi=10.1021%2Fjm060379l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30aR"><div class="casContent"><span class="casTitleNuber">30a</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of hERG optimizations: Highlights and hang-ups</span></div><div class="casAuthors">Jamieson, Craig; Moir, Elizabeth M.; Rankovic, Zoran; Wishart, Grant</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5029-5046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  A brief summary of the in silico, in vitro, and in vivo approaches employed to measure blockade of hERG and QT prolongation is detailed.  The discussion aims to summarize the approaches engaged to circumvent activity at hERG, identified through an extensive literature survey.  The optimizations are recorded as pairs of compds., which have been categorized in terms of the tactics employed to diminish hERG activity. Examn. of the properties of the compds. within each category has enabled formulation os some empirical guidelines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv6eM5w53KebVg90H21EOLACvtfcHk0lirfRXqk4XE1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D&md5=117c84a010f877c835b7dbc945996b92</span></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.1021%2Fjm060379l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060379l%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMoir%26aufirst%3DE.%2BM.%26aulast%3DRankovic%26aufirst%3DZ.%26aulast%3DWishart%26aufirst%3DG.%26atitle%3DMedicinal%2520Chemistry%2520of%2520hERG%2520Optimizations%253A%2520Highlights%2520and%2520Hang-Ups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5029%26epage%3D5046%26doi%3D10.1021%2Fjm060379l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit30b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, M.</span></span> <span> </span><span class="NLM_article-title">A Risk Assessment of Human Ether-a-Go-Go-Related Gene Potassium Channel Inhibition by Using Lipophilicity and Basicity for Drug Discovery</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1110</span>– <span class="NLM_lpage">1116</span>, <span class="refDoi"> DOI: 10.1248/cpb.59.1110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1248%2Fcpb.59.1110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=21881254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlCgtbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2011&pages=1110-1116&author=Y.+Kawaiauthor=S.+Tsukamotoauthor=J.+Itoauthor=K.+Akimotoauthor=M.+Takahashi&title=A+Risk+Assessment+of+Human+Ether-a-Go-Go-Related+Gene+Potassium+Channel+Inhibition+by+Using+Lipophilicity+and+Basicity+for+Drug+Discovery&doi=10.1248%2Fcpb.59.1110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30bR"><div class="casContent"><span class="casTitleNuber">30b</span><div class="casTitle"><span class="NLM_cas:atitle">A risk assessment of human ether-a-go-go-related gene potassium channel inhibition by using lipophilicity and basicity for drug discovery</span></div><div class="casAuthors">Kawai, Yukinori; Tsukamoto, Shinsaku; Ito, Junko; Akimoto, Katsuya; Takahashi, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1110-1116</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">The blockade of human ether-a-go-go-related gene (hERG) potassium channels is widely regarded as the predominant cause of drug-induced QT prolongation.  The correlation anal. between the inhibition of the hERG channel (hERG inhibition) and physicochem. properties was investigated by use of inhouse quinolone antibiotics as model compds.  In order to establish a simple prediction model of hERG inhibition, we focused on the comprehensible physicochem. parameters such as lipophilicity (log P) and basicity (pKa).  At first, the risk assocd. with increasing log P and pKa was examd. by statistical anal.  It was demonstrated that the risk assocd. with increasing log P and pKa by one unit, resp., almost identically increased.  Consequently, equal attention should be paid to both parameters on hERG inhibition.  Next, a prediction model of hERG inhibition which was represented by log P and pKa was investigated.  As a result, we built the stepwise discriminant prediction model which took advantage of the risk judgment by zone classification.  In conclusion, the impact of log P and pKa on hERG inhibition was clarified relatively and quant.  The quant. risk assessment established based on both parameters, was considered to be a practical and useful tool in avoiding hERG inhibition and in the rational drug design for drug discovery, esp. in lead optimization.  Moreover, we also carried out a trend anal. using a different deriv. and demonstrated that both parameters were equally significant for hERG inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEKu_OZWyq1LVg90H21EOLACvtfcHk0lilNYrv3Myizg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlCgtbrP&md5=d86268b2844bfcd471fc12a81b32e413</span></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.1248%2Fcpb.59.1110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.59.1110%26sid%3Dliteratum%253Aachs%26aulast%3DKawai%26aufirst%3DY.%26aulast%3DTsukamoto%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DJ.%26aulast%3DAkimoto%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DM.%26atitle%3DA%2520Risk%2520Assessment%2520of%2520Human%2520Ether-a-Go-Go-Related%2520Gene%2520Potassium%2520Channel%2520Inhibition%2520by%2520Using%2520Lipophilicity%2520and%2520Basicity%2520for%2520Drug%2520Discovery%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2011%26volume%3D59%26spage%3D1110%26epage%3D1116%26doi%3D10.1248%2Fcpb.59.1110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piper, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duff, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliason, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frazee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuerstenau-Sharp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jachec, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollok, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shekhani, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, S. D.</span></span> <span> </span><span class="NLM_article-title">Development of the predictor HERG fluorescence polarization assay using a membrane protein enrichment approach</span>. <i>Assay Drug Dev. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">223</span>, <span class="refDoi"> DOI: 10.1089/adt.2008.137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1089%2Fadt.2008.137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=18471075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BD1cXls1Kqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=213-223&author=D.+R.+Piperauthor=S.+R.+Duffauthor=H.+C.+Eliasonauthor=W.+J.+Frazeeauthor=E.+A.+Freyauthor=M.+Fuerstenau-Sharpauthor=C.+Jachecauthor=B.+D.+Marksauthor=B.+A.+Pollokauthor=M.+S.+Shekhaniauthor=D.+V.+Thompsonauthor=P.+Whitneyauthor=K.+W.+Vogelauthor=S.+D.+Hess&title=Development+of+the+predictor+HERG+fluorescence+polarization+assay+using+a+membrane+protein+enrichment+approach&doi=10.1089%2Fadt.2008.137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Development of the predictor hERG fluorescence polarization assay using a membrane protein enrichment approach</span></div><div class="casAuthors">Piper, David R.; Duff, Steve R.; Eliason, Hildegard C.; Frazee, W. Jack; Frey, Elizabeth A.; Fuerstenau-Sharp, Maya; Jachec, Christine; Marks, Bryan D.; Pollok, Brian A.; Shekhani, Mohammed Saleh; Thompson, David V.; Whitney, Pam; Vogel, Kurt W.; Hess, Stephen D.</div><div class="citationInfo"><span class="NLM_cas:title">Assay and Drug Development Technologies</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-223</span>CODEN:
                <span class="NLM_cas:coden">ADDTAR</span>;
        ISSN:<span class="NLM_cas:issn">1540-658X</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">The life-threatening consequences of acquired, or drug-induced, long QT syndrome due to block of the human ether-a-go-go-related gene (hERG) channel are well appreciated and have been the cause of several drugs being removed from the market in recent years because of patient death.  In the last decade, the propensity for block of the hERG channel by a diverse and expanding set of compds. has led to the requirement that all new drugs be tested for hERG channel block in a functional patch-clamp assay.  Because of the need to identify potential hERG blockers early in the discovery process, radiometric hERG binding assays are preferred over patch-clamp assays for compd. triage, because of relative advantages in speed and cost.  Even so, these radiometric binding assays are laborious and require dedicated instrumentation and infrastructure to cope with the regulatory and safety issues assocd. with the use of radiation.  To overcome these limitations, we developed a homogeneous, fluorescence polarization-based assay to identify and characterize the affinity of small mols. for the hERG channel and have demonstrated tight correlation with data obtained from either radioligand binding or patch-clamp assays.  Key to the development of this assay was a cell line that expressed highly elevated levels of hERG protein, which was generated by coupling expression of the hERG channel to that of a selectable cell surface marker.  A high-expressing clone was isolated by flow cytometry and used to generate membrane prepns. that contained >50-fold the typical d. of hERG channels measured by [3H]astemizole binding.  This strategy enabled the Predictor (Invitrogen, Carlsbad, CA) hERG fluorescence polarization assay and should be useful in the development of other fluorescence polarization-based assays that use membrane proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZM6EWKp8Hv7Vg90H21EOLACvtfcHk0lilNYrv3Myizg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXls1Kqurk%253D&md5=e7d8aad7c76722779653b38ca60ee242</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1089%2Fadt.2008.137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fadt.2008.137%26sid%3Dliteratum%253Aachs%26aulast%3DPiper%26aufirst%3DD.%2BR.%26aulast%3DDuff%26aufirst%3DS.%2BR.%26aulast%3DEliason%26aufirst%3DH.%2BC.%26aulast%3DFrazee%26aufirst%3DW.%2BJ.%26aulast%3DFrey%26aufirst%3DE.%2BA.%26aulast%3DFuerstenau-Sharp%26aufirst%3DM.%26aulast%3DJachec%26aufirst%3DC.%26aulast%3DMarks%26aufirst%3DB.%2BD.%26aulast%3DPollok%26aufirst%3DB.%2BA.%26aulast%3DShekhani%26aufirst%3DM.%2BS.%26aulast%3DThompson%26aufirst%3DD.%2BV.%26aulast%3DWhitney%26aufirst%3DP.%26aulast%3DVogel%26aufirst%3DK.%2BW.%26aulast%3DHess%26aufirst%3DS.%2BD.%26atitle%3DDevelopment%2520of%2520the%2520predictor%2520HERG%2520fluorescence%2520polarization%2520assay%2520using%2520a%2520membrane%2520protein%2520enrichment%2520approach%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2008%26volume%3D6%26spage%3D213%26epage%3D223%26doi%3D10.1089%2Fadt.2008.137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pristupa, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kish, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niznik, H. B.</span></span> <span> </span><span class="NLM_article-title">Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">135</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=8302271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADyaK2cXhsFemu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1994&pages=125-135&author=Z.+B.+Pristupaauthor=J.+M.+Wilsonauthor=B.+J.+Hoffmanauthor=S.+J.+Kishauthor=H.+B.+Niznik&title=Pharmacological+heterogeneity+of+the+cloned+and+native+human+dopamine+transporter%3A+disassociation+of+%5B3H%5DWIN+35%2C428+and+%5B3H%5DGBR+12%2C935+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding</span></div><div class="casAuthors">Pristupa, Zdenek B.; Wilson, Julie M.; Hoffman, Beth J.; Kish, Stephen J.; Niznik, Hyman B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-35</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">Controversy exists as to whether the functional state of the dopamine (DA) transporter is identical to sites mediating the specific binding of selective DA transporter radioligands.  Therefore, the authors compared the pharmacol. profile of numerous dopamine transport substrates and inhibitors on [3H]DA uptake with the binding of [3H]WIN 35,428 and [3H]GBR 12,935 to COS-7 cells transiently expressing the cloned human DA transporter.  [3H]DA uptake and [3H]WIN 35,428 binding was specific, saturable, and to a single class of binding sites with an estd. Km/Vmax of ∼2 μM and 6 pmol/min/105 cells for DA uptake and Kd/Bmax values of ∼10 nM and 113 fmol/105 cells for [3H]WIN 35,428.  [3H]DA uptake was inhibited in a concn.-dependent and uniphasic manner by dopaminergic agents with an appropriate rank order of potency for the DA transporter.  Although most uptake blockers inhibited [3H]WIN 35,428 binding in a uniphasic manner, WIN 35,428, Lu 19,005, D-amphetamine, and DA clearly displayed the presence of both high and low affinity components.  Comparison of the Ki values for the inhibition of [3H]DA uptake with [3H]WIN 35,428 binding reveals that, for uptake blockers and D-amphetamine, it is the high affinity component that shares pharmacol. identity with effects on DA uptake (r = 0.9985), whereas for DA it is the low affinity site.  In striking contrast, however, [3H]GBR 12,935 binding to COS-7 cells could not be made to exhibit a pharmacol. profile indicative of the DA transporter and suggests that the site regulating functional [3H]DA uptake may not be identical with sites labeled by [3H]GBR 12,935 in these cells.  Moreover, these sites appear unrelated to those previously described in native membranes as "piperazine acceptor" or P 450 proteins.  Comparison of Ki values and rank order of potency for the inhibition of [3H]WIN 35,428 or [3H]GBR 12,935 binding to human caudate membranes reveals pharmacol. homol., but not identity, with that of the cloned DA uptake process.  Taken together, these data suggest that 1) [3H]WIN 35,428 recognizes two sites of the DA transporter, of which only one appears to represent the functional state of the protein, and 2) [3H]WIN 35,428 and [3H]GBR 12,935 do not appear to bind the same functional form/state of the DA transporter.  Whether the nonidentity of binding sites is a manifestation of some post-translational regulatory event (e.g., phosphorylation/accessory binding protein) or caused by the existence of multiple mol. forms of the DA transporter is currently unknown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU2Vc8HuOAsLVg90H21EOLACvtfcHk0lhF6b6lpFXfqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhsFemu7c%253D&md5=a6ce271aad17d6f7f282bd716bbd1ddf</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPristupa%26aufirst%3DZ.%2BB.%26aulast%3DWilson%26aufirst%3DJ.%2BM.%26aulast%3DHoffman%26aufirst%3DB.%2BJ.%26aulast%3DKish%26aufirst%3DS.%2BJ.%26aulast%3DNiznik%26aufirst%3DH.%2BB.%26atitle%3DPharmacological%2520heterogeneity%2520of%2520the%2520cloned%2520and%2520native%2520human%2520dopamine%2520transporter%253A%2520disassociation%2520of%2520%255B3H%255DWIN%252035%252C428%2520and%2520%255B3H%255DGBR%252012%252C935%2520binding%26jtitle%3DMol.%2520Pharmacol.%26date%3D1994%26volume%3D45%26spage%3D125%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maron, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ames, B. N.</span></span> <span> </span><span class="NLM_article-title">Revised methods for the Salmonella mutagenicity test</span>. <i>Mutat. Res.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">173</span>– <span class="NLM_lpage">215</span>, <span class="refDoi"> DOI: 10.1016/0165-1161(83)90010-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1016%2F0165-1161%2883%2990010-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=6341825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADyaL3sXhvFarsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1983&pages=173-215&author=D.+M.+Maronauthor=B.+N.+Ames&title=Revised+methods+for+the+Salmonella+mutagenicity+test&doi=10.1016%2F0165-1161%2883%2990010-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Revised methods for the Salmonella mutagenicity test</span></div><div class="casAuthors">Maron, Dorothy M.; Ames, Bruce N.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Environmental Mutagenesis and Related Subjects </span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">173-215</span>CODEN:
                <span class="NLM_cas:coden">MEMSE8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A revision of methods for detecting carcinogens and mutagens with the Salmonella mutagenicity test (A. et al., 1975b) is described.  Two new tester strains, a frameshift strain (TA 97) and a strain carrying an ochre mutation on a multicopy plasmid (TA 102), are added to the std. tester set.  TA 97 replaces TA 1537.  TA 1535 and 1538 are removed from the recommended set, but can be retained at the option of the investigator.  TA 98 and 100 are retained.  Other special purpose strains are discussed and minor changes in procedure, (principally in the growth, storage, and preservation of the tester strains) are presented.  Two substitutions are made in diagnostic mutagens to eliminate MNNG and 9-aminoacridine.  Some test modifications are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzIjKbxaVZYrVg90H21EOLACvtfcHk0lhF6b6lpFXfqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXhvFarsb4%253D&md5=415285947b98c9ddbbd79bbe000c9dca</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2F0165-1161%2883%2990010-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1161%252883%252990010-9%26sid%3Dliteratum%253Aachs%26aulast%3DMaron%26aufirst%3DD.%2BM.%26aulast%3DAmes%26aufirst%3DB.%2BN.%26atitle%3DRevised%2520methods%2520for%2520the%2520Salmonella%2520mutagenicity%2520test%26jtitle%3DMutat.%2520Res.%26date%3D1983%26volume%3D113%26spage%3D173%26epage%3D215%26doi%3D10.1016%2F0165-1161%2883%2990010-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span> </span><span class="NLM_article-title">Panel composed of 96 binding and enzyme
assays</span>. <a href="https://www.eurofinsdiscoveryservices.com/catalogmanagement/viewitem/Diversity-Panel/P9#testingInfo" class="extLink">https://www.eurofinsdiscoveryservices.com/catalogmanagement/viewitem/Diversity-Panel/P9#testingInfo</a> (accessed March 19, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Panel+composed+of+96+binding+and+enzyme%0Aassays.+https%3A%2F%2Fwww.eurofinsdiscoveryservices.com%2Fcatalogmanagement%2Fviewitem%2FDiversity-Panel%2FP9%23testingInfo+%28accessed+March+19%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DPanel%2520composed%2520of%252096%2520binding%2520and%2520enzyme%250Aassays%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span> </span><span class="NLM_article-title">Commercially available assay</span>. <a href="https://www.eurofinsdiscoveryservices.com/catalogmanagement/viewitem/hERG-Human-Potassium-Ion-Channel-Cell-Based-Automated-Patch-Clamp-CiPA-Assay-5-Conc/CYL8038QP2DR" class="extLink">https://www.eurofinsdiscoveryservices.com/catalogmanagement/viewitem/hERG-Human-Potassium-Ion-Channel-Cell-Based-Automated-Patch-Clamp-CiPA-Assay-5-Conc/CYL8038QP2DR</a> (accessed March 19, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Commercially+available+assay.+https%3A%2F%2Fwww.eurofinsdiscoveryservices.com%2Fcatalogmanagement%2Fviewitem%2FhERG-Human-Potassium-Ion-Channel-Cell-Based-Automated-Patch-Clamp-CiPA-Assay-5-Conc%2FCYL8038QP2DR+%28accessed+March+19%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DCommercially%2520available%2520assay%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span> </span><span class="NLM_article-title">Commercially available assay</span>. <a href="https://www.eurofinsdiscoveryservices.com/catalogmanagement/viewitem/DAT-Rat-Dopamine-Transporter-Functional-Antagonist-Uptake-Assay-Cerep/394" class="extLink">https://www.eurofinsdiscoveryservices.com/catalogmanagement/viewitem/DAT-Rat-Dopamine-Transporter-Functional-Antagonist-Uptake-Assay-Cerep/394</a> (accessed March 19, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Commercially+available+assay.+https%3A%2F%2Fwww.eurofinsdiscoveryservices.com%2Fcatalogmanagement%2Fviewitem%2FDAT-Rat-Dopamine-Transporter-Functional-Antagonist-Uptake-Assay-Cerep%2F394+%28accessed+March+19%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DCommercially%2520available%2520assay%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Boyle, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banck, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandermeersch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchison, G. R.</span></span> <span> </span><span class="NLM_article-title">Open Babel: An open chemical toolbox</span>. <i>J. Cheminf.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">33</span>, <span class="refDoi"> DOI: 10.1186/1758-2946-3-33</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1186%2F1758-2946-3-33" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=21982300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVWjurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=33&author=N.+M.+O%E2%80%99Boyleauthor=M.+Banckauthor=C.+A.+Jamesauthor=C.+Morleyauthor=T.+Vandermeerschauthor=G.+R.+Hutchison&title=Open+Babel%3A+An+open+chemical+toolbox&doi=10.1186%2F1758-2946-3-33"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Open Babel: an open chemical toolbox</span></div><div class="casAuthors">O'Boyle, Noel M.; Banck, Michael; James, Craig A.; Morley, Chris; Vandermeersch, Tim; Hutchison, Geoffrey R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cheminformatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">33</span>CODEN:
                <span class="NLM_cas:coden">JCOHB3</span>;
        ISSN:<span class="NLM_cas:issn">1758-2946</span>.
    
            (<span class="NLM_cas:orgname">Chemistry Central Ltd.</span>)
        </div><div class="casAbstract">Background: A frequent problem in computational modeling is the interconversion of chem. structures between different formats.  While std. interchange formats exist (for example, Chem. Markup Language) and de facto stds. have arisen (for example, SMILES format), the need to interconvert formats is a continuing problem due to the multitude of different application areas for chem. data, differences in the data stored by different formats (0D vs. 3D, for example), and competition between software along with a lack of vendor-neutral formats.  Results: We discuss, for the first time, Open Babel, an open-source chem. toolbox that speaks the many languages of chem. data.  Open Babel version 2.3 interconverts over 110 formats.  The need to represent such a wide variety of chem. and mol. data requires a library that implements a wide range of cheminformatics algorithms, from partial charge assignment and aromaticity detection, to bond order perception and canonicalization.  We detail the implementation of Open Babel, describe key advances in the 2.3 release, and outline a variety of uses both in terms of software products and scientific research, including applications far beyond simple format interconversion.  Conclusions: Open Babel presents a soln. to the proliferation of multiple chem. file formats.  In addn., it provides a variety of useful utilities from conformer searching and 2D depiction, to filtering, batch conversion, and substructure and similarity searching.  For developers, it can be used as a programming library to handle chem. data in areas such as org. chem., drug design, materials science, and computational chem.  It is freely available under an open-source license.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfQ1lvaS5767Vg90H21EOLACvtfcHk0lhF6b6lpFXfqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVWjurbF&md5=74e4f19b7f87417f916d57f7abcfb761</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1186%2F1758-2946-3-33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1758-2946-3-33%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DN.%2BM.%26aulast%3DBanck%26aufirst%3DM.%26aulast%3DJames%26aufirst%3DC.%2BA.%26aulast%3DMorley%26aufirst%3DC.%26aulast%3DVandermeersch%26aufirst%3DT.%26aulast%3DHutchison%26aufirst%3DG.%2BR.%26atitle%3DOpen%2520Babel%253A%2520An%2520open%2520chemical%2520toolbox%26jtitle%3DJ.%2520Cheminf.%26date%3D2011%26volume%3D3%26spage%3D33%26doi%3D10.1186%2F1758-2946-3-33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, J. J. P.</span></span> <span> </span><span class="NLM_article-title">MOPAC: A semiempirical molecular orbital program</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1007/BF00128336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1007%2FBF00128336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=2197373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADyaK3cXksFyjurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1990&pages=1-103&author=J.+J.+P.+Stewart&title=MOPAC%3A+A+semiempirical+molecular+orbital+program&doi=10.1007%2FBF00128336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">MOPAC:  a semiempirical molecular orbital program</span></div><div class="casAuthors">Stewart, James J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-105</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    </div><div class="casAbstract">An overview is presented of MOPAC, a semiempirical MO program for the study of chem. reactions involving mols., ions, and linear polymers.  The program implements the semiempirical Hamiltonians MNDO, AM1, MINDO/3, and MNDO-PM3 and combines the calcns. of vibrational spectra, thermodn. quantities, isotopic substitution effects, and force consts. in a fully integrated program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr44czad1cLAbVg90H21EOLACvtfcHk0lhF6b6lpFXfqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXksFyjurc%253D&md5=983366b4ba2797f0fd8a91aec6d366ed</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2FBF00128336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00128336%26sid%3Dliteratum%253Aachs%26aulast%3DStewart%26aufirst%3DJ.%2BJ.%2BP.%26atitle%3DMOPAC%253A%2520A%2520semiempirical%2520molecular%2520orbital%2520program%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D1990%26volume%3D4%26spage%3D1%26epage%3D103%26doi%3D10.1007%2FBF00128336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Carmona, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Garcia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foloppe, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garmendia-Doval, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juhos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidtke, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morley, S. D.</span></span> <span> </span><span class="NLM_article-title">rDock: A Fast, Versatile and Open Source Program for Docking Ligands to Proteins and Nucleic Acids</span>. <i>PLoS Comput. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e1003571</span>, <span class="refDoi"> DOI: 10.1371/journal.pcbi.1003571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=10.1371%2Fjournal.pcbi.1003571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=24722481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGlsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=e1003571&author=S.+Ruiz-Carmonaauthor=D.+Alvarez-Garciaauthor=N.+Foloppeauthor=A.+B.+Garmendia-Dovalauthor=S.+Juhosauthor=P.+Schmidtkeauthor=X.+Barrilauthor=R.+E.+Hubbardauthor=S.+D.+Morley&title=rDock%3A+A+Fast%2C+Versatile+and+Open+Source+Program+for+Docking+Ligands+to+Proteins+and+Nucleic+Acids&doi=10.1371%2Fjournal.pcbi.1003571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">rDock: a fast, versatile and open source program for docking ligands to proteins and nucleic acids</span></div><div class="casAuthors">Ruiz-Carmona, Sergio; Alvarez-Garcia, Daniel; Foloppe, Nicolas; Garmendia-Doval, A. Beatriz; Juhos, Szilveszter; Schmidtke, Peter; Barril, Xavier; Hubbard, Roderick E.; Morley, S. David</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Computational Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e1003571/1-e1003571/7, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">PCBLBG</span>;
        ISSN:<span class="NLM_cas:issn">1553-7358</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Identification of chem. compds. with specific biol. activities is an important step in both chem. biol. and drug discovery.  When the structure of the intended target is available, one approach is to use mol. docking programs to assess the chem. complementarity of small mols. with the target; such calcns. provide a qual. measure of affinity that can be used in virtual screening (VS) to rank order a list of compds. according to their potential to be active. rDock is a mol. docking program developed at Vernalis for high-throughput VS (HTVS) applications.  Evolved from RiboDock, the program can be used against proteins and nucleic acids, is designed to be computationally very efficient and allows the user to incorporate addnl. constraints and information as a bias to guide docking.  This article provides an overview of the program structure and features and compares rDock to two ref. programs, AutoDock Vina (open source) and Schrodinger's Glide (com.).  In terms of computational speed for VS, rDock is faster than Vina and comparable to Glide.  For binding mode prediction, rDock and Vina are superior to Glide.  The VS performance of rDock is significantly better than Vina, but inferior to Glide for most systems unless pharmacophore constraints are used; in that case rDock and Glide are of equal performance.  The program is released under the Lesser General Public License and is freely available for download, together with the manuals, example files and the complete test sets, at online.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL0qXwzBNIxLVg90H21EOLACvtfcHk0liXfKv9G9vd9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGlsL%252FO&md5=e4cb786d6567fdc7f2a46f64955a9992</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pcbi.1003571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pcbi.1003571%26sid%3Dliteratum%253Aachs%26aulast%3DRuiz-Carmona%26aufirst%3DS.%26aulast%3DAlvarez-Garcia%26aufirst%3DD.%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DGarmendia-Doval%26aufirst%3DA.%2BB.%26aulast%3DJuhos%26aufirst%3DS.%26aulast%3DSchmidtke%26aufirst%3DP.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DMorley%26aufirst%3DS.%2BD.%26atitle%3DrDock%253A%2520A%2520Fast%252C%2520Versatile%2520and%2520Open%2520Source%2520Program%2520for%2520Docking%2520Ligands%2520to%2520Proteins%2520and%2520Nucleic%2520Acids%26jtitle%3DPLoS%2520Comput.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3De1003571%26doi%3D10.1371%2Fjournal.pcbi.1003571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RM4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RM4','PDB','3RM4'); return false;">PDB: 3RM4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NRA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NRA','PDB','5NRA'); return false;">PDB: 5NRA</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RM9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RM9','PDB','3RM9'); return false;">PDB: 3RM9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RM8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RM8','PDB','3RM8'); return false;">PDB: 3RM8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NR8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NR8','PDB','5NR8'); return false;">PDB: 5NR8</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i107"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00681">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_30524"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00681">10.1021/acs.jmedchem.9b00681</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H NMR spectra and HPLC profiles for compounds <b>4–30</b>, chiral HPLC profiles for compounds <b>30</b> and <b><i>rac-</i>30</b>, crystallographic information for compound <b>50</b>, analysis of Trp99 side-chain orientation in published AMCase crystallographic structures, comparison of human and murine AMCase sequences and their binding sites (experimentally solved and homology model, respectively), and comparison of human and murine CHIT1 sequences and their binding sites (experimentally solved and homology model, respectively) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00681/suppl_file/jm9b00681_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings, IC<sub>50</sub> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00681/suppl_file/jm9b00681_si_002.csv">CSV</a>)</p></li><li><p class="inline">Computational model of hAMCase with compound <b>2</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00681/suppl_file/jm9b00681_si_003.pdb">PDB</a>)</p></li><li><p class="inline">Computational model of hAMCase with compound <b>30</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00681/suppl_file/jm9b00681_si_004.pdb">PDB</a>)</p></li><li><p class="inline">Computational model of hCHIT1 with compound <b>30</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00681/suppl_file/jm9b00681_si_005.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00681/suppl_file/jm9b00681_si_001.pdf">jm9b00681_si_001.pdf (5.27 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00681/suppl_file/jm9b00681_si_002.csv">jm9b00681_si_002.csv (3.28 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00681/suppl_file/jm9b00681_si_003.pdb">jm9b00681_si_003.pdb (470.3 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00681/suppl_file/jm9b00681_si_004.pdb">jm9b00681_si_004.pdb (470.61 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00681/suppl_file/jm9b00681_si_005.pdb">jm9b00681_si_005.pdb (499.96 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates have been deposited in the CCDC with accession code for compound <b>50</b>: CCDC 1901012. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via <a href="http://www.ccdc.cam.ac.uk/structures" class="extLink">www.ccdc.cam.ac.uk/structures</a>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00681&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00681%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-15%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00681" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67992ae5f970d203","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
